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ABSTRACT OF DISSERTATION

THE WILLINGNESS TO PAY FOR
THE DETECTION AND TREATMENT OF
VULNERABLE PLAQUE RELATED TO HEART ATTACKS

Recent medical studies have led cardiologists to revise theories regarding the
cause of heart attacks. Rather than a gradual clogging of the arteries, eruption of a
“vulnerable plaque” is thought to be the cause of approximately 75% of all heart attacks.
As a result, traditional risk factors are no longer sufficient indicators of who is at risk for
a heart attack. Therefore, this research investigates the willingness to pay (WTP) for a
new, hypothetical detection (screening) and treatment method for vulnerable plaque. For
this study, two survey instruments were developed that take advantage of the visual and
interactive aspects of the Internet. Individuals report their perception of heart attack risk
both prior to and after receiving new information on who cardiologists currently believe
to be at risk for a heart attack. In addition, respondents are provided with information
about the effectiveness and risks associated with screening and treatment. Using webbased surveys, which follow a contingent valuation format, an iterative bidding process is
used to elicit the respondent’s WTP for either the screening or treatment method.
Internet, on-line surveys are often prone to coverage bias; however, the survey valuing
screening (a simple blood test) used a Knowledge Networks panel and resulted in a
sample of 268 adults that is essentially representative of the general population. The
survey valuing treatment (a more invasive heart catheterization procedure) was
administered only to individuals with doctor-diagnosed heart problems, who are
presumably more familiar with these types of medical decisions, and resulted in a sample
of 295 adults. The mean for screening is $69 and the mean WTP for treatment that is

85% effective is $5,816. A two-part model is used to identify the factors that influence
WTP, as well as the decision to receive the screening/treatment. The data suggests that
these factors vary across genders. The data obtained for this study demonstrate construct
validity; therefore, the results may provide useful information for policy analysis
regarding the screening and treatment of heart attack.
Key words: Willingness to pay, iterative bidding, Internet, stated preference, health
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Chapter I: Introduction
1.1 Motivation
This research was motivated by a recent development in the medical literature
regarding the primary cause of heart attack. Many of us are familiar with the idea that
“clogging of the arteries” typically associated with high cholesterol levels can lead to a
heart attack. However, new medical evidence has shown that gradual plaque build up is
not always the cause of heart attack – in fact, cardiologists now believe that 75% of all
heart attacks are caused by pools of “vulnerable plaque” that lie hidden within the arterial
walls. Stress or other extrinsic triggers cause these plaques to erupt, creating a blood clot
to form almost instantaneously within the coronary arteries, resulting in a heart attack.
The reason this new information is so important is because it implies that prior to a heart
attack, the individual’s vessels may be relatively free of plaque build-up, such that the
individual never experiences chest pain or any other warning sign of a heart problem
prior to the attack. In fact, evidence from the Framingham Heart Study1 indicates that
over half of those who die from a heart attack do so without ever experiencing any
symptoms of heart disease (American Heart Association 2003). Therefore, this new
theory of an erupting vulnerable plaque explains why individuals who appear in good
health and have low cholesterol levels have been known to die suddenly from heart
attacks.
Unfortunately, the factors that contribute to vulnerable plaque are not well
understood; therefore, physicians still base heart attack risk on traditional factors that are
associated with plaque build up, such as high cholesterol, smoking, and being
overweight. Although these factors may provide some information on who is at risk for a
heart attack due to vulnerable plaque, an important piece of the equation is still missing,
such that many individuals who are at risk for a heart attack are not being identified as
needing treatment until they actually experience a heart attack. Approximately 50% of
the individuals who experience a heart attack die as a result. For those who survive,
outcomes can vary greatly – from essentially no effect, to the individual being left

1

The Framingham Heart Study is an ongoing study that is well-known and well-respected among
cardiologists.

1

permanently disabled. In response to the need for an inexpensive and non-invasive
screening method that could be used on the general population, researchers have
discovered some simple blood tests that may prove useful in identifying those who are at
risk for vulnerable plaque. With such a test available, treatment could be started on those
identified as being at high risk to reduce the probability of a potentially fatal heart attack.
Unfortunately, the only treatment currently available for treating vulnerable plaque is
drug therapy, which is only about 30% effective. In addition, drug therapy requires a
considerable amount of time to become effective, so the currently available method of
treatment offers little immediate benefit in terms of risk reduction for heart attack.
Therefore, in addition to a new screening method for identifying those who are at high
risk for a heart attack due to vulnerable plaque, a more effective treatment method is also
needed. Medical research is currently underway to develop both of these goods. In fact,
early forerunners offering limited potential as screening methods are already becoming
available. Therefore, it is expected that both screening and treatment for vulnerable
plaque will be available in the near future.
1.2 Why is Screening and Treatment of Vulnerable Plaque an Economic Issue?
Although a growing number of heart attacks are occurring in younger individuals,
heart attack risk is primarily an issue for those individuals 65 years of age or older, who
are covered by Medicare. As such, a large percentage of the expenditures associated with
treating these individuals is borne by the government and financed with tax revenues.
Therefore, decisions regarding who receives this screening and treatment (when it
becomes available) will largely be at the discretion of public policy decision makers.2
However, little is currently known about the underlying consumer preferences for these
goods, which should be directing public policy decisions. Even for those individuals not
covered by Medicare, heart attacks and the symptoms associated with coronary heart
disease (i.e. chest pain) are the “leading cause of premature, permanent disability in the
U.S. labor force, accounting for 19 percent of disability allowances by the Social Security
Administration” (American Heart Association 2003 p. 12) Therefore, understanding the

2

In January 2002, Medicare started covering the cost of C - reactive protein (CRP), a simple blood test that
indicates high levels of inflation (Comarow 2002), which may be associated with vulnerable plaque.

2

value individuals place on screening for preventing a heart attack and its associated
treatment is necessary to ensure the efficient allocation of available health care resources.
1.3 Measuring Health Benefits
Benefit cost analysis (BCA) is often used as a means to measure the gain to
society for various programs in order to determine which programs are potentially paretoimproving. BCA offers many advantages over other methods of valuation (i.e. costeffectiveness analysis) because net benefit is measured in dollars, which allows for a
direct comparison of programs. In addition, BCA is consistent with the assumption of
consumer sovereignty, that is, that the individual is the best judge of his/her own utility
(Mitchell and Carson 1989). As a result, BCA analysis has become the accepted standard
for evaluating the societal gains of a program and is now required by Federal agencies
and many state agencies as an integral part of the implementation process (List et al.
2004).
The requirement for a formal measure of benefits in public policy decision
making has created a particular challenge for environmental and health policy because
environmental goods are not typically exchanged in consumer markets, and many
markets for health-related goods and services are influenced by the presence of insurance
companies as third-party payers. Therefore, in valuing environmental and health-related
goods, economists often utilize stated preferences obtained through a contingent
valuation (CV) survey. CV is a stated preference method that uses a survey to elicit
individual preferences by asking respondents directly about their willingness to pay for a
particular good or service contingent upon a market for that good existing. A distinct
advantage of stated preference is that this method has the potential to measure both direct
values (those that are obtained through revealed preference methods), as well as passive
use values. Therefore, stated preference methods have the potential to measure the total
value of the good, and as a result, are important to BCA in estimating the total benefit
associated with a good or program (Carson et al. 2001).
There has been some debate regarding the ability of CV to provide accurate
measures of valuation for non-market goods (Hanemann 1994; Diamond and Hausman
1994). One of the current concerns regarding values obtained using CV is that several

3

studies have indicated a tendency for stated preferences elicited through hypothetical
markets to overestimate revealed preferences observed in actual markets (Cummings et
al. 1995, List and Gallet 2001).

However, many studies have demonstrated that

hypothetical bias can successfully be eliminated ex ante using a cheap talk script or ex
post using a certainty follow-up question, such that stated preferences obtained in
contingent markets coincide with actual purchase decisions (Cummings and Taylor 1999,
Blumenschein et al. forthcoming 2007)
Valuing health is important because, from a benefit-cost standpoint, it is
necessary in order to ensure the combination of health services being offered is the one
that will maximize the wellbeing of its citizenry. Therefore, valuing health-related goods
and services is necessary in order to make efficient decisions regarding the number and
types of health programs to offer, and CV offers a meaningful method to accomplish this
objective. A review article by Diener et al. (1998) indicates that CV surveys have been
utilized in valuing several health-related conditions and treatments, including (but not
limited to) hypertension (Johannesson et al. 1993, Johannesson et al. 1991), screening for
cystic fibrosis (Donaldson et al. 1995), anti-depression medication (O’Brien et al. 1995),
and in-vitro fertilization (Neumann and Johannesson 1994).
Although some studies have looked at the macroeconomic benefits and costs
associated with heart disease, as measured by the number of cases avoided (Long et al.
2006) or reduced medical expenditures (Cutler et al. 1998); few studies have asked
individuals directly about their valuation for potential improvements in heart-related care.
A Swedish study conducted by Johannesson et al. (1993) uses a CV survey to estimate
the WTP of those with high cholesterol for participation in a program that would promote
normal cholesterol levels. In addition, two studies (Kartman et al. 1996 and Chestnut et
al. 1996) estimate the WTP to reduce chest pain, a potentially debilitating symptom
associated with CHD. However, it does not appear from a review of the economic
literature that any published studies have asked respondents to value a screening test that
would better identify those at risk for a heart attack or treatment that would directly
reduce the risk of heart attack by a specifically stated amount. Therefore, this study
utilizes two CV surveys to value these two health-related goods (screening and treatment)
related to the prevention of heart attacks.

4

1.4 Method
As part of the survey development process, decision trees (typically used in
clinical decision analysis) were created to better understand the decision(s) that an
individual would face both in the current state of the world (when screening and a more
effective treatment are not available) and in the desired state of the world (when
screening and a more effective treatment are available). Using the decision trees as
guides, two surveys were developed - one to elicit the WTP for screening and the other to
elicit the WTP for a more effective treatment. Both surveys were administered via the
Internet. The survey for screening was administered to adults in the general population
using a nationally representative panel. The survey on treatment was administered to
adults who have a past medical history of heart-related problems, who are therefore more
familiar with heart-related treatment options and, as a result, are expected to provide
more reliable estimates of valuation. As part of the surveys, individuals were provided
with information on vulnerable plaque (similar to the information presented in the
opening section of this chapter). Respondents were asked to assess their perceived risk of
having a heart attack both prior to and after receiving the new information. Respondents
were then asked about their WTP using an iterative bidding process.
According to Alberini et al. (2003), “single-bounded dichotomous choice
questions are notoriously imprecise as the only information revealed as whether WTP
resides above or below the threshold provided by a single bid” (p. 42). Therefore, both
surveys used for this study utilize an iterative bidding process to increase the efficiency
of obtaining welfare estimates. The iterative bidding process used for this study was
inspired by the interactive computer program used by Viscusi, Magat and Huber (VMH)
(1991).3 Respondents are assumed to have an underlying WTP that remains constant,
such that the iterative bidding process (in conjunction with a series of follow-up
questions) will elicit the maximum WTP (for either screening or treatment) for each
respondent.
Valuations obtained using iterative bidding have been known to be subject to
starting point bias (Whitehead 2002, Watson and Ryan 2007); therefore, some

3

VMH (1991) use an interactive computer program to generate a series of pair-wise comparisons (based on
the respondent’s pervious answers) to elicit risk-risk and risk-dollar tradeoffs related to chronic bronchitis.
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economists advocate using a payment card as an alternative to iterative bidding as a
means of obtaining stated WTP (Mitchell and Carson 1989, Alberini et al. 2003). In the
economics literature, many bidding games that are referred to as “iterative” do not
actually allow the bids to both increase and decrease to converge upon the respondent’s
WTP. Rather pre-set bids are offered starting with a randomly chosen initial bid that
increases (decreases) monotonically until the respondent changes from a “yes” to “no”
response (or vice-versa).4
The iterative bidding process used for this study is truly “iterative,” offering bids
that become both higher and lower depending on the individual’s responses to each bid.
In addition, subsequent bids are not pre-set, but rather created by a computer algorithm,
that allows each survey to be tailored to the individual respondent.

The computer

program also allows the bids to cover a much wider range than would be feasible to offer
on a payment card. For example, the algorithm used for the screening survey elicits WTP
for screening to within a $5 margin and covers a range of $0 to $1600, which creates a
number of possible bid options that would be impractical to include on a single payment
card. Therefore, the iterative bidding used in this study allows the potential bids to
increase (decrease) quickly when several sequential “yes” (“no”) bids are indicated, while
at the same time narrowing the range of WTP if the respondent changes their response
frequently.
Results from this study are analyzed using a two-part model, which is often used
for analyzing health care data.

The hurdle model treats the decision to have the

screening/treatment as one decision, and the WTP for screening/treatment as another,
completely separate, decision. A probit was used to model the decision to have the
screening/treatment, and an OLS regression on WTP for those who chose to have the
screening/treatment was used to determine the factors that influence the WTP. The
results suggest that the factors that influence the decision to have screening/treatment are
not necessarily the same as those that determine the individual’s WTP.
4

Bids are either increased or decreased according to a pre-set group of bids. For example, if the pre-set
bids are $5, $10, $15, $20, $25 and $30, and the respondent answered “yes” to the initial bid of $15, the
interviewer would ask if the respondent was willing to pay $20. The interviewer will continue to the next
highest pre-set bid until the respondent answers “no”; thus, determining a narrow range in which the
respondent’s WTP lies. A similar process would occur if the respondent answered “no” to the initial bid.
In that case, the interviewer would then proceed to go down to the next pre-set bid until the respondent
switched their answer to “yes.”
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1.5 Contribution to the Literature
This study contributes to the literature in several ways. Primarily, this study
provides a consumer-derived valuation for two health-related goods that are likely to
become available in the near future, offering insights into specific demographics and risk
factors that affect those valuations and provides potentially useful information in
determining public policy. This study also provides additional information regarding the
feasibility and accuracy of obtaining WTP valuations using a contingent valuation survey
administered via the Internet.

And finally, this study provides insights into how

information influences medical decisions made by the consumer patient, and whether
individuals place a value on information even when it does not affect medical outcomes.

1.5.1 Valuing Heart-Related Health
As discussed above, only a few studies have used contingent valuation to estimate
consumer benefits associated with improvements in heart-related health. Kartman et al.
(1996) and Chestnut et al. (1996) estimate the WTP to reduce chest pain. Although chest
pain is a symptom of heart disease, which may be related to heart attack,5 these studies
only focus on the value of reducing this symptom, not a reduction in the risk of heart
attack. A CV study by Johannesson et al. (1993) estimates the WTP for a cholesterol
lowering program for individuals in Sweden with high cholesterol. In a self-administered
survey, respondents are asked to value a program that reduces their cholesterol to a
normal level. This study does include information which states: “the risk of heart attack
is influenced by, for instance, high blood pressure, high cholesterol levels, and smoking”
indicating that high cholesterol levels increase the risk of heart attack; however, as this is
one of several factors listed, the specific reduction in heart attack risk offered by the
program is not included as part of the survey. However, given the strong connection
between cholesterol and heart attack risk at the time the Johannesson et al. (1993) survey
was administered, it is likely that the results from this earlier study would be comparable
to those obtained in this study; although it is certainly possible that cultural differences
5

As Chapter 3: Medical Background will explain, an individual may experience chest pain from calcified
(stable) plaques and not necessarily be at risk for a heart attack. However, due to the fact that chest pain
can be debilitating, causing extreme discomfort which can cause the individual to limit work and other
activities, it is not surprising that individuals express a significant WTP for the reduction of these
symptoms.
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between individuals in Sweden and the United States may account for some degree of
variation in WTP.

1.5.2 Iterative Bidding with Cheap Talk and Follow-up Certainty Question
In the economics literature, the term “iterative bidding game” refers to the use of
a multiple-bounded dichotomous choice (DC) question in which respondents are asked
repeatedly if they are willing to pay $X for a good. Although this process is termed
“iterative” in some ways it is misnomer because the process does not go back and forth to
converge on a single value. Instead, the initial bid is monotonically raised or lowered
(depending on the respondent’s answer to the first bid) until the respondent’s answer
changes from “yes” to “no” (or “no” to yes”).6 Although bidding games increase the
efficiency with which WTP values can be obtained, they are often prone to starting point
bias (Whitehead 2002, Watson and Ryan 2007).
Typically bidding games are administered using trained interviewers using a set
of pre-determined bids.

Based on the initial bid, each subsequent bid is increased

(decreased) in small increments until the respondent switches their initial response
(Kartman et al. 1996, Desvousges et al. 1987, Randall et al. 1974). For example, in the
study by Randall et al. which estimates the WTP for aesthetic environmental
improvements, respondents who answer “yes” to the starting bid receive higher bids until
the respondent answers “no.”

Those that answer “no” to the starting bid receive

incrementally smaller bids until the respondent answers “yes.” In this form of bidding
game, the same objective could clearly be accomplished using a payment card,
eliminating the potential for starting point bias.

In fact, this is the reason several

economists advocate the use of a payment card in place of this form of bidding game
(Mitchell and Carson 1989, Alberini et al. 2003).
Instead of a single range of preset bids from which the starting bid is randomly
chosen, some bidding games use multiple “sets” of preset bids, in which respondents are
randomly assigned. Asgary et al. (2004) use three sets of four possible bids to estimate
the WTP for health insurance in developing countries. Each respondent is randomly
6

Examples of studies employing some form of this type of monotonic bidding game include Whitehead
2002, Langford et al. 1996, Kartman et al. 1996, Desvouges et al. 1987, Randall et al. 1974, and Asgary et
al. 2004.
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assigned to one of the three possible “bidding games.” As long as the respondent
answers “yes,” the next pre-selected bid for that game is offered. In this form of iterative
bidding game, no option was available to reduce the bids; therefore, a “no” response to
the first bid was simply recorded as a WTP=0 (Asgary et al. 2004).
Langford et al. (1996) employ a more sophisticated model in which 8 randomly
assigned starting bids are either doubled or halved (for up to 3 subsequent bids). Again,
the bids only increase or decrease based on the response to the first bid, and the bidding
terminates when the respondent’s answer is reversed. Therefore, the range of potential
WTP values remains fairly wide if the respondent switches answers in the first follow-up
question. If additional iterations are known to increase the efficiency of WTP estimates
and up to 4 bids were potentially planned for each respondent, then why not take
advantage of asking all 4 questions to narrow down the WTP even further? Most likely
the reason is that performing the mathematical operations necessary to accomplish this
task (quickly and accurately enough) does not lend itself well to surveys utilizing
telephone or in-person interviewers.

Therefore, in order to ensure consistency and

accuracy in the interviewing process, the iterative process terminates once the
respondent’s answer changes.
However, as VMH’s (1991) study demonstrated, a computer program can quickly
and accurately use the respondent’s previous answers to determine the next question.
Although VMH applied this to a series of risk-risk trade-offs, the same idea can be
applied to a multiple-bounded DC question on risk-dollar tradeoffs that is truly “iterative”
in nature – in which bids increase and decrease to converge on the respondent’s true
WTP. Given the fact that many multiple-bounded processes only move monotonically
and often cover only a small range of bids, it is not surprising that economists have found
iterative bidding to be subject to starting point bias. Therefore, this study will take
advantage of the quick and accurate mathematical capabilities of the computer to explore
whether using a truly iterative bidding process administered via the Internet can be used
to efficiently elicit values of consumer WTP that are free from starting point bias.
Blumenschein et al. (forthcoming 2007) found that a cheap talk script was not as
effective in removing hypothetical bias as a follow-up certainty question. In an effort to
ensure that hypothetical bias did not enter consumer valuations, both a cheap talk script
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and certainty follow-up question were included in the surveys used for this study.
Although actual WTP is unknown, collecting data on WTP both after the cheap talk
script and after the certainty follow-up question does offer some potential for comparing
these two methods. Many focus group participants indicated that they were “definitely
sure” of their stated WTP values by the end of the elicitation process. Therefore, this
study offers some potential to determine if an elicitation format that utilizes an iterative
bidding process with a cheap talk and follow-up certainty question is a potential method
for eliciting consumer WTP that are free from hypothetical bias.

1.5.3 The Role of Information on Consumer Demand for Health-related Goods
This study offers insight into the relationship between prior and new information
regarding individual risk assessments and subsequent health decisions.

Hoehn and

Randall (2002) state that new information may have different affects on respondents’
perception of risk, depending on the individual’s priors, and thus affect WTP
accordingly.

Therefore, the surveys used for this study allow for this potential

heterogeneity by collecting data on risk perceptions both prior to and after new
information is presented to the respondent. In addition, a qualitative question regarding
the change in the respondent’s risk from the new information provides information on the
strength of the individual’s priors and is used in the data analysis. The empirical results
suggest that the strength of priors plays an important role both on who chooses the
treatment and on the individual’s WTP.

1.5.4 Does Information have Value for its own Merit?
Finally, this study investigates the question of whether individuals are WTP for
information, even when it offers no value in terms of medical decision making. A CV
study by Berwick and Weinstein (1985) find that women with normal pregnancies place a
value on information received from an ultrasound even when it offers no value in terms
of medical decision making. Based on these finding Berwick and Weinstein conclude
that information obtained from screening may have value simply “for its own sake.”
They explain that the decision to pay for information that has no relevance to medical
decision making is analogous to people valuing being informed about world/local events,
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which is evidenced by individuals purchasing newspapers and taking the time to read
them or watch the evening news. Clearly these behaviors reveal that people value being
informed; therefore, Berwick and Weinstein surmise that individuals would be no less
willing to expend some of their financial resources to have more information about their
own health (Berwick and Weinstein 1985), especially if it has the potential to improve
their expected level of utility.
In order to test whether information has value for its own sake, a small arm of the
screening sample received a version of the survey in which respondents were asked to
value the screening when no treatment was available. Although the sub-sample was
relatively small in size, the results suggest that information does in fact have value to the
patient consumer. Berwick and Weinstein’s (1985) results indicated that 25% of the
valuation for an ultrasound by women with normal pregnancies stemmed from
information that had no bearing on medical decision making. The results from this study
suggest that the informational value (not related to medical decisions of treatment) for
heart attack screening is potentially even larger.
1.6 Study Objectives
Valuation of health-related goods and services is necessary in order to make
public policy decisions that maximize social welfare. In the area of health, a large
proportion of individual expenditures occur in the last few years of life, when many
Americans are covered by Medicare. In particular, one of the main health concerns for
those over 65 is heart disease and heart attack. In addition, a significant percentage of
disability allowances paid by the Social Security Administration (and financed with tax
revenues) are related to CHD and heart attacks. Therefore, a better understanding of the
valuation individuals place on heart-related screening and treatment is necessary for
sound public policy.
Thus, the primary objective of this research is to estimate the demand for (1) a
new screening method that would better identify those at risk for a heart attack and (2) a
new minimally-invasive procedure for the detection and treatment of vulnerable plaque.
Willingness to pay (WTP) estimates for each of these “goods” will provide insight into
the value individuals place on health, specifically the value they place on avoiding a heart
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attack. In addition, a better understanding of the marginal effects of factors that influence
demand for these services can assist policy makers in determining who should receive
these services to help ensure the efficient allocation of our scarce health care resources.

Copyright © Patricia L. Ryan 2007
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Chapter II: Review of the Literature

The purpose of this chapter is to provide a review of the literature relevant to the
dissertation. As such, this chapter presents support for using benefit-cost analysis (BCA)
as a tool to efficiently allocate scarce economic resources. In addition, the chapter
includes a discussion of the possible methods for valuing changes in health, including
willingness to pay (WTP) in contingent markets, which is used for this study. Due to the
fact that there has been some debate regarding the validity of obtaining reliable
valuations for non-market goods using stated preferences (Hanemann 1994; Diamond and
Hausman 1994), a large section of this chapter is devoted to exploring this issue. As part
of the basic understanding of what drives the demand for health, this chapter also
includes an explanation of Grossman’s (1972) household production model of health and
the implications it has on the demand for health-related goods and services. Finally, this
chapter concludes with an overview of how risk and uncertainty and the availability of
information in markets for health-related goods and services may influence consumer
decisions in regard to the health choices they make.
2.1 Welfare Economics and the Concept of Value
In his book entitled The Measurement of Environmental and Resource Values,
Freeman (1993) states “The basic premises of welfare economics are that the purpose of
economic activity is to increase the well-being of the individuals who make up society,
and that each individual is the best judge of how well off he or she is in a given situation”
(Freeman 1993 p. 6). If individuals are assumed to have well-defined preferences and
can substitute between goods, the trade-offs that are made will reveal information about
the value the individual places on that good (Freeman 1993). If individuals are further
assumed to be rational economic agents, they will choose the bundle of goods that will
maximize their utility given their budget constraint (Mitchell and Carson 1989). It
therefore follows that as each individual maximizes his/her own utility, that society’s
welfare will also be maximized in the absence of a market failure.
The problem is that for many environmental goods, the non-rivalry and nonexcludability of these public goods means that private markets would tend to under
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produce them as some individuals choose to be free-riders. In an attempt to correct this
market failure, the government often chooses the amount7 of these goods that will be
provided and pays for them with tax revenues. In addition, the quantity of some healthrelated goods, especially those consumed by the elderly who are covered by Medicare,
are also determined by the government. In these cases, it is still important for the
government to choose the amount of the good that will maximize overall societal utility;
however, a problem arises in identifying this optimal amount because individual
preferences are unknown. As a result, several methods have emerged to assist policy
makers in efficiently allocating scarce economic resources among competing public
programs.
2.2 Methods for Evaluating Public Policy Programs
Methods that have been used to evaluate public programs include: Internal Rate of
Return (IRR)8, Benefit/Cost Ratio9, Social Net Benefit, Cost Effectiveness Analysis
(CEA)10, and Payback Period11; however, many of these methods have significant
shortcomings. For instance, IRR does not take into consideration the size of the project
under consideration, nor the increase in consumer utility that will result from the project.
CEA has an advantage over IRR in that it does take into account the size of the effect of
the program; however, it is designed to find the least cost method of achieving a specific
goal. As a result, CEA will not provide decision makers with information on how to
efficiently allocated resources among programs with different goals. Therefore, using the
Benefit/Cost Ratio is superior to CEA because it allows comparisons across programs
and time; however, like the IRR, it does not indicate the size of the gain. In addition, the
Benefit/Cost Ratio can be unduly influenced by whether an improvement is classified as

7

Through direct provision of the goods or indirectly through regulation
IRR compares the rate of return from the investment to the market interest rate. The decision rule
suggests that those projects for which the IRR is higher than the market interest rate should be approved.
9
The Benefit/Cost Ratio is calculated by dividing the benefits associated with a program by the costs
associated with a program. The resulting ratio is then used as a measure to compare programs.
10
Cost Effectiveness Analysis (CEA) allows decision makers to compare the costs of various programs in
achieving a specific program goal. Therefore, this method will theoretically identify the least costly
method of achieving a unit of effectiveness (such as a one point increase in test scores or incremental
increase in health status).
11
Payback period indicates how long it will take the benefits derived from a program to pay back the costs
associated with the program.
8
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a decrease in costs or an increase in benefits, creating some ambiguity in decisions made
using this method. Finally, using Payback Period has the distinct disadvantage in that it
does not allow decision makers to distinguish between programs for which most of the
benefit occurs early versus programs in which the majority of the benefits accrue later; in
particular, it does not consider the value of benefits accrued beyond the payback period
(Zerbe and Dively 1994).
Unlike these other methods, Social Net Benefit does not suffer from any of these
shortcomings and is clearly the preferred method for evaluating public programs and
making policy decisions. Social Net Benefit is calculated by taking the total marginal
benefits that accrue from a program and subtracting the total marginal costs associated
with the program. Therefore, unlike the Benefit/Cost Ratio methodology, calculating the
Social Net Benefit through benefit-cost analysis (BCA) will yield a consistent value
regardless of whether improvements resulting from the program are classified as a
decrease in costs (savings) or increase in benefits. In addition, Social Net Benefit allows
programs to be compared across regions and time (using present value) and also allows
for the comparison of programs with different goals. Another advantage of using Social
Net Benefit is that this method naturally produces a measurement of the social gain
derived from the program in monetary terms. This value can then be used to rank
programs according to those offering the highest net benefit to society. The level of
financial resources available will then allow decision makers to select the bundle of
programs offering the highest collective social net benefit (Zerbe and Dively 1994).
From the above discussion, it is clear to see that BCA can be used to maximize
utility for society because it will identify the programs that are potentially paretoimproving. The pareto-criterion suggests that if one person can be made better off
without making another worse off, then it will increase society’s welfare. Of course,
improvements may accrue to certain members of society at the cost of others, but from
the perspective of society as a whole, a positive social net benefit indicates an
improvement to society. To account for the possibility that some individuals within
society may have gained at the expense of others, the assumption can be made that the
benefits accrued to the “winners” are more than enough to compensate the “losers” such
that overall everyone will be at least as well off as they were before the change (Mitchell
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and Carson 1989). In fact, one of Harberger’s (1971) three postulates for applied welfare
economics states that for a given action “the costs and benefits…be added without regard
to the individual(s) to whom they accrue” (Harberger 1971, p. 785).
Clearly, BCA offers many advantages over other options as a tool for assisting
decision makers in making efficient allocations of our scarce economic resources. In
addition, BCA is consistent with the assumption of consumer sovereignty, that is, that the
individual is the best judge of his/her own utility (Mitchell and Carson 1989). Therefore,
it is not surprising that BCA is the preferred method for valuing programs. In fact,
Executive Order 12866 made during the Clinton Administration12 “explicitly requires
federal agencies to consider costs, benefits, and economic impacts of regulations prior to
their implementation” (List et al. 2004 p. 742) and state agencies are increasingly
employing BCA as a prerequisite for policy implementation (List et al. 2004).
2.3 Valuing Non-Market Goods through Revealed and Stated Preference
Unfortunately, determining the benefits of some environmental and health-related
goods can prove challenging. Environmental goods pose a problem in that as public
goods, individuals have an incentive to act as free riders and understate their true
preferences. Although goods in the health care sector tend to be more private in nature,
the presence of insurance companies as third-party payers distort the true preferences of
consumers within the market.

In fact, the extensive use of co-payments (where

consumers only pay a portion of the actual cost) suggests that individuals will consume
more than they would if they were bearing the full cost of these goods out of pocket
(Phelps 1992).
In addition, many environmental and some health care goods simply do not have a
market. For example, better air quality and increased safety can not be purchased directly
in a consumer market; however, related purchase decisions may provide insight into the
value individuals place on these “goods.” When actual purchases (in either an explicit or
implicit market) reveal how much an individual values a good, this method is referred to
as revealed preference. When questions are asked such that the individual states how
much they value a good or service, this is referred to as a stated preference method.
12

This reaffirmed an earlier executive order made during the Reagan Administration (List et al. 2004)
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2.3.1 Revealed Preference – Explicit Markets
Valuation can be made directly by observing preferences revealed explicitly in
consumer markets. One of the three postulates made by Harberger (1971) in regards to
applied welfare economics suggests that the market price of a good can be used as a
measure of the value the consumer places on that good. This stems from the fact that if
the individual does not buy the good, then the price is an upper bound on the individual’s
WTP; however, if the purchase is made, the price is clearly a lower bound on the
individual’s maximum WTP. Therefore, when a good can be purchased in an explicit
market, the market price will provide information regarding the valuation of the good.
As a result, for policies that involve marginal changes in the quantity of the good
provided, market price can serve as a good starting point for valuation; however, for
policies that involve larger changes in the provision of the good, a better measure of
valuation is the area under the demand curve since this allows consumer WTP to vary
with the quantity of the good provided (Blomquist and Whitehead 1995). Although
preferences revealed through actual market transactions are an effective way of valuing
goods and services, a problem arises when estimating the value of a good that is not
traded explicitly, or what is referred to as a non-market good.

2.3.2 Revealed Preference – Implicit Markets
Implicit values for many non-market goods have been estimated by observing
purchases made in markets for related goods (Blomquist and Whitehead 1995). For
example, information on the value individuals place on their health and safety can be
obtained by studying other markets in which these health-related goods are implicitly
purchased, such as the market for housing or automobiles. Following Rosen’s (1974)
hedonic pricing model, the value of air quality has been derived by looking at median
home values as a function of neighborhood characteristics, including air quality (Harrison
and Rubinfeld 1978). A meta-analysis performed by Smith and Huang (1993) indicated
that using hedonic equations to estimate implicit prices is effective; however, further
research by Smith and Huang (1995) suggests that the equation specification (including
the functional form and number of characteristics included) could affect the marginal
WTP values (Zabel and Kiel 2000).
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Likewise, hedonic models can be applied to labor market data to obtain
information on the value individuals place on their health and safety. Compensating
wage differentials are paid to induce workers into riskier positions. Therefore, since
labor markets are well-defined, observed wages and known levels of occupational risk
can be used to determine the dollar tradeoff that an individual requires to accept a job
with additional risk to personal health and safety.13
Analyzing travel costs is another method that has been used to value public goods
such as national parks.

Calculating the “travel costs” associated with visiting the

destination, including the opportunity cost of time traveled, provides an estimate of the
value individuals place on the natural resource. However, this valuation method will
only provide a lower bound on WTP because it does not include non-use or existence
values14 for individuals who do not travel to the park.

2.3.3 Stated Preference- Hypothetical Markets
Although revealed preference methodologies such as those described above have
allowed economists to place a monetary value on some non-market goods, what happens
when a good has no close market from which to collect data? In this case, economists
have used surveys to create a hypothetical market in which the good is offered and asks
individuals directly about the value they place on that good. This technique is referred to
as contingent valuation and is a considered a stated preference technique because it relies
on preferences stated by those surveyed rather than preferences that are revealed through
actual observed behavior (Blomquist and Whitehead 1995). A distinct advantage of
stated preference methods is that they have the potential to measure both direct values
(those that are obtained through revealed preference methods), as well as passive use
values.15 In theory, stated preference methods have the ability to measure the total value
of the good being valued, as either a willingness to pay (WTP) or willingness to accept
13

See Viscusi (1986, 1993) and Viscusi and Aldy (2003) for a review of the literature including risk-dollar
trade-offs in consumer markets and risk-wage trade-offs in labor markets.
14
Valuation associated with non-use or existence values may derive from the intrinsic value of the
environmental resource, altruism, or a bequest motive (Blomquist and Whitehead 1995)
15
Although the term “passive-use” was not coined until later, Krutilla (1967) introduce the concept in his
article entitled “Conservation Reconsidered” in which he suggests that individuals may place value on the
existence of a natural resource (such as the Grand Canyon), and thus, may be willing to pay to preserve it
even if they never plan to utilize it themselves.
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(WTA) amount.16

Since revealed preference techniques may exclude important

components of an individual’s true WTP or WTA, stated preference methods have
become increasingly important to BCA as a means of estimating the total valuation of a
good (Carson et al . 2001).
2.4 Valuing Health
Just as individuals reveal their preferences for consumer goods and services
through the purchases they make, the same basic approach can be applied to valuing
health; however, instead of making financial outlays to purchase goods, “expenditures”
for health and wellbeing are often revealed through the choices individuals make
regarding their time and lifestyle choices (Tolley et al. 1994).

2.4.1 Grossman’s Household Production Model of Health
Grossman’s (1972) household production model of health demonstrates how
individuals, as rational economic agents, make choices on a daily basis that affect their
health and overall utility. According to the model, utility is defined as a function of the
goods and services consumed, as well as the individual’s level of health or “health stock.”
Individuals are endowed with a certain level of health stock, which gradually depreciates
with age. In addition, an illness or accident can cause a decrease in the health stock. The
model assumes no uncertainty, so when an individual’s health stock falls below some
minimum level, death will occur (Grossman 1972).
To counter decreases in the health stock caused by aging and illness, individuals
can make investments in their health. Specifically, an individual can purchase market
goods and services (i.e. doctor visits, prescription medication, tennis shoes, healthy
foods, etc.) and combine them with their own time (i.e. time spend exercising, preparing
healthy meals, etc.) as a means of “producing” health and adding to their health stock.
Furthermore, market goods and own time are translated into a higher health stock
according to the individual’s own production process; thus, allowing for the possibility
that some individuals may be more efficient than others at producing health.
16

In

WTP measures how much the individual is willing to pay to receive an improvement or increase in a
good. WTA measures how much the individual requires to accept damages or a decreased level of the
good. The decision to use WTP versus WTA depends on how property rights are assigned.
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particular, Grossman suggests that those with more education may be better at combining
market goods with own time to produce health, such that they will tend to be more
efficient producers of health (Grossman 1972).
Because utility depends on the individual’s level of health,17 an illness can change
the marginal rate of substitution between medical care and all other goods by increasing
the marginal value of medical care.

As a result, individuals will increase their

consumption of medical care relative to other goods. However, if an illness reduces the
individual’s ability to earn income, then both medical services and other consumption
may fall in response to a lower budget constraint. Acting as rational economic agents,
individuals will continue to invest in their health as long as the present value of the
marginal cost of gross investment is less than or equal to the present value of the
marginal benefit (Grossman 1972).

2.4.2. The Demand for Health
Following Grossman’s model, several conclusions can be made as to the demand
for health. First, if the rate of depreciation in the health stock increases with age, then the
demand for health will also increase with age because larger and larger amounts of
investment will be required to maintain the individual’s prior health stock. In addition,
an increase in the individual’s wage rate will have the effect of increasing the value of
healthy time, thereby increasing the marginal product of health capital. This suggests
that individuals with higher wages will choose a higher level of health stock and have a
higher demand for health. Finally, those who have more education may be able to
combine market goods and own time to produce health more efficiently (Grossman,
1972). Therefore, it is expected that education will increase the marginal efficiency of
health, and thus result in more educated individuals choosing a higher optimal level of
health (Grossman 1972).
Grossman’s empirical findings support his theoretical predictions. Using data
from the 1963 Health Interview Survey conducted by the National Opinion Research
17

Empirical work by Viscusi and Evans (1990) supports Grossman’s assumption that utility is dependent
on the health state. Using data on chemical workers, Viscusi and Evans (1990) find that the marginal
utility of income is higher when an individual is healthy (higher state of health) as compared to when the
individual is injured (lower state of health).
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Center (NORC) and the University of Chicago’s Center for Health Administration
Studies, data showed a positive correlation between medical care with restricted activity
days and work-loss days, suggesting a positive relationship between medical care and the
depreciation rate. Using health stock measures obtained through self-reported health
status, depreciation rates were found to increase with age.

Grossman estimated

depreciation to be approximately 2.1%, implying that 70% of the initial health stock
would have depreciated by age 58, 80% by age 77, and 90% by age 96. Education was
found to have a positive and significant effect. In addition, the wage rate was found to be
positively related to the stock of health and the number of healthy days, which supports
the hypothesis that an increase in an individual’s wages raises the return on an investment
in health, thus resulting in the individual choosing a higher stock of health (Grossman
1972).

2.4.3 Tradeoffs Involving Health
Household production models of health, such as that developed by Grossman,
imply that “individuals will make expenditures of money and time to improve their health
and reduce risks to their health” (Berger et al. 1994 p. 25). For example, the decision to
purchase a smoke detector is an averting behavior in consumption that requires an
expenditure of income in order to reduce the risk of fatality by a marginal amount.
Therefore, even though health is not explicitly traded in a well-defined market, the value
that an individual places on their health, and ultimately their life, can be derived from
observing the choices they make in markets for other goods and services that affect their
health (Berger et al. 1994).

2.4.4 Risk and Uncertainty
Risk is an inherent part of our everyday lives. We face risks when we drive/ride
in a car, fly on a plane, or take a bus. In addition, we face possible risks of injury at our
place of employment from the use of heavy equipment or coming into contact with
hazardous materials. In our recreation, whether it is downhill skiing or simply jogging,
the risk of injury or death exists. We even face significant risks in our homes, where a
surprisingly large number of individuals are injured/die every day. And finally, we are at
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risk from disease and other medical conditions, such as cancer and heart attack.
Although the average risk of injury or death from any single cause may be relatively
small, the consequences from an unfortunate event have the potential to be life altering.
Therefore, it is not surprising that individuals acting as rational economic agents will
chose to expend some of their limited resources to reduce the probability of one or more
of these risks (Viscusi 1992).
Because risk can not be eliminated completely, some risk of injury and/or death
will always exist for each of us; however, it is possible to reduce those risks. Individuals
can purchase cars with added safety features, choose a job that is less risky (although it
may pay less), use safety equipment (such as a helmet, goggles, etc.) while participating
in recreational activities, invest in carbon monoxide detectors for the home, and choose to
have medical screening, to name just a few examples. These purchases which represent
averting behavior in consumption will help reduce the probability of injury, illness,
and/or death; however these risk minimizing efforts often involve a cost, either in
monetary terms, utility, or both. For example, choosing to wear a helmet while downhill
skiing involves both the monetary cost required to purchase the helmet, as well as a
potential utility cost in that the individual may not enjoy the experience of skiing as much
due to wearing the helmet.
Because individuals make decisions every day regarding how much risk to accept,
these tradeoffs have the power to implicitly tell us how much a person would pay to
avoid a certain amount of risk (either monetarily or in terms of lost utility). Therefore,
“these tradeoffs in effect set the price that people are willing to pay for greater
safety”(Viscusi 1992, p. 4). Thus, by observing these tradeoffs, estimates can be made as
to the value society places on saving a life, as well as the value individuals place on their
own health and wellbeing.

2.4.5. Value of Life
Thaler and Rosen introduced a methodology for estimating the value of a
statistical life by addressing the question “How much will a person pay to reduce the
probability of his own death by a ‘small’ amount?” (Thaler and Rosen 1976, p. 265).
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In calculating the value of a statistical life, the identity of the person at risk is
unknown. This is appropriate since decisions regarding risks to health and safety are
often made by society in this manner. In fact, people often behave much differently in
situations where the person at risk is known (Blomquist 2001). For example, it is not
uncommon to hear in the news a story of a small town that expended many of its
available resources for a short time in order to save a child who became trapped in a well.
In cases such as this, “society will often spend whatever is available or do whatever is
possible to save the life” because “the situation involves a potentially large change in
survival for a known individual” (Blomquist 2001). Therefore, it is important to note that
behavior under these circumstances is much different than when the risk is significantly
smaller and exists for an unidentified group of individuals within society.
Risk in our daily lives is unavoidable (Viscusi 1992).

As discussed above,

individuals make risk tradeoffs everyday, including the choice to accept a riskier job in
return for a higher wage – what Adam Smith (1776, 1994) referred to as compensating
wage differentials.18 What is interesting to note is that these observed tradeoffs provide
an implicit value of avoiding additional risk, which is illustrated by the following
statement:
Suppose a person is observed taking a known incremental
risk that could be removed by spending one dollar. Then the
implicit value of avoiding the additional risk must be
something less than one dollar or else it would not have been
observed (Thaler and Rosen 1976, p. 266).

18

The theory of equalizing or compensating wage differentials was first described by Adam Smith in The
Wealth of Nations. Smith explained how some workers could expect to earn higher wages than others
because of differences in key job characteristics. For example, those individuals who worked in jobs that
were generally considered harder, more dangerous or required special training would typically earn higher
wages than those individuals with otherwise identical characteristics who were employed doing jobs that
offered more favorable working conditions. The higher wages paid to these workers was considered a
means of compensating them for withstanding the unpleasant aspects of their job. The amount of the wage
differential paid for each type of job and its associated unpleasantness would be determined by the market.
The wage would have to be high enough in order to induce the marginal worker to accept the unpleasant
job rather than taking a more pleasant job offering a lower wage.
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Using data from the 1967 Survey of Economic Opportunity (SEO)19 and the 1967
Occupation Study of the Society of Actuaries,20 Thaler and Rosen (1976) test Adam
Smith’s theory of compensating wage differentials. They do this by incorporating risk
into a standard wage equation to estimate the dollar amount required to induce an
individual worker to accept a job with a slightly higher degree of risk (fatality). This
estimate is based on the assumption that if each worker is willing to pay $50 to avoid,
say, a .001 chance of dying, it logically follows that 1,000 workers together would pay
$50,000 to eliminate the probability of death and statistical save a life.
Using this methodology, Thaler and Rosen (1976) estimate the value of life to lie
in the range of $140,000 to $260,000 (in 1976 dollars), which would amount to
approximately $500,000 to $940,000 in today’s dollars.21 Although this range is lower22
than many of the more recent studies, Thaler and Rosen’s 1976 study contributed
something incredibly significant - a meaningful way of “valuing” a human life in
monetary terms. The meta analysis by Viscusi and Aldy (2003) find the most reliable
estimates for prime-age workers to be in the range from 5 to 9 million in current dollars.
Tradeoffs involving risk are not unique to the labor market. In fact, there are
countless such tradeoffs that occur each day in consumer markets.

Consider for a

moment the automobile and housing markets. Individuals purchase used cars offering
fewer safety features than newer models, and families buy homes in areas abutting
19

This data set provided demographic information, as well as the individual’s occupation and industry in
which they work.
20
This study used insurance company records between 1955 and 1964 to measure additional risks
associated with extremely hazardous occupations. Because the data reported information using a
combination of both industry and occupation, it could be directly matched to individuals in the SEO
sample. In this regard, it provided a better measure of risk than data from the Bureau of Labor Statistics
(BLS), which was the traditionally source for industry hazards data. The BLS only reported the average
hazard for each industry, regardless of occupation. Since occupations within an industry could vary
widely with regard to risk, use of this data could cause a large degree of measurement error. Therefore,
Thaler and Rosen used the 1967 Occupational Study on Society of Actuaries to avoid the aggregation
problem inherent in the BLS data.
21
(CPI March 2007 – Ave. CPI 1976)/ Ave. CPI 1976 = (205.352-56.9)/56.9 = 2.608998
$140,000 * 3.608998 = $505,260 & $260,000 * 3.608998 = $938,340
22
This is most likely a result of Thaler and Rosen’s chosen data set. The Society of Actuaries data includes
individuals in very high-risk occupations, and therefore would be expected to yield a lower value of life
because of “the self-selection of individuals with low risk-dollar tradeoffs into the most hazardous pursuits”
(Viscusi 1993). For a detailed discussion of this and other data and econometric issues, see Mrozek and
Taylor (2002) and Viscusi and Aldy (2003). As Shogren and Stamland (2002) argue and Kniesner et al.
(2005) find, self selection on unobserved productivity in dealing with risk in the labor market can produce
estimates of value of life that are biased upward. The net effect depends upon the relative strength of the
effects of the unobservable factors.
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Superfund sites. Despite the fact that these purchases may pose a potentially higher
health hazard, these goods are still consumed because they tend to be more affordable.
Therefore, value of life estimates can be derived by observing purchasing behavior in
certain private consumer goods markets that entail some amount of risk. In particular, the
demand for automobile safety features, cigarettes, and housing locations all provide
information on the underlying safety preferences of individuals; and hence, can be used
to estimate society’s willingness to pay to avoid higher levels of risk (Tolley et al. 1994,
Blomquist 2004).
For example, Atkinson and Halvorsen (1990) estimate the value of a life based on
the premise that individuals pay more for an automobile that offers a higher level of
safety (or a lower probability of fatality risk). Using the risk-dollar trade-off framework
initially proposed by Thaler and Rosen (1976), Atkinson and Halvorsen use data obtained
in the automobile market to estimate the value of a statistical life. Since accident rates
may be affected by the personal characteristics of the individuals who tend to buy that
type of automobile, they use a hedonic equation to control for this possible effect. After
adjusting for the average number of occupant fatalities per accident (dividing by 1.15),
they estimate the value of a statistical life to be $3.4 million (in 1986 dollars), which is
approximately $6.3 million in today’s dollars.23 This amount is consistent with the
findings in Viscusi and Aldy’s (2003) review article and therefore lends credibility to this
method as a means of valuing a human life.

2.4.6 Methods for Valuing Health
Although placing a value on something as intangible as one’s health may at first
seem implausible, just as economists have found reliable means of valuing a life, they
have used similar methods to value improvements in health. Valuing health is important
because, from a benefit-cost standpoint, it is necessary in order to ensure that the
combination of health services being offered is the one that will maximize the wellbeing
of its citizenry. Therefore, finding a meaningful way to value health is necessary in order
to make efficient decisions regarding the number and types of health programs to offer.

23

(CPI March 2007 – Ave. CPI 1986)/ Ave. CPI 1986 = (205.352-109.6)/109.6 = .873650
$3.357 million * 1.873650 = $6.29 million
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As a result, economists have strived to improve the methodology employed to value
health.

The following describes several methods that economists have utilized in

estimating the value of health.
Cost of Illness
One method that has been used to value health is the cost of illness (COI), or
human capital, approach.24 The theoretical basis for this method relies on the assumption
that individuals within our society represent human resources that produce goods and
services (Berger et al. 1994). Therefore, when individuals within our society become sick
and are not able to work, there is a cost involved – specifically, the cost of medical
services utilized, as well as the loss of productivity during the illness. These costs can be
classified as either direct or indirect costs of illness. Costs such as health expenditures
and the value of resources used for treatment (doctor’s time, medical supplies,
medications, etc.) are all considered direct costs; whereas the value of lost productivity
and lost wages resulting from being sick (or dying prematurely) are considered indirect
costs. Therefore, using this approach, the value of a health improvement is equal to the
sum of the direct and indirect costs associated with the illness (Berger et al. 1994).
When an individual works in a clearly defined market and/or has a specified
wage, the COI approach can be used to estimate a lower bound for the value of
improvements to health.

This method can only provide a lower bound for health

valuations because it does not take into consideration the value an individual places on
avoiding the pain and suffering associated with an illness (lost utility). In addition,
significant problems arise when this approach is used in an attempt to estimate the value
the general population places on a health improvement. This is because it completely
disregards the value placed on health by those who are retired or who work in nondefined markets (i.e. full-time homemakers). Because these individuals do not have a
market wage, their loss of productivity due to sick time is simply recorded as a zero in the
calculation. Therefore, this method clearly has limitations in estimating reliable values
on health improvements and at best can only yield a lower bound (Berger et al. 1994).
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For examples, see Weisbrod (1971) and Cooper and Rice (1976)
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Cost-Effectiveness Analysis
The inherent shortcomings of the COI approach for valuing health - its lack of a
theoretical foundation in utility theory, the fact that it does not account for the intrinsic
value and quality of life, and that it discriminates against those not in the labor force lead to the development of cost-effectiveness analysis (CEA).

Cost-effectiveness

analysis measures the effectiveness of an intervention in terms of health outcomes (such
as life years gained) for each dollar spent and is most often used in the field of public
policy (Johannesson 1996). In determining how to allocate financial resources between
competing health programs, the decision rule is to maximize the effectiveness for a given
budget. This methodology works best when comparing alternate treatments that have the
same goal; however, as discussed earlier in this chapter, CEA falls short when comparing
programs with different outcomes. The problem with this method is that it does not
provide a basis for comparison between outcomes measured in different units. Therefore,
although this method is useful in finding the least costly way to achieve a specific healthrelated outcome, it provides no systematic way to choose between programs designed to
pursue unrelated health goals.
Cost-Utility Analysis
One of the concerns with cost-effectiveness analysis was that the utility associated
with a single outcome measure of life years gained could vary considerably depending on
the quality of life associated with those years. For example, consider two programs, both
of which have an outcome of 5 additional life years gained. One program will grant
individuals 5 additional years with relatively no side effects, whereas the other will grant
an additional 5 years with significant side effects. Clearly, the outcome without side
affects is preferable; however, cost-effectiveness analysis would rate these two programs
equally. Therefore, cost-utility analysis was developed as a special form of costeffectiveness analysis in which life years gained are adjusted for the quality of life
obtained in those years. As a result, this method uses quality adjusted life years (or
QALYs) as the measure of effectiveness. QALYs are often obtained by taking the gain
in life years and multiplying by a utility index based on the quality of life achieved in
those years. For example, if an individual has a quality of life equal to 80%, then 5 life
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years gained would equal 4 QALYs (5 life years *.8). Because cost-utility analysis is
essentially an extension of cost-effectiveness analysis, the same problems that are
prevalent in cost-effectiveness analysis also exist for cost-utility analysis. In addition,
cost utility analysis faces the added challenge of measuring quality of life and
transferring it into a valid utility index25 (Johannesson 1996).
Household Production and Preventative Expenditures
Whereas the COI approach looks at the expenditures made after the onset of an
illness, the household production and preventative expenditures approach looks at
expenditures intended to prevent illness (Berger et al. 1994). From the earlier discussion
of Grossman’s (1972) model on health production, it is clear that individuals can make
purchases that contribute to their overall health. Therefore, one way to value health is to
calculate the sum of the additional income that can be earned plus the monetary value
resulting from a higher level of utility associated with good health (Berger et al. 1994).
Thus, the household production and preventative expenditures method not only includes
the indirect cost of illness (lost wages), but unlike the COI approach, also includes a
preference-based measure that stems from the individual’s own consumption and
resulting utility26
Willingness to pay – Implicit markets
Household production models can also utilize observations of self-protection to
estimate the WTP for small changes in fatality risks (Blomquist 2004). Self protection
refers to individual actions which avert risk, such as wearing a seatbelt, choosing not to
smoke, or as discussed above, making purchases that improve the individual’s level of
safety (buying smoke detectors for the home, purchasing a car with added safety features)
(Blomquist 2004). A study by Smith and Desvousges (1985) showed that households in
the suburbs of Boston took varying preventative measures (including purchasing bottled

25
26

methods used to measure utility include the standard gamble and time-trade off
For examples, see Cropper (1981), Gerking and Stanley (1986), and Dickie and Gerking (1991)
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water, installing water filters, and attending public meetings) as a means of reducing the
health risks associated with toxins in the drinking water (Berger et al. 1994).27
Because people invest time and money in producing their own health, it is
possible to observe the consumption of goods that are indirectly related to health (and
purchased in well-defined markets) to derive the value people place on health
improvements. As discussed earlier in this chapter, individuals chose jobs that reveal
their preferences regarding risk (averting behavior in the labor market) and purchases in
consumer markets (averting behavior in consumer markets) that involve dollar-risk tradeoffs that can be used to estimate valuations for health in terms of the individual’s WTP.
WTP provides a more complete measure of valuation compared to COI and is preferable
measure over cost-utility and cost-effectiveness measures because it is compatible with
BCA. Therefore, WTP28 is the preferred measure in valuing improvements in health.
Willingness to pay – Contingent markets
In valuing goods for which no market exists (i.e. lower health risk, reduced side
effects), economists have used surveys to get respondents to reveal their willingness to
pay (WTP) for a specific health commodity contingent on the existence of a market for
that good. This is known as the contingent valuation method (CVM). The CVM is a
stated preference method that uses surveys to elicit individual preferences by asking
respondents directly about their willingness to pay for a particular good or service. As
discussed earlier in this chapter, stated preference methods have an advantage over
revealed preference methods in that they have the potential to determine the total
valuation of a good, including passive-use values. Therefore, this method is incredibly
useful for BCA. As a result, contingent valuation (CV) is widely used to estimate values
of environmental resources and is growing in popularity as a means for valuing healthrelated goods and services.
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See Blomquist (2004) for a review of the literature on self-protection and averting behavior
WTP is the maximum amount an individual is willing to pay for a given quantity of a good. Therefore,
the benefit associated with a health improvement can be found by measuring the area under the aggregate
demand curve (WTP plotted against quantity).
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2.5 Contingent Valuation Methodology (CVM)
Contingent valuation (CV) is a stated preference methodology that utilizes a
survey to elicit information regarding an individual’s valuation for an improvement in a
health, environmental, or other good for which a well-defined market does not exist. CV
surveys have been conducted face-to-face using an interviewer, over the phone, and
through self-administered surveys delivered through the mail and via the Internet.

2.5.1 Description of the Contingent Valuation Survey
Although no formal standard exists, most CV surveys contain a detailed
description of the good to be valued, including the manner in which it would
hypothetically be made available to the respondent; a mechanism by which the
respondent reveals his/her willingness to pay for the good; demographic questions; and
questions regarding the individual’s attitudes that may influence his/her valuation of the
good (Mitchell and Carson 1989).
Since the CVM has a variety of applications, the “good” described in the survey
can take many forms. It can be a public good such as electric wind power (Champ and
Bishop 2001), preserving rain forests acreage (Cummings and Taylor 1999), or
reclaiming wilderness areas at the Grand Canyon (Champ et al. 1997); a semi-private
good, such as a diabetes management program that may have positive externalities
(Blumenschein et al . forthcoming 2007); or a private good, such as an electric juice
maker (Cummings et al. 1995), sportscards (List 2001), sunglasses (Blumenschein et al.
1998), or a box of chocolates (Cummings et al. 1995). Regardless of the good being
valued, it is important to fully and accurately describe the good, to help ensure the
respondent has a clear understanding of the good they are being asked to value. This will
help prevent unwanted scope effects or embedding problems.

2.5.2. Payment Mechanism for Eliciting WTP
Once the respondent has been provided with a description of the good, they are
asked to value it in some way. For public goods, a common method of eliciting estimates
of WTP is through the use a dichotomous choice (DC) referendum question.
Respondents are asked to vote either in favor or against everyone contributing a certain
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dollar amount to a good (Brown et al. 2003, List et al. 2004, Cummings and Taylor
1999). Due to concerns that the referendum essentially “forces” everyone to contribute,
information on individual WTP has been obtained by asking for voluntary donations for a
public good, such that an individual’s decision to contribute does not affect others.
Voluntary contribution mechanisms (VCM), in which respondents are asked to make
voluntary donations may also include a provisional point mechanism (PPM) (Murphy et
al. 2005). In the context of the survey, respondents are informed of a minimum amount
that is needed in order for the good to be provided (the provisional point). It is thought
that inclusion of a PPM with a “one-shot” voluntary donation reduces the occurrence of
free-riding, and therefore provides more accurate measures of WTP (Poe et al. 2002). It
is not uncommon for CV studies that include a PPM to also tell respondents that if the
total contributions do not reach the dollar amount needed to provide the good, individuals
donations will be refunded (Murphy et al. 2005).
In valuing private goods, WTP can be elicited using a DC question in which
respondents are asked if they would be willing to pay a certain amount for the good.
Because this method will only yield a yes/no response from each individual, providing
either an upper or lower bound on the respondent’s WTP, econometric techniques are
needed to estimate the mean WTP. Therefore, in an effort to obtain additional data from
each respondent, DC choice questions are sometimes repeated with different price
offerings. Depending on the number of times the question is asked, this is referred to as a
single bounded, double bounded, or multiple bounded DC question (“bidding game”).
In the economics literature, the term “iterative bidding game” refers to the use of
a multiple bounded DC question in which respondents are asked repeatedly if they are
willing to pay $X for a good. Bids are either increased or decreased according to a preset group of bids. For example, if the pre-set bids are $5, $10, $15, $20, $25 and $30,
and the respondent answered “yes” to the initial bid of $15, the interviewer would ask if
the respondent was willing to pay $20. The interviewer will continue to the next highest
pre-set bid until the respondent answers “no”; thus, determining a narrow range in which
the respondent’s WTP lies. A similar process would occur if the respondent answered
“no” to the initial bid. In that case, the interviewer would then proceed to go down to the
next pre-set bid until the respondent switched their answer to “yes.” Although this
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process is termed “iterative” in some ways it is misnomer because the process does not
go back and forth to converge on a single value. Instead, bids are simply move in a
single direction until the respondent’s answer changes.
Bidding games are often subject to starting point bias (Mitchell and Carson 1989);
therefore, Mitchell and Carson (1989) suggest the use of a payment card in which
respondents are provided with all the bids and asked to circle the highest amount they
would be willing to pay. Finally, another approach to eliciting respondent WTP is to
simply let respondents state the maximum they would be willing to pay in an open-ended
question.
Through the use of one of these elicitation methods, CV surveys can determine
WTP for a good contingent upon a market for that good existing. This information can
then be used to estimate the benefit of the good/program and subsequently be used to
make recommendations regarding the efficient allocation of available resources.

2.5.3 The Growing Use of CVM
The use of contingent valuation (CV) first appeared in the environmental
literature, see Carson (2001). Valuing environmental goods posed a somewhat unique
difficulty in that market transactions reflecting consumer preferences are seldom
observed since many environmental goods are public goods provided with tax revenues
by the government. However, the development of the CV approach allowed economists
to collect data on the demand for environmental goods by asking individuals “to give
their willingness to pay for some outcome contingent on the assumed existence of a
market in which it [could] be purchased” (Magat, Viscusi, and Huber 1988, p. 395).
Although a market for health care does exist, economists face similar problems in valuing
health-related goods because of the presence of insurance companies as third party
payers, which tend to obscure the true preferences of consumers in these markets.
Therefore, the CVM gradually started appearing in the health literature as a means of
evaluating the value of health-related goods and services.
According to Portney (1994), the first mention of CVM occurred in 1947 in an
article by Ciriacy-Wantrup about the benefits of preventing soil erosion; however, early
applications of the method did not occur until years later. Perhaps the first to employ the
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CVM was Davis (1963), who as part of his dissertation research, used a survey to
estimate the demand hunters and wilderness lovers placed on a particular recreational
area. In an effort to validate his results, Davis compared his estimates to those obtained
using the “travel cost” approach, in which the quantity of visits is plotted against a range
of “prices.” In this case, the “price” is determined by the inferred cost required to travel
the distance.

Davis discovered that the estimates derived using the CVM were

comparable to those estimated using the travel cost method (Portney 1994); thus lending
credibility to the use of CV as a method for valuation.
In the early 1970’s, economists began to recognize the importance of CVM as a
valuation method for environmental and resource economics. In fact, Mishan (1971)
encouraged economists to use this direct questioning approach to elicit willingness to pay
values as opposed to methods that employed cost of illness measures (Berger et al. 1994).
During the 1970’s the CVM became increasingly important for its potential to fully value
environmental resources, including existence values (Blomquist and Whitehead 1995).
In addition, the use of the method was not limited to environmental goods.
Coincidentally enough, one of the first applications of the CVM in health economics was
a study by Acton (1973) who used a CV survey to value reductions in the risk of death
from heart attack (Portney 1994).
One of the unique features of the CVM is that it has the potential to capture
passive use values29 that may not be obtained using other valuation methods (Carson et
al. 2001). Therefore, CVM is highly useful for benefit-cost analysis. As a result, this
method gained popularity as a means of valuing environmental goods and resources that
were thought to have high passive use values.30 However, the use of this method to value
environmental resource damages in Alaska following the Exxon Valdez oil spill, which
resulting in a highly public court case and large monetary award for damages (resulting
primarily from high existence and non-use values) has brought a lot of attention to the
CVM and fostered a debate as to whether CV can provide accurate measures of valuation
29

“passive use value” was a term adopted by the courts intended to be a broad descriptor which included
the following: non-use value, existence value, preservation value, bequest value, stewardship value,
intrinsic value, and option value (Carson et al. 2001).
30
In valuing environmental resources it is often the case that individuals place a value on a good even if
they never plan to use it. These existence values are utility based and may arise from purely intrinsic
values, altruism, or the fact that individuals would like to see the resource preserved for future generations
(Blomquist and Whitehead 1995).

33

(Portney 1994). Unfortunately, opposition to the CVM may not be coming solely from
individuals within the economic profession who are attempting to shed light on this issue
for the sake of academic integrity. Industry groups outwardly opposed to the use of
CVM have sponsored research investigating the reliability of the CVM (Carson et al.
2001). This means that sources of financing for CV validation studies may need to be
considered when making broad assessments as to the reliability of the CVM in valuing
non-market goods.
In response to the criticism over the validity of the CVM, a panel of wellrespected economists was convened by the National Oceanic and Atmospheric
Administration (NOAA). The purpose of the panel was to answer the question “Is
contingent valuation capable of eliciting reliable estimates?” (Portney 1994, p 8). The
panel concluded that “CV studies can produce estimates reliable enough to be the starting
point for a judicial or administrative determination of natural resource damages including
lost passive use values” (Arrow et al. 1993 p. 4610). In addition, the panel including a
set of guidelines intended to help ensure the reliability of estimates obtained using this
stated preference method (Arrow et al. 1993). The NOAA panel has periodically updated
these rules in accordance with general findings derived from the growing contingent
valuation literature to help ensure the credibility of CV as a valuation method (List and
Gallet 2001, Little and Berrens 2004, NOAA 1994, 1996).
Although there are still some unanswered questions as to whether CV can
accurately reflect consumer preferences in all cases, the CVM continues to be widely
used in the environmental literature and a growing number of studies are using CV as a
method to value health-related goods and services.31 It is expected that this trend will
continue due to the important role stated preference methodology (including the use of
CV surveys) plays in providing valuations for benefit-cost analysis which is required by
federal agencies and more and more by state and local government for the
implementation of public policy programs (List et al. 2004).
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See Diener et al. (1998) for a review of the health care studies utilizing the CVM.
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2.6 Potential Concerns with CVM
Some economists have expressed concerns regarding the validity and reliability of
estimates obtained using CV (Diamond and Hausman 1994, Kahneman and Knetsch
1992). Therefore, the following section includes a discussion of each of these possible
issues: Hypothetical bias and other potential biases, embedding, insensitivity to scope,
familiarity, and warm glow.

2.6.1 Bias
There are several types of bias, or systematic error, that can occur when
conducting a CV study including: hypothetical bias, strategic bias, starting point bias,
vehicle bias, and information bias. Hypothetical and strategic bias are an inherent part of
any CV study, whereas the other biases stem primarily from the design of the survey
instrument (Kenkel et al. 1994). The bias that currently appears most often in the
literature, and potentially poses the greatest concern for obtaining accurate valuations
using CVM, is hypothetical bias. The following provides a more detailed explanation of
each of these potential biases.
Hypothetical Bias
The term “hypothetical bias” is commonly used in the empirical literature to refer
to the tendency of stated values in hypothetical markets to overestimate preferences
revealed through actual behavior. Hypothetical bias has serious implications regarding
the validity of utilizing CV valuations for policy decisions. According to Kenkel et al.
(1994) hypothetical bias can occur when the respondent does not believe the credibility
of the question being asked. If the respondent puts little or no faith in the validity of the
question, then their response will also tend to be less than credible (Kenkel et al. 1994).
Because decisions being made in contingent markets do not require a financial outlay,
one of the challenges in designed a CV survey is to select a payment mechanism that is
incentive-compatible; that is, one that will provide an incentive for respondents to reveal
their true WTP.
One of the current concerns regarding values obtained using the CVM is that
several studies have shown that stated preferences elicited through hypothetical markets
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tend to overestimate revealed preferences observed in actual markets (Cummings et al.
1995, List and Gallet 2001). Cummings et al. (1995) compared decisions to purchase
three goods: an electric juicer, a box of chocolates, and a thin solar calculator, and found
that respondents were more likely to say they would purchase the good when the decision
was hypothetical versus when the decision was real. List and Gallet (2001) perform a
review of the literature and find that for several studies, hypothetical values exceed actual
values for both public and private goods. This finding indicates that hypothetical bias is a
real concern for CV surveys that needs to be addressed in order to obtain valid benefit
measures using this method.
Strategic Bias
Even if the respondent believes the question to be credible (to help address
hypothetical bias), the potential for strategic bias still exists. According to Mitchell and
Carson (1989), “strategic bias occurs when respondents deliberately shape their answers
to influence the study’s outcome in a way that serves their personal interest” (Mitchell
and Carson 1989, p. 238). Therefore, the more credible the question is perceived to be by
the respondent, the more likely he/she is to misrepresent a response in a strategic manner.
In this case, the respondent’s valuation for a good would not necessarily be a statement of
their true preferences, but rather would reflect their strategy to accomplish another,
possibly completely unrelated, pursuit (Kenkel et al. 1994).
Strategic bias is much more likely to occur in the valuation of a public good,
because of the tendency for individuals to try and become “free-riders.” When
respondents believe that the valuation they give in a survey could ultimately affect how
much they would have to pay for the good (perhaps through an increase in taxes), there is
an incentive to act strategically and give a valuation that is below their true valuation.
Or, if the individual expects that because of their limited income, there may be a
maximum amount that would be required of them to receive the good, there could be an
incentive for these individuals to overstate their preferences in an attempt to ensure that
the good becomes available. In general, the overall expectation is that if strategic bias
does exist in the sample, then a slight overestimation is likely to occur. (Mitchell and
Carson 1989). However, even in this case, there is little evidence to support the theory
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that people act strategically in completing CV surveys and because this is much less
likely to occur in valuing a private good, strategic bias does not appear to be a significant
issue for this particular study.
Starting Point Bias
Starting point bias arises from the tendency of respondents to perceive the initial
bid as reasonable, thus causing valuations to cluster around the starting point. This can
potentially be avoiding in several ways. One way is to vary the starting points among the
surveys.

Another method is to use a dichotomous choice framework in which the

respondent is simply asked to accept or reject a single, random bid. Based on the series
of yes and no responses, the mean WTP can be calculated (Kenkel et al. 1994) using
econometric techniques such as Kriström’s (1990) non-parametric approach.
Vehicle Bias
Vehicle bias occurs when a response is influenced by the payment vehicle. For
example, the questionnaire may state that the good will be financed by an increase in
taxes. In this case, the respondent may state their maximum WTP is zero as a protest to
any increase in taxes, even though they may actually place a significantly higher value on
the good (Kenkel et al. 1994). Vehicle bias can potentially be avoided by wording the
question in such a way that the payment method is vague; however, this could
inadvertently increase the potential for hypothetical bias as it may reduce the credibility
of the proposal as perceived by the respondent (Kenkel et al. 1994).
Information Bias
Finally, information bias can occur as a result of the information provided in the
questionnaire.

It is necessary for contingent valuation surveys to provide some

information, as asking an individual to value a good with no understanding of that good
would not provide accurate assessments of valuation (Fabian and Tolley 1994).
However, it is not always the case that more information is better. As Mitchell and
Carson (1989) point out, sometimes adding information to make the survey scenario
more realistic can cause respondents to focus on unimportant details while losing sight of
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the good being valued. Therefore it is necessary to find a balance in which enough
information is conveyed so the respondent understands and can credibly value the good,
while avoiding too much detail that can will take excessive time and potentially lead to
boredom on the part of the respondent (Fabian and Tolley 1994).
Mitchell and Carson (1989) caution that information bias can have a significant
effect on WTP values if respondents misunderstand the good being valued. For example,
if the researcher asks respondents to value a low-probability risk, but it is misperceived
by respondents to be a high-probability risk, then it is likely to have an effect on stated
WTP (Mitchell and Carson 1989). Therefore, care should be taken to clearly define the
good and test respondents’ understanding of the good, perhaps through the use of focus
groups. In addition, the potential for information bias can be diminished by ensuring the
CV survey focuses on two types of information – elements that are valuation relevant
(which are intended to be taken into account in the valuation process) and elements that
are valuation neutral (those that provide a credible market for the good, and are not
intended to influence the valuation) (Mitchell and Carson 1989).

2.6.2 Embedding
Some economists, including Diamond and Hausman (1994), have argued that
stated WTP obtained through the CVM can be subject to an embedding effect.
Embedding occurs when respondents to a CV study value more than what the researcher
intends (Schulze et al. 1998). For example, in an air quality study by Tolley at al. (1985),
respondents were asked to provide a WTP amount for improved visibility. In stating their
WTP for improved visibility, it is possible that respondents also included a dollar value
associated with the improved health that would additionally result from better air quality
(Schulze et al. 1998).32
32

Schulze et al. (1998) offer three possible reasons why embedding might occur: (1) Individuals gain
“moral satisfaction” from giving to a good cause; however, marginal utility derived from increased giving
diminishes rapidly. Therefore, giving to more than one cause or increasing the amount of the good has
little effect on the individual’s WTP; (2) If goods have high substitutability, then respondents may view
giving to one program as having high value, but giving to a second program would have little value; (3)
Individuals consider “joint products” when making their valuations. This occurs when respondents value
more than they are asked to value. For example, a respondent may be asked how much they would be
willing to pay to save an endangered species of butterfly in the Amazon. If the respondent feels that the
only way to save the butterfly is to preserve its habitat, then the respondent may state their valuation for
saving the forest, as opposed to just saving the butterfly (Schulze et al. 1998).
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Hoehn and Randall (2002), two of the economists who worked on the Tolley et al.
(1985) study, later utilize a procedure for valuing multi-dimensional goods that
eliminates the embedding problem. Hoehn and Randall (2002) use a CV survey to value
improvements to the Coeur d’Alene River Basin that had sustained environmental
damages due to years of coal mining. Using an information booklet,33 respondents are
asked to assess the severity of individual environmental injuries (i.e. toxicity to the area,
fish mortality, swan mortality) associated with the resource damage. After all of the
information regarding resource injuries was made, respondents were then asked to state
their preferences for improving the area by voting in favor or against a one-time tax (tax
amounts ranged from $60 to $220). Marginal WTP for each individual benefit stemming
from the overall treatment can then be obtained using a linear model (in a manner similar
to hedonic regression) in order to decomposes WTP into the implicit prices associated
with each specific improvement (Hoehn and Randall 2002). Although the authors agree
that this method may still be susceptible to question order effects (Hoehn and Randall
2002) which could affect marginal WTP values, this method does address the issue of
embedding, and as such, should result in reliable valuations for the overall improvement
being valued.

2.6.3 Insensitivity to Scope
Problems associated with scope occur when economic theory dictates that people
should be willing to pay more (for an increase in quality or quantity of the good) and yet
WTP remains relatively constant. In an attempt to discredit the CVM, Diamond and
Hausman (1991) cite a study by Desvousges et al. (1993) in which, according to
Diamond and Hausman, the WTP valuations obtained were essentially the same for
saving (a) 2,000, (b) 20,000, or (c) 200,000 birds. Although this seems like strong
evidence to suggest a problem with scope, Carson et al. (2001) point out that this
statement is misleading because in fact, the Desvousges et al. (1993) survey was worded
such that respondents were valuing “saving (a) much less than 1%, (b) less than 1%, or
(c) about 2% of a population of 8.5 million migratory waterfowl” (Carson et al. 2001).

33

According to the authors, the booklet was organized following the hierarchical format suggested by
Bettman et al. (1987) and Magat et al. (1988).
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This is not to say that problems with scope are not possible; however, it does suggest that
clearly defined goods (in terms that are easy for the respondent to understand), can help
prevent scope from being an issue. One area in which scope is known to be a valid issue
is “valuing small changes in small probabilities in health risk” (Carson et al. 2001).
Beattie et al. (1998) find that individuals have difficulty understanding low-level changes
in risk which can result in valuations that are insensitive to scope.

2.6.4 Level of Familiarity
When people choose to make a purchase in an actual market, they generally know
something about the good they are planning to purchase. However, in asking about a
good in a contingent market, respondents may not be familiar with the good they are
being asked to value. This can lead to problems associated with embedding or scope, as
mentioned above, and can also bring into question the accuracy of using stated
preferences as a method of valuation.

Regarding the degree of familiarity that is

necessary to make valid estimations of value, some economists (Carson et al. 2001,
Hanemann 1994) argue that numerous new products are introduced in consumer markets
each year, such that individuals routinely make “purchase decisions involving goods for
which they have no prior experience” (Carson et al. 2001 p. 178).

Therefore, the

information provided in contingent valuation surveys may actually provide more
information about the good than consumers have in making purchases for “unfamiliar or
infrequent commodities” (Hanemann 1994 p. 20).
Although this theoretical argument may appear to have merit, the empirical
evidence suggests otherwise. Whitehead et al. (1995) find that in valuing improvements
in the water quality and wildlife habitat for an environmental resource in North Carolina,
on-site and off-site users provide estimates of WTP that meet tests of construct validity;
whereas those provided by non-users did not (Whitehead et al. 1995). In addition, Boyle
et al. (1993) find that experienced boaters provide more valid WTP responses than
inexperienced boaters in valuing flow levels that can affect the quality of a white water
rafting trip through the Grand Canyon. These findings suggest that those who are more
familiar with the good may give more valid estimates of WTP. In addition, sampling
respondents who are more familiar with the good being valued may also prevent other
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related CV issues.

In a review of the CV literature, findings by Schulze et al. (1998)

suggest that embedding may be less of an issue for respondents who are familiar with the
good versus those who are unfamiliar. These studies provide evidence that sampling
respondents who have some degree of familiarity with the good may improve the
accuracy of WTP estimates; however, it does not preclude the possibility that individuals
with lower degrees of familiarity can still provide accurate valuations for certain types of
goods, provided the CV survey provides relevant information and precautions are taken
to mitigate the effect of hypothetical bias.

2.6.5 Question Order and Context Effects
Question order effects arise when the valuation of multiple goods presented in a
single CV survey is influenced by the order in which the goods are presented. The
following example illustrates a common occurrence for CV studies in which two or more
goods are valued as part of the same survey. If respondents are asked about their WTP to
save whales in a certain natural resource area, and then asked about their WTP to save
dolphins in the same area, respondents’ WTP for saving whales tends to be higher;
however, when the order of the questions is reversed, respondents’ WTP for dolphins is
higher. Another related problem is when two different surveys are used to value whales
and dolphins separately. In this case, the sum of the WTP valuations when the two goods
are valued independently tends to be larger compared to the sum of the WTP valuations
for the two goods when they are valued together as part of the same survey. Carson et al.
(2001) asserts that these outcomes can largely be explained by income and substitution
effects. When two goods are valued together, the household income available to spend
for the second is diminished by the respondent’s stated WTP for the first. In addition, if
these goods are viewed as substitutes, then it is not surprising that WTP for the first
would diminish WTP for the second. However, income and substitution effects would
not be observed when the goods are valued independently. Therefore, Carson et al.
(2001) caution that summing up CV estimates obtained independently does not take into
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account substitution and income effects, and this is necessary in order to derive
valuations that do not overstate true WTP.34
Evidence regarding question order effects in CV studies includes a study by Boyle
et al (1993). In this study related to the quality of a white water rafting trip along the
Colorado River in the Grand Canyon, 8 different levels of river flow were valued in the
same CV survey (Half the sample received a survey in which the flows ranged from low
to high, and the other half received surveys in which the flows ranged from high to low).
Since the goods being valued were completely independent of each other, resulting
valuations should also have been unaffected by question order. Boyle et al. (2003) found
that those with more familiarity of the good (i.e. experienced boaters) did not
demonstrate question order effects; however, those with less experience did have
variances in their valuations that could be attributed to question order. This finding
suggests that those with a higher level of familiarity may be less susceptible to question
order in valuing goods through CV.

2.6.6 Warm Glow
Warm glow35 is a concept that suggests that individuals can be motivated because
they “derive utility from the act of giving through the associated social approbation,
prestige, or moral satisfaction” (Carson et al. 2001 p. 177). Empirical evidence from the
CV literature suggests that the warm glow effect may be an issue when respondents make
their preferences known in such a way that the information may be made public.
A CV study by Leggett et al. (2003) in which visitors to Fort Sumter National
Monument in South Carolina were asked about their WTP for a fort visit, suggested that
conducting the survey using an interviewer resulted in “social-desirability bias” as
compared to WTP estimates obtained using a self-administered mail survey. However, a
study by Carson et al. (1994) found that using a standard CV format with an interviewer
versus a secret ballot box resulted in no statistically significant difference in WTP
estimates. In addition, in a comparison of mail versus telephone surveys, Ethier et al.
34

In as much as it does not take into account income and substitution effects, Carson et al. (2001) do not
agree that the “adding-up test” proposed by Diamond and Hausman (1994) should be used to validate CV
valuations.
35
According to Carson et al. (2001), Becker (1974) used the term “warm glow” to describe the concept of
impure altruism which was first introduced by Olsen (1965).
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(2000) found that hypothetical decisions to participate in an environmentally-friendly
energy program were not statistically different between survey modes, suggesting that
social desirability bias did not occur when a respondent was interviewed over the
telephone.
Like Leggett et al. (2003), List et al. (2004) also found evidence of the warm glow
or social-desirability bias when stated preferences were obtained using an in-person
interviewer and, in addition, when there was a possibility that the respondent would have
to make his/her preference known to a group. List et al. use a referendum format to ask
respondents whether or not they would support contributing $20 to the start-up of a new
Center for Environmental Policy Analysis (CEPA) at the University of Florida.
Respondents included a total of 268 undergraduate students recruited from the College of
Business. The students were divided into three groups representing different degrees of
anonymity under which they would state their preferences for the good. A split-sample
format was used, such that half the students in each group received the hypothetical
questions and the other half participated in the actual referendum. Study results indicated
that those in the peer group (in which 10 members of each group were required to share
their response) were more likely to vote “yes” compared to those surveyed using the
other two methods. In addition, there was a statistically significant difference between
those in the baseline group (for which only the surveyor would know the respondent’s
stated preferences) as compared to the percentage of “yes” responses given by the group
for which respondent answers were completely anonymous (List et al. 2004).
The List et al. study suggests that when individuals are asked to state their WTP
in a manner in which they feel their answers may be made public, there is a tendency for
individuals to be influenced by an external source of utility -namely, that of “advertising
one’s own goodwill” (List et al. 2001 p. 749) and including that as part of their stated
WTP. Since this value should not be included in assessing the WTP for the good itself,
this study provides evidence that suggests confidentiality when stating preferences is
important to elicit WTP values that are free from bias.36

36

This result also brings into question that assumption that is often made in validity tests – that “real”
responses in laboratory and field experiments reflect true WTP. If, in fact, these “real” values are inflated
due to warm glow, then that implies the degree of hypothetical bias may not be as large as previous
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2.7 Evaluating the Validity and Reliability of CVM
The validity of CVM refers to how well stated preferences match actual
valuations, and the reliability of CVM refers the consistency of stated preferences over
time or across different samples of the population (Carson et al. 2001). Meeting one of
these criteria does not necessarily imply that a contingent value measure will meet the
other (Whitehead et al. 1995).

2.7.1 Validity
Ideally, validity would be confirmed by comparing results to a known standard
(such as validating the weight of an object by comparing it to a known weight at the
National Bureau of Standards); however, true underlying consumer preferences are
unknown, such that no standard is available for comparing valuations obtained through
CVM. Therefore, researchers typically rely on two tests to determine validity: construct
validity and convergent validity (Carson et al. 2001).
Construct Validity
Construct validity is determined by how well stated preferences are explained by
factors that economic theory would predict.

For example, economic theory would

predict that the percentage of individuals willing to pay for a good will decrease as the
price increases (Carson et al. 2001). According to a review of the literature by Carson et
al. (2001), this result is widely confirmed. In addition, construct validity implies that
individual WTP can be explained by characteristics of the good and individual, in ways
that economic theory would predict.37 In particular, one would expect WTP for a good to
increase with higher levels of income (for a normal good), and for WTP to also rise for
increases in the quantity (or quality) of the good being provided (Carson et al. 2001).
The later is often referred to as a scope test.
According to Carson et al. (2001), “a scope test looks at whether respondents are
willing to pay more for a good that is larger in scope, whether in a quality or quantity
sense” (Carson et al. 2001 p. 181). Carson et al. further state that failure to pass a scope
thought. However, the fact that hypothetical bias has been observed for private goods, suggests that even if
this theory is true, it cannot account for the entire difference between revealed and stated preferences.
37
Testing this assumption is referred to as a theoretical validity test (Blomquist and Whitehead 1998).

44

test may be due to (1) insufficient statistical power as described by Arrow and Leamer
(1994); (2) poor survey design or administration as explained by Carson and Mitchell
(1995); or (3) CV results that are inconsistent with economic theory as discussed by
Hausman (1993).
Two types of scope tests exist. An internal scope test uses stated preferences
from the same individuals at different levels of the good to see if the results are consistent
with economic theory (i.e. a higher WTP is observed when larger amounts, or a higher
quality, of the good is offered). An external scope test examines the same assumption,
but by comparing stated preferences from statistically equivalent subsamples, each of
which value a different level of the good (Carson et al. 2001). A study by Blomquist and
Whitehead (1998) uses a CV survey to estimate the WTP to preserve wetlands offering
various levels of quality. Blomquist and Whitehead find that individual WTP does
respond to differences in wetland quality as described in the CV survey; thereby
suggesting that individuals do respond to variations in scope in CV surveys.
Although some critics of the CVM, contend that scope is a serious problem,
Carson et al. (2001) argue that these claims are based on a small subsample of the
literature that is not representative. In a review of the CV literature, Carson et al. (2001)
find that 31 CV studies passed a scope test, while only 4 did not. Based on these studies,
Carson et al. conclude that “poorly executed survey design and administration procedures
appear to be a primary cause of problems in studies not exhibiting sensitivity to scope”
(Carson et al. 2001 p. 183).

Thus, suggesting that many issues related to scope

insensitivity can be prevented with careful survey design and implementation.
Convergent Validity
Convergent validity is the degree to which stated preferences obtained through
CVM match preferences revealed in implicit markets. Therefore, convergent valuation
can be tested by looking at either (1) the degree of correlation or (2) the ratio between
valuations derived using CV surveys to estimates of value for the same good obtained
using implicit market methods (namely, travel cost or hedonic pricing).38

Another

potential way to test for convergent validity is to compare results of a CV survey
38

For examples, see Loomis et al. (1991) and Blomquist (1988).
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involving an upcoming referendum and then comparing the results predicted by the CV
method to the actual voting results (Carson et al. 2001). According to Carson et al.
(2001), CV studies using a referendum format that are conducted relatively close to the
actual vote have been quite successful at predicting actual voting outcomes.39

2.7.2 Reliability
Reliability is a measure of the consistency of CV results over time or across
different samples.

Two tests of reliability include testing the consistency of CV

responses by (1) surveying the same respondents at two different points in time, and (2)
surveying two different samples at two different points in time (Carson et al. 2001).
Carson et al. (2001) cite several studies40 that found valuations remained consistent over
time,41 suggesting that the CVM has the potential to produce results that are reliable over
time, both for across sample and same sample designs.
2.8 Addressing Hypothetical Bias: Evidence Supporting the Validity of the CVM
As mentioned previously, hypothetical bias appears to currently pose the greatest
problem for the CVM. A meta-analysis conducted by List and Gallet (2001) compare
hypothetical values to real values for 29 CV experiments and find the calibration factor42
for many of these studies exceeds 1.2; thus, supporting the conclusion that valuations
obtained through stated preferences (utilizing a CV survey) are, indeed, prone to
hypothetical bias. Hypothetical bias has been observed for both private (Blumenschein et
al. 2007, Cummings et al. 1995, List 2001) and public goods (Champ and Bishop 2001,
Champ et al. 1997, Cummings and Taylor 1999) and across a wide range of payment
mechanisms; therefore it is unlikely that this phenomenon is dependent on these factors43

39

Carson et al.’s (2001) conclusion is drawn from studies by Carson, Hanemann, and Mitchell (1987) and
Polasky, Gainutdinova, and Kerkvliet (1996)
40
Studies include Carson and Mitchell (1993), Carson et al. (1997), Whitehead and Hoban (1999)
(independent samples) and McConnell, Strand, and Valdes (1998) (same sample).
41
For some studies, including Whitehead and Hoban (1997) and McConnell, Strand, and Valdes (1998),
WTP changed (which could potentially be explained by changes in the household’s income or other
relevant factors overtime), but the valuation function was unchanged (Carson et al. 2001).
42
The calibration factor is found by dividing the mean hypothetical value by the mean real value and is
used as a measure of the degree of hypothetical bias present in the valuation (List and Gallet 2001).
43
Results from List and Gallet’s (2001) meta-analysis suggest that hypothetical bias will be less
pronounced when private (versus public) goods are valued using WTP (versus other mechanisms);
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As a result of the presence of hypothetical bias in stated preference valuations,
several methods have been employed to remove hypothetical bias from the data ex post
using various calibration methods. Many of these methods involve assessing the degree
of certainty with which the respondent states their preferences using a certainty scale or
in answering a polychotomous choice question regarding how sure they are about their
decision. Another, completely different, approach focuses on encouraging respondents to
address the potential for hypothetical bias before stating their preferences. The idea
being that if respondents are aware of the potential for hypothetical bias, they will then be
able to correct for it before making a statement regarding their preferences for the good
being valued. This ex ante method was introduced by Cummings and Taylor (1999) and
is often referred to as the “cheap talk”44 approach.

2.8.1 Cheap Talk
Cummings and Taylor (1999) introduce a potential method of eliminating
hypothetical bias in which they use a “cheap talk” script to inform respondents directly
about the possibility of hypothetical bias prior to stating their preferences for the good
being valued. Cummings and Taylor find that for decisions regarding donations toward
several public goods, there is no statistically significant difference between actual
referendum voting and hypothetical referendum voting when a cheap talk script is
utilized. Furthermore, additional testing on these public goods revealed that this result
was robust for modifications of the cheap talk script and across variations in experimental
design (Cummings and Taylor 1999). The results of this study are supported by Ajzen et
al. (2004) who found that hypothetical student donations toward a scholarship fund under
a referendum model exceeded real donations; however, inclusion of a corrective entreaty,
which followed the cheap talk script proposed by Cummings and Taylor, effectively
removed the difference between real and stated preferences.
Although the results of the Cummings and Taylor (1999) and Ajzen et al. (2004)
studies suggest that utilizing a “cheap talk” script within a contingent valuation
however, these findings were not supported in a meta-analysis performed by Little and Berrens (2004),
which expanded on the work done by List and Gallet (2001).
44
The name “cheap talk” is a reference to the term used in bargaining for the costless transmission of
information or signals (Cumming and Taylor 1999).
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framework has the potential to effectively eliminate the difference between decisions
made in real markets versus those made in contingent markets, other studies reveal that
cheap talk may be limited in its effectiveness at removing hypothetical bias, at least in
certain cases (Blumenschein et al. forthcoming 2007, Brown et al. 2003, Murphy et al.
2005, List 2001).
Brown et al. (2003) and Murphy et al. (2005) found that utilizing a cheap talk
script reflective of the one used by Cummings and Taylor (1999) was effective at
removing hypothetical bias for higher dollar amounts, but was not as effective at lower
dollar amounts. Brown et al. (2003) use a split-sample design to test whether the cheap
talk script is effective at eliminating hypothetical bias for students making donations to a
scholarship fund through a referendum mechanism. The amount of the donation was
varied between $1, $3, $5, and $8. As economic theory would predict, the results
indicate that the percentage of students voting “yes” decreased as the price increased
when the referendum was real.

However, when the decision was hypothetical, the

percentage of “yes” votes remained fairly constant across price levels. This result implies
that hypothetical bias may be larger for higher payment amounts; however, including a
cheap talk script that mimicked the one used by Cummings and Taylor was very effective
in eliminating the hypothetical bias for the higher bid amounts of $5 and $8. The cheap
talk method; however, did not sufficiently remove the hypothetical bias at the $3 level
(Brown et al. 2003).
A similar study conducted by Murphy et al. (2005) supports the finding that the
cheap talk script may not be effective at lower price levels. Murphy et al. investigated
the use of a provisional point mechanism in making donations to a public good. The
purpose of the study was to use a wider range of values ($3 to $30) to further test the
results of the Brown et al. study. Murphy et al. found that the cheap talk script was not
effective at lower amounts ($3 and $6), but for higher dollar amounts ($9 and greater) the
percentage of hypothetical donations converged with real donations (Murphy et al. 2005).
Interestingly enough, if you consider the prices used by Cummings and Taylor
(1999) and Ajzen et al. (2004) in their referenda, then the conclusion drawn by Brown et
al. (2003) and Murphy et al. (2005) - that the cheap talk script is only effective at higher
dollar amounts - is not necessarily inconsistent across these four studies. Cummings and
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Taylor used a price of $10 for all of its public good referenda and Ajzen et al. used a
price of $8. The results of Brown et al. and Murphy et al. suggest that a price of $8 and
$10 are high enough to fall within the range of prices for which the cheap talk was
effective at eliminating hypothetical bias. Therefore, Brown et al. and Murphy et al.
seem to have discovered a limitation of the cheap talk method that was not observed by
Cummings and Taylor and Ajzen et al. due to the fact that all the goods used in these
experiments had relatively high prices for which the cheap talk method appears to work
well.
Another possible limitation of the cheap talk method is suggested by List (2001)
who found differences in effectiveness based on familiarity with the good being valued.
Using a Vickery second-price auction to value sportscards, List found that the cheap talk
script proposed by Cummings and Taylor (1999) was effective at eliminating
hypothetical bias for non-dealers, but not for dealers. Although this finding may suggest
that a cheap talk script is more effective for those less familiar with a good due to the fact
that those who are more familiar with the good may “rely on few, if any, external signals
when formulating their value” (List 2001 p. 1498); it is also possible that a difference in
recruiting methods between dealers and non-dealers may have contributed, at least in
part, to this result.45
Although several laboratory experiments and field tests indicate that cheap talk is
effective at eliminating hypothetical bias for higher dollar amounts, a recent field test by
Blumenschein et al. (forthcoming 2007) and meta-analysis by Little and Berrens (2004)
suggests that the cheap talk script is not effective in eliminating hypothetical bias in
45

The study includes both dealers and non-dealers of sportscards and was conducted at a sportscard show.
Non-dealers were recruited for the study when interested parties stopped and inquired about the specific
sportscard being valued (which was displayed on a table). Dealers, on the other hand, were approached by
the researchers at their own booths prior to the start of the show (between 7AM and 12 PM on Saturday
and Sunday). Therefore, there was a distinct difference in the recruitment method between these two
groups that may account for the difference in effectiveness of the cheap talk script for this study. The nondealers recruited for the study expressed a specific interest in the card being auctioned, and as such, had a
vested interest in performing well in the auction (in order to win the card). Dealers, on the other hand, may
have been preoccupied with setting up their own booth when approached by the interviewer. If the dealers
included in the study were, in fact, pressed for time, they may not have taken the time and effort necessary
to adequately read the lengthy cheap talk script and learn about the Vickery auction through the
information sheet that was included as part of the study. If dealers were less motivated to read the cheap
talk script and auction procedure due to the circumstances in which they were recruited versus non-dealers,
then the results of this study may be more a reflection of the study design as opposed to a true difference in
the effectiveness of the cheap talk scheme across those with varying degrees of familiarity with the good.
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stated preference studies that use the contingent valuation methodology. Blumenschein
et al. use face-to face interviews to value a pharmacy-provided diabetes management
program. The field test includes 260 diabetics recruited from nine pharmacies in the state
of Kentucky. Prices for the program varied between $15, $40, and $80. Respondents at
three of the pharmacies actually received the program, respondents at three different were
given an opportunity to express their intentions of participating in the program by
answering a dichotomous choice contingent valuation question, and respondents at the
remaining three pharmacies were also asked whether they would participate in the
program if it were offered, but prior to making their decision were read a cheap talk script
similar to the one used by Cummings and Taylor (1999) in which hypothetical bias is
described.

Blumenschein et al. find a significant difference between real and

hypothetical stated preferences, indicating the presence of hypothetical bias in the data.
Based on their study, the cheap talk script is ineffective at removing the hypothetical
bias; however, when the follow-up certainty question is used to calibrate hypothetical
responses there is no statistical difference between real and hypothetical responses for
those who were “definitely sure” of their response (Blumenschein et al. forthcoming
2007).
The results of the Blumenschein et al. (forthcoming 2007) study suggest that the
cheap talk approach is not an effective tool at removing hypothetical bias in stated
preference valuations. Since the prices used in the Blumenschein et al. study were clearly
in the range of “high prices” for which the cheap talk methodology worked in earlier
studies (Brown et al. 2003, Murphy et al. 2005), these latest results certainly bring into
question the reliability of stated preferences obtained using only a cheap talk script. In
addition, a meta-analysis by Little and Berrens (2004) also indicate that the cheap talk
approach is not necessarily effective, but that using a certainty correction does effectively
eliminate hypothetical bias.

2.8.2 Using Certainty to Eliminate Hypothetical Bias
One possible explanation of the cause of hypothetical bias is based on the
“discrepancy between intentions and behavior” (Ajzen et al. 2004 p. 1109). This theory
implies that individuals with strong dispositions in favor of (against) the provision of a

50

good, will vote in favor of (against) it regardless of whether the decision is real or
hypothetical.

However, for individuals for whose disposition is not as strong,

inconsistencies between real and hypothetical decisions will be more likely to occur
(Ajzen et al 2004). Although the results of the study by Ajzen et al., whose main purpose
was to explore the formation of intentions and their relationship to actual behavior,
suggest that those who vote consistently and those who vote inconsistently may express
equally strong beliefs, they may do so with different degrees of confidence (Ajzen et al.
2004). This finding explains the difficulty economists have encountered in trying to
develop a calibration function based on attitudes and beliefs, and lends support to
pursuing the possibility of addressing hypothetical bias by looking at the certainty with
which stated preferences are made. In particular, this finding is not inconsistent with the
hypothesis that individuals who have a lower degree of certainty in their stated
preferences are more likely to be the source of hypothetical bias.
There are two basic approaches to using certainty to “calibrate” hypothetical
choices: (1) the use of a certainty scale first used by Champ et al. (1997), and (2) the use
of a follow-up certainty question. Since the heart of the debate is the accuracy with
which “hypothetical choices in the contingent valuation method correspond to real
economic choices” (Johannesson et al. 1999), numerous studies have specifically tested
this as a hypothesis by comparing stated preferences obtained in a hypothetical market
with actual purchase decisions.
Follow-up Certainty Scale
Champ et al. (1997) included a certainty scale in their CV study that explored the
difference between stated donations and actual donations to an environmental public
good. Using a mail survey, respondents were asked to make a donation to remove roads
along the North rim of the Grand Canyon and return the area to wilderness. The amount
of the public good provided was continuous in that total donations would determine the
amount of road that would be removed. For some respondents, the decision was real and
for others, the decision was hypothetical. Following the voluntary donation question,
respondents were asked to rate the level of certainty associated with their decision using a
scale of 1 to 10 (where 1 was “very uncertain” and 10 was “very certain”). Champ et al.
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found that hypothetical donations exceeded actual donations; however, when a
hypothetical “yes” was recoded to a “no” for all the respondents except those who were
“very certain” (indicated a 10 on the certainty scale); hypothetical donations were not
statistically different from actual donations. Thus, these findings provide evidence to
suggest that using a certainty scale to calibrate stated responses has the potential to
effectively remove hypothetical bias, such that actual preferences can be obtained using a
CV survey.
Since the Champ et al. (1997) study, several other studies have successfully used
certainty scales to calibrate hypothetical responses, such that they correspond with real
decisions; however, the degree of certainty used to recalibrate the responses varied to
some extent across studies. For example, in a study by Ethier at al. (2000) on consumer
participation in Green Choice (an environmentally-friendly electricity program), stated
participation rates converged with actual participation rates at certainty level of 7
(hypothetical participation rates at a certainty level of 8 were also not statistically
different from actual participation rates).

Similarly, in a follow-up mail study that

utilized a split-sample design, Champ and Bishop (2001) found that hypothetical
donations toward the purchase of wind-generated energy corresponded to actual
donations when a certainty level of 8 was used for calibration. Like, Ethier et al. (2000),
a study by Poe et al. (2002) also used the Green Choice program as their good to be
valued, but in addition to evaluating participation rates, this study also used a voluntary
contribution mechanism with a PPM. Results were similar to those of Champ and Bishop
and Ethier et al. in that hypothetical contributions most closely corresponded to actual
donations when respondents indicated a certainty level of 7 or 8.
Collectively these studies suggest that hypothetical bias can be eliminated such
that stated preferences obtained using a CV will reflect revealed preferences for public
goods. However, the potential difficulty with the certainty scale method is that it is not
entirely clear which level of certainty is the appropriate level to use for calibration.
Although these studies suggest that a value of 7 or higher is appropriate, the exact value
to be used for calibration may be dependent on the good being valued.
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Follow-up Certainty Question (Definitely/ Probably)
Another approach that has proved very successful as a means of calibrating
hypothetical responses, such that they correspond with real decisions, is the use of a
follow-up certainty question in which respondents indicate if they are “definitely sure” or
“probably sure” of their stated intensions. Like the certainty scale, this question is
presented immediately after the respondent indicates their hypothetical decision
regarding the provision of the good. To test the validity of using this type of certainty
question as a means of calibration, several laboratory and field experiments have been
conducted using private goods. Overall, this method shows excellent potential as a
means of eliminating hypothetical bias, such that hypothetical responses reflect actual
behavior. The following provides details on several related studies that trace the
development of this technique.
An experiment conducted by Johannesson et al. (1998) asked business and
economics students at Lund University in Sweden about their WTP for a box of Belgian
chocolates.

Following the hypothetical decision to purchase the box of chocolates,

respondents were asked to assess how certain they were of their purchase decisions.
Certainty could be expressed as “fairly sure” or “absolutely sure.” The results showed
that hypothetical “yes” responses overestimated real “yes” responses, indicating
hypothetical bias. However, only counting those who were “absolutely sure” as a true
“yes” response underestimated real “yes” responses, providing a conservative estimate of
WTP.
In another laboratory experiment by Blumenschein et al. (1998), the certainty
categories were modified to “probably sure” and “definitely sure.” In this experiment,
133 college students were asked about their willingness to purchase a pair of sunglasses,
either in a hypothetical or real context. Students who responded “yes” to the hypothetical
question to purchase the sunglasses were then asked to indicate if they were “definitely
sure” or “probably sure” about their decision. Using a nonparametric contingency table
chi-squared test, the results revealed that simply using “yes” responses did tend to
overestimate the true willingness to make the purchase; however, when only “definitely
sure” responses were counted as a true “yes” there was no statistically significant
difference between the two groups (Blumenschein et al. 1998). Therefore, this study
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suggested that hypothetical bias could be eliminated from CV estimates by simply adding
a certainty follow-up question, and then calibrating the results using those who were
“definitely sure” as a signal of a true intention to purchase the good.46
Given the success of this laboratory experiment, Blumenschein et al. (2001,
forthcoming 2007) then applied this methodology to in two field tests valuing healthrelated goods.

In the Blumenschein et al. (2001) study, patients taking asthma

medication were asked about their willingness to participate and pay for a pharmacist
provided asthma management program. Although 30% of the patients in the hypothetical
group stated they would participate in the program at the stated price, compared to only
12% who actually participated in the program, when hypothetical responses were
adjusted to only include those who were “definitely sure” as true “yes” responses, there
was no statistically significant difference in participation rates between the real and
hypothetical groups.
As discussed earlier, the Blumenschein et al. (forthcoming 2007) study which
compared hypothetical and real decisions to participate in a pharmacy-provided diabetes
management program, provides additional evidence to suggest that including only
“definitely sure” respondents as a measure of true intentions to participate, can be an
effective method to mitigate the effect of hypothetical bias often observed in CV studies.
Clearly hypothetical bias is an issue for the CVM; therefore, several studies have
focused on validating calibration methods such that preferences state in contingent
markets correspond to actual behavior. One of Diamond and Hausman’s arguments
against CV is that calibrations in prior studies have been arbitrary, however, Mitchell and
Carson (1989) correctly point out that quantifying the difference between actual behavior
and that stated on CV surveys is the key to accurate calibration.

46

Johannesson et al. (1999) further explore the data collected in the experiments conducted by
Johannesson et al. (1998) and Blumenschein et al. (1998), both of which included a certainty scale similar
to the one used by Champ et al. (1997). Using the respondent’s self-reported value on the certainty scale, a
variable representing the price level, and socio-economic variables including age and gender as explanatory
variables, Johannesson et al. estimate a probit function to determine the probability of a “yes” response
being a “true yes” response. After calibration, there was no statistically significant difference between the
hypothetical “yes” responses and the actual “yes” responses in either study (Johannesson et al. 1999).
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The results of several studies by Blumenschein et al. (forthcoming 2007, 2001,
1998) suggest that using a simple follow-up certainty question in which respondents
indicate whether they are “probably sure” or “definitely sure” of their stated preference
holds vast potential for eliminating hypothetical bias in CV surveys. Therefore, the
results of these studies provide additional evidence to support that CV can accurately
elicit individual WTP and provide valid valuations in deriving the benefits associated
with health-related and other non-market goods.
2.9 Information and Risk
When making decisions regarding risk and uncertainty, individuals often do not
have perfect information. However, According to Viscusi “if individuals were fully
informed of the consequences of their decisions and made rational choices, then in a
democratic society we should respect these choices” (Viscusi 1992, p. 4). This could
imply that if individuals chose to skydive or ride in a car without a seatbelt, then society
should allow them to do so. However, Viscusi (1992) goes on to state that it is often the
case that consumers are not fully informed about risks, and therefore often make
decisions with imperfect information. Therefore, if individuals are not fully informed of
the risks they face, then there is a potential for market failure which could potentially
justify government intervention (Viscusi 1992). So this suggests the question, “Do
individual risk perceptions tend to correspond with actual measures of statistical risk?”

2.9.1 Perceived versus Actual Risk
If individuals do not fully understand the risks they face, then their perceived risk
may be different from their actual risk. Viscusi and O’Connor (1984) test whether
chemical workers update their risk assessment when the current chemical they are
working with is replaced. Viscusi and O’Connor find that workers update their risk
assessments in the correct direction, suggesting that individuals may, in fact, be good
judges of actual risk. A study by Lichtenstein et al. (1978); however, finds a general
tendency for individuals to overestimate small risks, while underestimating larger ones;
thereby suggesting that an individual’s perception of risk may not always correspond
with actual risk.
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2.9.2 The Effect of New Information on Risk Assessment
Although Viscusi’s findings suggest that workers may be good judges of
occupational risk, the result by Lichtenstein et al. (1978) demonstrate that individuals
may not be good assessors of risk in all cases. If this is true, then does providing
additional information help? What is the relationship between prior and new information
regarding individual risk assessments? Viscusi’s (1992) prospective reference theory
(PRT) provides one explanation of how new information is incorporated into forming
new risk assessments that are closer to the true value of statistical risk. PRT is based on
an expected utility model in which information is processed in a Bayesian manner, such
that prior and new risk assessments carry a “weight” that is dependent on the perceived
credibility of the new information being presented and the strength of the individual’s
prior assessment of risk (Viscusi 1992). This theory suggests that the higher the degree
of credibility that is placed on prior information, the less “weight” will be given to the
new information. Findings by Tkac (1998) support this theory. Tkac finds that although
respondents with higher levels of prior information have a higher WTP for treatment,
valuations by knowledgeable individuals were not influenced by the information
presented (Hoehn and Randall 2002). This finding supports the hypothesis that those
with strong priors will place less weight on new information.
Hoehn and Randall (2002) modify the Bayesian updating model used by Viscusi
and O’Connor (1984) by making it more general. In particular, Hoehn and Randall relax
the “assumption that prior information is necessarily proportional to objectively true
information” and “allow prior knowledge to differ across individuals” (Hoehn and
Randall 2002 p 16). Poe (1998) and Carson et al. (1996) suggest that heterogeneity exists
in the prior information held by individuals; therefore, dropping these assumptions allows
Hoehn and Randall to account for this difference across individuals in valuing the quality
of an environmental resource. Allowing for heterogeneity in prior knowledge implies
that the new information may increase or decrease the individual’s perception of resource
quality, depending on their prior perception.

In particular, if the new information

suggests that the quality of the resource is higher (lower) than the individual previously
thought, then they will have a positive (negative) change in their perception. Therefore,
Hoehn and Randall allow for the possibility that the same information can have different
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effects for each individual.47 This, in turn, is expected to affect individual WTP (Hoehn
and Randall 2002).
Smith and Desvousges (1990) study the effect of various information
presentations on the formation of risk perceptions of households relating to the presence
of radon in their homes and discover that individuals systematically update risk
perceptions when presented with new information regarding that risk. They also find that
providing only minimal information regarding risk can, in fact, cause individuals to
overestimate the actual risk. Therefore, from a public policy standpoint, the results of
Smith and Desvousges (1990) suggest that providing more complete information
regarding risk will lead to more accurate risk perceptions.
In addition, a study conducted by Magat, Viscusi, and Huber (1988) also revealed
the importance of information on the validity of respondents’ valuations. This study
focused on consumers’ willingness to pay for an increase in product safety for two
common household items- bleach and drain cleaner. Based on the responses, the value of
avoiding a “statistical” injury from bleach gas poisoning was $1.38 million, child
poisoning was $0.5 million, drain cleaner burn was $1.24 million, and $.82 million for
drain cleaner poisoning. These valuations are much higher than comparable morbidity
valuations obtained through hedonic studies. One possible explanation posed by the
authors is that the respondents looked primarily at the percentage decrease in risk posed
in the question, without giving careful consideration to the base number of households
subject to the risk. If this were indeed the case, the responses would have essentially
have been unaltered if the study had been based on 2 million, 200,000 or perhaps even
20,000, which would have lowered the resulting valuations by a power of 10 to 100.
Therefore, the authors caution that individuals must fully understand the risks if their
responses are to be used to estimate benefits for the purpose of policy decisions (Magat et
al. 1988).

47

This is different from past studies which assumed that the new information would have the same effect
across individuals.
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2.10 Applications to this Study
2.10.1 Addressing the Potential for Hypothetical Bias
This study utilizes two CV surveys to value two health goods related to the
prevention of heart attacks.48 Because hypothetical bias was a concern, several measures
were included as part of the survey to prevent the possibility of hypothetical bias from
entering the data. First, a modified version of the cheap talk script originally used by
Cummings and Taylor (1999) was used. Although recent literature (conducted after the
fielding of this study) suggests that the cheap talk methodology may not be effective
(Blumenschein et al. forthcoming 2007), some studies have shown that cheap talk is very
effective at eliminating hypothetical bias for higher prices (when hypothetical bias is
thought to be the greatest issue). Therefore, the inclusion of the cheap talk script is still
an important component of the CV surveys used for this study, especially since the goods
being valued are expected to have relatively high valuations.
A second measure to prevent hypothetical bias was the inclusion of a certainty
scale. The meta-analysis by Little and Berrens (2004) indicates that use of certainty
calibration within a CV survey is an effective method for eliminating hypothetical bias.
In addition, Blumenschein et al. (forthcoming 2007) find that there is essentially no
difference in hypothetical decisions to utilize a diabetes managements program once
adjusting for individuals who are “definitely sure” as compared to real decisions.
Therefore, these studies suggest that asking respondents to assess the certainty of their
stated preferences is an important step in mitigating hypothetical bias.

2.10.2 Information and Perceived Risk
The concepts proposed by Hoehn and Randall (2002) are particularly relevant to
this study. Presumably “new” information on who is at risk for a heart attack is presented
and measures of individual risk perception are obtained both before and after respondents
are made aware of this new information.

As Hoehn and Randall suggest, new

information may have different affects on respondents’ perception of risk, depending on
their priors. The CV surveys used for this study allow for this heterogeneity.

In

addition, data was collected in order to determine the direction and magnitude of the
48

See Chapter 5: Development of the Web-based Surveys for details related to the survey instruments.
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change in each respondent’s perception of their own risk of heart attack. Data was
collected both as a quantitative variable in which each unit increase (decrease) of risk
corresponded to a 1/100,000 increase (decrease) in fatality risk. In addition, respondents
were asked to qualify their change in risk by indicating whether they felt their risk of a
heart attack after reading the new information was much higher (lower), somewhat higher
(lower), or the same. Although it was expected that the information presented was truly
“new” and would increase individual’s perceived risk of a heart attack, both risk
assessment methods allowed respondents to indicate that the new information did not
change their risk perceptions. In addition, risk perceptions were also allowed to decrease.
Therefore, this data can be used to assess how risk perceptions changed in response to the
new information, and how that in turn influenced individual WTP.

2.10.3 Iterative Bidding
Starting point bias has been known to be a problem in iterative bidding as a result
of respondents “anchoring” their WTP on the first bid presented; however, Fabian and
Tolley (1994) find evidence from focus groups to suggest this becomes less of a problem
“as questionnaires are enriched in their information and preference review” (Fabian and
Tolley 1994 p. 143). Therefore, the CV surveys used in this study contain detailed
information that is relevant to the formation of the individual’s valuation and several
opportunities are given for the respondent to reflect on their true valuation before stated
their WTP. In doing so, this study utilizes a form of iterative bidding inspired by the
interactive computer program used by Viscusi, Magat, and Huber (1990), which was used
to elicit risk-risk and risk-dollar valuations of chronic bronchitis.

The interactive

computer program in the Viscusi et al. (1990) study offers paired-comparisons for which
the attributes differ (based on the respondent’s previous responses) until indifference
between the two is reached (Viscusi et al. 1990). The iterative bidding program used for
this study is similar in that subsequent bids are determined by the respondent’s answers to
previous bids, such that each survey is tailored to the individual respondent. In addition,
unlike other iterative bidding processes that simply increase or decrease using a predetermined set of bids, the computer program in this study follows a specially designed
algorithm that allows the series of bids to vary considerably across respondents
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dependent on their responses.

Through the use of this well-designed algorithm,

respondent’s WTP is obtained by asking only a minimum number of questions.
2.11 Summary
Federal agencies, as well as an increasing number of state agencies, require a
comparison of benefits and costs before implementing public policy. Therefore, benefitcost analysis has become the “gold standard” for valuing improvements in economic
goods, including those related to health. For goods exchanged explicitly in well-defined
markets, the market price offers a reasonable measure of value; however, for non-market
goods such as environmental resources, market prices are not observed and therefore are
not available for making valuations. However, placing a monetary value on these goods
is “essential for sound policy” (Hanemann 1994 p. 19). This point became increasingly
clear immediately following the Exxon Valdez accident, which spilled 11 million gallons
of crude oil into Prince Edward Sound off the coast of Alaska. In the wake of this
unfortunate accident, the courts were left wondering how to assess damages. Contingent
valuation, a method that asks respondents to state what they would pay for a good
contingent on the fact that it was available in a market, provided one possible answer.
Contingent valuation not only offered a viable means in which to value goods that
are not explicitly traded, but it also had the added advantage of including passive use
values, which are often a significant component of the total benefit derived from
environmental resources. As a result, the use of CV grew rapidly in the environmental
literature and its use is now growing in the health literature as well.
Although markets for health-related goods and services exist, prices do not
accurately reflect consumer preferences due to the large presence of insurance companies
as third-party payers. Therefore CV offers a method of eliciting underlying consumer
WTP for health-related goods and services that would otherwise be unknown.

In

addition, the CVM is utility-based and derives a measure of benefit in terms of monetary
value (WTP), which is preferable to other measures (i.e. COI) that have been used to
value improvements in health.
There has been some debate as to the reliability and validity of the CVM method,
in particular the tendency of stated preferences to be subject to hypothetical bias.

60

However, several studies suggest that calibration mechanisms, specifically those
involving the degree of certainty with which the preference is stated, have the potential to
correct for hypothetical bias and provide accurate reflections of observed consumer
behavior. Although refinements to the CVM are certainly likely to occur as the further
studies suggest additional improvements, several existing studies have already
demonstrated that CV surveys can produce reliable and valid results. In addition, using
stated preference offers a methodology for valuing non-market goods that could
otherwise not be valued. Therefore, due to its importance to BCA, especially for valuing
environmental resources, it is likely that the CVM will continue to be used as it provides
the potential to obtain valuable information that is necessary to make efficient use of our
scarce economic resources, including those related to health.

Copyright © Patricia L. Ryan 2007
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Chapter III: Medical Background
The purpose of this chapter is to provide the medical information necessary to
understand a recent change in theory regarding the primary cause of heart attacks and to
also explain why traditional risk factors currently used by physicians fail to identify a
large percentage of the population who are at risk for a heart attack. This chapter will
also describe how medical technology is changing in response to this new information
and will provide the basis for the hypothetical screening and treatment that respondents
are asked to value in the two surveys used for this study. In addition, this chapter will
explain the current standard of care for a patient who presents with symptoms of heart
disease, subsequent decisions that would typically be made regarding the course of
treatment; and finally, how anticipated future developments in medical technology will
affect these decisions. Thus, the information in this chapter will explain the medical
advances that motivated this study as well as provide the medical background necessary
to fully understand the decisions trees that are presented as part of the theoretical model
in the next chapter.
3.1 Changing Theory Regarding the Primary Cause of Heart Attacks
It has long been thought that the primary cause of heart attacks is coronary
stenosis – the buildup of plaque within the small arteries of the heart (Gazelle 2000).
Doctors diagnose this condition as atherosclerosis, but many of us have heard it
commonly referred to as “hardening of the arteries.” For decades, it was presumed that
as the degree of stenosis progressed and decreased the size of the lumen (vessel opening
through which blood passes), it would restrict the flow of oxygenated blood to the heart.
Then, when the heart muscle did not receive a sufficient amount of oxygen (for example,
during times of exertion), the individual would experience chest pain, or angina. As the
individual’s medical condition worsened, the symptoms would persist and become more
frequent until eventually the build up of plaque within the vessel was severe enough to
cause a heart attack (Gazelle 2000).
Although this medical theory still correctly explains why individuals experience
chest pain associated with heart disease, it does not explain why numerous heart attacks
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occur in individuals who, prior to having the attack, never experienced chest pain or any
other symptoms of heart disease (Ryan 2000). In fact, according to the American Heart
Association, at least 50% of the individuals who experience a heart attack have no
symptoms prior to the attack (American Heart Association 2003). In addition, autopsy
data from several studies have revealed that heart attacks and stenosis are often NOT
correlated (Shah 1996); thereby, directly contradicting the theory that plaque build-up is
the primary cause of heart attacks. Further evidence to refute this theory includes studies
that have found lipid-lowering medication to significantly reduce the mortality and
morbidity risk due to heart attack, while having little improvement on the size of the
lumen (Gazelle 2000). In other words, the risk of heart attack for individuals who take
cholesterol lowering medication has been shown to decrease significantly, without
diminishing the amount of plaque within the coronary arteries.
Findings such as these led cardiologists to revisit an earlier study on plaque
composition (Davies and Thomas 1984) published in the New England Journal of
Medicine in the mid-1980’s. In fact, the work by Davies and Thomas (1984) is now
considered a landmark study in linking plaque composition to heart attacks (Ryan 2000).
Looking at histology from patients who had experienced heart attacks, Davies and
Thomas (1984) found that approximately 75% of the patients who had experienced a
heart attack died from a blood clot (or thrombosis) in the vessel. Interestingly enough,
the clot that caused the heart attack was not necessarily located in an area of the coronary
vessel that contained stenosis. Instead, these clots were located at a point in the vessel
where lipid-rich lesions (fatty plaques) were present (Davies and Thomas 1984).
Therefore, this study strongly suggested that the cause of heart attacks was not due to the
amount of plaque within the vessel, but rather to the composition of that plaque.
Unfortunately, numerous other studies indicated that plaque burden was a more
powerful predictor of a patient’s prognosis (Yock 2001); therefore, advances in medical
technology continued to focus on opening the restricted vessels, specifically by placing
coronary stents and performing angioplasty (Ryan 2000). During the late 80’s and early
90’s significant advancements in cardiac inpatient care took place and the number of
procedures performed increased dramatically.

These procedures clearly reduced the

occurrence of chest pain and improved the quality of life for these patients (Ryan 2000);
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however, what continued to puzzle cardiologists was that despite these great advances in
the type and number of procedures performed to treat patients, national heart attack
mortality rates remained high (Muller 1999).
This prompted cardiologists to return to the idea that plaque composition rather
than plaque burden was the primary cause of heart attacks. After further investigation, it
is now the general consensus among cardiologists that it is not the volume of plaque in
the coronary arteries, but rather the composition of that plaque that presents the greatest
risk for a potentially fatal heart attack (Falk et al. 1995, Ravn and Falk 1999). Therefore,
cardiologists and medical researchers in this field now believe that correctly determining
the type of plaque is an important key in accurately identifying those at risk for a heart
attack, or what physicians commonly refer to as myocardial infarction.

3.2 What is a Myocardial Infarction?
Myocardial Infarction, or “MI” as it is often called, is the medical term used to
describe a heart attack. A MI occurs when cells within the heart muscle do not receive a
sufficient supply of oxygenated blood, resulting in cell death and permanent damage to
the heart muscle. If the depletion of oxygen to the heart is great enough, it can cause the
heart to stop (cardiac arrest) and result in death. Even if a heart attack is not fatal, it
causes irreversible damage which weakens the heart muscle; therefore, individuals who
experience a MI are at much greater risk for a future heart attack (American Heart
Association 2003).

3.3 Social Costs Associated with Heart Attack
An individual who experiences a heart attack is typically diagnosed with coronary
heart disease (CHD). CHD includes both MI and angina pectoris49 (a medical term for
chest pain). According to the Heart and Stroke Statistical Update published by the
American Heart Association, “CHD is the single largest single killer of American males
49

CHD includes International Classification of Disease (ICD/9) codes 410-414, and 429.2 Note: Every
10-20 years the ICD codes are revised. These revisions reflect changes in medical technology, diagnosis
and terminology. Starting in 1999, the tenth revision of these codes was used. Therefore, according to
ICD/10 the codes for CHD include I20-I25.
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and females” (p. 12) and is responsible for more than 1 out of every 5 deaths in the U.S.
(American Heart Association 2003). In the year 2000, an estimated 681,000 individuals
died from CHD, of which 239,000 were due to MI (American Heart Association 2003).
Each year, more than 500,000 Americans experience a heart attack, and approximately
47% of those individuals die as a result (American Heart Association 2003). Of those
who do survive, only about one-third will make a complete recovery. In fact, “CHD is
the leading cause of premature, permanent disability in the U.S. labor force, accounting
for 19 percent of disability allowances by the Social Security Administration” (American
Heart Association 2003, p. 12).
Since the risk of heart attack increases with age, the elderly population is typically
thought to be at greatest risk for a heart attack. Although it is true that 84% of the people
who die of CHD are over the age of 65, there has recently been an increase in the number
of heart attack related deaths in young people, especially women. In addition, almost
50% of the men and women under age 65 who experience a MI die within 8 years of the
attack (American Heart Association 2003). Furthermore, what is possibly even more
concerning is that evidence from the Framingham Heart Study indicates that over half of
those who died suddenly of CHD had no previous symptoms of this disease (American
Heart Association 2003). Therefore, thousands of people who are at risk for a heart
attack are not even identified as needing treatment until it is too late.
3.4 Plaque Rupture: The Primary Cause of Heart Attacks
So, how could current medical technology fail to identify so many individuals
who are at risk for a heart attack? The answer lies in the fact that for years, physicians
have been looking at only part of the problem. As discussed in the opening section of
this chapter, physicians thought that the long-term build up of plaque was the primary
cause of heart attacks; however, medical research now suggests that most heart attacks
(as many as 75%) are actually caused by plaque rupture (Falk et al. 1995, Davies and
Thomas 1984). This rupture can almost instantaneously create a blood clot (thrombosis)
that can completely or partially block the vessel, thereby preventing oxygenated blood
from traveling to the heart and causing a heart attack (Falk et al. 1995). Prior to the
plaque rupture, the blood vessel may be relatively clear and the individual may not
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experience any symptoms (such as chest pain) typically associated with heart disease
(Shah 1996). Therefore, because plaque rupture is not necessarily correlated with a
substantial build-up of plaque within the vessel, the individual may be completely
symptom free and unaware that they are at risk for a sudden and possibly fatal heart
attack.

3.4.1 Plaque Composition
There are different types of plaque that exist within the coronary vessels and
medical research has shown that not all plaques are equally dangerous (Falk et al. 1995).
In fact, some plaques are more prone to rupture than others; therefore, correctly
identifying the composition of a plaque has become an important key in determining who
is at risk for a heart attack.
Plaques are generally comprised of different types of materials. In fact, the term
“atherosclerosis” is derived from the two main components of a mature plaque: (1) the
soft, lipid-rich atheromatous gruel and (2) the hard, collagen-rich sclerotic tissue.
Although the sclerotic component makes up about 70% of the plaque, it is the smaller
atheromatous component that is by far more concerning (Ravn and Falk 1999). This is
because the soft atheromatous gruel tends to “destabilize” the plaque, making it more
prone to rupture (Falk et al. 1995). Plaques that are primarily composed of the hard,
collagen-rich sclerotic tissue tend to be mature plaques that are considered more stable –
that is, less prone to rupture.

There are different types of stable plaques, including

calcified plaques, which are so named because they contain calcium that forms deposits
when present in large amounts. These are the plaques typically associated with long-term
plaque build-up that results in chest pain (Ryan 2000). Fatty plaques, on the other hand,
are plaques that are comprised primarily of the soft, lipid rich atheromatous gruel. These
plaques are more prone to rupture (Falk et al. 1995). In fact, it is a specific type of fatty
plaque that researchers believe is most vulnerable to rupture; hence it has been given the
name “vulnerable plaque” (Ryan 2000).

66

3.4.2 What is Vulnerable Plaque?
Vulnerable plaque is so named because its soft atheromatous component tends to
“destabilize” the plaque, making it vulnerable, or prone, to rupture (Schroeder and Falk
1996). A vulnerable plaque is comprised of a lipid pool that lies hidden beneath the wall
of the artery, much like lava within a volcano. The only thing that separates the lipid
pool from the blood flow in the vessel is a very thin cap (Ryan 2000). This cap is
extremely important because the gruel of the vulnerable plaque is highly thrombogenic,
meaning that when it comes into contact with blood, it will cause the blood to clot almost
instantaneously (Schroeder and Falk 1996). As long as the vulnerable plaque stays
within the arterial wall, there is no problem; however, once it ruptures and enters the
bloodstream, the resulting clot (thrombosis) can restrict the flow of blood to the heart,
resulting in an almost instantaneous and possibly fatal heart attack. Therefore, plaques
that are comprised primarily of the lipid-rich (fatty) atheromatous gruel pose a greater
risk because they are more likely to rupture and cause a clot that will lead to a heart
attack. Although some heart attacks are the result of arrhythmias (irregular beating of the
heart) and stenosis (narrowing of the arteries), cardiologists now believe that 75% of all
heart attacks are caused by the eruption of a “vulnerable” plaque (Falk et al. 1995).

3.4.3 Vulnerable vs. Stable Plaques
In addition to being more prone to rupture, vulnerable plaques also differ from
stable plaques in that they tend to be smaller in size and appear in much greater frequency
within the vessel, which can make detection and treatment difficult. Since the likelihood
of having vulnerable plaque increases with plaque burden, it is not coincidental that
patients with atherosclerosis often suffer heart attacks – it is just that the cause of the
heart attack is different than previously thought (Ryan 2005). What is interesting to note
is that it is not simply the presence of plaque or even the size of the plaque, but rather the
likelihood of plaque rupture that places an individual at risk (Falk et al. 1995). In fact,
someone who has been diagnosed with atherosclerosis, and has a significantly large
amount of plaque which is predominantly stable could actually be at lower risk for a heart
attack than an individual with a small amount of vulnerable plaque. This means that
individuals with large deposits of calcified (stable) plaques who periodically experience
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chest pain and shortness of breath could actually be at lower risk for a heart attack than
an individual with vulnerable plaque who is completely asymptomatic. In addition,
traditional risk factors only give us one piece of information in determining an
individual’s actual risk. Therefore, the key to early detection is finding a screening
method that can distinguish between those individuals who have stable, calcified plaques
versus those who have fatty, vulnerable plaques.
3.5 Who is at Risk for a Heart Attack?
According to Falk et al. (1995) “age, male sex, hypercholesterolemia,
hypertension, smoking, and diabetes correlate with the coronary plaque burden” meaning
that the degree of atherosclerosis is associated with these risk factors; however “apart
from…age and possibly male sex, a relation of specific risk factors to composition of
plaque burden remains to be identified” (Falk et al. 1995). This suggests that traditional
risk factors (age, sex, cholesterol level, etc.) may be good indicators of stenosis and
identifying those individuals who are likely to experience chest pain and other symptoms
of heart disease, but these risk factors provide very little information regarding who has
vulnerable plaque and is actually at risk for a heart attack. Therefore, simply using
traditional risk factors for heart disease (as is often done today) will fail to identify many
individuals at risk for a heart attack (Gazelle 2000). This is why apparently “healthy”
individuals who are asymptomatic suddenly die from heart attacks (Falk et al. 1995).
Currently, a definitive set of risk factors is not known – that is why it is so important to
find a way to determine who has vulnerable plaque in order to correctly identify those at
risk so treatment can be started.
3.6 Limitations in Detecting Vulnerable Plaque
There are several potential treatments for vulnerable plaque once it is detected.
The main problem lies in consistently and correctly detecting its presence within the
coronary vessel.

Unfortunately, the medical community does not currently have a

method for doing so, although numerous research efforts are pursuing this goal (Muller
2001). In light of the potential risks posed by the presence of vulnerable plaque, a
growing number of people, especially male physicians over the age of 50, have opted to
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take lipid-lowering medications, even though they have no other indication that they are
at risk for vulnerable plaque (Ryan 2000). Although statin (cholesterol lowering) drugs,
such as Lipitor, Pravachol, and Zocor, have been somewhat successful in lowering
cholesterol levels, at best, they lower the individual’s risk of heart attack by only about
30% (Waters 2000). Not to mention that prolonged usage of these drugs can have serious
side effects, including liver failure (Ryan 2000). Therefore, medical researchers are
working on developing a more effective way to detect and treat vulnerable plaque.
Many companies are funding these research efforts, including Pfizer, a Fortune
500 company, and other well-known medical device firms including Guidant and Boston
Scientific (Muller 2001). Current research in this area involves a wide range of imaging
technologies including ultrasound, MRI, laser, and spectroscopy (Ryan 2000). Although
it is not entirely clear which technology will ultimately prove successful, it is highly
likely that a method for detecting and treating vulnerable plaque will be developed in the
near future.

3.6.1 Screening for Vulnerable Plaque
However, simply detecting vulnerable plaque is not enough. In order to be used
as a screening method, it must also be inexpensive and non-invasive enough to use
routinely on the general population (Muller 2001). In addition, the test should be very
sensitive – that is give few to no “false-negatives.” Sensitivity refers to how well a test
finds everyone within the population that has a disease. Typically, highly sensitive tests
have a tendency to pick up individuals who do not have the disease as well; thereby
resulting in false-positives. On the other hand, a highly specific test is more specific to
what the test is looking for, but it is also more likely to miss someone – resulting in a
false-negative (Ryan 2000).

Ideally, you would want a test that has both a high

sensitivity and a high specificity; however, due to the nature of laboratory tests, there is
often a tradeoff between the two. In practice, the goal for many health care professionals
is for the screening method not to miss anyone who is at risk.50 Therefore, tests with a
50

Economists would recognize that false positives (stemming from higher sensitivity) will result in
disutility for the patient/consumer. Therefore, from an economic standpoint, the goal of a screening
method would be to balance the value derived from high sensitivity against the social costs associated with
false positives.

69

high sensitivity are generally used for screening. This reduces the chances of missing
someone who has the disease, but as discussed above, will result in false-negatives.
Therefore, for those testing positive to the screening, a follow-up test or procedure that is
more specific (and typically more invasive) would be necessary to identify those
individuals who are actually at risk.

3.6.2 Using Technology to Detect Vulnerable Plaque
There are several technologies that are currently being explored as methods for
detecting vulnerable plaque and identify those at risk for a heart attack. However, as
described below, each technology still has limitations in either its ability to correctly and
consistently identify those individuals with vulnerable plaque or to do it in a timely and
cost effective manner.
CT scan
Coronary CT (computed tomography) scanning, specifically electron beam
(EBCT) and multi-detector CT, which cost about $500 to $700, has proven to be an
effective way of identifying plaque build up (Yorke 2005). This non-invasive method
takes only about 10 minutes and clearly shows calcium in the arteries. Because calcium
is drawn to inflammation in the plaque, calcium is known to be correlated with plaque
burden. Therefore, CT scans can provide physicians with good information on the
amount of calcified plaques in the arteries; however, the technology can not (as of yet)
detect the fatty vulnerable plaques (Yorke 2005) that are now thought to be the most
dangerous (Falk et al. 1995). Although this test is non-invasive, it is too expensive to be
used as a screening method. In addition, with false negatives in the 5-10% range (Yorke
2005), the results of CT scans are not yet reliable enough to use this method, even as a
secondary test that would follow the initial general screening.
Ultrasound
Unlike CT scans, high-resolution ultrasound uses no radiation, costs much less,
and can be performed by a physician after receiving only minimal training. Like the CT
scan, ultrasound is non-invasive and is relatively fast, taking only about 12 minutes to
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perform (Yorke 2005). Ultrasound allows the physician to see plaque in the six major
arteries in the body. This is done by placing a high-frequency probe on the neck and
groin, which allows the physician to see the arteries from the outside in. Performing this
procedure on a routine basis allows the physician to track plaque build up over time and
treat the patient accordingly.

However, the primary drawback of high-resolution

ultrasound is that it can not be used to see the arteries within the heart (Yorke 2005).
Since the coronary arteries are where the vulnerable plaque that causes heart attacks is
located, this technology is currently not useful as a screening method for vulnerable
plaque.
MRI
MRI can provide limited images of the arteries as well as plaque; however, it does
not yet have sufficient resolution to distinguish between different types of plaques (Ryan
2005). Therefore, the inability of this technology in being able to identify those who
have vulnerable plaque and well as the fact that this is very costly procedure, preclude
MRI as an means of screening. Although this technology may prove useful as a
secondary, confirming method as the resolution produced by this technology improves,
more studies will still be needed to determine the efficacy of using this as a definitive
means of identifying those at risk for a heart attack.
From these descriptors, it is clear to see that none of these technologies currently
meet the criteria needed for an effective, cost-efficient, and relatively non-invasive
screening technique.

Yet, another completely different approach which utilizes the

correlation between inflammation and plaque, may allow researchers to develop a simple
blood test that may prove useful as a screening method (Comarow 2002, Falk et al.
1995). In order to understand the correlation between inflammation and plaque rupture,
it is necessary to understand in more detail the process by which a plaque ruptures.
3.7 Factors that Lead to Plaque Rupture and MI
There are two factors that increase the risk of plaque disruption, or rupture. As
discussed above, the first is the composition of the plaque. A plaque that contains more
of the soft atheromatous gruel is more unstable and therefore considered “vulnerable” to
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rupture. Plaques that are comprised almost entirely of the harder collagen-like sclerotic
material are considered more “stable” (Falk et al. 1995). This is why some studies
utilizing autopsy data have revealed individuals with substantial stenosis who never
experienced a MI, and who are now believed to have been at lower risk for a heart attack
than someone with a much smaller amount of vulnerable plaque (Ryan 2000).
The second factor that increases the likelihood of plaque rupture is the presence of
an extrinsic force or “trigger” acting on the plaque (Falk et al. 1995). This can be caused
by strenuous exercise, emotional stress, or in some cases, simply getting out of bed in the
morning (Schroeder and Falk 1996, Muller 1999). In short, the presence of vulnerable
plaque predisposes the individual to an acute coronary event, whereas the trigger or acute
risk factors can precipitate the rupture (Falk et al. 1995). Although it is beyond the scope
of this dissertation, it is interesting to note that a similar process occurring in the carotid
arteries of the neck is now believed to be a major cause of stroke (Ryan 2000).

3.7.1 How does Plaque Rupture Occur?
The lipid-rich soft atheromatous gruel typically makes up the “core” of the plaque
and is surrounded by the collagen-rich sclerotic tissue. For the most part, this is located
within the vessel wall, with the exception of a “cap” which is created where the sclerotic
tissue is exposed to the lumen (or vessel opening). Therefore, the only thing separating
the highly thrombogenic lipid pool from the blood stream is this very thin cap. Triggers
that increase blood pressure and tensile forces can then cause the cap to rupture at a weak
point. This typically occurs at the shoulder region of the plaque, where the cap is thinnest
(Falk et al. 1995).
From this discussion, it is clear to see that the risk of plaque rupture is dependent
on (1) the size and consistency of the atheromatous core, (2) the thickness and collagen
content of the fibrous cap covering the core, and (3) the amount of cap “fatigue” (Falk et
al. 1995). In addition, researchers now typically list “inflammation within the cap” as a
fourth risk factor (Falk et al. 1995). The following provides an explanation of the role
inflammatory cells are thought to play in vulnerable plaque rupture.
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3.7.2 Inflammation
Autopsy data has revealed that a higher number of inflammatory cells (such as
macrophages that are associated with fighting infection) are often present at cites of
plaque rupture (Falk et al. 1995). Researchers theorize that the inflammatory cells help
create the lipid pool and eat away at the surface of the vessel, leaving only a “thin cap”
(Ryan 2002, Falk et al. 1995). Because of the high correlation between inflammatory
cells and the occurrence of plaque rupture, it is thought that inflammation itself may
provide the key to finding a screening test for those potentially at risk for a heart attack
due to vulnerable plaque (Falk et al. 1995, Comarow 2002).
One possible method of screening is a blood test that detects inflammatory cells
that form the lipid pool of the vulnerable plaque (Comarow 2002).

This potential

screening method would consist of a simple blood test similar to existing tests that detect
high density lipoprotein (HDL) and low density lipoprotein (LDL), commonly referred to
as “good” and “bad” cholesterol.
3.8 Potential Screening and Treatment Methods
3.8.1 CRP: A Possible Screening Test for Vulnerable Plaque
The November 25, 2002 issue of U.S. News and World Report describes a test
that measures levels of C - reactive protein (CRP), an indicator for inflammation, which
could potentially be used in the near future to screen for those at risk for a heart attack.
This article describes the results of an eight-year study of nearly 28,000 individuals in
which it was found that CRP was a better indicator of MI and stroke than high levels of
LDL (“bad” cholesterol) (Comarow 2002). The CRP test is similar in nature to any
simple blood test, such as cholesterol, HDL, or LDL, and is conducted by many
laboratories across the country. The test generally costs between $10 and $25 but is not
yet covered by most insurance companies; however, Medicare did start covering the cost
of this test starting in January 2002 (Comarow 2002).
Since “half of all heart attacks strike people who don’t have a cholesterol
problem…and at least 25 percent of heart attacks happen to individuals with no major
risk factors” (Comarow 2002), at the very least CRP could provide an additional piece of
information in assessing a patient’s risk of having a heart attack. However, as of yet,
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there is no standard regarding the use of CRP testing. In fact, several different CRP tests
exist, each with varying degrees of sensitivity. Therefore, according to a top researcher
in the field, the first step is to establish a uniform test, with agreed upon guidelines
regarding the interpretation of the results (i.e. high, moderate, and low levels of risk)
(Comarow 2002).
After establishing a uniform test, studies would then need to be done to verify that
there is a statistical correlation between high levels of CRP and a higher risk of heart
attack (Comarow 2002). Unfortunately, the current CRP test can not distinguish between
inflammation associated with lipid pools versus inflammation due to injury or infection
Ryan 2002). This means that someone who has a common cold virus (and has a large
number of macrophages present in their blood stream) would likely have an abnormally
high CRP test result, yet it would be a result of the infection and not necessarily an
indicator of the presence of lipid pools and possible risk of heart attack. Therefore, the
CRP test may not be specific enough to serve as an effective screening method for
identifying those at risk for heart attack. For now, physicians may choose to use this test
on a limited basis – specifically, as a source of additional information to help assess the
risk of marginal patients (Comarow 2002). Although it is still unclear whether the CRP
test will ultimately prove effective as a general screening method to detect those at risk
for heart attack, it is clear that the potential of a simple blood test being used in this
fashion is certainly feasible.

3.8.2 Inflammation as an Indicator for Treatment
If inflammation is an indicator for lipid pools and could potentially be used as a
screening method, then could it not also be used as an indicator in developing a
detection/treatment method for vulnerable plaque as well? Unfortunately, the answer to
this question is “probably not.”

Although the presence of a large number of

inflammatory cells may be an indicator of a higher risk of heart attack and offer a
potential method for screening, it is unlikely that locating inflammatory cells could be
used in the detection/treatment of the lipid pools. This is because the inflammatory cells
can be located in many places within the coronary vessels, including many places where
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lipid pools are not present. Therefore, using inflammation as an indicator would lead to
treating numerous areas unnecessarily (Ryan 2002).

3.8.3 Potential Treatments for Vulnerable Plaque
Currently, drug therapy (taking a cholesterol-lowering drug such as Lipitor,
Pravachol, or Zocor) is the only treatment for vulnerable plaque. Unfortunately, as
mentioned previously, this treatment method is only about 30% effective (Waters 2000).
In addition, these drugs work slowly and therefore require a considerable length of time
to reduce the individual’s risk of having a heart attack (Ryan 2000). Therefore, this is not
a very effective treatment for the immediate threat posed by the presence of vulnerable
plaque within the coronary vessels. This has led medical researchers to explore several
potential treatment techniques in an attempt to develop a more effective detection and
treatment method for vulnerable plaque. Several of these methods utilize a heart catheter,
a device that can be threaded through the coronary arteries so that the physician may
either “see” or treat a specific area of the vessel. The following describes drug therapy,
as well as some other potential methods that may ultimately prove successful in the
development of a detection and treatment method for vulnerable plaque.
Systemic drug therapy
“Systemic” means to put in the blood stream, typically by mouth or intravenously
(IV). Drug therapy is the current “standard of care” and requires the patient to take a
statin (cholesterol lowering) drug like Lipitor, Pravachol, or Zocor on a daily basis, often
for the remainder of the patient’s life. Although these drugs have been shown to lower
cholesterol (and CRP), they are only about 30% effective at reducing the individual’s risk
of heart attack. In addition, individuals taking these drugs have a higher risk of liver
failure. However, to reduce this risk, patients taking statin drugs typically have liver
function tests periodically (about every three months for the first year) to monitor for
potential liver damage (Ryan 2000).
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Localized drug treatment
This is a catheter directed treatment, meaning that a heart catheter is used to apply
a drug at the point of interest. One possible procedure for treating vulnerable plaque
would be similar to catheter-directed TPA (tissue plasminogen activator), a procedure in
which a clot dissolving drug is given at the site of an acute thrombosis (clot). However,
the treatment of vulnerable plaque would require a catheter that could deliver the drug
into the coronary wall. Such a device does not currently exist (Ryan 2000).
Photo-activated drug therapies
For this therapy a patient is given a systemic “inactive” drug treatment. A fiber
optic heart catheter is then used to emit a certain frequency of light at the point of
interest. The light causes the systemic drug to become active, but only at the point of
interest. This allows the drug to take effect only at designated points within the body, as
opposed to the entire body. Therefore there is less risk of an adverse side effect from the
drug being administered. Although some photoactive drugs currently exist, none are
commercially available at this time for the treatment of vulnerable plaque (Ryan 2000).
Angioplasty
Balloon angioplasty is traditionally performed to expand a vessel; however, the
same treatment could potentially be used for treating vulnerable plaque.
treatment, a patient is given a dose of heparin through an IV.

For this

This drug acts

instantaneously to prevent the patient’s blood from clotting; however, this is only a short
term effect. A heart catheter is then used to expand a balloon within the coronary vessel
at the point of interest. The balloon will cause the plaque to rupture; however, due to the
effect of the heparin, a clot will not result. Therefore, this method reduces the risk of
heart attack by allowing for a controlled rupture. This is analogous to how controlled
fires are used to reduce the risk of forest fires (Ryan 2000).
Stent
This is similar to angioplasty, except that the balloon has a wire mesh around it,
resembling a Chinese finger puzzle. As the balloon inflates the wire mesh expands and
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once in place remains in the coronary vessel to help stabilize the point of interest. This
method is designed to force the cap up and prevent it from rupturing. In fact, the use of a
stent will often cause the cap to thicken, making it more stable. It is possible for the
placement of the stent to rupture the plaque; however, just as in angioplasty, the use of
heparin prior to the procedure will allow for a controlled rupture with little to no resulting
clot.

Therefore, this procedure will have one of two outcomes: stabilization or a

controlled rupture (Ryan 2000).
As indicated by these descriptions, a method tailored to the detection and
treatment of vulnerable plaque does not yet exist; however, almost all of the potential
therapies do have one thing in common – localized treatment. This is a strong indication
that the detection/treatment method that is ultimately developed will utilize a heart
catheterization procedure, such as those described above (Yock 2001, Ryan 2000).
Therefore, for the purpose of this dissertation, a heart catheterization procedure will be
utilized as the hypothetical detection/treatment method that is more effective than drug
therapy.
3.9 Standard of Care
3.9.1 Current Standard of Care for Symptomatic Individuals
When a patient presents with symptoms of heart disease, such as chest pain or
shortness of breath, the physician will typically order a stress test. If the results of the
stress test indicate a possible blockage of the coronary vessels, then the patient will
undergo an angiogram in the catheterization lab (Ryan 2000). This procedure cost
around $4,000 (Yorke 2005) and requires making a small incision in the upper thigh and
placing a “guide” wire. A heart catheter is then threaded through the artery up to the
coronary vessels. This procedure allows the physician to determine if a blockage exists
and identify its location (Ryan 2000).
Depending on the degree of stenosis found, the physician may choose to place a
stent in specific locations where the stenosis could potentially create a blockage. Placing
a stent typically reduces angina (chest pain) because it expands the lumen, thereby
increasing the flow of oxygenated blood to the heart. In the past, it was also believed that
this procedure would reduce the patient’s risk of a heart attack; however, in light of new
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evidence involving vulnerable plaque as the primary cause of heart attacks, this is no
longer believed to be the case. Although placing a stent may allow a controlled rupture
or stabilize a single lipid pool located directly beneath the stent as described above,
vulnerable plaques tend to be small and appear in multiple locations within the coronary
arteries. Since a stent only treats an area up to 30 mm in length, this procedure does
little, if anything, to prevent the occurrence of a heart attack if vulnerable plaque is
present in the individual’s vessel walls. Following the stent procedure, patients are
placed on a statin drug, which is typically taken for the remainder of the patient’s life.
Although placing a stent may alleviate the patient’s chest pain, any reduction in the
occurrence of heart attacks for these patients can most likely be attributed to the drug
therapy, and not from the placement of the stent (Ryan 2000).

3.9.2 Current Standard of Care for Asymptomatic Individuals
For asymptomatic individuals, a stress test may be ordered if the patient has a
family history of heart problems or a large number of risk factors.

However, an

estimated 25 million Americans who do not have traditional risk factors or exhibit
symptoms of heart disease are also at risk for a heart attack, and are not receiving
treatment (Yorke 2005). Since it is not feasible (or affordable) to perform a heart catheter
procedure on everyone to determine who is at risk (Yock 2001), there is a need for an
inexpensive, non-invasive screening method to begin the process of better identifying
those at risk. This will get potential “at risk” individuals “into the system” such that
additional (and often more invasive) procedures can be performed to determine if they
are truly at risk (Muller 2001).
However, even if the individual is found to be at high risk for a heart attack, the
current treatment of drug therapy is only about 30% effective, and because it takes time
for the drugs to become effective, it offers very little in terms of immediate risk reduction
(Ryan 2000). Therefore, a new treatment method that is more effective at reducing the
occurrence of a heart attack is also needed.
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3.9.3 What change is needed?
To effectively identify and treat those at risk for a heart attack due to vulnerable
plaque, there are two things that would need to occur. First, an inexpensive and relatively
non-invasive screening method would need to be developed that could be administered to
the general public. Second, a more effective detection and treatment method would need
to exist (Muller 2001).
In this particular case, detection and treatment go hand-in hand. Since potential
treatment methods already exist, the key is being able to accurately locate the pockets of
vulnerable plaque within the coronary vessels so they can be treated. According to
doctors conducting research in this field, the most likely candidate for a
detection/treatment method is one that is localized, meaning that it utilizes a heart
catheter (Yock 2001, Ryan 2000). Although such a device would look similar to a heart
catheter used to place a stent, it would need to be specifically designed for the sole
purpose of detecting and treating vulnerable plaque (Ryan 2000). Because this device
would be able to discern between stable and vulnerable plaque, it would allow the
physician to assess with greater accuracy the patient’s risk of a future heart attack. If the
physician detects a significant amount of vulnerable plaque, he/she would also be able to
treat the patient as part of the same procedure; thereby eliminating the risks (primarily
resulting from anesthesia and the possibility of infection) associated with an entirely
separate surgical procedure51.
Since stress tests, angiograms, and stents are primarily used to treat blockages and
chest pain, these procedures would most likely no longer be part of the treatment regimen
for the detection and treatment of vulnerable plaque. Therefore, for the patient found to
be at high risk for vulnerable plaque, the only real alternatives would either be drug
therapy or a new detection/treatment procedure.

51

It is important to note that when the patient agrees to undergo the catheterization procedure to detect
vulnerable plaque, he/she will be sedated during the procedure such that the individual would not be able to
give informed consent for subsequent treatment. Therefore, by consenting to the procedure, he/she is also
giving consent for treatment should the physician determine that it is warranted.
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3.10 Summary
Although there are many factors that may play into who is at risk for a heart
attack (age, gender, stress), and several tests (CRP, LDL) can provide some additional
information, the bottom line is: there is currently no method to correctly and consistently
identify who is at risk for a heart attack. In fact, current risk factors and tests miss a large
percentage of the “at risk” population, such that 50% of those individuals who currently
die from a heart attack do so without ever having been diagnosed with CHD or
experiencing a warning sign prior to the attack (American Heart Association 2003).
Recently the idea of plaque burden as the primary cause of heart attacks has been
replaced by a newer theory that indicates that it is not the amount of plaque, but rather the
type of plaque that places an individual at risk for a heart attack. Specifically, the
existence of vulnerable plaques, which are prone to rupture, are now thought to be the
primary cause of heart attacks.

Therefore, efforts are underway to develop a new

screening method, such as the CRP blood test, which is inexpensive and non-invasive
enough to use routinely on the general population that will better identify those at risk for
a heart attack due to vulnerable plaque. Since this is clearly the direction medical
technology is taking, it was logical to choose a simple blood test as the hypothetical
screening method that respondents would be asked to value in Survey 1: Screening.
As discussed in this chapter, highly sensitive screening methods have a tendency
to result in false-positives. Therefore, it is often necessary to further test those who have
positive screenings using a more specific procedure in order to gain additional
information and more accurately assess the individual’s true risk.

A more specific

procedure for identifying those at risk for a heart attack currently does not exist, but in
the near future it may involve having a MRI or heart catheterization procedure.
Once a patient is correctly identified as being at risk for a heart attack, the only
treatment that currently exists is drug therapy. However, because drug therapy requires a
significant time to take effect, and even then is only about 30% effective at reducing the
occurrence of a heart attack, this treatment method does not really address the immediate
threat of a vulnerable plaque rupture. Therefore, a new, more effective treatment method
is also needed.

Since the potential treatments currently being explored all involve

localized procedures in which a heart catheter is utilized, it followed that the detection
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and treatment procedures would most likely be combined to reduce the risks associated
with anesthesia and infection stemming from having an additional procedure.
Furthermore, because a slight modification to the heart catheter procedure that is
commonly used today was a likely candidate for eventually being able to detect and treat
vulnerable plaque, this was the logical choice for the hypothetical treatment that
respondents were asked to value in Survey 2: Treatment.

Copyright © Patricia L. Ryan 2007
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Chapter IV: Theory
The purpose of this chapter is to develop a theoretical framework to identify the
factors that will influence willingness to pay (WTP) for both a screening and
detection/treatment method for vulnerable plaque. This is accomplished by using a set of
decision trees that represent decisions faced by individuals in the current state of the
world, as well as potential decisions that are likely to occur if a new screening and
detection/treatment method for vulnerable plaque were made available.

Using the

decision trees, equations representing expected utility are derived for various treatment
alternatives in both the current and desired states of the world. Then, using a model
which closely resembles that of Michael Jones-Lee (1974), expected utility is held
constant under different conditions in order to define the consumer’s maximum WTP for
a change in his/her risk of having a heart attack, or for additional information regarding
that risk. In addition, the factors affecting the marginal WTP for treatment are also
identified since payment for a new treatment method reduces the individual’s risk of a
heart attack. Finally, this chapter concludes with a discussion of how these models
influenced the development of the surveys, such that the theoretical expectations
regarding WTP for screening and treatment could be tested empirically.
4.1 Fundamentals of Clinical Decision Analysis using Decision Trees
In treating patients, physicians are continually faced with having to make
decisions involving risk and uncertainty. Since decision analysis provides a “systematic
approach to decision making under conditions of uncertainty” (Weinstein and Fineberg
1980 p. 3) it is appropriate to utilize this method when making clinical decisions. In fact,
because decision analysis allows the physician to determine the treatment option that
would maximize a desired outcome (such as the highest probability of survival), decision
analysis provides a valuable tool in determining the best treatment for an individual
patient as well as for an entire population. Therefore, decision analysis can be used to
identify what physicians often refer to as the “best practice” or “standard of care”52 and
can also be applied in decisions regarding social policy (Weinstein and Fineberg 1980).
52

The usual course of treatment when a patient presents with a certain set of symptoms.
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Decision analysis often utilizes decision trees as a means of visualizing the
problem being addressed. The decision trees presented in the figures at the end of this
chapter were developed in accordance with the information presented in Weinstein and
Fineberg’s (1980) book Clinical Decision Analysis. Each branch of the decision tree
represents actions or consequences that occur over time. A square represents a decision
node, or a point at which a decision is made (it should be noted that for this type of
analysis, doing “nothing” is considered a decision). Branching points that do not involve
a decision (but are merely a function of chance) are referred to as chance nodes and are
indicated by a circle.
When the decision tree is completed, it visually illustrates all of the possible
courses of action (paths) and their resulting outcomes.

For example, consider the

decision tree presented in Figure 4-4. This tree illustrates the treatment decision that is
made when a physician is presented with a patient who has already been identified as
being at high risk for a heart attack (or MI)53. The physician54 has two options: he/she
may either choose to (1) simply monitor the patient (do nothing) or (2) place the patient
on a cholesterol lowering medication (drug therapy). Since this branch represents a
decision, it is considered a decision node and is indicated by a square.
For illustrative purposes only, assume that the physician decides not to put the
patient on drug therapy. Once the decision to simply monitor the patient has been made
(i.e. do nothing), the subsequent outcome is based solely on chance. The patient may or
may not experience an MI (the probability of each possibility is indicated on the
respective branch). Because the occurrence of a MI is beyond the control of the patient
or physician, it represents a chance node and is illustrated with a circle. If the patient
does experience an MI, he/she will either live or die as a result. The final outcomes are
represented by boxes at the end of each path. In this case, there are three possible
outcomes: (1) the patient lives without experiencing an MI (denoted as L); (2) the patient
experiences a MI, but survives (M); or (3) the patient experiences a MI and dies (D).
53

“Heart attack” and “MI” (the abbreviation for myocardial infarction, which is the medical term for heart
attack) are used interchangeably throughout this chapter.
54
When clinical decision analysis was first developed, the physician was often viewed as the primary
decision maker; however, as will be discussed in the following section, more recent applications of clinical
decision analysis are more oriented toward the consumer-patient as the primary decision maker, instead of
being expert-based.
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The expected utility of an entire branch can be determined by assigning a utility to
each outcome and then using a process that Weinstein and Fineberg refer to as “folding
back.” Basically, this is nothing more than using the probabilities assigned to each
branch as “weights.” For a simple example, refer to Figure 4-1. Suppose that the
probability of having an MI for an individual who demonstrated no symptoms of heart
disease was 2 percent (r = .02).55 Therefore, the probability of not having an MI would
be 98 percent (1-r = .98).

According to the Heart and Stroke Statistical Update

published by the American Heart Association (2003), the probability of dying as a result
of an MI is approximately 0.5, and is already indicated in the figure. Therefore, the
probability of surviving the MI is also 0.5. If the utility associated with L, M, and D were
10, 7, and 0 respectively, then the expected utility could be calculated as:
E(U) = .98 (10) + .02 (.5) 7 + .02 (.5) 0 = 9.8 + .07 + 0 = 9.87
When this branch is part of a larger tree (such as when it appears as the upper
branch in the decision tree presented in Figure 4-3), this process can be used to estimate
the expected utility of each branch stemming from a decision node; thereby allowing the
physician to choose the treatment option corresponding to the path offering the highest
expected utility.
4.2 Utilizing Decision Trees to Identify Risk-Dollar Tradeoffs
As described above, decision trees are used in clinical decision analysis to
identify the treatment option (path) that offers the highest level of utility, best chance of
survival, or some other desired outcome. The application of the decision trees in this
study; however, is slightly different. Instead of identifying the branch that maximizes the
individual’s utility, the expected utility from different branches is equated in order to hold
expected utility constant and identify risk-dollar tradeoffs associated with lower levels of
heart attack risk. Each decision tree identifies a different state of the world - the current
state in which no screening and limited treatment exists, and the desired state in which

55

According to the American Heart Association, the 10-year risk of an individual with no risk factors is 2%
(Wilson et al. 1998).
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screening and a better treatment method exist - for both high risk and asymptomatic
individuals. By identifying the individual’s expected utility in the current state and
holding that level of utility constant, the decision trees can be used to set up equations
similar to those used by Jones-Lee (1974), such that the WTP for a change in heart attack
risk can be determined.

4.2.1 Risk-Dollar Tradeoffs
Michael Jones-Lee (1974) developed an expected utility model that can be used to
determine how much an individual would be willing to pay in order to lower the
probability of death by a marginal amount. The model assumes two possible states: life
and death. If the probability of death is p (0 < p < 1); then, the probability of not dying is
1-p. The model also includes the individual’s utility as a function of wealth, W, in each
state of the world.56 Therefore, the individual’s initial expected utility is given by:
E(U) = (1-p) L(W) + p D(W),
where L(W) is the individual’s indirect utility associated with the good state “life” and
D(W) is the individual’s utility in the bad state “death.” The model assumes that L(W)
and D(W) are continuous and twice-differentiable, such that L'(W) > 0 and L''(W) < 0.
These conditions imply that in the good state utility increases with increased wealth, but
at a decreasing rate. In addition, the individual derives more utility in the good state than
in the bad state for a given level of wealth, such that L(W) > D(W). The marginal utility
of wealth is also assumed to be greater in the good state than in the bad, such that L'(W)
>D'(W). And finally, L''(W) >D''(W), which implies that the individual is more sensitive
to changes in wealth in the good state as compared to the bad state.
The individual can make an expenditure, X, to reduce the probability of death to
p*, such that expected utility becomes:
E(U) = (1-p*) L(W-X) + p* D(W-X)

56

The utility associated with death is derived from wealth being passed on to the individual’s heirs.
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The expenditure occurs regardless of whether the individual lives or dies, and although
the expenditure reduces the probability of death from p to p*, there is no guarantee that
the expenditure will prevent death from occurring (Jones-Lee 1974).57 According to
Jones-Lee, the maximum amount an individual would be willing to pay to reduce their
probability of death to p* is defined as the expenditure that will still provide the
individual with their initial expected level of utility. Mathematically, the individual’s
willingness to pay, or Hicksian compensating variation58, can be found by setting the
expected utilities equal and then solving for X using the following equation:
(1-p*) L(W-X) + p* D(W-X) = (1-p) L(W) +p D(W)

(4.1)

The marginal willingness to pay for a change in risk can also be found by differentiating
the entire expression by p and then rearranging terms to solve for ∂X/∂p (Jones-Lee
1974). Assuming that wealth (W) and the risk of death without the expenditure (p) are
constant, differentiating equation 4.1 with respect to p will cause the entire right hand
side of the equation to go to zero and result in the following expression:
- L + (1-p*) L' ∂X/ ∂p + D + p* D' ∂X/ ∂p = 0

(4.2)

where L = L(W-X), D = D(W–X), L' = ∂L(W-X)/ ∂X, and D' = ∂D(W-X)/ ∂X.
Rearranging terms in equation 4.2 and solving for ∂X/∂p, Jones-Lee (1974) provides the
following equation which defines the risk-dollar tradeoff:

57

This expenditure is made prior to the individual knowing which state of the world they will experience,
and is therefore considered an option price. According to Freeman (1999), option price is defined as the
maximum amount an individual would be willing to pay in order to reduce a given risk and return to a state
in which the risk does not exist, thereby maintaining the individual’s initial level of utility.
58
The Hicksian compensating variation refers to the maximum amount that the individual is willing to pay
(WTP) to avoid a loss, such that the individual’s utility is equal in both states. When a loss has been
imposed on an individual (or group of individuals), then the Hicksian equivalent variation refers to the
amount that the individual is willing to accept (WTA) in order to return them to their prior level of utility.
As discussed in Chapter 2, the appropriateness of WTA versus WTP is based on the assignment of property
rights. The Hicksian compensating variation assumes that the individual will move to a lower level of
utility, whereas the Hicksian equivalent variation assumes that the individual will be returned to their prior
level of utility before the loss was imposed on them. WTA was used in assessing damages for the Exxon
Valdez Oil Spill and illustrated that WTA and WTP measures may, in fact, be considerably different.
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∂X/ ∂p = [L – D] / [(1-p*) L' + p* D']
Since L > D, the numerator will always be positive. The denominator will be negative,
indicating that a reduction in risk, p, requires an increase in expenditures, X.
Many decisions regarding risk do not involve life and death, but rather varying
degrees of quality of life. Diseases such as multiple sclerosis and chronic conditions like
asthma can greatly influence the utility an individual derives from wealth. In fact,
Viscusi and Evans (1990) find empirical evidence to indicate that the utility derived from
income is higher in the healthy state compared to utility in an ill state. Therefore, it is
useful to modify the model developed by Jones-Lee (1974) such that the “good” and
“bad” state are not “life” and “death”, but rather different states of health.

4.2.2. Developing the Decision Trees
Although the final decision trees presented in Figures 4-1 through 4-5 appear
relatively simple, their development required considerable research regarding the various
types of treatment used for patients presenting with symptoms of heart disease. In
addition, it was necessary to understand how new developments regarding the screening
and treatment of vulnerable plaque would alter the current standard of care.59 Thus, the
decision trees were developed after attending vulnerable plaque seminars sponsored by
CIMIT (Center for Innovative Minimally Invasive Therapies) at the Massachusetts
General Hospital (MGH) and after numerous conversations with several M.D.s familiar
with vulnerable plaque research.

Once the underlying medical issues were clearly

understood, the decisions that would be faced by the patient/physician60 were simplified

59

Information related to this can be found in section 3.9 of Chapter 3 under the heading “Standard of
Care.”
60
This analysis is done from the patient’s point of view. Although the physician may recommend a
particular course of action, most decisions are ultimately that of the patient. Therefore, all decisions that
are made by the patient (with or without his/her doctor’s advice) will be represented as decision nodes. For
the few exceptions where the physician must make a decision without conferring with the patient (for
example, when the doctor must decide whether or not to treat the patient while performing the detection
procedure described in scenario 5), it is assumed that the physician will follow the “standard of care.”
Meaning that if the detection procedure reveals a certain level of plaque, treatment will be performed,
otherwise, it will not. Since this decision is out of the hands of the patient, and is in essence contingent
only on the level of plaque discovered during the detection procedure, it will be represented as a chance
node. Throughout this paper, the term “patient/physician” will generally be used when describing a course
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into five scenarios. The following provides a description of these scenarios that are used
to develop the theoretical framework for this project. Some scenarios represent the
current state of the world, while others represent hypothetical situations modeling the
decisions that would most likely exist if a screening and detection/treatment method did
exist.61 Each scenario is accompanied by a list of relevant assumptions/conditions and by
a decision tree that visually illustrates the scenario.
The first three scenarios are related to the benefits associated with a screening
method that could be used to identify individuals within the general population who are at
risk for a MI due to vulnerable plaque (including those who are asymptomatic). The first
scenario illustrates the current situation in which no such screening exists. The third
scenario illustrates the hypothetical state in which both screening and treatment exist.
Since drug therapy is currently available for those individuals who are identified as being
“at high risk” for a heart attack, the second scenario (in which screening is available, but
no treatment exists) would never occur. However, it is included as a stepping stone, and
will be utilized later in this chapter to isolate the individual’s WTP for information
obtained from the screening in the absence of possible treatment.
The last two scenarios are used to illustrate the benefits associated with
developing a more effective treatment for those who have already been identified as
being at high risk for a MI due to vulnerable plaque. The fourth scenario describes the
current state of the world in which only drug therapy is available, and the fifth scenario
describes the hypothetical state of the world in which a more effective
detection/treatment is available.
4.3 Theoretical Framework for a New Screening Method
4.3.1 Current State for an Asymptomatic Individual
The first scenario (See Figure 4-1) represents the current state in which no
screening is available. Therefore, individuals who do not exhibit symptoms of heart
problems are currently “left out of the system” even though they may be at risk for a
of treatment involving several decisions, which could be made by the patient, physician, or a combination
of the two. This term also reflects the collaborative nature with which most medical decisions are made.
61
It was necessary to simplify the medical process that actually occurs to some degree in order to make the
decision trees manageable. However, care was taken not to simplify any element that was thought to be
meaningful, given the scope of the analysis.
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heart attack.

Since screening and treatment are currently not available to these

individuals, the following conditions apply:
•

Individual has NO symptoms of coronary heart disease (CHD)

•

Screening for vulnerable plaque is NOT available
If the individual’s probability of having a heart attack (or MI) is r (0 < r < 1), then

with probability (1 - r) the individual will NOT experience an MI. It should be noted that
r is specific to the individual and is largely unknown. The individual may have some
information (N0) regarding r based on family history, past cholesterol tests, and other
traditional risk factors; however, as explained in Chapter 3: Medical Background, these
factors are not always good indicators of who is at risk for a heart attack. Therefore, the
current information held by the individual (N0) provides very little information as to
his/her actual risk of having a heart attack.
The medical literature indicates that an individual who experiences an MI has
about a 50 percent chance of survival (American Heart Association 2003). Surviving a
heart attack may leave the individual in a state of significant disability, or at the very
least, with a weaker heart muscle that puts them at greater risk for a future heart attack
and may place limits on their activity. Therefore, it is reasonable to consider the utility
associated with three possible health outcomes: the individual lives without experiencing
an MI, the individual experiences an MI and lives, or the individual experiences an MI
and dies as a result. The indirect utility62 associated with each health state will be
denoted as L, M, and D respectively.
Following the model developed by Michael Jones-Lee (1974) for the willingness
to pay for reductions in the risk of death, utility in each state is dependent on the
individual’s wealth (W); however, this model is modified such that instead of paying to
reduce the risk of death, the individual can pay to reduce his/her risk of a heart attack, r.
62

Consumers will choose the quantities of available goods and services that maximize his/her utility
subject to a budget constraint. Therefore, it follows that an individual’s optimal utility level will be
indirectly determined by his/her income and the prices of the goods being purchased (Nicholson 1992 p.
116). The indirect utility function is useful because it is expressed in terms of income and prices, which are
measured in dollars. Therefore, by using indirect utility it is possible to examine the effect changes in prices
and income will have on consumer utility (Nicholson 1992 p. 117).
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In addition, the bad state of the world - having a heart attack – has two consequences:
survival and death. Viscusi and Evans (1990) find empirical evidence to suggest that the
utility derived from income is higher when the individual is in the healthy state compared
to an unhealthy state. Therefore it would follow that L(W) > M(W) > D(W). In addition,
the marginal utility of wealth diminishes in each of the health states, such that L'(W),
M'(W), and D'(W) are all negative. Applying these indirect utilities to the decision tree in
Figure 4-1, expected utility can be written as:
E(U)1 = (1-r) L(W | N0) + r (.5) M(W | N0) + r (.5) D(W | N0),
where the utility derived from each health state is a function of the consumer’s wealth
(W), given the current amount of information (N) that the individual possesses on their
risk of heart attack. If the individual’s utility from death is assumed to be zero, then the
individual’s expected utility becomes:
E(U)1 = (1-r) L(W | N0) + .5 r M(W | N0)

(4.3)

The simple decision tree illustrated in Figure 4-1 will appear as a branch in several other
trees and is indicated by chance nodes labeled α. In addition, other branches that appear
in more than one decision tree will similarly be labeled to facilitate comparisons across
figures.

4.3.2 Intermediate State for an Asymptomatic Individual
The second scenario (See Figure 4-2) represents an intermediate state of the world
in which screening exists, but treatment does not. Drug therapy currently exists for those
identified as being at high risk for a heart attack, therefore, the following scenario is not
realistic; however, it is possible that individuals would be willing to give up some of their
wealth in order to find out more about their risk of having a heart attack, even if a
treatment is not available. Therefore, this scenario is included as a stepping stone to
isolate the factors affecting the WTP for information provided by the screening in the
absence of a treatment. Therefore, in the second scenario the following conditions apply:
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•

Individual has NO symptoms of coronary heart disease (CHD)

•

Non-invasive screening for vulnerable plaque IS available to the general
public (i.e. routine blood test similar to a cholesterol test)

•

BUT a treatment does NOT exist
The individual now has the option to find out more about their risk of having a

heart attack by paying some dollar amount for a screening test. Interestingly enough,
regardless of whether the individual has the screening or not, they will still face the same
gamble illustrated in Figure 4-1. As illustrated in Figure 4-2, the only difference between
the upper (α) and lower (γ) branches is the amount of information (N) the individual
possesses regarding his/her risk of heart attack.

Since there is no treatment, the

individual’s risk of heart attack, r, will remain unchanged. Although screening will not
lower r, it will provide the individual with more information regarding the actual value of
r. Therefore, by offering individuals more information as to their actual risk of having a
heart attack, screening has the potential to enable the individual to make decisions that
would enhance his/her utility.
Even though this scenario assumes no treatment is available, there are possible
benefits derived from being screened. Namely, individuals found to be “at low risk”
receive peace of mind. In addition, this new information regarding the true value of r
may allow some individuals to alter their behavior in ways that increases their utility. For
example, an individual who discovers herself to be “at low risk” after believing that she
was “at high risk” may no longer feel compelled to adhere to as strict a routine of diet and
exercise, which could potentially increase utility. For an individual found to be “at high
risk” this new information can also be beneficial in that it allows him to better prepare for
the future. For example, the individual now has the opportunity to obtain more life or
disability insurance to provide financial security for his family in the event of a heart
attack. Additionally, this new information may lead the individual to spend their time
differently or alter their consumption patterns, thereby reducing feelings of regret in the
event that death or disability does occur.
Although there are many possible benefits, it is also possible that the information
provided from the screening could lower utility for some individuals. An individual who
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is found to be “at high risk” may experience stress and anxiety from knowing they have a
medical condition for which no treatment is available. Therefore, it is not clear that more
information will increase the utility in each health state for all individuals.
Again, following the model by Jones-Lee (1974), a payment (Ps) is required to
receive the screening. The payment will reduce the individual’s wealth, but will increase
their level of knowledge regarding their risk of heart attack from N0 to N1. Therefore,
expected utility derived from the screening (lower branch in Figure 4-2) can be expressed
as:
E(U)2 = (1-r) L(W - Ps | N1) + .5 r M(W - Ps | N1)

(4.4)

Assuming utility is held constant at the initial level of E(U)1, the individual’s
maximum WTP for information (WTPi) from the screening (when no treatment is
available) is defined by setting E(U)1 = E(U)2. Because this decision is made ex ante
(prior to the individual knowing whether he/she is at risk), this expenditure is an option
price that is paid regardless of whether the individual experiences a heart attack or not.
Substituting in for the expected utility using equations 4.3 and 4.4 and changing Ps to
WTPi yields the following expression:
(1-r)L(W | N0) + .5rM(W | N0) = (1-r)L(W –WTPi | N1) + .5rM(W –WTPi | N1) (4.5)
As this equation implies, there is clearly a tradeoff between information and
wealth. Choosing to have the screening will not change the individual’s probability of
having a heart attack (because no treatment is available); however, if the individual
chooses to pay for screening, then he/she will obtain information (N1) regarding his/her
risk of having a heart attack. Therefore, the maximum WTP for screening when no
treatment is available (WTPi) will be dependent on the dollar equivalent of the marginal
utility derived from the additional information (which could be either positive or negative
as the previous discussion illustrates).

Therefore, it is expected that those who

experience a gain in utility from the information will be willing to pay some dollar
amount for it, but those individuals for which the information causes disutility will not
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elect to have the screening, and may even require compensation in order to accept the
screening.

4.3.3 Desired State for an Asymptomatic Individual
The third scenario (See Figure 4-3) represents the desired state of the world in
which an asymptomatic individual can be screened for vulnerable plaque, and if found to
be at high risk, can receive treatment. Figure 4-3 is very similar to Figure 4-2. However,
since the possibility of treatment now exists, a bottom branch is included in Figure 4-3
and the chance node γ becomes a decision node. Drug therapy which is 30% effective
currently exists, and it is anticipated that a new treatment which is even more effective
will be available in the near future. Therefore, in the third scenario, the following
conditions apply:
•

Individual has NO symptoms of coronary heart disease (CHD)

•

Non-invasive screening for vulnerable plaque IS available to the general
public (i.e. routine blood test similar to checking your cholesterol)

•

A treatment DOES exist in the form of drug therapy which is 30% effective,
and a new treatment which is 85% effective also exists.
The treatment received will reduce the individual’s risk of a heart attack r, such

that the individual’s new level of risk with treatment is r*. The new lower level of risk
will be determined by the effectiveness of the treatment. Therefore, having the new
treatment will lower r more than if the individual chooses drug therapy. The expected
utility derived from screening is illustrated in the lower branch of Figure 4-3. In this case
screening offers information as well as the opportunity for treatment. Treatment is not
actually delivered; however, an individual who pays for the screening has the opportunity
to receive treatment if the results indicate that the individual is at high risk, which occurs
if the individual’s risk of heart attack, r, is found to be above some threshold amount, z.
Therefore, using the lower branch of Figure 4-3, expected utility from screening can be
written as:
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E(U)3 = (1-p(r>z))[(1-r) L(W - Ps | N1) + .5 r M(W - Ps | N1)]
+ (p(r>z))[ [(1-r*) L(W - Ps | N1) + .5 r* M(W - Ps | N1)]

(4.6)

Since screening involves an expenditure, utility will be reduced if the screening
indicates the respondent is not at high risk. However, as the last scenario illustrated, only
those who have a positive marginal utility associated with the information will elect to
have the screening.63 Plus, the other potential gain from the screening is the benefit from
the treatment if the individual is found to be at high risk.64 Holding the individual’s
utility constant at the level defined by E(U)1 , the WTP for screening will be determined
by:
E(U)1 = E(U)3
Substituting in equations 4.3 and 4.6, the WTP for screening (WTPs) is defined by the
equation:
(1-r) L(W| N0) + r (.5) M(W| N0) = (1-p(r>z))[(1-r)L(W-WTPs| N1) + .5rM(W-WTPs |N1)]
+ p(r>z) [ [(1-r*) L(W - WTPs | N1) + .5 r* M(W - WTPs | N1)]65
63

This lends support to the two-part model included in Chapter 7: Data Analysis
In estimating the total benefits derived from the screening and/or treatment, it would be necessary to
consider potential effects on markets for substitute goods. For example, if the screening test identifies
individuals who do not currently know they are at risk for a heart attack, the demand for statin (cholesterollowering) drugs is likely to increase. Likewise, development of a localized treatment (such as that
described in Survey 2: Treatment) would most likely reduce the demand for stent procedures, but have little
effect on the demand for statins since those having either procedure would still receive drug therapy
regardless of the procedure. In addition, another consideration in conducting a benefit-cost analysis would
be to consider the potential for offsetting behavior, or the Peltzman effect (Peltzman 1975). Studies
(Peltzman 1975, Chirinko and Harper 1993) have shown that auto safety regulations have had little (if any)
net effect on the reduction of highway traffic fatalities. One potential explanation is that consumers have a
constant demand for health/safety and will therefore engage in offsetting behavior (such as driving faster)
in response to additional auto safety features that reduce the probability of a auto fatality (Peltzman 1975).
Therefore, given this evidence of the Peltzman effect in the demand for highway safety, it is reasonable to
expect that consumers may also engage in some degree of offsetting behavior if an improved treatment
which reduces the risk of heart attack is developed.
65
This equation does not include a cost for treatment, which is consistent with the design of the survey
instrument. For those respondents who received a version of the survey in which treatment was available,
they were informed that treatment was either 30% or 85% effective (corresponding to the two treatment
options); however, no mention of the cost of the treatment was includes. However, this is not necessarily an
unrealistic specification. Typically, insurance companies will cover the cost of treatment that is determined
necessary. Therefore, if the screening indicates that the individual is at high risk for a heart attack, then the
insurance company is likely to cover the cost of drug therapy.
64
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From this equation, it is clear that WTP for screening is a combination of the
informational value it provides as well as the expected decrease in risk that treatment
offers if the individual is found to be at high risk. Therefore, it is expected that those who
are offered a greater effectiveness for treatment will be willing to pay more; however,
this may be influenced by their perceived level of risk. If the individual does not
perceive their risk to be very high, then they may anticipate that the screening will
indicate that they do not need treatment. For example, consider the extreme case of
p(r>z)=0 in which the individual believes there is zero probability that the screening will
indicate that they are at high risk, such that their individual risk of a heart attack, r, is
above the threshold level z. In this extreme case, the effectiveness of the potential
treatment will have no impact on the individual’s WTP for screening. In fact, if p(r>z) =0
then the last two terms on the right side of the equation become zero.

Thus, the

expression simplifies to equation 4.5 and is no different from the second scenario in
which the screening only offers informational value.
4.4 Theoretical Framework for a More Effective Treatment
The last two decision trees apply to individuals who are already known to be at
high risk for a heart attack. The decision tree in Figure 4-4 represents the current options
(drug therapy) available to the patient/physician, while the added branch in Figure 4-5
represents the options available if a new detection/treatment method were made available.
In scenario 4, the individual has already been identified as being at high risk for MI,
therefore, he/she has some additional information (N1) regarding his/her actual risk of
heart attack. However, in scenario 5, the patient now has the opportunity to choose a new
detection method that would provide more precise information (N2) about his/her risk of
MI. Notice that if the patient chooses drug therapy, no additional information is gained,
which is indicated by the level of information N1 in the indirect utility function.

4.4.1 Current State for an Individual at High Risk for a MI
Individuals who experience symptoms of coronary heart disease (or who have in
the past) are considered “at high risk” for an MI. Therefore, the decisions facing these
individuals would be the same as those who are identified as being “at high risk” for MI
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through screening. Currently, the only treatment available is drug therapy, which is
considered to be 30% effective at reducing the risk of heart attack. Therefore, the fourth
scenario (See Figure 4-4) represents the current state of the world for those individuals
who have been identified as being “at high risk” for a heart attack, given the following
conditions:
•

Individual has been identified “at high risk” for MI either through screening
or because the individual has symptoms and/or a medical history of coronary
heart disease (CHD).

•

A treatment does exist in the form of drug therapy; however, at best, it is
only 30% effective
Once a patient is identified as being “at high risk” for a MI, he/she has two

possible options.

The first option is to do nothing.

Although this would not be

recommended by a physician, a patient does have the right to refuse medical treatment.66
If the patient elects not to have treatment, he/she will still possess information N1
regarding his/her risk of heart attack; therefore, selecting this option would simply lead to
a branch (γ), which is identical to the branch in Figure 4-2 in which no treatment is
available.
The patient’s second option is drug therapy, which would involve the patient
taking a statin (cholesterol lowering) medication on a daily basis.

A very small

percentage of patients (<1/10,000)67 who take statins die from medical complications
(such as liver failure). However, because this risk is so small and because the focus of
the study is the WTP for a new treatment, this negligible risk associated with drug
therapy was not mentioned in the survey, and therefore is not included in the decision
trees.
Studies have shown that for patients taking statin drugs there is a statistically
significant difference in the probability of having a MI, and that drug therapy reduces the
66

Although the patient does not choose medical treatment, it does not preclude the possibility that the
individual may respond to the information that he/she is “at high risk” of a heart attack by adjusting his/her
behavior in ways that could potentially improve health (e.g. increased exercise, improved diet).
67
Any medical risk that is lower than 1/10,000 is simply reported as “< 1/10,000”
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risk of heart attack by an average of 30% (Ryan 2007). This means that a statin drug
may have a larger effect for an individual at very high risk of a heart attack, while having
a much smaller effect for an individual who is just over the threshold of being “at high
risk.” Thus, just as the risk of heart attack, r, is dependent on the individual, so will the
magnitude of the risk reduction resulting from drug therapy. Therefore, the individual’s
risk of a heart attack while on drug therapy, rd, is unique to the individual and, like r, is
largely unknown. However, it is clear that rd < r due to the fact that the individual’s risk
of heart attack is lower from drug therapy compared to when the individual receives no
treatment.
The decision tree illustrated in Figure 4-4 is essentially the same as the entire
bottom branch in Figure 4-3 except, in this case, treatment is defined. The top branch of
Figure 4-4 illustrates the expected utility for the individual if he/she refuses treatment,
and is given by:
E(U)4 = (1-r) L(W | N1) + .5 r M(W | N1)

(4.7)

Clearly the expected utility for someone who knows they are at higher risk for a
heart attack will be different than the utility, E(U)1, for an individual who does not have
this information; therefore, E(U)4 will become the baseline level of utility for those
known to be at high risk for a heart attack. Since the focus of this study was the WTP for
the new procedure, the out-of-pocket cost for drug therapy was assumed to be zero.
Therefore, the expected utility from drug therapy is defined by the bottom branch (λ) in
Figure 4-4 such that:
E(U)5 = (1-rd) L(W | N1) + .5 rd M(W | N1)

(4.8)

As stated earlier, rd < r; therefore expected utility68 from the drug therapy is
clearly higher when compared to the expected utility derived from doing nothing. This is
why drug therapy is currently the standard of care for those who are identified as being
“at high risk” for a heart attack. Although not formally modeled, it is possible that an
68

As defined by equations 4.7 and 4.8
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individual would elect not to have drug therapy if the losses in utility from possible side
effects or having to take the medicine on a daily basis outweighed the benefits associated
with the reduction in heart attack risk.69

4.4.2 Desired State for an Individual at High Risk for an MI
Currently, the only available treatment for those known to be “at high risk” for a
heart attack is drug therapy, which is only 30% effective. Therefore, this final scenario
(See Figure 4-5) describes the desired state of the world in which a detection/treatment
method for vulnerable plaque does exist, such that patients at high risk for a heart attack
have a treatment option available to them that is more effective than drug therapy.
•

Individual has been identified “at high risk” for MI either through screening
or because the individual has symptoms and/or a medical history of coronary
heart disease (CHD).

•

A NEW method for detecting and treating vulnerable plaque exists that is
MORE effective than drug therapy
Although screening and/or symptoms of coronary heart disease (i.e. chest pain)

may place an individual “at high risk” for MI, these are only indicators. As explained in
Chapter 3: Medical Background, these “indicators” only provide limited information as to
the individual’s true risk of having a heart attack. Therefore, the development of a
procedure that could locate pockets of vulnerable plaque within the coronary arteries
would allow the physician to better assess the patient’s actual risk and determine the best
course of treatment (either drug therapy or the new treatment procedure utilizing a heart
catheter). Regardless of the final treatment option selected, having this procedure would
increase the patient’s information regarding his/her actual risk of a heart attack (from N1
to N2).

69

The decision trees are modeled using the individual’s actual probability of having a heart attack, r;
however, individuals will make their decisions based on their perception of this risk. Therefore, if the
individual has poor information regarding their actual risk of having a heart attack, they may make
decisions that are non-optimizing.
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As the lower branch in Figure 4-5 illustrates, the new procedure does involve an
additional risk of death. As explained in the previous chapter, this risk of death stems
from the possibility of medical complications from the surgical procedure. In the survey,
respondents were told that the added risk of death from the procedure was equal to
1/10,000; therefore, the probability of survival (ps) for this study was 0.9999. However,
in writing the equations it will be left as a variable, so that it is clear how changes in the
risk of death from the procedure will affect WTP.
In looking at the bottom branch of Figure 4-5, it is interesting to note that once the
patient chooses the catheter procedure, all remaining decisions are beyond his/her
control; therefore, all the branches stemming from this decision appear as chance nodes.
Assuming the patient survives the detection procedure, the physician will then be able to
determine if vulnerable plaque is present, such that the new catheter treatment is
warranted. Because there is a significant added risk from performing the procedure more
than once (due to the anesthesia involved) and because additional procedures are an
inefficient utilization of medical resources, the procedure includes both detection and
treatment (if it is warranted). However, because the patient is medicated and cannot
provide his/her informed consent, the decision to treat the vulnerable plaque will be
determined by the physician, who is assumed to follow the accepted standard of care.
Therefore, once the patient chooses to have the procedure, the resulting outcome (path) is
dependent solely on the existing probabilities associated with this treatment option.
If the detection procedure reveals that vulnerable plaque is not present, then the
patient will be treated using drug therapy which, as discussed earlier, lowers the
individual’s risk of heart attack to rd. However, if vulnerable plaque is detected, then the
new treatment will be performed. The new treatment will lower the individual’s risk to rt
and because the treatment is more effective than drug therapy, rt < rd for each individual.
Earlier it was determined that if the individual did not receive treatment at all, expected
utility would be equal to:
E(U)4 = (1-r) L(W | N1) + .5 r M(W | N1)
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(4.7)

Since E(U)4 defines expected utility if the individual does not receive any form of
treatment, this will be used as the individual’s baseline utility level. Following the lower
branch of Figure 4-5, the individual’s expected utility from the new treatment procedure
is given by:
E(U)6 = (ps){ pv (1-rt) L(W - Pt | N2) + .5pv rt M(W - Pt | N2) +
(1-pv)(1- rd) L(W - Pt | N2) + .5(1-pv) rd M(W - Pt | N2) }

(4.9)

where ps is the probability of surviving the procedure,70 pv is the probability that
vulnerable plaque is detected during the procedure,71 Pt is the price of the treatment, and
N2 is the higher level of information on heart attack risk that is gained from having the
procedure. Therefore, the WTP for the reduction in heart attack risk due to the treatment
can be found by holding expected utility constant, such that E(U)4 = E(U)6 . Substituting
in equations (4.7) and (4.9) gives:
(1-r)L(W| N1)+.5rM(W| N1)=(ps)[pv(1- rt)L(W-WTPt | N2)+.5pv rtM(W-WTPt | N2) ]
+ (ps)[(1-pv)(1- rd)L(W-WTPt | N2) + .5(1-pv) rd M(W-WTPt | N2) ]

(4.10)

Assuming that the information effect from the procedure is negligible, WTP for
the change in risk associated with the procedure can be found by differentiating 4.10 with
respect to r. Since risk remains constant without the treatment, the left side will become
zero, such that:
0 = -pspvL + pspv(1-rt)L' ∂WTPt/∂r + ps(1-rt)L ∂Pv/∂r + .5pspvM + .5pspvrtM' ∂WTPt/∂r
+ .5psrtM ∂Pv/∂r – ps(1-pv)L + ps(1-pv)(1-rd)L' ∂WTPt/∂r - ps(1-rd)L ∂Pv/∂r +.5ps(1- pv)M
+ .5ps(1-pv)rdM' ∂WTPt/∂r - .5psrdM ∂Pv/∂r
Solving for ∂WTPt/∂r gives an expression for the marginal change in WTP for treatment
for a change in heart attack risk, and is defined by:
70

For this study ps is equal to 1 minus the probability of death from the new treatment procedure;
ps =1 -.0001 = .9999
71
pv is dependent on the individual’s risk of heart attack, r
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∂WTPt/∂r = [pspvL - ps(1-rt)L ∂Pv/∂r - .5pspvM - .5psrtM ∂Pv/∂r + ps(1-pv)L
+ ps(1-rd)L ∂Pv/∂r -.5ps(1- pv)M + .5psrdM ∂Pv/∂r] / [ pspv(1-rt)L' + .5pspvrtM'
+ ps(1-pv)(1-rd)L' + .5ps(1-pv)rdM']

(4.11)

Some simple algebra results in some terms cancelling out, such that equation 4.11
simplifies to:
∂WTPt/∂r = L -.5M + rtL ∂Pv/∂r -.5rtM ∂Pv/∂r + .5rdM ∂Pv/∂r - rdL ∂Pv/∂r] /
[pv(rd-rt)L' + (1-rd)L' +.5pvrtM' + .5(1-pv)rdM']

(4.12)

where L = L(W-WTPt |N2), D = D(W-WTPt |N2), L' = ∂L(W-WTPt |N2)/ ∂WTPt, and D' =
∂D(W-WTPt |N2)/ ∂ WTPt .
From equation 4.12, it follows that higher the effectiveness of the treatment, the
higher the WTP for treatment; however, the higher the effectiveness of drug therapy, the
lower the WTP for treatment. Therefore, this implies that the greater the difference
between the effectiveness of the two treatments, the larger the WTP for treatment. In
addition, the higher the likelihood of having vulnerable plaque, the greater the expected
WTP.72
4.5 Application to Survey Instruments
The theoretical framework presented in this chapter is used to develop the two
surveys utilized for this study: Survey 1: Screening and Survey 2: Treatment. Survey 1:
Screening was developed based on scenarios 1-3 and was administered to a sample
representative of the general population.

Through this survey, information on the

individual’s perceived risk of a heart attack, health characteristics, financial resources,
and other demographics was obtained. In addition, the survey elicited the individual’s
WTP for screening. In order to better understand how treatment effectiveness might
72

The probability of the individual having vulnerable plaque is unknown; however, it may be possible to
use the individual’s perceived risk of a heart attack as a proxy for this variable in the empirical analysis in
Chapter 7.
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influence the WTP for screening (as suggested by the third scenario), respondents
received versions of the survey in which treatment effectiveness was 30% (corresponding
to drug therapy) or 85% (corresponding to the new treatment). In addition, in order to
explore the question of whether screening has value if it offers purely informational value
(scenario 2), a small arm of the sample received a slightly modified survey in which no
treatment was available.
Scenarios 4 and 5 are addressed by Survey 2: Treatment. Since these scenarios
involve patients who are already known to be at high risk for a heart attack, the sample
for this survey only included individuals with doctor-diagnosed heart problems. Like
Survey 1: Screening, Survey 2: Treatment collects information on the individual’s
perceived risk of a heart attack, health characteristics, financial resources, and other
demographics. In addition, respondents for this survey were presented with the treatment
options discussed in the final scenario and were asked about their WTP for a more
effective detection/treatment method for reducing their probability of experiencing a
heart attack.
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Figure 4-2: Intermediate State for Asymptomatic Individuals: Screening Available, But
No Treatment

Figure 4-1: Current State for Asymptomatic Individuals: No Screening Available
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Figure 4-3: Desired State for Asymptomatic Individuals: Screening and Treatment
Available
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Chapter V: Development of the Web Surveys
The purpose of this chapter is to describe the development of the two web-based
survey instruments used in this study. Survey 1: Screening was designed to elicit the
maximum willingness to pay (WTP) for a screening method that would better identify
individuals in the general population who are at risk for a heart attack. The goal of
Survey 2: Treatment was to determine the value an individual, who is known to be at high
risk for a heart attack, places on a procedure that could provide more precise information
regarding his/her risk of a heart attack, in addition to providing treatment that could
substantially reduce the individual’s risk of a future heart attack. Both surveys elicited
the respondent’s maximum WTP through the use of an iterative bidding process, which
utilized the real-time interaction capabilities of a web-based survey.
Web-based surveys are relatively new and provide researchers with several
advantages over other survey modes; however, research on web-based survey
methodology indicates that there are several issues related to this survey mode that have
the potential to affect the quality of the data (Solomon 2001). Therefore, the first half of
this chapter explores what is known about web-based surveys - the advantages and
potential drawbacks – as well as identifies a set of guidelines for developing an effective
and reliable web-based survey. The second half of this chapter explains the development
of the individual survey questions included in Survey 1: Screening and Survey 2:
Treatment. In particular, this section focuses on the rationale for including each question,
as well as its contribution to the overall purpose of the survey. In addition, explanations
as to how the web-based guidelines presented in the first half of this chapter were
integrated into the creation of the individual questions (as well as the overall survey
format) are included throughout the second half of this chapter in the form of footnotes.
5.1 Emergence of Electronic Surveys
Electronic surveys, which include e-mail and web-based surveys, emerged with
the development of e-mail and the Internet. Although the initial use of e-mail surveys
dates back to the late 1980’s, it was the rapid growth of the Internet during the 1990’s
that resulted in electronic surveys becoming prevalent (Schonlau et al. 2001). The
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increased use of e-mail as a means of communication made e-mail surveys attractive to
researchers as a way to reach a lot of people in a short amount of time. In addition,
electronic surveys (specifically e-mail surveys) can be less expensive to conduct than
paper surveys because they eliminate the need for printing, postage, and data entry
(Dillman 2000). As a result, the use of e-mail surveys over paper surveys has increased
significantly in the past decade.

5.1.1 E-mail Surveys
E-mail surveys are essentially paper surveys delivered via e-mail. The e-mail
received by a respondent typically includes a brief introduction to the survey, followed by
the actual survey. The respondent may then be instructed to print the survey and mail it
back, or if the design allows, fill out the survey electronically and submit it via e-mail
(Dillman 2000). Although e-mail surveys have the potentially to reduce the time and cost
associated with conducting a survey, e-mail surveys are still limited in much the same
way as self-administered paper surveys (Schonlau et al. 2001). In particular, e-mail
surveys do not allow for extensive skip patterns (Dillman 2000). As a result, researchers
have gravitated toward the use of a more intricate form of electronic survey: web-based
surveys (Schonlau et al. 2001).

5.1.2 Web-based Surveys
Web-based surveys are surveys that are administered using the Internet, or worldwide web.

Web-based surveys are typically programmed using HTML (Hypertext

Markup Language), Java or other web-design computer language, and are accessed by a
computer with Internet access using a specific URL (universal resource locator), or “web
address” (Dillman 2000, Solomon 2001). Programming a web-based survey in HTML
has several advantages including the ability to tailor the survey to each individual based
on responses given throughout the survey (Solomon 2001). Web-based surveys also
allow answers keyed in by the respondent to be automatically transferred into a database
(Solomon 2001), thereby preventing the need for data entry and eliminating the potential
for transcription error (Schonlau et al. 2001). In addition, the ability of the Internet to
deliver video and audio gives web-based surveys far more versatility than electronic
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surveys delivered via e-mail (Schonlau et al. 2001). In fact, in Don Dillman’s book
entitled, Mail and Internet Surveys, Dillman asserts that Internet surveys have the
potential to revolutionize surveying in much the same way as random sampling
techniques did in the 1940’s and telephone interviewing did in the 1970’s (Dillman
2000). Therefore, due to several distinct advantages, including their greater versatility,
web-based surveys have replaced e-mail surveys as the electronic survey of choice
(Solomon 2001).
5.2 Potential Drawbacks of Web-based Surveys
5.2.1 Coverage and Self-Selection Bias
By far, the greatest challenge facing the administration of web-based surveys is
coverage bias (Solomon 2001, Schonlau et al. 2001). The primary cause of this coverage
bias is the lack of computer ownership and access to the Internet among U.S. households
(Schonlau et al. 2001). According to a U.S. Census Bureau report, less than 62% of U.S.
households owned a computer in 200373 (Day, Janus, and Davis 2005). Although this is
significantly higher than the 8.2% reported in 1984 (Day, Janus, and Davis 2005), this is
far lower than the percentage necessary to generate a reliable random sample of the
general population.
It has been argued that although individuals may not own computers, they may
have Internet access (and e-mail address) at their place of work. However, the difficulty
associated with using e-mail accounts to invite survey participants is that unlike 10-digit
telephone numbers, e-mail addresses are not standardized, and it is possible for a single
individual to have more than one e-mail address.74 Therefore, random sampling methods,
such as those that have been used for telephone surveys, can not be applied directly to email addresses (Dillman 2000).

As a result, web-based surveying often relies on

73

This is the relevant time period because it is when the web-based surveys used for this study were
administered.
74
It is interesting to note that in the future, phone interviewing will most likely face similar issues. With
the emergence of cell phones, some households have chosen to no longer carry (and pay for) a land line,
but rather use their cell phone as their “home” number. In addition, it is not uncommon for a single
household to include several members who each have their own cell phone. Therefore, 10-digit telephone
numbers no longer have a one-to-one correspondence with individual households. In addition, as the use of
cell phones increases, generating a sample using only land lines will become less reliable as a means of
generating a random sample because it will exclude households who no longer carry land lines, but rather
rely solely on a cell phone for their phone service.
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recruiting respondents by advertising the survey or posting it where respondents who are
interested in the topic may naturally come across it while surfing the web. Because this
approach to sampling involves individuals self-selecting into surveys that interest them,
these convenience samples do not provide valid data for drawing conclusions regarding
the entire population (Pineau and Slotwiner 2003). Although part of this problem could
potentially be overcome by mailing the survey invitation (which would then direct the
individual to the survey’s web address), limited access to the Internet would then become
the critical issue. Data analyzed from the Current Population Survey (CPS) indicates that
there is a large disparity in computer ownership and Internet access by income, race, and
level of education (McConnaughey and Lader 2007). Therefore, this clearly suggests that
data obtained using a standard web-based survey approach would not be representative of
the general population, but instead would be prone to systematic bias and unreliable
results.
One strategy Dillman (2000) suggests for overcoming the coverage bias
associated with web-based surveys is to administer the survey using mixed modes. This
method acknowledges the existence of coverage bias and attempts to overcome it by
collecting additional data from underrepresented groups using an alternative mode of the
survey – for example, through a paper or telephone survey. The problem with this
strategy is that it introduces the potential for mode effects – that is, inconsistencies in the
data arising from obtaining the data using different “modes” or formats of the survey
(Dillman 2000).

5.2.2 Minimum Hardware and Software Requirements
Another challenge presented by web-based surveys is that they often require a
minimum hardware capacity. In addition, updates in hardware and software occur so
rapidly, there is no equipment “standard” on which to base the design of an Internet
survey. Thus, web-based surveys may appear differently across respondents due to
variations in the size of the monitor being used, the horizontal and vertical configuration
of the viewing “window”, variations in the operating system (PC versus Macintosh), web
browser version, capacity of the hardware, or formatting specifications of the software.
These variations (if not caught through extensive pre-testing) can result in the respondent
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having to scroll to see the entire question, text wrapping to the next line, misalignment of
items in tables, or other visual disparities that could inadvertently influence respondents
in unknown ways (Dillman 2000).
In addition, Internet connection speeds can vary significantly across users,
creating vast differences in the time (from a few seconds to several minutes) it takes an
item to appear on the respondent’s screen. This is especially true when transmitting
larger files such as those that contain audio or video (Schonlau et al. 2001, Dillman 2000)
Because there is a tendency for businesses and higher income areas to have better Internet
service providers (offering faster Internet connection speeds); variations due to Internet
speed can create a systematic disparity across socioeconomic groups (Dillman 2000). As
a result, survey designers are encouraged to minimize the size of files and extensively test
the entire survey on systems with varying Internet connection speeds (especially those
that are slower) to help ensure consistent survey appearance and delivery (Schonlau et al.
2001, Dillman 2000).

5.2.3 Lack of Computer Experience Among Respondents
Another issue for web-based surveys is that it is not uncommon for individuals
(especially those who are older) to have limited experience using computers. Even those
individuals who have mastered using a word processor or other specific computer
application may have difficulty transferring those skills and applying them to the
relatively “new” format of an online survey (Dillman 2000). As a result, individuals with
limited computer knowledge may have difficulty completing a web-based survey, as
compared to the same survey offered in a more familiar paper or telephone format.
To help prevent the introduction of survey error due to lack of computer
knowledge, web-based surveys should be designed at a level at which those with limited
computer experience would feel comfortable. In addition, the survey should also include
any instructions regarding relevant computer functions that are necessary to move
through the survey (Dillman 2000).

For example, it may be important to inform

respondents to click on the button marked “next” when they are ready to move on to the
next screen.

These basic computer logic functions can be easily overlooked by

programmers familiar with computers; however, they are important in keeping response
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rates high since respondents may abandon a survey if they become confused or unsure of
how to continue (Dillman 2000).

5.2.4 Security and Confidentiality
Finally, web-based surveys are prone to security issues because information
transferred over the Internet could potentially be viewed by unauthorized individuals.
Therefore, administering a web-based survey necessitates utilizing additional security
measures, such as encryption, in order to safeguard the confidentiality of the data. In
addition, the survey should establish a perceived level of confidentiality for the
respondent, such that he/she will feel confident answering the questions honestly
(Schonlau et al. 2001, Dillman 2000).
5.3 Advantages of Web-based Surveys
5.3.1 Real Time Interaction
One of the foremost advantages of web-based surveys is that this format allows
interaction between the survey and the respondent. Real time interaction allows the
computer program generating the survey to tailor the survey questions to the respondent
based on his/her prior answers. Therefore, web-based surveys have the advantage of a
telephone survey in that they can provide seamless skips based on the respondent’s
responses, but without the need for extensive human resources to administer the survey
(Dillman 2000) and without introducing the possibility of interviewer bias.

5.3.2 Use of Color, Video, and Audio
In addition, web-based surveys can utilize color, audio, and video, which greatly
increases the type of information that can be presented. Web-based surveys also have the
option of allowing respondents to access pop-up help screens whenever needed. In
addition, drop-down boxes for long lists (such as “state of residence”) reduce the need for
typing and help eliminate data entry error (Dillman 2000).
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5.3.3 Shorter Fielding Time & Fewer Human Resources
The nature of the Internet also allows surveys to be administered to
geographically diverse populations quickly and easily (Dillman 2000). Therefore, webbased surveys can often be conducted faster than comparable mail surveys (Schonlau et
al. 2001) and without the extensive training or manpower required to administer a
telephone survey.

5.3.4 Less Expensive “on the Margin”
Finally, the cost of a web-based survey does not increase proportionally with
sample size (as is the case with paper and telephone surveys). As a result, “lower costs
are often touted as one of the benefits of Internet surveys” (Schonlau et al. 2001, p. 24).
Although some e-mail surveys may be administered with a lower overall cost in relation
to a comparable paper survey, this is far less likely to be the case with a well-designed
web-based survey. Web-based surveys typically have a high initial cost associated with
the time required to program and extensively test the survey (Schonlau et al. 2001).
However, after the survey is developed and tested, the marginal cost of administering the
survey to an additional person is relatively low, if not negligible. This is not to imply that
web-based surveys are less expensive overall when compared to a comparable paper
survey – in fact, the expense associated with the time and computer resources required to
create and extensively test a well-designed web-based survey can far exceed that of a
paper survey (Dillman 2000). Therefore, the decision to utilize a web-based survey
should stem from the nature of the survey itself, which dictates certain functions that only
a web-based survey can provide.
5.4 Decision to Use a Web-based Survey
For this study, the decision to use a web-based survey was driven primarily by the
desire to achieve a nationally representative sample utilizing a survey mode that allowed
extensive skip patterns and offered real-time interface. The interactive capabilities of the
web-based survey meant that an iterative bidding process could be used to obtain each
individual’s maximum willingness to pay (WTP) for the screening and treatment of
vulnerable plaque as a means of better understanding the value individuals place on their
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health by avoiding a heart attack. Typically, paper surveys have been used to obtain
WTP estimates for various goods and services using a dichotomous choice question in
which respondents either accept or reject a single bid.

Subsequently, econometric

techniques such as Cameron’s (1988) or Johansson’s (1995) parametric approaches or
Kriström’s (1990) non-parametric approach are then required to derive the mean WTP.
This study does not rely on econometric techniques to derive the mean WTP, but rather
uses an iterative bidding process to elicit an exact WTP value from each respondent.
However, in order for this value to be meaningful from a policy perspective, it was
imperative that the sample represent the U.S. population. Therefore, a web-based survey
which could be used to administer the iterative bidding process to a national sample was
the desired format. As such, an understanding of web survey design was needed in order
to create the survey and ensure the reliability of the data collected.
5.5 Guiding Principles for Web Survey Design
The virtually endless possibilities of web-based technology for creating surveys
also poses a problem in that it carries with it the vast potential for introducing survey
error.

Therefore, basic principles have evolved to help govern the design and

implementation of web-based surveys. In the chapter entitled “Internet and Interactive
Voice Response Surveys” of the book Mail and Internet Surveys, Dillman (2000)
identifies a comprehensive list of principles intended to guide the design and delivery of
web-based surveys. Likewise, Schonlau et al. (2001) includes many of the same ideas in
the chapter entitled “Guidelines for Designing and Implementing Internet Surveys” of
their online book, Conducting Research Surveys via E-mail and the Web. Therefore, the
following includes specific guidelines from each of these sources to establish a set of
guiding principles that were used to develop the web-based surveys for this study:

Introduce the survey with a welcome screen that provides motivation for completing
the survey and also include instructions that will direct the respondent to the
appropriate web address and to the first question of the survey. Respondents may be
contacted and directed to the web survey either through a mailed invitation or an emailed hyperlink; therefore, it is important to make it clear to the respondent that they
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have arrived at the correct location (Dillman 2000). A simple way to do this is to use
a logo that is on both the invitation as well as the welcome screen. The welcome
screen will set the tone for the entire survey; therefore, it should motivate the
respondent to complete the survey as well as convey that completing the survey will
not require extensive or specialized computer knowledge. The final goal of the
welcome screen is to move the respondent to the first question of the survey with ease
so he/she can begin the survey (Dillman 2000).

Utilize a password, personal identification number (pin), or some other means to
limit access to the survey to only those invited to respond. Because web surveys are
located on the Internet which can be accessed by anyone who types in the correct web
address, it is necessary to limit access to the survey in some manner. Utilizing a
password or pin will prevent access to individuals who were not invited to take the
survey, as well as prevent invited respondents from completing the survey more than
once (Dillman 2000, Schonlau et al. 2001). The password or pin can be included with
the survey invitation along with a simple set of instructions informing the respondent
on how to use it to access the survey (Dillman 2000). When choosing a password for
the survey, it is important to select one that can not easily be guessed. In addition, in
typed form, it is very difficult to distinguish the letter “l” from the number “1” or the
letter “O” from the number “0”; therefore, it is recommended that these be avoided
when creating passwords or pins (Schonlau et al. 2001).

Make the first question one that applies to everyone, is easily answered, and is of
interest to respondents. This will convey to the respondent that the survey is on a
topic that is of interest to them and that completing it does not require extensive
computer knowledge. Therefore, drop-down boxes, scrolling, and other higher level
computer functions should be avoided on the first question. In addition, numerous
demographic questions should not appear first (Dillman 2000) as they often do in
paper surveys – instead, these can be included at the end of the web-based survey.
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Avoid unconventional formats, instead present questions in a familiar manner (such
as those often used on paper surveys). Web-based surveys should strive to look as
much like paper surveys as possible, therefore, it is not advisable to use an unfamiliar
format that is likely to confuse the respondent. On a computer screen, individuals
tend to start at the upper left hand corner, so this is an ideal location to start a new
question (Dillman 2000). This can easily be achieved if each screen only includes
one question.

Use radio buttons for questions with a relatively small number of answer choices.
Radio buttons are named for the round knobs found on older radios that were used to
“tune-in” to a station (Schonlau et al. 2001). Radio buttons appear as circles before
each answer choice in a web-based survey and look similar to the “bubbles” that often
appear in front of each answer choice on paper surveys. Therefore, radio buttons can
give questions on a web-based survey an appearance similar to that of a paper survey,
as Dillman (2000) suggests. To select an answer choice using a radio button, all the
respondent needs to do is point the cursor at the radio button and “click” the mouse.
As such, radio buttons are easy to use and require very little computer knowledge on
the part of the respondent. In addition, radio buttons have the added benefit of
automatically “deselecting” the respondent’s first answer choice if a second answer
choice is selected (Schonlau et al. 2001). Therefore, in a self-directed web-based
survey (in which an interviewer is not available to answer questions) radio buttons
will convey to the respondent that only one answer choice may be selected (Schonlau
et al. 2001).
Minimize the use of colors. Color is very easy to add to a survey; therefore, there is a
natural tendency to overuse it, and this can lead to potential interference with the
survey itself (Dillman 2000). The exact color shown on a monitor is determined by
the color palette, which can vary greatly across computers (Schonlau et al. 2001,
Dillman 2000). Therefore, web survey programmers should be careful to restrict
themselves to a smaller palette to help insure consistency in viewing and also reduce
the necessary time it takes to transmit the survey (Dillman 2000). In addition, some
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combinations of background colors with font colors can make the text difficult to
read; therefore, if color is used, it is important to choose colors that have a sufficient
amount of contrast (black font on a neutral background, blue font on a bright yellow
background). Even red and green, which is a high contrast combination, can cause
problems if any of the respondents are color-blind and cannot distinguish red from
green. Mistakenly choosing colors that make it difficult for the respondent to read the
survey questions can lead to an increased likelihood of non-response or potential
survey error. In addition, the use of large blocks of color may inadvertently attract
the eye away from what the survey designer intended the respondent to focus on.
Similarly, when color is used around word choices of different length, some color
bars will appear longer than others, which could possibly influence the respondent’s
choice. Finally, colors often have meanings associated with them, such as red means
“stop” and green means “go.”

As a result, including color may inadvertently

introduce meanings that have no relevance to the survey question being asked, and
thereby influence the respondent in unintended ways (Dillman 2000). Appropriate
uses of color include intentional “highlighting” to draw the respondent’s attention to
special elements or directions.

Color can also be used (cautiously) to direct

respondents to navigational elements that will help them proceed with the survey,
assuming that it does not distract the respondent from the survey question (Schonlau
et al. 2001, Dillman 2000). Since there is no evidence to support that the use of color
enhances response rates, Dillman recommends using color sparingly in web-based
surveys in order to help avoid the numerous potential risks associated with it
(Dillman 2000).

Limit the use of graphics.

Although the web allows a designer to incorporate

graphics and video clips with ease, these applications should be used sparingly.
Graphics and video require a large amount of information to be transferred and can
lead to large variances in the time required to display the survey and result in
frustration (and lower response rates), particularly for those using modems or other
slower Internet connections (Schonlau et al. 2001). Another potential problem with
graphics is that they may unintentionally alter the meaning of a question. Schonlau et
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al. (2001) present an example from an actual marketing survey in which individuals
are asked how many times they have gone shopping within a certain time period.
Although the question was intended to inquire about all shopping, the picture
adjacent to the question shows people shopping in a grocery store. As a result, it is
unclear whether respondents are indicating the number of times they have gone
shopping at any store or have limited their response to include only visits to the
grocery store (Schonlau et al. 2001). Therefore, the use of graphics and videos within
a web-based survey should be limited and done in such a manner as to not alter the
intended meaning of the question.

Program the questions as to avoid differences in appearance across different
machines. The display resolution configuration determines the number of pixels that
appear horizontally and vertically on the computer monitor. Although there are some
configurations that tend to be more common, such as 640 X 800, 800 X 600, and
1024 X 748, there is no definitive standard. Therefore, different settings of the
resolution configuration can certainly influence the appearance of a web-based
survey. In addition, the actual physical size of the monitor can also affect how the
survey is displayed. A survey that appears in its entirety using a larger screen and
configuration may require scrolling (either horizontally or vertically) on a smaller
screen in order for the respondent to view the entire question with answer choices.
Although the proportionality of the survey will tend to stay the same, smaller
configurations may also result in wrapping of the text, which can lead to
misalignment. This is particularly problematic if it makes the question unclear, or if
it leads to the misalignment of headings and their associated choice buttons. To help
prevent this from occurring, it is recommended that web survey programmer limit the
horizontal width to 600 pixels – this allows even the smallest configurations to
present the entire line of text without wrapping, and helps ensure that the survey will
be presented consistently regardless of the size or configuration of the monitor.
Finally, testing should be done using different types of computers with various
configurations in order to ensure the consistency of survey viewing across machines
(Dillman 2000).
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Provide detailed instructions on necessary computer functions required to complete
the survey; however, do not provide extensive instructions at the beginning of the
survey as several pages of detailed instruction may make the survey look complicated
and deter individuals from proceeding. Instead, Dillman suggests providing specific
instructions on necessary computer functions at the time they are needed.

For

example, instructions on operating a drop-down box may appear in a floating window
on the screen in which this type of question first appears.

This will provide

information on an “as needed” basis, as opposed to testing the respondent’s ability to
learn and remember several computer functions throughout the survey. Another
possible way to accomplish this is include a “help” button on each screen or to
provide instructions following the stem of each question using a different font that
will easily be recognized by the respondent as instructions rather than an integral part
of the survey. Again, these instructions should be clear and limited only to the
information needed to perform the necessary computer functions required to answer
the specific question being addressed (Dillman 2000).

Refrain from overusing drop-down boxes, and always include the direction “click
here” in the visual line item of a drop-down box. This will not only help the
respondent identify the presence of a drop-down box, but will also provide clear
instructions on how to make the answer choices visible.

Drop-down boxes are

appealing to web survey programmers because they can hide a lot of information until
it is needed. For example, when asking a respondent which state he/she lives in, a
drop-down box can be accessed that lists all 50 states (Dillman 2000). Although the
advantage of this is clear from a programming perspective, drop-down boxes do have
some potential drawbacks that should be addressed. First, if data is collected using
both web and paper surveys, the use of drop-down boxes only on the web-based
version of the survey can present issues related to mixed modes. If the survey is not
being administered using additional modes, then drop-down boxes should still be
reserved for questions which have several possible answer choices. Clearly, using
radio buttons for yes/no questions is more efficient (and a more logical) choice than
using a drop-down box. In addition, Dillman suggests that when using a drop-down
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box, the visual line item (the one item that is visible even when the drop-down box is
not activated) should simply read “click here” and that the first answer choice should
then be included on the next line (which is hidden). This suggestion has two positive
effects. First, it prevents unnecessary bias because it does not allow the default
answer choice to be visible while the other possible choices are hidden; and second, it
helps prevent the respondent from unintentionally skipping a question. When a
default choice is displayed, respondents are more likely to think they have already
responded to that question and because closing a drop-down box may move the
cursor unexpectedly on the screen, it can make it easy for the respondent to lose their
place in the survey. Therefore, including the words “click here” in the visible line
item will clearly indicate which questions still remain to be answered and help the
respondent avoid unintentional skips in completing the survey (Dillman 2000).

Include a mechanism in the survey design that allows respondents to skip questions.
Although it may seem advantageous that the format of web-based surveys could
essentially be used to “force” respondents to answer each question in order to proceed
with the survey, this is certainly not advisable. First, designing a web-based survey in
this manner could potentially cause problems from a human subject protection
prospective if permission for the survey was granted under the proviso of voluntary
participation in the survey and on each question. In addition, the respondent may not
feel that any of the possible answer choices adequately match their intended response
(Dillman 2000).

Therefore, from a human subject protection standpoint, it is

necessary to program the survey such that the respondent is allowed to skip any
question item. In addition, from a research perspective, it may also be advisable to
include a choice of “prefer not to answer” or “I don’t know” as a possible answer
choice, such that unintentional skips can be distinguished from other causes of item
non-response.
Let the questions dictate the design of the web-based survey. Web surveys can either
be constructed such that each screen includes a single question with a “next” button
that will make the next screen (and question) appear, or it can be designed such that
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the web-based survey looks similar to a paper survey with respondents scrolling to
view all the questions. Dillman (2000) recommends following the paper survey
format with scrolling, which permits respondents to move back and forth between
questions. As such, this format enables respondents to view previous questions when
making decisions about subsequent questions, and because this format requires less
interaction with the host computer, it minimizes transmission time (Dillman 2000).
However, Schonlau et al. (2001) disagree and recommend including only one (or a
few) questions per screen in order to prevent excessive scrolling that may give the
respondent the impression that the survey is too long; thereby increasing
abandonment and lowering response rates. However, both are in agreement that
questions which are intended to be considered together, should be grouped; and that
when questions are meant to be completed in a specific order, they should appear on
their own screen (Dillman 2000, Schonlau et al. 2001). In the latter case, respondents
may be reminded of previous information when it is likely to be needed, or the survey
can allow the respondent to move back and forth only within a certain section of the
survey.

Give respondents a sense of where they are in the survey to avoid abandonment close
to the end. In a paper survey, it is easy for respondents to judge how much of the
survey remains at any given point; however, the same is not true with web-based
surveys. Therefore, it is recommended that the survey include a graphical progress
indicator or other mechanism that gives respondents a sense of how much of the
survey remains to be completed. The rationale is that by keeping the respondent
informed of his/her progress, they are less likely to abandon the survey because they
have a sense of how much remains (Schonlau et al. 2001, Dillman 2000). For
example, even a simple transitional phrase such as “Finally, please answer a few
questions about yourself” will indicate that the survey is near completion and
encourage respondents to answer the last few remaining questions (Dillman 2000).

Avoid ‘check-all-that-apply and other question formats that have not traditionally
worked well on paper formats. Questions that ask the respondent to “check all that
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apply” have not traditionally worked well in paper surveys; therefore, these types of
questions should be avoided in web-based surveys as well. The problem with “check
all that apply” questions is that respondents have a tendency to satisfice – that is,
simply check boxes until they feel satisfied that they have checked enough boxes to
adequately answer the question. Therefore, an alternate to this is often used in
telephone surveys in which the respondent is asked a series of yes/no questions. This
same approach is recommended for web-based surveys.

Each question can be

presented separately with answer choices of “yes” and “no” which the respondent can
select by clicking on the appropriate radio button. Another question type that can
create issues on paper surveys, as well as web-based surveys, is open-ended
questions. On paper surveys, open-end questions are typically not well received, with
respondents often providing little information or information for which the meaning
is unclear. The good news regarding the potential use of open-ended question on
web-based surveys is that there is preliminary evidence that respondents may provide
more specific responses when using an electronic format when compared to a paper
survey (Dillman 2000). Regardless, open-ended questions should still be used
sparingly due to the difficulty they pose in reporting and making comparisons across
respondents.
Overall, keep it simple. Utilizing a relatively simple web-based survey will increase
the probability of a uniform survey being viewed across varying systems (Dillman
2000) and avoid many of the other issues discussed above. As a result, the best
programmers of web-based surveys are likely to be those who can create a relatively
simple survey that is efficient in size and can be transferred quickly and with a low
likelihood of crashing the receiving system (Dillman 2000). Furthermore, simple
web-based surveys that load faster have been found to have higher response rates
compared to “fancier” versions that require more time to load (Solomon 2001).
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5.6 Development of the Survey Instruments
In addition to adhering to the guiding principles on web survey design presenting
in the first half of this chapter, developing the survey instruments also required an
understanding of the medical process and types of decisions a patient would be asked to
make regarding his/her heart-related health. Therefore, information was collected by
attending seminars on vulnerable plaque at the Massachusetts General Hospital in Boston
as well as having several discussions with researchers and physicians in the field (See
Chapter 3: Medical Background). As the medical background suggests, there are two
economic questions of interest. First, what are individuals willing to pay for a screening
method that will better identify those at risk for a heart attack; and second, how much
will those individuals found to be at high risk for a heart attack be willing to pay for a
more effective treatment method? To address these questions, two survey instruments
were developed: Survey 1: Screening and Survey 2: Treatment (See Appendix A).
Survey 1: Screening would be administered to adults in the general population.
After providing respondents with some new information on the cause and potential risk
factors associated with heart attacks, each individual would be asked about his/her
maximum WTP for a screening test that would indicate if they were at high or low risk
for a heart attack. Survey 2: Treatment would be administered to adults with doctordiagnosed heart problems. These individuals (who are already at high risk of having a
heart attack) would be asked to value a procedure that would more precisely determine
their risk of a heart attack, as well as provide treatment which could significantly reduce
their risk of a future heart attack.
Since the medical decisions respondents would be asked to consider are
preventative in nature, both surveys were designed from an ex ante perspective. When
making the decision to have a blood test designed to identify those at risk for a heart
attack or to undergo a procedure to obtain more exact information on that risk, the patient
does not know if he/she will eventually experience a heart attack. Therefore, medical
decisions involving uncertainty lend themselves to an ex ante approach in which the
respondent is asked about his/her willingness to pay before the actual risk is known.
Even though the sample for the second survey is comprised of those who have doctor
diagnosed heart problems (including individuals who have experienced one or more heart
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attacks), the relevant question is still prevention – prevention of a future heart attack that
could result in permanent disability or even death.
The following includes a detailed description of the thought process that went into
the creation of the questions included in the survey instruments, including how each
question (or set of questions) contributed to the overall purpose of the survey (See
Appendix A for survey instruments). Once the initial surveys were created, focus groups
were conducted to refine them, and then the completed surveys were submitted to
Knowledge Networks (KN) for programming (Background information on Knowledge
Networks and the reasons why this company was chosen to administer the web-based
surveys is presented in Chapter 6: Data Collection).

5.6.1 Initial Question
Following Dillman’s advice, both Survey 1: Screening and Survey 2: Treatment
begin with a question that is easy to answer and applicable to everyone taking the survey.
The purpose of this question was to generate interest in the survey as well as convey the
ease of completing the survey in an online format. With this in mind, the first question
(which was the same for both surveys) asked the respondent how important it was for
their doctor to include them in decisions regarding their own health. The question
included three answer choices: “very important”, “somewhat important”, “not very
important” and respondents indicated their answer by simply clicking on a radio button75
next to the desired answer choice. Given that 99.8% of the respondents who saw this
question completed the entire survey, it appears that this opening question was quite
effective in achieving its intended purpose.

5.6.2 Warm Up Questions
A contingent valuation survey typically begins with a series of “warm-up”
questions in which the respondent is familiarized with the good or service he/she will be
asked to value later in the survey. In Survey 1: Screening, the warm-up section includes a
75

Radio buttons were used almost exclusively throughout the two online surveys. The use of radio buttons
allows the web-based survey to closely reflect the format of a paper survey, as Dillman (2000) suggests. In
addition, radio buttons do not require the higher level of computer experience needed to correctly use dropdown boxes.
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series of questions related to the respondent’s experience with heart conditions and
treatments, as well as a risk assessment quiz published by the American Heart
Association (AHA). This quiz lists several risk factors typically used by physicians to
assess a patient’s risk of having a heart attack and is designed to remind/inform the
respondent of factors that could influence his/her own risk of having a heart attack. In
Survey 2: Treatment the warm-up section consists of the same “experience” questions
used in Survey 1: Screening. In addition, it includes a set of questions designed to get the
respondent thinking about how having a heart attack could affect his/her ability to work
and overall quality of life.
In both Survey 1: Screening and Survey 2: Treatment, the questions used to obtain
information about the individual’s experience and/or familiarity with heart disease are
questions 2-7. These questions are worded exactly the same in both surveys and include
items such as: “Have you ever experienced a heart attack?”; “Have you ever taken
medication to reduce your cholesterol?”; “Do you have a relative in your immediate
family who has experienced a heart attack?; and if so, “Were you involved in making the
decisions regarding the treatment of this family member’s heart condition?”76

The

original intent of this series of questions was to identify individuals who were familiar
with heart related conditions and possible treatments such that the sample could be split –
with more familiar respondents being directed to Survey 2: Treatment. However, during
a conversation with Dr. Bill McCready, Vice President of Client Development at
Knowledge Networks, it was discovered that health data obtained when individuals
joined the panel was available and could be used to create two distinct samples – one for
each survey. Therefore, it was decided that Survey 1: Screening would be administered
to a sample representing the general population, and Survey 2: Treatment would be
administered to individuals with doctor-diagnosed heart conditions.

From a survey

design standpoint, this method was clearly superior and therefore, was the method chosen
for this study. However, even with this change, the familiarity questions still provided

76

For multi-part questions such as this one, the web-based survey was an excellent survey format in that it
allowed skip patterns that were completely unobserved by the respondent. Those who answered “yes” to
the first part of the question received the follow-up question; whereas those who answered “no” would
simply receive the next question.
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information that could provide valuable information in explaining the individual’s WTP.
Therefore, these questions remained in the opening section of both surveys.
The final question in this series (question #8) asked respondents if they have ever
experienced a life threatening condition or illness.

Discussion from focus group

participants indicated that those who had experienced life threatening conditions or
illnesses in the past (not necessarily related to the heart) tended to be willing to pay more
for screening and subsequent treatment; therefore, this question was included so it could
be used as a possible explanatory variable of an individual’s WTP for
screening/treatment.
Following this initial set of questions,77 the two surveys diverged slightly. Survey
1: Screening included a risk assessment quiz published by the American Heart
Association (AHA). The purpose of this quiz was to provide information to respondents
regarding their risk of having a heart attack based on the criteria typically used by a
physician to assess a patient’s risk of a heart attack. The risk assessment quiz asked
respondents to answer “yes”, “no” or “don’t know”78 to a series of traditionally accepted
risk factors, including: “Are you a man over 45 years old”; “Are you a woman over 55
years old”; “Do you smoke, or live or work with people who smoke every day”; and “Are
you 20 pounds or more overweight for your height and build.”79 Because respondents
completing Survey 2: Treatment had already experienced a heart attack or been diagnosed
with a heart problem (and therefore were already aware that they were at high risk of a
heart attack), this quiz did not seem pertinent. However, information regarding the effect
a heart attack could have on an individual’s quality of life was relevant, especially since
heart attack outcomes can vary substantially. Therefore, the final segment of the warmup section for Survey 2: Treatment focused on an individual’s quality of life following a
heart attack.

77

In the online version of the surveys, each of the first eight questions appeared one at a time on its own
screen. This allowed the font size to stay large and prevented the respondent from having to scroll.
Possible answer choices (including “I don’t know” for some questions) appeared immediately below the
question stem and the answer choices were selected simply by clicking the corresponding radio button.
78
This is the format recommended by Dillman (2000) because it more closely reflects the method used in
telephone surveying and is preferable to the “check-all-that-apply” format which is subject to satisficing.
79
These questions could certainly be viewed together; however, keeping the font size sufficiently large
prevented all the items from appearing on a single screen. Therefore, the questions were grouped with 3-4
items appearing together on a series of three screens.
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The quality of life section included two parts – the first section provided
information on heart attack outcomes, including the fact that “about half of the people
who experience a heart attack die as a result.” The text further stated that “for those who
do survive, the results can vary substantially – from ‘no difference’ for some, to others
who are left permanently disabled…” Information on chronic symptoms experienced by
those who have had a heart attack was presented in a table, such that individuals could
assess how having a heart attack may affect their lives. Before moving on, respondents
were asked to review the table carefully and told that in a moment they would be asked
how having a heart attack could affect their life.80
The second part of the quality of life section asked respondents to indicate how a
heart attack would affect or has affected different aspects of their life. The exact wording
of the question was tailored to the individual based on his/her response to an earlier
question “Have you ever experienced a heart attack?” If the respondent answered “yes”
to this question, they were asked to assess the degree to which the heart attack has
affected their life including their “ability to perform daily functions”; “ability to
effectively complete work duties”; “ability to provide for family”; and “overall quality of
life.” The question was set up as a matrix with radio buttons corresponding to each of the
five possible answer choices ranging from “not at all” to “extremely.”81

For the

respondents who had not experienced a heart attack, the wording to this question was
slightly altered to read “Imagine that you experience a heart attack and survive…”
Respondents were asked to reflect on the amount of physical exertion required by their
daily lives and work, as well as their ability to handle stress during a typical day. They
were then asked to “indicate to what extent each area of your life would be affected by
these symptoms” using the same matrix question described above.
Both the risk assessment quiz in Survey 1: Screening and the quality of life
questions in Survey 2: Treatment provided a natural transition into the next section of the
survey – the individual’s perceived risk of having a heart attack.

80

Respondents in the focus group for Survey 2: Treatment indicated that this was a very effective question
that really got them thinking about the impact a heart attack could have on their quality of life.
81
Following Dillman’s advice on basic survey design (for paper or web-based surveys), all answer choices
for questions such as this contained a neutral response and an equal number of positive and negative
options, presented in either ascending or descending order (Dillman 2000).
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5.6.3 Perceived Risk
It is expected that an individual’s WTP for screening and/or treatment of heart
attacks would be related to his/her perceived risk of having a heart attack. Therefore, in
conducting this study, it was necessary to obtain both an estimate of the individual’s
perception of risk as well as their change in perceived risk upon receiving the new
information on the cause of heart attacks. For paper surveys this has been accomplished
using a visual analog scale in which the respondent is asked to place an “X” (or other
mark) on a horizontal line that measures 10 cm in length and ranges from “no risk” at one
endpoint to “certain risk” at the other. A reference point somewhere in between is often
provided to give the respondent an “anchor” on which to base his/her assessment of risk
for the proposed situation.

Then, the respondent’s perceived risk is obtained by

measuring the distance from 0 to his/her mark. As such, this method will result in a
measure of perceived risk that is continuous between 0 and 10.82 The advantage of using
this method is that once new information is provided, respondents can be asked to assess
their risk a second time, such that the change in perceived risk can be calculated and will
represent a meaningful quantitative variable.
To emulate this method using the computer, respondents were asked to assess
their risk using a computerized version of the visual analog scale. The figure was labeled
“Annual Risk of Fatality (Deaths per 100,000 Persons).” The horizontal line started at 0
“no risk” and continued to 100,000 and beyond (as indicated by an arrow). Two anchors
were included – 19 (corresponding to the risk of fatality from an auto accident) and 50
(which was labeled “high risk”). Respondents were asked to use the scale as a guide and
enter the number that they felt best reflected their risk of having a heart attack within the
next year.
The risk of fatality from an auto accident was selected as a reference point for
several reasons. First, it was felt that since most respondents would be familiar with
driving (and riding in a car), they could relate fairly easily to this level of risk. Also,
from a theoretical standpoint, this reference works well because it is a risk that remains
fairly constant over time and throughout a person’s life (See Table 5-1), unlike the risk of

82

Measuring out to 1 or 2 decimal places and then multiplying by 10 will result in a continuous measure of
perceived risk ranging from 0 to 100, where 0 is “no risk” and 100 is “certain risk”
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cancer that tends to increase with age. Table 5-2 includes statistics for actual death rates
from a sudden heart attack (acute myocardial infarction) by age group. Table 5-2 clearly
shows that the risk of death from a heart attack increases substantially for each age group,
particularly for individuals 55 years of age and above.83 A comparison of Tables 5-1 and
5-2 indicates that for individuals below the age of 45, the risk of dying from a heart attack
is lower than the risk of dying in a car accident; however, this relationship is reversed for
individuals over the age of 45, such that the risk of dying from a heart attack becomes
greater than the risk of dying in a auto accident. Therefore, it is expected that younger
people would place their perceived risk of a heart attack below that of a car accident,
while an older individual (particularly one who is over 55 and has other risk factors)
would be more likely to place their perceived risk of a heart attack above that of a car
accident. In fact, discussion from the focus groups indicated that many of the participants
followed this logic when selecting their level of perceived risk.
The value of 19 which corresponds to an annual risk of fatality from an auto
accident of 19/100,000 was based on the number of fatalities per 100,000 registered
vehicles as reported in national fatality statistics published by the U.S. Department of
Transportation and the National Highway Traffic Safety Administration for the year
2000.84 Two other statistics were considered - including the number of fatalities per
100,000 population (15.23) and the number of fatalities per licensed driver (21.94) (U.S.
Department of Transportation 2002). The fatality rate for the entire population of 15.23
was significantly lower than the fatality rate of 21.94 for licensed drivers, presumably
because a significant portion of the population is comprised of minors. Since this survey
was only being administered to adults, it seemed that using the fatality risk per 100,000
population would underestimate the auto fatality risk faced by an adult.85 In addition,

83

The significant decrease in death rates between 1979 and 1995 for acute myocardial infarction is most
likely due to the substantial improvements in the treatment of heart disease that occurred during that time
period; however, death rates from heart attack have remained fairly constant in the last decade, therefore,
the 1996 values (the year for which data was available) are most likely good estimates of current death
rates from heart attack.
84
This was the most current data available at the time the survey instruments were developed.
85
Table 5-2 also supports the use of the higher value. As the table indicates, death rates from car accidents
are higher for individuals who are elderly - ranging from 18.3 per 100,000 (for individuals 65 -74 years of
age) to 30.1 per 100,000 (for individuals 85 years of age and over). Since the samples, particularly the
sample for Survey 2: Treatment includes a large percentage of elderly individuals, the use of the higher
value as the mean fatality risk from auto accidents seems appropriate.
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restricting this statistic to licensed drivers seemed too narrow in that many individuals
(including the elderly) may be unlicensed but are still placed at risk (and are well aware
of that risk) as passengers in a vehicle. Therefore, it seemed most appropriate to use
19.27 (fatalities per 100,000 registered vehicles), which was rounded to 19. An added
feature of using the number 19 (as opposed to 15) was that respondents would not feel
constrained to selecting numbers rounded to the nearest 5, thereby helping to ensure a
continuous variable for perceived risk.
After indicating their level of perceived risk of having a heart attack within the
next year, respondents were given new information on vulnerable plaque as a cause of
heart attacks. The information provided was based on a news segment that aired on the
television program 20/20 in January 2001. The purpose of the new information was to
make the respondent aware of a potential misconception regarding who is at risk for a
heart attack, and to make them aware that those who show no signs or symptoms of heart
problems may still be at risk for a fatal heart attack. Focus group participants indicated
that the new information section of the survey was clear, concise, and easy to understand.
After reading the new information, respondents were asked again about their level
of perceived risk. First, they were asked a qualitative question about the degree to which
the new information had changed their level of perceived risk. Then they were asked to
quantify their new level of risk a second time using the computerized visual analog scale
described earlier.

As a result, information could be obtained on the individual’s

perceived risk before and after receiving the new information, as well as a qualitative and
quantitative measure of their change in perceived risk resulting from the new
information.

5.6.4 Willingness to Pay
The goal of Survey 1: Screening was to estimate the WTP for a simple blood test
that would screen for those at risk for a heart attack and the goal of Survey 2: Treatment
was to estimate the WTP for a treatment method that is more effective than medication,
the current standard of care. Therefore, the WTP section of the survey was a key element
of the surveys in that it would elicit the individual’s maximum WTP for either the
screening or the treatment. This was accomplished using an iterative bidding process in
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which the respondent would receive up to five bids, each of which could be accepted or
rejected. The first bid was selected at random, then, subsequent bids were based on the
accept/reject pattern of the respondent, utilizing the web’s capacity for real-time
interaction. Prior to the bidding process, respondents were provided with a framework in
which the hypothetical good they were being asked to value was presented. In addition,
they were asked questions intended to remind them of their budget constraint. And
finally, several steps were taken throughout the WTP section of the survey to help
prevent the possibility of hypothetical bias.
In Survey 1: Screening, respondents were given a scenario in which their regular
physician recommends an additional blood test as part of their routine exam.

The

physician explains that studies have shown that people with low cholesterol and no other
risk factors can still be at risk for a heart attack, and that this additional test would
provide better information on the patient’s risk of having a heart attack. If the test comes
back negative, it will give the patient peace of mind, but if it comes back positive, then
further testing could be done to see if treatment is necessary.86 The respondent is then
asked to take a moment to think about what information from this screening would be
worth to them.
While the respondent reflects on how much they would value this test, they are
presented with information on hypothetical bias. The rationale for including this section
is consistent with Cummings and Taylor’s (1999) finding that using a “cheap talk” script,
in which hypothetical bias is explained directly to respondents being asked to value a
good as part of a contingent valuation survey, can reduce the occurrence of hypothetical
bias in the data. Therefore, using a script modeled after the original “cheap talk” script
used by Cummings and Taylor (1999), respondents were told about hypothetical bias and
how it often leads to respondents saying they would pay more for a good or service than
they actual would if the purchase decision were real. Following the explanation of
hypothetical bias (which included two full screens), respondents were asked if they
86

This is similar to the type of information that would typically be presented by a doctor at a routine visit
(if such a test existed). It is interesting to note that many decisions regarding our health are made “on the
spot” and without perfect information. Therefore, it was thought that the information on risk factors and
the brief description of the risk due to vulnerable plaque presented in the first part of the survey would be
comparable to information that would be provided by a physician in a clinic/hospital setting prior to an
individual being asked to make a decision regarding the screening.

131

understood hypothetical bias, to which they could select either “yes” or “no, I would like
further clarification.” If the respondent requested further clarification, they were directed
to an additional screen that provided more detailed information on hypothetical bias,
including an example.87 After being presented with the additional information, those
respondents were once again asked if they understood hypothetical bias.88
Following the discussion on hypothetical bias, respondents were asked how much
they typically spent each month on medical care. The purpose of this question was to
remind respondents of their actual purchase decisions regarding health care. In addition,
the wording following this question, which read: “Based on what I am already spending
for medical care, how much do I have available to spend on this test” was also designed
to remind respondents of their budget constraint before proceeding to the WTP section of
the survey.
As stated earlier, an iterative bidding process was used to elicit the respondent’s
maximum WTP for the screening (treatment). Each respondent received up to five
possible bids using the following question format: “If this blood test (procedure) costs
$____, would you choose to have it done?” The question was framed in this manner to
reflect an actual purchase decision in which the consumer is offered a good or service at a
given price, which he/she can choose to accept or not. To avoid starting point bias, one
of five possible starting bids was selected at random by the computer.89 If the respondent
answered “yes” to the question, the bid was doubled. If the respondent answered “no”
then the bid was reduced by half. Once the respondent’s answers established a relevant
range of possible WTP values, subsequent bids were derived by dividing the remaining
range in half. For example, if the first bid is $40 to which the respondent answers “no”
the bid will decrease to $20. If the respondent answers “yes” to $20, then the computer
will split the difference between the upper and lower values, and generate $30 as the next
bid.
87

Only 12 out of 268 respondents (4.5%) for Survey 1: Screening and 28 out of 295 respondents (9.5%) for
Survey 2: Treatment requested additional information and viewed the more detailed explanation of
hypothetical bias.
88
A total of 5 out of 268 respondents (1.9%) for Survey 1: Screening and 6 out of 295 respondents (2.0%)
for Survey 2: Treatment answered “no” to both hypothetical bias questions – more specific information on
how these observations influence the overall results of this study is included in Chapter 6: Data Collection.
89
The starting bids for Survey 1: Screening were $10, $40, $50, $60, and $100. The starting bids for
Survey 2: Treatment were $1,000, $2,000, $5,000, $8,000, and $10,000.
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The iterative bidding process continues until either (1) the respondent’s answers
converge and result in a maximum WTP (to within a specified margin of error)90 or (2)
the respondent receives a maximum of five bids.91 For example, if the bidding sequence
described above continues such that the respondent answers “no” to $30, then a fourth
bid of $25 would be generated. If the respondent answers “yes” to $25, then the bidding
process would end and the individual’s maximum WTP would be recorded as $25 (after 4
bids). The use of this algorithm allowed the bids to cover a large range of values if
necessary,92 while at the same time enabling the program to quickly narrow the range to
converge on the respondent’s maximum WTP.
If, after a series of five bids, the respondent’s WTP could not be determined, then
the respondent was reminded of the range of WTP values obtained through the bidding
process and then asked to state the maximum amount they would be willing to spend to
have the test.93 For example, if the respondent was given an initial bid of $40 and they
chose “yes” the following bid would be $80. If the respondent answered “yes” again, the
third bid would be $160. A “no” response to $160 would then yield a fourth bid of $120.
Another “no” response would result in a fifth (and final) bid of $100. During the bidding
process, the computer was programmed to keep track of the respondent’s highest “yes”
bid and lowest “no” bid. Therefore, if the respondent said “no” to $100, the computer
would recognize that the respondent was willing to pay at least $80, but not $100 or
more. The bidding process would conclude (since the maximum of five bids had been
reached) and the respondent would receive the following reminder and question:
You indicated that you would pay at least $80 {computer will insert highest “yes” bid},
but less than $100 {computer will insert lowest “no” bid}.
What is the most you would be willing to spend out of pocket for this test to find out if
you are at increased risk for a heart attack?
90

The margin of error was $5 for Survey 1: Screening and $100 for Survey 2: Treatment.
The iterative bidding process terminated after a maximum of five bids in order to prevent the survey from
appearing too redundant and prevent respondents from abandoning the survey.
92
If the respondent received a starting bid of $40 for Survey 1: Screening and continued to answer “yes” to
each subsequent bid, their fifth (and final) bid would be $640. The lowest start bid was $10 and the highest
was $100, which yields a possible bid range of $0 to $1600 across respondents.
93
A similar version of this question was used for individuals who answered “yes” to every bid.
91
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Enter dollar amount here [ _________]
Immediately following the bidding process, the respondent is asked to state how
certain they are that they would actually pay this amount. Respondents use a scale of 0
(“not sure at all”) to 10 (“definitely sure”) to indicate how certain they are that they
would really pay this amount out of pocket for the test. After stating their degree of
certainty, the respondent is reminded of their previously stated WTP amount and given
the opportunity to revise it if they so chose.94 The survey reads: “Earlier you said that
you would pay $____{computer will insert previously stated WTP amount} for this test.
Now that you have had a chance to consider how sure you are about this decision, please
enter the amount you would definitely (beyond any doubt) pay for this test.”
During a focus group, one participant remarked that the number of times an
individual expected to get the test may affect how much they were willing to pay for it.
If the respondent expected this was an annual test (as suggested in the survey), he/she
may be willing to pay less for it than if they felt it was something they would only need
to purchase once in their lifetime. Therefore, the final question in this section asked
respondents how many times they expected to get this test over the course of their
lifetime.
For Survey 2: Treatment, the WTP section followed a format very similar to that
of Survey 1: Screening; however, there were a few differences. In Survey 2: Treatment,
the wording of the initial scenario was modified to support a more immediate need for
potential treatment. Again, respondents for this survey are individuals with doctordiagnosed heart problems. Therefore, in Survey 2: Treatment, the section describing the
good began with: “Suppose you begin to experience chest pain. You immediately go see
your regular doctor...” The respondent is then informed by the doctor that his/her tests
indicate that he/she is at high risk for a heart attack and two possible treatment options
are presented. The physician explains that the standard treatment for patients with this
94

Respondents did not feel compelled to revise their WTP due to the inclusion of the certainty question. In
fact, 131 out of 268 individuals (48.9%) sampled for Survey 1: Screening did not choose to revise their
maximum WTP amount following the certainty question. A relatively large percentage (32.8%) of these
individuals reported a 10 on the certainty scale, indicating that they were “definitely sure” of their initial
WTP value. For Survey 2: Treatment, 109 out of 295 individuals (36.9%) sampled did not choose to revise
their maximum WTP following the certainty question, and 33 of those 109 respondents (11.2%) reported a
10 on the certainty scale, indicating that they were “definitely sure” of their initially stated WTP.
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condition is to prescribe a cholesterol-lowering medication; however this treatment is
only 30% effective. Therefore, the physician recommends a new treatment option that
involves a minimally invasive procedure. The physician explains that the procedure in
addition to medication will reduce the risk of heart attack by 85%. The physician further
explains that the procedure does have a small risk of death associated it – about 10 out of
100,000 people who have the procedure die from complications. To make this risk level
less abstract for the respondent and to relate it back to the perceived risk scale presented
earlier in the survey, the doctor qualifies this risk by stating the following: “To put this in
perspective, your risk of dying in a car accident each year is about twice this high or 19
out of 100,000.” The respondent is then told that another trusted physician was consulted
for a second opinion and both doctors agree that the new procedure (with medication) is
the recommended treatment. The respondent is shown a table clearly illustrating the two
treatment options, including the effectiveness of each treatment as well as the additional
risk of death associated with the procedure. Respondents are then asked to indicate
which treatment option they would choose based on the risk and effectiveness of each
option. Their choices include: “Procedure and Medication”, “Medication Only”, “Not
sure, I would like more information before deciding.”
The option for additional information was included in response to comments
made by focus group participants who completed Survey 2: Treatment. It is expected that
individuals will spend more time considering the implications of undergoing a more
invasive procedure before consenting (compared to time and consideration given before
consenting to a simple blood test such as the one presented in Survey 1: Screening).
Therefore, it was very encouraging when focus group participants made comments
clearly indicating that prior to making their decision to undergo the procedure they had
considered things such as: the opportunity cost associated with recovery time, if they
could afford to take time away from work, and possible arrangements for childcare while
they are hospitalized. These comments demonstrated that the focus group participants
were taking the hypothetical situation presented in the survey seriously and basing their
decision on actual limiting factors (and resources) for their household.
Because these factors were clearly important considerations for many individuals
when faced with this treatment decision, respondents were given an option of requesting
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additional information before making a treatment choice. By selecting “Not sure, I
would like more information before deciding” the respondent was directed to an
additional screen in which the doctor who would be performing the procedure provides
more specific information on what the procedure entails, including the use of a sedative;
a description of how the procedure is performed; the expected level of discomfort that
can be expected during the procedure; the projected length of stay in the hospital;
expected recovery time; and anticipated time away from work.95
Following this additional information regarding the procedure, respondents were
once again asked to make a treatment choice. Those who selected “Medication Only”
received an open-ended question asking why they chose not to have the procedure.96
Respondents who chose “Procedure and Medication” were presented with information on
hypothetical bias described earlier and reminded of their budget constraint by asking the
same question regarding monthly medical expenditures used in Survey 1: Screening.
However, because the treatment method described in Survey 2: Treatment could
significantly reduce the individual’s risk of having a heart attack (whereas the screening
test described in Survey 1: Screening only provides information on that risk), it is
expected that the individual would place a much more substantial value on the treatment.
Therefore, respondents for Survey 2: Treatment were also asked about the amount of
money they currently had available in savings. Although the answer choices to the
savings question included broad ranges in order to minimize refusals, it was anticipated
that some respondents would chose not to provide an answer to this relatively personal
question.97 However, regardless of whether the respondent answers the question or not,
the mere presence of the savings question immediately prior to the bidding still serves the
purpose of reminding respondents of their available financial resources when making
decisions regarding their WTP for the treatment.98
95

The content of the information provided was based on questions asked by focus group participants.
However, it was presented to respondents in a manner designed to closely reflect the way it would be
presented to a patient prior to making this type of decision in an actual clinic/hospital setting.
96
Additionally, respondents who answered “no” to a zero bid (during the iterative bidding process) were
also directed to an open-ended question which asked the respondent to please explain why they chose not to
have the procedure even when it was offered for free.
97
27 out of 295 respondents (9.2%) refused the question asking about the amount they currently have in
savings.
98
After completing the extensive willingness to pay section of the survey, it would be natural for
respondents to want to stop taking the survey. Therefore, in order to prevent respondents from abandoning
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5.6.5 Demographic Questions/ End of the Survey
The final section of the survey consisted of demographic questions.

Since

Knowledge Networks already had a great deal of demographic information on each of its
panel members (including age, race, marital status, education, etc.) it was not necessary
to ask those questions again. Therefore, this section included only four questions related
to: general health status, life insurance, existence of dependents (such as a child or elderly
parent) that did not reside at the same address, and level of financial security of the
respondent’s family if he/she were to die suddenly.
Survey 1: Screening concluded by thanking the individuals and making them
aware that the November 22, 2002 issue of U.S. News and World Report describes a
blood test that some researchers now believe could provide additional information on
who is at risk for a heart attack. In Survey 2: Treatment respondents were also thanked
and reminded that the proposed treatment they were asked about was hypothetical, but
that clinical research is currently being done such that this type of procedure could
become available in the near future.
5.7 Addressing Hypothetical Bias
As discussed in Chapter 2 (Literature Review), one of the main criticisms of
contingent valuation studies is the occurrence of hypothetical bias. Therefore, because
the goods being valued in Survey 1: Screening and Survey 2: Treatment do not represent
actual purchase decisions, several methods were employed in the survey to help prevent
the possibility of hypothetical bias from occurring.
The first method was the use of an abbreviated “cheap talk” script modeled after
the one used by Cummings and Taylor (1999). Focus group participants reported that
they understood the concept of hypothetical bias from the information provided in the
survey.

In addition, specific comments made by focus group participants while

discussing how each individual had arrived at their WTP revealed that several

the survey so close to the end, the following verbal cue (consistent with Dillman’s advice) was given to
indicate that the survey was near the end: “To complete this survey, please answer a few questions about
your background…”
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participants had taken hypothetical bias into account either directly or indirectly when
determining their maximum WTP for the screening/procedure.
A second means of preventing the existence of hypothetical bias was to remind
respondents of their budget constraint. This was achieved in Survey 1: Screening by
asking respondents how much they spend on medical care each month. In addition,
respondents for Survey 2: Treatment were asked about the amount they had available in
savings. After answering these questions, respondents were then asked to consider how
much they have available to spend and if they would really choose to spend their money
in this way (a reminder of the tendency for hypothetical bias to enter into the response).
Individuals participating in the focus groups seemed to take these prompts seriously and
again, based on their comments during the discussion, took several moments during the
course of the survey to reflect on their decisions and really evaluate the benefits and costs
associated with them.
Another method used to eliminate hypothetical bias included the use of a certainty
scale. Following the iterative bidding process and determination of the individual’s
initial WTP, each respondent was asked to assess their degree of certainty using a scale of
0 to 10 (with 0 being “not sure at all” and 10 being “definitely sure”) that they would
really be willing to pay this amount out of pocket. This type of certainty scale was first
used by Champ et al. (1997) in comparing hypothetical dichotomous choice questions
about donations to a public good with actual donations to the public good.

After

indicating their degree of certainty, respondents were given an opportunity to enter a
revised amount of what they “would definitely pay” for this test/procedure.
In the original survey given to focus group participants, a second certainty
question was included after the respondent stated their final WTP.

However, this

certainty question was formatted as a fixed-choice which more closely reflected an actual
purchase decision. Respondents were asked “Would you have the screening (procedure)
if it were offered to you at a price of $_____ {computer would insert respondent’s stated
WTP amount}?” Answer choices included the following: definitely yes, probably yes, not
sure, probably no, definitely no. The motivation for including this question was that
Blumenschein et al. (forthcoming 2007) conducted a field experiment offering a diabetes
management program delivered by a pharmacist, and found that individuals who were
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“definitely sure” of their response in a contingent valuation exhibited no hypothetical bias
compared to similar individuals who made real purchase decisions about the program
(For a detailed discussion of the effect these methods had on the data collected for this
study, see Chapter 6: Data Collection).
5.8 Conclusions
This chapter highlights several guidelines that were instrumental in developing
the two web-based surveys used for this study: Survey 1: Screening and Survey 2:
Treatment. In addition, this chapter provides a detailed explanation on how each survey
question was developed and discusses the motivation for including each question in the
survey instrument. By giving careful attention to the recommendations governing websurvey design, the surveys created for this study served as a valuable and reliable tool in
the data collection process.
In addition to providing a set of guidelines for developing a web-based survey and
explaining the process by which the two surveys used for this study were developed, this
chapter also offers a practical understanding of the extensive computer resources and
expertise that is required to program and administer a reliable web-based survey. As
Dillman (2000) points out, it is not necessary (or even desirable) to have a programmer
who creates a survey that utilizes the most cutting edge technology, but rather it is far
more important that the programmer understand how differences in hardware and
software capabilities can affect the consistency of viewing, such that the web-based
survey can be designed with this in mind. This type of understanding requires expertise
as well as extensive computer resources in order to adequately test the survey and feel
confident that visual aspects of viewing the survey will not affect the data collection
process.

As such, this chapter provides support for the decision to outsource the

programming and fielding of the survey instruments used for this study.
Knowledge Networks, the organization chosen to program, test, and administer
the surveys for this study, specializes in the design and administration of web-based
surveys. As such, they clearly demonstrated their extensive knowledge of web-based
programming and understanding of the principles presented in this chapter throughout the
programming process. In addition, outsourcing the fielding of the surveys addressed the
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remaining issue of coverage bias.

Utilizing their nationally representative panel,

Knowledge Networks offers a unique (and highly marketable) sampling method designed
to overcome the coverage bias typically associated with web-based surveys. Background
information on Knowledge Networks as well as detailed description of their recruiting
and survey administration process is included in the following chapter.
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Chapter VI: Data Collection
The purpose of this chapter is to describe the data collection process used for this
study, as well as provide an overview of the type and source of data collected. In
addition, this chapter includes a discussion of the study design; sampling methodology;
the three versions for Survey 1: Screening; pre-testing of the survey instruments; and
background information on Knowledge Networks, the company that was chosen to
administer the web-based surveys.

Response rates and the effects of the methods

incorporated into the surveys to prevent hypothetical bias are also discussed.
As stated in Chapter 1, the objective of this research is to estimate demand curves
for (1) a new screening method that would better identify those at risk for a heart attack
and (2) a new minimally-invasive procedure for the detection and treatment of vulnerable
plaque. Willingness to pay (WTP) estimates for each of these “goods” will provide
insight into the value individuals place on health, specifically the value they place on
avoiding a heart attack. In addition, a better understanding of the marginal effects of
factors that influence demand for these services will allow society to make more efficient
decisions in the delivery of our scarce health care resources.
6.1 Study Design and Sampling Methodology
This cross-sectional study utilized two contingent valuation surveys in order to
better understand the WTP for information on heart attack risk and the WTP to reduce
that risk. Survey 1: Screening was given to a national random sample of adults in the
general population. These respondents were asked to value a blood test that would
provide them with additional information on their risk of having a future heart attack.
Survey 2: Treatment was administered to adults with previously diagnosed heart
problems. These respondents, who are more familiar with heart related issues, were
asked to value a procedure that would provide more precise information on their risk of
heart attack than could be obtained from the screening alone. In addition, the procedure
they were being asked to value would also allow for the treatment of vulnerable plaque if
it was detected, thus reducing their potential risk of a future heart attack.
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In both Survey 1: Screening and Survey 2: Treatment, the respondent’s WTP was
elicited through an online survey utilizing an iterative bidding process. The iterative
bidding process, which allowed subsequent bids to be based on past responses, was
similar to that generated by an interactive computer program used by Viscusi, Magat, and
Huber (1991). In the Viscusi, Magat, and Huber study, they obtained a nationally
representative sample by recruiting volunteers in a mall whose visitors were known to
have demographics that closely reflected those of the U.S. population. Like their study,
one of the goals of this study was to also achieve a nationally representative sample, but
through the use on an online survey. Online surveys, however, have the inherent problem
of being prone to bias due to the uneven access of computers and the Internet across
socioeconomic groups.

Therefore, to overcome the potential for coverage bias and

achieve a nationally representative sample, Knowledge Networks was selected to
administer the online surveys.
6.2 Knowledge Networks
6.2.1 Background on Knowledge Networks and its Founders
Knowledge Networks (KN) was founded as a private company in 1998 by two
Stanford University professors and has established itself as a reputable and reliable
resource for researchers conducting online surveys.

Knowledge Networks and the

company’s co-founders, Norman Nie and Douglas Rivers, have received recognition
from national organizations, including the American Association of Public Opinion
Research (AAPOR) who awarded them the 2001 Innovators Award for “their
development of a probability sampling method for Internet based surveys in the United
States” (McPhee 2001). In addition, the founders of Knowledge Networks have each
served for several years in well respected positions in academia, and prior to establishing
KN, “had already made significant contributions in the development of quantitative tools
to facilitate social science research” (McPhee 2001).
Norman Nie, the current Chairman of Knowledge Networks, received his Ph.D.
from Stanford University. Prior to that position, he was a professor of Political Science
at the University of Chicago and a Senior Study Director at the National Opinion
Research Center for more than 25 years.
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He founded SPSS, which has become

prominent among statistical software used in research and business applications. In
addition, Nie has served as chairman of SPSS and as Director of the Stanford Institute for
Quantitative Studies in the Social Sciences. His co-founder, Douglas Rivers, has equally
impressive credentials. Rivers received his Ph.D. from Harvard University and holds the
position of Professor at Stanford University and Senior Fellow at the Hoover Institute.
Rivers currently serves as the CEO of Knowledge Networks and is considered “a leading
authority on the application of statistical methods to social science” (McPhee 2001).

6.2.2. Why Knowledge Networks?
Knowledge Networks and its founders have established well respected reputations
in statistically based research methods.

Although this was certainly an important

consideration, the main determinant in selecting KN to administer the web-based surveys
was the fact that KN has established a panel of randomly selected households; thereby
allowing researchers to obtain a national random sample through an online survey.
Previously, data collected through web based surveys were prone to selection bias, which
made data collected in this manner subject to credibility issues. However, Knowledge
Networks has overcome this potential shortfall by offering Internet access to all of the
households that participate on its panel.

6.2.3. How is KN’s Panel Selected?
In creating its panel, Knowledge Networks uses random digit dialing to obtain a
sample of phone numbers. Addresses corresponding to those phone numbers are then
located using a reverse directory, and a letter is mailed to those households. These letters
of introduction are followed a few days later by a phone call inviting members of the
household to participate on the panel. In return for completing no more than one survey
per week, panel members receive free Internet access. If a household does not have a
computer, KN provides WebTV equipment at no charge. Therefore, this reduces the
possibility of selection bias as any U.S. household with a telephone has the potential to be
invited and to participate in Knowledge Network’s panel.
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6.2.4 How are KN’s Surveys Administered?
Once a household chooses to participate, each panel member receives a password
protected e-mail account and is asked to respond to no more than one survey per week
(household members between the ages of 13 and 18 can become members of the panel
with the written permission of their parents; however, no panel member under the age of
18 was contacted for this study). Surveys for which that panel member has been chosen
will appear in their mailbox. Participation in the Knowledge Network panel and in any
individual survey is completely voluntary; therefore, if a panel member chooses not to
participate in a survey, they will simply receive another one.
Prior to viewing a survey, panel members are asked to provide their informed
consent. In return for their consent, KN agrees to uphold their previously agreed upon
policy of privacy and terms of use for the information provided. This includes protecting
the panel member’s identity so that it cannot be linked to the information provided in the
survey. Since panel members can easily withdraw their participation from any survey or
from the entire panel at any time, it is of interest as to whether there has been an effect as
a result of individuals leaving the panel over time. A study by Josh Clinton examined the
effects of attrition on the KN panel. According to his study, he found “no evidence of
systematic panel attrition among any population subgroup” (McPhee 2001). His results
also suggest that individuals who participate on the panel for an extended period of time
are not systematically different in terms of attitude and behavior from those who have
just joined the panel (McPhee 2001).

6.2.5 Commitment to Research Involving Human Subjects
Knowledge Networks has worked with researchers from leading universities across
the United States, and is therefore familiar with the standards governing research
involving human subjects. In fact, over the years, KN’s has made modifications to their
materials in response to requests from Internal Review Boards from certain universities.
This compliance with past IRB requests, along with KN’s desire to maintain their
reputation and profitability, provided assurance that Knowledge Networks would
continue to demonstrate a high level of care in regards to protecting the rights of the
individuals being asked to participate in this survey. An application for this study was
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submitted to the University of Kentucky Internal Review Board (IRB), and approval was
granted in January, 2003.

Upon receiving approval, Knowledge Networks was

contracted to begin programming the online surveys.
6.3 Survey Instruments – Versions of Survey 1: Screening
As stated earlier, both web-based surveys utilized an iterative bidding process to
elicit the respondent’s WTP.99 In Survey 1: Screening, respondents were first given
warm-up questions, including a heart attack risk assessment quiz published by the
American Heart Association. After reflected on these risk factors, respondents were
asked to indicate their perceived risk of having a heart attack in the next year using a
visual analog scale that started at 0 (no risk) and went to infinity (100,000 and beyond).
Two benchmarks were included: 19, a measure of the annual risk of fatality from a car
accident (19/100,000)100, and 50, which was labeled “high risk”.
After indicating their initial perceived level of risk, respondents were provided
with new information on who is at risk for a heart attack, including a description of
vulnerable plaque and the role it plays in causing heart attacks. Following the new
information, respondents were asked to again assess their perceived risk, this time taking
into account the new information. Respondents were then told of the new blood test that
could provide them with additional information regarding their risk of heart attack.
In order to better understand how treatment effectiveness would affect the WTP
for screening, there were three (3) versions of Survey 1: Screening. The majority of the
respondents who completed Survey 1: Screening received a survey in which the treatment
effectiveness was either 30% (corresponding to the existing drug therapy) or 85% (the
effectiveness assigned to the new procedure). In addition, a small number of respondents
received a version of the survey in which “no treatment” was available. The purpose of
this survey “arm” was to determine how much individuals would pay for the screening if
it only offered informational value. Even with no treatment available, the information
99

An advantage of iterative bidding is that more information about a respondent’s WTP is obtained
compared to other elicitation formats such as dichotomous choice in which only an upper or lower bound
on WTP is obtained. The additional information may come at the cost of incentive incompatibility in any
format that elicits WTP responses beyond the first dichotomous choice question. For further discussion,
see Alberini, Kanninen, and Carson (1997), Whitehead (2002), and Watson and Ryan (2007).
100
From the 2000 Traffic Safety Facts published by the U.S. Department of Transportation and the
National Highway Traffic Safety Administration.
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received from the screening could potentially allow individuals to plan their consumption
and savings activities better.
The contract with Knowledge Networks included a total of 500 observations to be
obtained from the two web-based surveys. Although it is not possible for Knowledge
Networks to determine in advance the exact number of individuals who will respond to
each survey, past response rates give them a good indication of the number of individuals
that need to be invited in order to achieve a specific number of respondents. Therefore,
in determining how the 500 observations would be divided between the two surveys, it
was planned that 270 observations would be obtained from Survey 1: Screening, while
the remaining 230 would come from Survey 2: Treatment. An additional 40 observations
were devoted to Survey 1: Screening in order to create the “no treatment” arm discussed
above (See Figure 6-1: Planned Sampling Distribution).
To elicit the WTP for screening, each respondent received an initial dollar amount
to which they could respond “yes” or “no”. To avoid starting point bias, the computer
was programmed to select one of several starting points for each survey.101 Based on the
respondent’s answers, the computer would provide up to four (4) additional bids. If the
bidding process did not sufficiently narrow the WTP value to within a specified margin
of error ($5 for the screening and $100 for the treatment), respondents were reminded of
the range they had selected through their bids and then asked to enter “the most you
would be willing to spend out of pocket for this test.”
Survey 2: Treatment followed the same format as Survey 1: Screening with two
main modifications. Because the panel members invited to take Survey 2: Treatment
were limited to individuals with doctor-diagnosed heart problems, it was reasonable to
assume that these individuals were already familiar with the risk factors associated with
coronary heart disease.

In fact, 110 individuals in the sample (37%) had already

experienced a heart attack. Therefore, the first difference between the surveys is that
instead of using the risk assessment quiz included in Survey 1: Screening, the warm-up
101

Starting points for each survey were based on the median and range of WTP values obtained from the
initial focus groups. Starting points for Survey 1: Screening were $10, $40, $50, $60, and $100. Starting
points for Survey 2: Treatment were $1,000, $2,000, $5,000, $8,000, $10,000. One of these 5 starting
points, corresponding to the appropriate survey, was randomly selected by the computer program for each
respondent.
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questions for Survey 2: Treatment included questions regarding the impact a heart attack
could have or has had on the respondent’s ability to work, perform daily functions, and
on their overall quality of life.
The second significant difference between the surveys is that in Survey 2:
Treatment, respondents had the option to choose their preferred treatment method.
Therefore, prior to eliciting their WTP for the procedure, respondents were given the
opportunity to select whether the procedure was indeed their preferred method of
treatment. After being asked to consider a hypothetical situation in which they were told
by their regular physician (and another trusted physician) that their initial tests indicated
they were at high risk for a heart attack, respondents were asked to make a treatment
choice.

They could either select “Medication only” which is 30% effective or the

“Procedure and Medication” which was stated as being 85% effective. Although the
“Procedure and Medication” option did offer a higher level of effectiveness, the survey
also stated that it had an additional risk of death equal to 10/100,000.102 Respondents
who chose “Medication only” as their preferred treatment option were given an openended question asking why they chose not to have the procedure, while those who
selected the procedure completed the bidding process to determine their maximum WTP.
6.4 Pre-Testing
A total of four focus groups were conducted prior to administering the online
survey. Two focus groups (one for Survey 1: Screening and one for Survey 2: Treatment)
were conducted in November 2002 using paper versions of the surveys. Two additional
focus groups (one for each survey) were conducted in March 2003 using the online
surveys programmed by Knowledge Networks. All of the focus groups were conducted
following the guiding principles set out in Richard Kruger’s book entitled Focus Groups.
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Drug therapy does have a risk of death; however, patients who undergo the type of procedure described
in this survey would have already been diagnosed as being at high risk for a heart attack and therefore
would most likely already be taking a cholesterol lowering medication. Since both treatment options
included drug therapy (and the associated risks), the survey focused only on the marginal increase in risk of
death associated with the procedure when presenting the treatment options. The additional 10/100,000
(1/10,000) risk of death associated with the procedure stems primarily from the risk of death due to
infection resulting from the minimally invasive procedure and from other complications that could arise
from the anesthesia used in performing this procedure.
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Prior to conducting the focus groups, the survey was also given to four individuals
(2 males and 2 females, ages 48-61) as an initial pre-test in November 2002. The most
significant finding from this pre-test was that the “cheap talk” dialog, which closely
followed the original cheap talk script proposed by Cummings and Taylor (1999), was
too lengthy for a web-based survey. All of the pre-test participants indicated that they
wanted to abandon the survey during this section. Following a suggestion made by one
of the participants, this section was significantly reduced in length. However, due to a
concern that shortening the cheap talk script would diminish its effectiveness, an optional
screen that provided more detailed information on hypothetical bias was added to the
online survey.
In the final version of each survey, respondents were asked if they understood
hypothetical bias after reading the shortened explanation. Those who responded “no”
were presented with the secondary screen that provided them with additional information
on hypothetical bias, including an example. Specific comments made by focus group
participants, who clearly indicated that they considered hypothetical bias before stated
their final WTP, confirmed that the abbreviated “cheap talk” script was indeed effective.

6.4.1 Initial Focus Groups: Paper Survey
Conducting a focus group for both Survey 1: Screening and Survey 2: Treatment
using the online format was clearly an important step prior to administering these webbased surveys nationwide. However, realizing that making significant changes (that
would require additional computer programming) would be costly, initial focus groups
for each survey were conducted using a paper version of the surveys. The purpose of the
initial focus groups was to ensure the clarity of the survey questions (both in terms of
intended meaning and interpretation by the respondent) in order to establish the basic
format of the surveys prior to programming. Participants for the first two focus groups
were recruited from a local scrapbooking group and Newcomer’s Club in Hopkinton,
Massachusetts. Upon completing the focus group session, which lasted about an hour
and a half, each participant received a small photo album (valued at about $15) as a thank
you gift.
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During the focus group session, participants completed the survey, and then as a
group were led in a discussion by the facilitator using a series of predetermined
questions. Each group was asked about the length of the survey, clarity of the questions,
and the process by which they arrived at their final WTP. In these initial focus groups,
participants were not given bids (as would be done later in the online versions), but rather
were asked to respond to an open-ended WTP question. The WTP values obtained in
these initial focus groups were then used to establish the relevant range of starting bids
that appeared in the online surveys. Key statistics from these initial focus groups can be
found in Appendix B.

6.4.2 Follow-up Focus Groups: Online Survey
After the programming for the online surveys was completed by KN, a second set
of focus groups were conducted (one for each survey). Again, participants included
individuals in the community of Hopkinton, MA, including a group of seniors with
doctor-diagnosed heart problems from the local Senior Center. At the completion of the
session, each respondent was given a $15 gift certificate to either a local restaurant or
grocery store as a thank you gift for participating.
During the focus group sessions, each participant was seated at his/her own
computer and given an opportunity to complete the online survey. The group then came
together around a table to discuss the survey. For the discussion, each participant was
given a paper version of the survey so they could refer to specific questions or sections of
the survey they completed online. Other than a few minor wording changes, the only
significant change that resulted from the online focus groups was the deletion of the
second follow up question which asked how sure the respondent was of his/her final
stated WTP amount. It was determined that this question was redundant because a follow
up certainty question was asked after the end of the iterative bidding. Therefore the
second certainty question was deleted from the final versions of the surveys.
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6.5 Survey Data
6.5.1 Survey Administration
Survey 1: Screening was fielded from May 9, 2003 through June 1, 2003 and was
given to a sample representing the general population. Knowledge Networks invited 552
panel members to participate. Of those, 269 consented. Respondents for Survey 1:
Screening took an average103 of 16 minutes to complete the survey, which is consistent
with the time it took for focus group participants to complete this survey. Only one
individual did not complete the survey, resulting in a final sample size of 268 and a
response rate of nearly 49%. Table 6-1 compares the sample for Survey 1: Screening to
the U.S. population in regards to several key demographics, including gender, age, race,
marital status, education, employment status, and household income. The sample from
this study is a bit more middle income and better educated, but overall, it is quite similar
to the U.S. population.
The fielding of Survey 2: Treatment also began on May 9, 2003 and lasted for
approximately two (2) weeks, ending on May 26, 2003. Because respondents who are
more familiar with a good tend to provide more reliable estimates (Mitchell and Carson,
Chapter 8, 1989), potential respondents for Survey 2: Treatment were limited to panel
members with doctor diagnosed heart problems. 466 panel members were invited, of
which 295 consented and completed the survey,104 resulting in a response rate of 63%.

103

KN allows respondents to leave the survey and return at a later time to complete the survey. Data
obtained from KN includes the “duration”; however, this variable measures the total amount of time that
elapses starting when the survey is first accessed until is completed; therefore, a few of the duration times
are extremely high (>10,000 minutes, which represents several days). 90% of the sample completed the
survey in 35 minutes or less; therefore, the median time of 16 minutes is a better measure of central
tendency (compared to the mean of 441 minutes – approximately 7 hours and 20 minutes).
104
The median completion time for Survey 2: Treatment was 28 minutes. A natural break appears in both
surveys the duration variable between the 2-3 hour mark, which could suggest that some individuals leave
the survey to conduct outside research prior to completing the WTP section. Interestingly, a larger
percentage of the sample appears to leave Survey 2: Treatment (12.5%) as compared to Survey 1: Screening
(6.7%). Focus group discussion indicated that individuals did take additional time to reflect on the decision
to have the more invasive treatment procedure compared to the blood test for screening. Unfortunately, no
information is available regarding the reason panel members leave and return to the survey; therefore, is not
clear whether respondents left the survey to reflect and/or possibly collect additional information, or if the
higher rate was simply due to the fact that the Survey 2: Treatment sample was more elderly and therefore
was more likely to take breaks while completing the survey.
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6.5.2 Response Rates
Both surveys had good response rates; however, during the fielding process there
was a noticeable difference in how quickly panel members chose to participate in the
surveys. In fact, due to a slightly slower rate of response than KN’s average, Survey 1:
Screening was fielded for an additional week. Interestingly enough, panel members
responded very quickly to Survey 2: Treatment, such that during the two week fielding
period, significantly more observations were obtained than were originally contracted
(See Figure 6-2: Actual Sampling Distribution).
The difference in the response rates between the two surveys can most likely be
attributed to the consent screen that panel members saw prior to beginning the survey. In
addition to requesting consent from the participant, the consent screen also indicated the
topic of the survey. Looking at the summary statistics of those who responded to Survey
1: Screening, it appears that younger individuals in the general population saw the topic
of heart attacks and felt the survey was not of interest to them, therefore, they did not
consent to the survey. Whereas Survey 2: Treatment, which was only offered to those
with doctor-diagnosed heart problems, appears to have been of very high interest to the
targeted panel members. The consent screen for both surveys followed the example
provided by KN (See Appendix C: Informed Consent Screens); however, in hindsight, it
may have been better to omit the specific topic of the survey and perhaps include only a
general statement about health or not include the topic at all. However, this may have
simply led to a high non-completion rate if those who were not interested in the topic
chose to abandon the survey upon discovered the topic. As is stands, only 1 out of the
564 respondents (< 0.2%) who gave their consent did not sufficiently complete their
survey to be included in the sample; thus, yielding a 99.8% completion rate for all the
respondents who began the surveys.

6.5.3 Hypothetical Bias
Hypothetical bias is the tendency of respondents in contingent valuation surveys
to say “yes” they would be willing to pay a specified amount more often than they would
actually pay that amount. Therefore, several methods were integrated into this survey to
avoid the potential for hypothetical bias. These include the use of an abbreviated version
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of the “cheap talk” script initially proposed by Cummins and Taylor (1999), inclusion of
a series of questions to remind the respondent of their budget constraint, the use of a
certainty scale in which respondents assess the certainty of their stated bid, and finally,
the use of a follow-up certainly question utilized during the focus groups.
Prior to respondents receiving a series of iterative bids, they were first asked to
consider what this test/procedure would be worth to them. While respondents reflected
on how much they would value the good, they were presented with a shortened version of
Cummings and Taylor’s (1999) “cheap talk” script in which the potential for hypothetical
bias was discussed. The motivation behind the “cheap talk” script is the idea that
informing individuals about the tendency of respondents in contingent valuation surveys
to say “yes” they would be willing to pay a specified amount more often than they would
actually pay, will then cause them to take hypothetical bias into account in stating what
they would do. Therefore, before asking respondents to make decisions regarding their
own WTP for the test/procedure, they were first given an abbreviated “cheap talk” script
followed by a question asking if they understood hypothetical bias. If they answered
“no” or indicated “I would like additional information” they were provided with further
explanation, including an example.
For Survey 1: Screening, 263 of the 268 respondents (over 98%) indicated that
they understood hypothetical bias. The mean WTP for the remaining five observations105
was $38, far below the sample mean of $94, suggesting that it is highly unlikely that
these observations artificially inflated the final WTP value obtained in this study. In
Survey 2: Treatment, 289 of the 295 respondents (98%) indicated that they understood
hypothetical bias. Of those that indicated they did not understand hypothetical bias, four
stated WTP values ($0, $100, $400, and $2,000) were far below the sample mean of
$7,821. The remaining two observations included stated WTP values of $30,000 and
$80,000. These two observations are in the top 5% of the values obtained, and therefore
may suggest the presence of a small degree of hypothetical bias. Excluding these two
observations reduces the mean WTP for the procedure to $7,499, a difference of $322
(4.1%). Excluding all six observations (all those who indicated they did not understand
105

The stated WTP values for these 5 observations were $0, $0, $10, $40, and $140. $140 is in the top 25th
percentile, suggesting a possibility of hypothetical bias. Excluding this observation from the sample yields
a WTP value of $93.84 (which is not significantly different from the mean WTP using the entire sample).
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hypothetical bias), reduces the mean WTP for the procedure to $7,594, a difference of
$227 (2.9 %) from the mean WTP derived when using the entire sample.
An additional measure to reduce the presence of hypothetical bias in the data set
was the inclusion of questions designed to remind respondents of their budget constraint.
While respondents reflected on what the test/procedure was worth to them, they were
asked about the amount of money they currently spend out of pocket for medical care.
They were also asked about the amount of money they currently have available in
savings. As expected, some respondents did not choose to answer the savings question,
however, it served its purpose in reminding respondents of the amount of money they
currently have available in savings (and perhaps other sources) to spend on this
test/procedure. In addition, by taking a few moments to consider their available funds
and ask how they typically spend their money on medical care, respondents are more
likely to consider their budget constraint when stating their WTP for the test/procedure.
Another method used to reduce the occurrence of hypothetical bias was the
inclusion of a certainty question.

Following the iterative bidding process and

determination of the respondent’s initial WTP, respondents were asked to assess “how
certain are you that you would pay this amount” using a scale of 0-10. A certainty scale
was first used by Champ et al. (1997) who compared hypothetical dichotomous choice
questions about donations to a public good with actual donations to the public good.
After indicating their degree of certainly, respondents were then given an opportunity to
enter a revised amount of what they “would definitely pay” for the test/procedure.
Discussion from the focus groups indicated that the use of a certainty question followed
by a chance to revise their stated WTP amounts appeared to be an effective way of
eliciting their true WTP. Interestingly enough, the focus groups showed that respondents
would sometimes (justifiably) revised their bids upward because evaluating their
certainly and having time to reflect on their WTP gave them time to consider additional
sources or available funds. For example, in the focus group for the treatment, one
participant increased her maximum WTP from $10,000 to $25,000. When asked about
this increase she explained that her life was important and that she would certainly pay as
much as she would for a car. Therefore, it would be worth it to her to sell her car, take
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out a second mortgage, or ask family members for help in order to obtain the funds
necessary to pay this amount for the procedure.
The final and closely related method of preventing the admission of hypothetical
bias into the data was the utilization of a follow-up certainty question in the focus groups.
In the versions of the survey that were given to the focus group participants, a second
certainly question was included after the final WTP value was given. This question
asked the respondent how certain they were that he/she would pay the stated amount.
However, this time, instead of a certainty scale, participants were asked how sure they
were that they would pay this amount by selecting one of the following: definitely yes,
probably yes, not sure, probably no, definitely no. This follow up question used in the
focus group indicated that almost all participants were “definitely sure” of their response
by the end of the survey.106

In a field experiment that offered a diabetes management

program delivered by a pharmacist, Blumenschein et al. (forthcoming 2007) found that
individuals who were “definitely sure” of their responses in contingent valuation were not
statistically different from individuals who made real purchase decisions about the
program.

Therefore, based on the responses to this question by the focus group

participants, it was determined that the combined use of an abbreviated cheap talk script,
and providing an opportunity for respondents to revise their stated WTP after assessing
their certainty seemed to provide an effective method for reducing the occurrence of
hypothetical bias in the data. In fact, the results of a study by Whitehead and Cherry
(forthcoming 2007) suggest that these two approaches to mitigating hypothetical bias
(cheap talk and a certainty follow-up question) are complements rather than substitutes,
and therefore, should be used together to help eliminate the possibility of hypothetical
bias.
6.6 Health Data
In addition to the data collected through the online surveys, detailed health
information on each respondent was also obtained from KN. Upon joining the KN panel,
extensive health data is collected on each individual. This health data contains several
variables of interest to this study, including frequency of exercise, amount of stress, body
106

This question was not included in the online survey because it was considered redundant.
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mass index (BMI), and numerous chronic conditions and diseases, such as high
cholesterol, hypertension, and diabetes. Therefore, this health data, together with the
survey data, provided a rich data set from which to conduct the data analysis presented in
the following chapter.
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Table 6-1: Comparison of U.S. Census Data to those who were Invited and Completed
Survey 1: Screening

Characteristics
Gender

Male
Female
Age
18-29
30-44
45-59
60+
Race/Ethnicity
White
Black
Other
Hispanic
Employment Status
In labor fource
Not in labor force
Marital Status
Married
Not married
Household Income
Under $10,000
$10,000 - $24,999
$25,000 - $49,999
$50,000 - $74,999
$75,000 or more
Education
Less than HS
High School
Some College
College
Region
Northeast
Midwest
South
West
*CPS data are weighted. K(Census data provided by KN)

U.S. Census (CPS,
Feb. 2002)
48.0%
52.0%
21.7%
31.1%
25.8%
21.4%
72.7%
11.6%
4.7%
11.0%
64.0%
36.0%
57.3%
42.7%
7.5%
18.5%
29.2%
19.9%
24.9%
16.4%
32.0%
27.4%
24.3%
19.1%
22.8%
35.6%
22.6%
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Invited
(n=552)
48.9%
51.1%
21.9%
30.8%
23.7%
23.6%
70.1%
12.3%
6.0%
11.6%
70.0%
30.0%
59.8%
40.2%
7.8%
17.6%
33.5%
21.2%
19.9%
10.1%
33.9%
30.4%
25.5%
17.6%
24.6%
35.3%
22.5%

Completed
(n=268)
53.4%
46.6%
16.0%
28.7%
24.6%
30.6%
76.9%
8.2%
6.0%
9.0%
64.6%
35.5%
60.4%
39.6%
7.1%
19.0%
35.8%
20.5%
17.5%
9.0%
36.6%
28.0%
26.4%
18.3%
25.7%
32.1%
23.9%
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Figure 6-1: Planned Sampling Distribution

Copyright © Patricia L. Ryan 2007
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Figure 6-2: Actual Sampling Distribution

Chapter VII: Data Analysis and Results
The primary purpose of this chapter is to present the results of the study, including
the mean value obtained for the willingness to pay (WTP) for (1) a new screening method
that will better identify those at risk for a heart attack, and (2) the mean WTP for a more
effective treatment method for those individuals who have been identified as being at
high risk for a heart attack.

The chapter includes a brief discussion of the data

preparation and how a single WTP value was defined for each respondent. Summary
statistics for the key variables used in the econometric analysis are presented.

In

addition, the chapter includes models of general health and perceived risk for both data
sets. These models are included because WTP is greatly influenced by the respondent’s
perceived risk of having a heart attack, which in turn, is affected by the individual’s
general health. Therefore, these models are reported to gain a better understanding of the
individual factors affecting these variables and the role they play in influencing WTP.
To further explore the factors that influence WTP for a new screening method and a
more effective treatment, a censored regression model and a two-part model (probit with
OLS) are used to isolate the marginal effects of individual factors on the respondent’s
WTP. Overall, the general health and perceived risk models provide evidence supporting
the reliability of the data set, including the reported mean WTP for screening and
treatment. In addition, the results from the WTP regressions offer insights regarding the
factors that may influence consumer WTP for the screening and treatment of vulnerable
plaque. Finally, the chapter concludes by making a connection between the WTP for
treatment obtained in this study and the value of a statistical life (VSL).
7.1 Data Preparation
7.1.1 Item Non-response and Internal Consistency Checks
For observations in which there was item non-response, the sample mean was
assigned, and then the models were run with and without those observations to check for
potential differences in the results. In addition, some internal consistency checks resulted
in a few minor adjustments – for example, a few individuals checked that they were both
“a male over 45” and “a female over 55.”
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Using data obtained from Knowledge

Networks on the respondent’s actual age and gender allowed for the correction of this
survey error. Appendix D includes a detailed accounting of adjustments made to the data
sets in preparation for analysis, as well as a complete list of the variables available in the
two data sets used for this study.

7.1.2 Defining WTP
As described in Chapter 5, the use of an iterative bidding process with follow-up
questions elicits a single WTP value from each respondent. If the bidding process itself
does not establish an initial WTP amount, respondents are reminded of the range they
were willing to pay based on the answers given for each bid and are then asked to enter
the most they “would be willing to spend out of pocket” for the test/procedure. After the
initial WTP value is established, respondents are then asked to assess how sure they are
on a scale of 0-10 (0=not sure and 10=definitely sure) that they would actually spend this
amount. Following the certainty question, respondents are reminded of their initial WTP
and asked to enter the amount they “would definitely pay for this test/procedure.”
For those who completed the process, a single WTP value was obtained.
However, a few respondents did not complete the entire process. In many of these cases,
the respondent did not answer the final WTP question after indicating that he/she was
very certain (10) of their earlier stated amount. Thus, it is reasonable to assume that the
individual was satisfied with their earlier amount, had expressed that they were definitely
sure they would spend this amount, and did not feel it was necessary to enter the number
again. Therefore, for observations in which the respondent did not complete the final
WTP question, the initial WTP value was used. Initial WTP is a good measure of the
respondent’s actual WTP because it was obtained either by the bidding process narrowing
the respondent’s WTP down to within the pre-specified margin of error, or it was entered
directly by the respondent. The only disadvantage of using this value is that it may have
a greater tendency to be subject to hypothetical bias because it was determined prior to
the respondent considering the follow-up certainty question.

However, as stated

previously, many of the individuals for whom this value was used indicated that they
were very certain of their initial WTP, therefore, this is considered a very good measure
of the respondent’s true WTP.
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There were a few respondents in both surveys for which the respondent did not
offer an initial WTP or final WTP value. In these cases, the bidding process did not
sufficiently narrow the range and the respondent did not complete the follow-up question
asking for their WTP. For these few observations, the highest “yes” bid was used as a
measure of the respondent’s WTP. Presumably the respondent may be willing to pay
more than their highest “yes” bid, therefore, this serves as a lower bound. Although
using this value may understate the individual’s true preference, it is the best available
measure because it will not artificially inflate the mean WTP for screening/treatment.
There was only one observation for which the process described above could not
be used to obtain the respondent’s WTP. For one observation in Survey 1: Treatment, the
respondent only spent a total of 8 minutes on the entire survey (significantly less than the
average), skipped both the initial and final WTP questions, and all the bidding questions.
With no available information on which to base the respondent’s WTP, the observation
was dropped from the sample, resulting in a final sample size of 268 for Survey 1:
Screening. This process of defining WTP was also applied to data from the second
survey (with no necessary exclusions); therefore, the full sample of 295 was utilized for
analysis of the Survey 2: Treatment data.
7.2 Summary Statistics for Survey 1: Screening Data
An overview of several key demographic and health variables for the sample data
obtained from Survey 1: Screening can be found in Table 7-1. These summary statistics
are also included for the Survey 2: Treatment data for easy comparison of the two
samples. A complete list of the variables used in analyzing the Survey 1: Screening data
can be found in Table 7-2. Table 7-2 also includes descriptors of each of the variables
and more detailed summary statistics, including minimum/maximum values and
frequency distributions.

7.2.1 Demographics
The sample for Survey 1: Screening includes 268 individuals (age 18 or older)
from the general population who responded to the survey invitation and offered their
informed consent.

The sample for the WTP for screening includes slightly more men
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(53%) than women (47%). The individuals comprising the sample range from 18 to 83
years of age, with the mean just under 48 years old. Over 90% of the sample competed
high school, with approximately 55% attending at least some college. Five percent of the
individuals in the sample earned an associates degree, 17% earned a bachelor’s degree,
and 9% completed a graduate or professional degree. Slightly more than three-quarters
(77%) of the sample is white, 8% is black, 9% is Hispanic, and 6% represent other ethnic
groups. Sixty percent of the individuals included in the sample are married, and the
average household size is 2.6. Approximately 65% of the sample is in the labor force,
20% is retired, and 6% is disabled. Mean household income for this sample is $48,223.
A fairly large percentage of respondents (85%) indicated that they were heads of their
household, and a majority of the respondents (83%) in this sample reside in a
Metropolitan Statistical Area (MSA).

7.2.2. Health Statistics
Of the 268 individuals in the general population sample, approximately 12% have
self-reported heart disease and nearly 5% have experienced a heart attack. Seventeen
percent are currently taking or have taken medication in the past to reduce their
cholesterol.

Mean self-reported health status is 3.4 on a 1-5 scale (1=poor and

5=excellent). Body Mass Index (BMI) for this sample ranges from 16 to 62, with a mean
of 28.3. The ideal range is 18.5 to 24.9; therefore, using published definitions based on
BMI, nearly 30% of the sample is overweight, 17% is obese, and over 19% of the sample
is comprised of individuals considered to be very obese. Thirty-five percent indicated
they have elevated cholesterol levels, 32% suffer from high blood pressure, and 8% are
diabetic. Thirty-four percent of the individuals in the sample indicate that they live or
work with people who smoke everyday, and 40% have a family history of heart problems
or have a member of their immediate family who has experienced a heart attack.
7.3 Summary Statistics for Survey 2: Treatment Data
As mentioned above, an overview of several demographic and health variables for
both data sets is presented in Table 7-1 for easy reference and comparison purposes. A
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complete list of the variables, descriptors, and more detailed summary statistics used in
analyzing the Survey 2: Treatment data can be found in Table 7-3.

7.2.1 Demographics
The sample for Survey 2: Treatment includes 295 individuals (age 18 or older)
with doctor-diagnosed heart problems who responded to the survey invitation and offered
their informed consent. The sample for the WTP for treatment is evenly comprised of
men (50.5%) and women (49.5%). The sample includes individuals between the ages of
18 and 91, with a mean of just under 64 years old.107 Since this sample is limited to
individuals with doctor-diagnosed heart problems, which tends to be more common after
age 55, it is not surprising that this sample has a much higher mean age compared to the
general population sample obtained for the screening survey (See Table 7-1 for a
comparison of the two samples). Given the considerably older age of the sample, there is
relatively little difference in the level of education for the two samples. Over 86%
graduated from high school, and 47% attended at least some college. Seven percent
earned an associates degree, 15% earned a bachelor’s degree, and over 6% completed a
graduate or professional degree. In terms of race, nearly 88% of the sample is white, 7%
is black, 3% is Hispanic, and 2% is representative of other ethnic groups. Approximately
two-thirds (66%) of the sample is married, and the average household size is 2.3. A large
percentage of the sample (47%) is retired, and 10% are disabled. Approximately 34% of
the sample is in the labor force, and the mean income is $43,538.

A fairly large

percentage of respondents (87%) indicated they were heads of household, and a majority
of the respondents (87%) in this sample reside in a Metropolitan Statistical Area (MSA).

7.3.2. Health Statistics
Of the 295 individuals with doctor-diagnosed heart problems included in this
sample, 75% report they have heart disease and over 37% have experienced a heart
107

Survey 2: Treatment was only administered to individuals with doctor-diagnosed heart problems. Since
heart problems are more common in elderly individuals, this sample included a high percentage of
individuals over the age of 65. Therefore, an additional age category (Age 75 and above) was included for
all the data analysis completed for Survey 2: Treatment to account for any differences in general health,
perceived risk, or WTP for this age group
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attack. Nearly 63% are currently taking or have taken medication in the past to reduce
their cholesterol. Mean self-reported health status is 2.8 on a 1-5 scale (1=poor and
5=excellent). Body Mass Index (BMI) for this sample ranges from 16 to 77, with a mean
of 29.2. As stated above, the ideal range is 18.5 to 24.9; therefore, using published
definitions based on BMI, nearly 38% of this sample is classified as overweight, 23% is
obese, and 16% of the sample is comprised of individuals considered to be very obese.
Approximately 40% of the individuals in the sample suffer from hypertension (high
blood pressure), 22% are diabetic, and 58% have a family history of heart problems or
have a member of their immediate family who has experienced a heart attack.
7.4 General Health
Respondents for both Survey 1: Screening and Survey 2: Treatment were asked to
report their health status using a five category scale (1=poor health, and 5=excellent
health). Self-reported general health was found to play a significant role in perceived
risk, which in turn, helped explain the WTP for screening.

Therefore, to better

understand general health, a standard OLS (Ordinary Least Squares) regression was run
on self-reported health status. Following Grossman’s model of health production, the
independent variables include age, education, significant decreases to the health stock (as
measured by the respondent reporting having had a life threatening condition or illness),
and several lifestyle variables, including amount of stress, frequency of exercise, and
amount the individual exceeds his/her ideal body mass index (BMI). The effects of
household income and frequent visits to the doctor’s office have on health status are also
explored.

7.4.1 General Health Model for Survey 1: Screening
In the general health model using data from Survey 1: Screening (See Table 7-4,
Column 1), age is negative and significant, as expected, with coefficients becoming
increasingly negative for each age category. All of the coefficients on education are
positive, with the coefficient on bachelor’s degree significant at the 5% level. The
positive effect of education on health is consistent with Grossman’s prediction that more
educated individuals will tend to have higher levels of health, all else constant. The
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regression results also support the fact that individuals who have experienced a life
threatening condition or illness have a significantly lower general health ceteris paribus,
indicating a reduction in the health stock for these individuals. In addition, individuals
who report being under higher levels of stress or who are above their ideal body weight
(as measured by the amount the individual exceeds his/her ideal BMI) also have a
statistically (at the 1% level) lower self-reported general health status. Finally, increased
frequency of exercise, which represents an investment in health according to Grossman’s
model, is highly significant and has the expected positive effect on the individual’s
general health.
Other specifications of the general health model include the addition of two
variables, frequency of visits to a doctor and household income, which were included to
measure investments in (or access to) health care (See Table 7-4, Columns 2, 3, and 4).
Although it was anticipated that going to the doctor would improve health, the highly
significant negative coefficient on frequency of doctor visits did not demonstrate that
these “investments” in health were having a positive impact on the individual’s health
status. Instead, it appears that this variable is standing in for the effect of “chronic”
conditions – that is, those that require a significant amount of care, yet treatment creates
little improvement in overall health.108 This hypothesis is further supported by the fact
that inclusion of frequency of doctor visits in the model (Table 7-4, Column 2) reduces
the coefficients on the age variables, particularly for those who are 65 and over.
Including household income as an independent variable (See Table 7-4, Column
3) yields a positive coefficient that is significant at the 1% level. Including household
income does increase the explanatory power of the model; however, not surprisingly, it
reduces the coefficients of the education variables and makes them statistically
insignificant.
It was thought that differences in attitudes toward health and the individual’s
willingness to make investments in health may be reflected in their degree of being
overweight. Therefore, instead of using a continuous variable that captures the amount
an individual is over their ideal BMI, many of the models analyzing data from Survey 1:
108

A simple regression conducted with frequency of doctor visits as the dependent variable and chronic
back pain, arthritis, asthma, and diabetes as the independent variables strongly supports the hypothesis that
frequency of doctor visits is capturing the effect of chronic conditions in the general health equation.
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Screening include dummy variables for the following weight categories: overweight,
obese, and very obese.109 Individuals are assigned to each category using their individual
BMI and standardized ranges for each weight category that are defined as: overweight
(24.9 < BMI < 30); obese (30 ≤ BMI < 35); and very obese (BMI ≥ 35) (Partnership
2007). Inclusion of these weight categories in the general health regression (See Table 75) yields very similar results to those just discussed when amount over ideal BMI is used
as the weight variable (Table 7-4). When the weight dummies are used in place of
amount over BMI, the coefficients on the other covariates remain essentially unchanged;
however, the marginal effects on overweight, obese, and very obese do suggest that the
relationship between increased weight and general health is not necessarily linear (See
Table 7-5). As expected, the coefficients on overweight, obese, and very obese are all
negative; however, the t-values indicate that those individuals who are classified as
overweight have no statistically significant difference in their self-reported general health
status from those who are not overweight; while individuals who are classified as “obese”
and “very obese” have statistically significant lower general health. In addition, the
coefficient on very obese is larger in magnitude than the coefficient on obese. Therefore,
the farther the individual is above their ideal weight, the larger the decrease that can be
expected in that individual’s general health.

7.4.2 General Health Model for Survey 2: Treatment
Comparable regressions performed on data for Survey 2: Treatment indicate very
similar results (See Table 7-6). The coefficients on age become increasingly negative
with higher age categories, with age having a statistically significant decrease on general
health for those individuals who are 55 years of age or older. In general, education has a
positive effect on health status, with statistical significance for individuals who hold
some type of college degree. This finding is consistent with the efficiency of health
production Grossman predicted for individuals with higher levels of education.

As

before, an individual who has experienced a life threatening condition reports a lower
level of general health ceteris paribus. Higher levels of stress and being overweight
lower the individual’s general health by a statistically significant amount, while increased
109

The excluded category is those individuals who are at (or slightly below) their ideal (normal) BMI.
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time spent exercising has a statistically significant positive effect on general health.
Again, those who visit the doctor more often (See Table 7-6, Column 3), tend to have
lower general health, suggesting that, as discussed previously, this variable is acting as a
proxy for chronic conditions. In addition, the fact that inclusion of this variable in the
model decreases the coefficients on the age variables (particularly for individuals 75 and
over) offers further evidence to support that this variable is capturing the effect of chronic
illnesses on health. And finally, as observed in the data from Survey 1: Screening,
income has a statistically positive effect on the individual’s self-report general health.
Overall, factors explaining the variation of general health status for both samples are
consistent with economic theory and provide confidence as to the reliability of the data
sets.
7.5 Perceived Risk
As discussed in Chapter 5, respondents for both Survey 1: Screening and Survey
2: Treatment were asked to enter the number that best represented their perceived risk of
having a heart attack in the next year using a computerized version of a visual analog
scale. The visual analog scale went from 0 (labeled no risk) to 100,000 and included two
anchors – 19, which corresponds to the annual fatality rate from a car accident
(19/100,000), and 50 (which was labeled “high risk”). Respondents were asked to assess
their perceived risk twice – once prior to receiving new information on vulnerable plaque
as a cause of heart attack (Initial Perceived Risk) and once immediately after receiving
the new information (Perceived Risk after New Information).
For the general population sample completing Survey 1: Screening, mean
perceived risk was 15.07 prior to the new information and 17.92 following the new
information.

Since the visual analog scale indicated that risk was per 100,000

individuals, these values indicate an average increase in perceived risk of about
3/100,000 due to the new information. For the Survey 2: Treatment sample, mean
perceived risk is significantly higher (which is expected given the health history of these
individuals), with a mean Initial Perceived Risk of 26.56, mean Perceived Risk after New
Information of 30.22, and Change in Perceived Risk equal to 3.65.
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Although the actual clinical risk associated with experiencing a heart attack is
specific to the individual (and can depend on several factors), one of the primary
determinants of heart attack risk is age. Table 5-2 includes the annual risk of fatality
from an acute myocardial infarction (heart attack) for twelve different age groups. As
Table 5-2 clearly indicates, the risk of fatality from heart attack increases substantially for
those individuals 55 years of age and above. The mean age-adjusted fatality rate for the
population is reported as 42 / 100,000. According to the American Heart Association,
approximately 47% of heart attacks are fatal; therefore, this value implies that the mean
annual probability of experiencing a heart attack is 89 / 100,000. This value is higher
than the annual perceived risk indicated by the individuals completing the survey;
therefore, it appears that both individuals in the general population and those with doctordiagnosed heart problems tended to underestimate the probability of experiencing a heart
attack.110 To gain a better understanding of the factors influencing perceived risk, an
OLS regression was estimated using both measures of perceived risk (before and after the
new information) as the dependent variable. The perceived risk models include various
risk factors for heart attack, while controlling for level of education, cholesterol
medication (which would tend to lower the individual’s perceived risk), and, in some
specifications, the individual’s general health. These models account for approximately
30% of the variation in Initial Perceived Risk and 25% of the variation in Perceived Risk
after the New Information.

7.5.1 Initial Perceived Risk with Risk Factors from AHA Quiz
As part of the warm-up section in Survey 1: Screening, respondents were asked to
complete a risk assessment quiz published by the American Heart Association (AHA).
As discussed in Chapter 5, the quiz contains 11 risk factors that are traditionally used by
physicians to assess a patient’s risk of having a heart attack. The eleven risk factors
(labeled r1 through r11) are all dummy variables, with 1 representing a “yes” response
and 0 otherwise. Regressions including these risk factors are presented in Table 7-7

110

For Survey 1:Screening, maximum values for Initial Perceived Risk and Perceived Risk after New
Information were 80 and 100 respectively. For Survey 2:Treatment, values were similar with a maximum
value of 85 for Initial Perceived Risk and maximum value of 100 for Perceived Risk after New Information.
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(using Initial Perceived Risk as the dependent variable) and Table 7-8 (using Perceived
Risk after the New Information as the dependent variable).
The first regression in Table 7-7 (See Column 1) includes the set of eleven AHA
risk factors, and controls for cholesterol lowering medication, and education. With Initial
Perceived Risk as the dependent variable several of the AHA risk factors are highly
significant, including (1) being a male over the age of 45, (2) being a female over the age
of 55, (3) having high cholesterol, (4) being 20 pounds or more overweight, and (5)
having coronary heart disease or having had a prior heart attack. All of the other risk
factors (with the exception of low HDL111) have the expected positive sign. Taking
medication to lower cholesterol lowers the individual’s probability of having a heart
attack, therefore, the negative coefficient on medication is expected; however, it is not
statistically significant. Education was highly significant and negative at all levels, with
coefficients larger in magnitude for college degrees, suggesting that those with more
education have lower levels of perceived risk.
Because some of the risk factors include more than one variable (i.e. male over
the age of 45), another regression was performed on Initial Perceived Risk separating out
these variables (See Table 7-7, Column 3). Specifically, risk factors r1 (male over age
45), r2 (female over age 55), and r11 (heart disease or heart attack) were replaced with
variables for gender, age, and independent variables for heart disease and heart attack. In
separating out these risk factors, there are two things that become of interest.
First, the two risk factors that include gender and age are highly significant (at the
1% level) in the first specification; however, by separated these out, it appears that age is
the driving factor. The coefficient on male is positive, however, it is not statistically
significant. In contrast, the age categories are positive and significant above 45 years of
age. In fact, the “55 to 64” and “65 and above” age groups are consistently significant (at
the 1% level and 5% level respectively) across all specifications (See Tables 7-7, 7-8, and
7-9). The second finding of interest results from separating out heart disease and heart
attack in the last risk factor (r11). Independently both variables are still significant; but in
111

Many respondents answered “I don’t know” for this risk factor. This is not unexpected since this is the
risk factor with which respondents would be the least familiar, therefore, making it the most difficult to
recall while taking the survey. “I don’t know” responses were coded as “no”; therefore, this is most likely
causing the negative sign on this variable.
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separating out these factors, the coefficient on heart attack is much larger than that of
heart disease (See Table 7-7, Column 3). This is not unexpected since those who have
experienced a heart attack are at higher risk of having another attack. Therefore, the
larger coefficient on heart attack provides validity to the model, indicating that those who
have experienced a heart attack in the past have a higher perceived risk compared to
those individuals who have simply been diagnosed with heart disease.
To explore whether those who have suffered an injury or illness in the past may
feel more at risk for a heart attack, general health was included as a possible explanatory
variable in the perceived risk model (See Table 7-7, Columns 2 and 4). The coefficient
on general health is negative and highly significant, indicating that those individuals with
lower self-reported general health status will tend to have higher levels of perceived risk.
As expected, including general health in the regression does affect the coefficients of
some of the covariates, such as diabetes; therefore, the two specifications discussed above
are presented both with and without general health included in the model.

7.5.2 Perceived Risk after New Information with Risk Factors from AHA Quiz
Table 7-8 includes the same regressions reported in Table 7-7, but uses Perceived
Risk after the New Information as the dependent variable (instead of Initial Perceived
Risk). As described in Chapter 5, the new information presented to the respondent
includes a description of vulnerable plaque and explains that individuals with no
symptoms of heart disease can still be at risk of a potentially fatal heart attack. Like the
previous specifications, age is positive and significant for higher age categories (See
Table 7-8, Column 3). As expected, having high cholesterol increases perceived risk and
is significant at the 5% level with a small decrease in the marginal effect from the Initial
Perceived Risk model. Smoking becomes significant at the 10% level and the coefficient
on r9 (20 pounds or more overweight) becomes considerably larger. Heart disease is no
longer significant, although having experienced a heart attack is still positive and
significant at the 5% level. When general health is added to the model, it is still negative
and highly significant across specifications (See Table 7-8, Columns 2 and 4). The
education variables are also still negative, although many lose some degree of
significance in the various specifications.
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In general, using the individual’s self-reported perceived risk obtained after the
new information was presented results in a lower R-squared with less explanatory power
compared to the same specifications using perceived risk prior to the new information.
Given that the new information essentially states that traditional risk factors for heart
attack are no longer thought to be good predictors of who is at risk for a heart attack, the
loss of explanatory power provides evidence to suggest that respondents understood the
new information and adjusted their perceived risk accordingly.

After the new

information, it appears that in stating their perceived risk, respondents tended to place
more emphasis on whether they live/worked in a smoking environment and on whether
they were overweight, two factors that are commonly known to be associated with heart
disease. In general, it appears that the new information was effective in dislodging (at
least to some extent) beliefs regarding the reliability of traditional risk factors in
predicting heart attack risk. This is evident by the lowered predictive ability of the
models presented in Table 7-8 (compared to Table 7-7) and the larger amount of “noise”
that entered respondent’s perceived risk assessment after the new information was
presented; whereas their initial perceived risk relied more heavily on the traditional risk
factors (r1 – r11) presented in the risk assessment quiz.

7.5.3 Perceived Risk – General Risk Factors – Survey 1: Screening Data
Substituting in for various factors in the risk assessment quiz was clearly useful in
identifying that age, rather than gender, was the driving force behind risk factors r1 (male
over 45) and r2 (female over 55) being significant. Therefore, other substitutions are
made and reported in Table 7-9. Risk factor r9 “are you 20 pounds or more overweight”
is fairly ambiguous, and as the general health model indicates, differences may exist
depending on the degree to which the individual is above their ideal BMI. Therefore, the
variables overweight, obese, and very obese (as defined earlier) are substituted for r9.
Risk factor r3 asks respondents whether their father or brother had a heart attack before
age 55 or their mother of sister had a heart attack before age 65. An additional survey
question asks if the respondent has a relative in their immediate family (regardless of age)
who has experienced a heart attack. Therefore, a more broadly defined dummy variable
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for Family History of a Heart Attack is included that is equal to 1 if the individual
responded “yes” to either of these questions.
The health panel data obtained from Knowledge Networks contains detailed
information on respondents’ health behavior and medical history.

Therefore, this

information was also incorporated into the model. Instead of using risk factor r8, which
asks the respondent if they typically get less than 30 minutes of physical activity per day,
a variable for exercise that captures the frequency with which the individual exercises on
a weekly basis was included.

In addition, medical information on diabetes and

hypertension were available, such that these two variables were broaden to include any
individuals who had a past medical history of these two conditions. Several individuals
were unsure of their HDL, and as a result this was coded as a “no” – and most likely
accounts for the negative sign for r6 in the regressions presented in Table 7-7. Since
those with High Cholesterol often have a low HDL, risk factors r5 and r6 were combined
into a single variable to indicate that the respondent has a medical problem related to
cholesterol – either their total cholesterol is too high or their good cholesterol (HDL) is
too low – both of which place the individual at higher risk for a heart attack. Finally, race
is added as a control variable.
Although race was not included in the AHA risk assessment quiz, the AHA
website includes race as a major risk factor for coronary heart disease (a contributing
factor for heart attack); therefore, it was added to the regression. Interestingly enough,
many people typically think of “white males” as being at high risk of a heart attack,
thereby suggesting that whites may be at higher risk. However, according to the AHA,
African Americans tend to have higher blood pressure than whites, and therefore, are at
higher risk of heart disease. In addition, Mexican Americans, American Indians, native
Hawaiians, and some Asian Americans are also at higher risk of heart disease, partly as a
result of higher rates of obesity and diabetes in these groups (American Heart Association
2006). Therefore, based on this information, whites would be expected to have a lower
risk of heart attack compared to non-whites, all else constant.
The model including the substitutions described above is presented in Table 7-9,
Columns 1 and 2. Initial Perceived Risk is used as the dependent variable in Column 1,
whereas the dependent variable in Column 2 is Perceived Risk after the New Information.
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A comparison of the Initial Perceived Risk model (See Table 7-9, Column 1) to the
regression presented in Column 3 of Table 7-7 reveals very similar results.

Age

categories 45 and above are still significant, with very little change in the marginal
effects. Being overweight is still negative and significant; however, as expected, the
coefficients in the new model increase with each higher overweight category. Heart
disease and heart attack are still significant and positive, with only a small decrease in the
coefficient on heart disease, which falls from 7.6 to 6.6. Since obesity is likely to
increase heart disease, this decrease is most likely due to the inclusion of the weight
dummies. In the new specification having a cholesterol problem is not significant;
however, it is significant at the 10% level in the Perceived Risk after the New Information
specification. The education control variables are also still negative and significant with
very little change in the marginal effects.
Although the overall R-squared does not really change between the two
specifications, it is thought that the models presented in Table 7-9 Columns 1 and 2
(Compared to Table 7-7, Columns 3 and 4) include variables comprising better
information, and therefore are likely to provide more precise estimates of the marginal
effects. In addition, this set of risk variables is included in the extended version of the
WTP equations discussed later in this chapter; therefore, it is helpful to see their effect on
perceived risk for comparison purposes.
Since the individual’s self-reported general health is highly significant in the
perceived risk equations (See Table 7-7 Columns 2 and 4); the two remaining factors112
that were significant in the general health model - having experienced a life threatening
condition and level of stress - are substituted in for general health (See Table 7-9,
Columns 3 and 4).

Neither variable is significant in the model explaining Initial

Perceived Risk; however, having experienced a life threatening condition or illness is
significant at the 10% level when explaining Perceived Risk after the New Information
(Table 7-9, Column 4) therefore, it is possible that this variable may play a role in
explaining the WTP for screening.

112

Age, Education, Exercise, and Amount Overweight were also significant, but are already included in the
model.
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7.5.4 Perceived Risk – General Risk Factors – Survey 2: Treatment Data
The Survey 2: Treatment data also includes two measures of perceived risk – one
before and one after receiving new information on who is at risk for a heart attack (See
Table 7-10). This model uses several of the same risk factors included in the perceived
risk equations for analyzing the Survey 1: Screening data. However, since respondents
completing Survey 2: Treatment were not asked to complete a risk assessment quiz (they
already know they are at high risk for a heart attack), there are a few variables, such as
information about living/working in a smoking environment, that were not available.
Health variables including high cholesterol, hypertension, exercise, BMI, and diabetes,
were obtained from the health data provided by Knowledge Networks as discussed in
Chapter 6. The remaining health variables – family history of heart attack, heart attack,
and expected/actual decrease in the quality of life following a heart attack – were
collected as part of the survey.
The regression results (See Table 7-10) indicate that perceived risk is higher (and
significant) for the 55 to 65 age group across all specifications. This is not surprising
given that physicians typically start treating heart disease more aggressively after age 55.
In addition, having high cholesterol or having experienced a heart attack results in a
statistically significant increase in an individual’s perceived risk.

Because the

consequences of a heart attack can vary from virtually no effect to a severe permanent
disability, a variable was included to capture the “severity” of the heart attack as
measured by the reduction in quality of life that resulted from (or is expected to result
from) a heart attack. This variable was highly significant (at the 1% level) and positive
across all specifications indicating that the more severe the heart attack was (or was
expected to be), the higher the perceived level of risk. Like the perceived risk equations
for the Survey 1: Screening data, general health is negative and significant at the 1%
level. The education variables are also negative and significant for individuals with a
Bachelor’s or graduate degree. This may be due, at least in part, to those with higher
levels of education having a better understanding of the visual analog scale; and
therefore, stating smaller and more “precise” measures of risk.

Finally, including

whether the individual has had a life threatening condition or illness in the past also
significantly increases perceived risk (See Table 7-10 Columns 3 and 4), as well as
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increases the explanatory power of the model. Overall, the models presented in Table 710 explain approximately 30% of the variation in perceived risk for the Survey 2:
Treatment data.
Interestingly, taking cholesterol lowering medication does not significantly reduce
perceived risk in any of the specifications, for either the Survey 1: Screening data or the
Survey 2: Treatment data. Currently, statin (cholesterol lowering) medications are only
about 30% effective and take a long time to work; therefore, the findings from the
perceived risk models suggest that individuals recognize the shortcoming of the drug
therapy treatment currently available, and lends support to the need for a new, more
effective treatment method.
7.6 Willingness to Pay
The goals of this study were to (1) determine the WTP for a screening method
that would better identify individuals in the general population who are at risk for heart
attack, and (2) determine the WTP for a new treatment method that is more effective than
the currently available standard of care. One of the distinct advantages of using a
multiple-bounded dichotomous choice question in comparison to a single-bounded
dichotomous choice question is that significantly more information is obtained from each
respondent. In fact, in this study, using an iterative bidding process with follow-up openended question elicited an exact WTP value from each respondent. Therefore, the mean
WTP obtained in this study did not rely on econometric techniques, but rather was simply
the mean of the reported WTP values from each respondent.

7.6.1 Mean WTP for Screening and Treatment
The distribution of the maximum WTP amounts for screening is illustrated in
Figure 7-1. The mean WTP for screening is $94 with a median of $50, and standard
deviation of $143. This distribution includes 16 individuals who chose not to have the
screening and were assigned a WTP=0. In addition, some individuals indicated during
the bidding process that they would have the test, but only if it were offered for free, and
therefore also had a WTP=0. However, most of the respondents indicated that the test is
valuable to them and provided a positive WTP for the screening that ranged from $1 up
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to $1,000. These WTP values include positive amounts for some individuals who were
told that no treatment existed, which provides evidence that individuals place a value on
the information provided by the screening even when no treatment is available; thereby
suggesting that having this information increases the individual’s utility because it allows
for better planning and allocation of the individual’s time.
The distribution of the maximum WTP amounts for treatment is illustrated in
Figure 7-2. The mean WTP for treatment is $7,821 with a median of $2,500 and standard
deviation of $21,084. This distribution includes 43 individuals who chose not to have the
procedure. Of those, 36 individuals chose medication as their treatment option, while 7
individuals did not select either treatment. Since none of these respondents were willing
to have the procedure, they were all assigned a WTP=0.113 In addition, there were others
who chose the procedure, but during the bidding process indicated that they would only
be willing to pay $0 for it. Therefore, these respondents also have a WTP=0. However,
many of the respondents reported positive values of WTP, ranging from $1 up to
$300,000114, indicating that a new, more effective treatment would be of value to them.

7.6.2 General Models for Analyzing Health Data
In addition to the mean WTP, it is also of interest to determine which factors
influence WTP. Understanding the factors that affect WTP can provide insight into
which individuals have the highest demand (and benefit) for the screening/ treatment.
Since the medical expenditures of many of these individuals are covered by Medicare,
understanding the specific factors that drive demand could potentially assist policy
makers in making determinations as to who should receive the treatment and who should
not. Typically this could be accomplished by simply regressing a set of explanatory
variables on WTP.

However, health data often present difficulties in econometric

analysis because the data is often characterized by (1) an outcome variable (in this case
WTP) which is non-negative, (2) a substantial number of zeros, and (3) a positively
skewed distribution for the non-zero observations (Manning et al. 2001). Therefore,
analyzing the data creates challenges in order to obtain estimates of the marginal effects
113

Before exiting the survey, all of the respondents who did not select the procedure were asked an openended question asking them to explain why they did not want the procedure even if it were offered for free.
114
The potential for outliers is addressed later in this chapter in the WTP models.
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for the covariates that are both unbiased and precise, which is warranted for policy
decisions.
For the Survey 1: Screening sample, a total of 31 (12%) of the 268 observations
indicated a WTP=0. Fifteen of these individuals indicated they would have the screening
if it were offered at no out-of-pocket cost to them, however, the remaining 16 indicated
that they would not have the screening even if it were offered for free. These individuals
were identified by their response to a zero bid. Those that answered “yes” to a zero bid
continued with the survey, while those who answered “no” to a zero bid were directed to
an open-ended question asking why the respondent chose not to have the screening even
when it was offered for $0 (free). Almost half of the respondents who said they would
not have the screening had received a version of the survey in which “no treatment” was
available. In fact, almost all of the respondents who chose not to have the screening and
had a “no treatment” version of the survey, indicated in their response that having no
treatment available was their reason for choosing to forego the screening.

Other

respondents whose surveys included a treatment option indicated that they would prefer
not to know so they did not worry. Some indicated a distrust of doctors and/or medicine
that would prevent them from having the treatment if the test came back positive, and one
indicated that he/she had had two heart attacks already, implying that the screening would
have little additional benefit (See Table 7-11 for all open-ended responses to Survey 1:
Screening).
For the Survey 2: Treatment sample, a total of 62 (21%) of the 295 observations
indicated a WTP=0.

Nineteen of these individuals indicated they would have the

screening if it were offered at no out-of-pocket cost to them, however, the remaining 43
indicated that they would not have the screening even if it were offered for free. Thirtysix of those individuals chose drug therapy as their treatment and 7 individuals “refused”
treatment (by not selecting either treatment option). During the survey, respondents were
presented with the possible treatment options and then asked to select the treatment they
would prefer.115 Respondents who chose the procedure continued with the iterative
115

This was prior to the iterative bidding, therefore, it is assumed that respondents were selecting their
preferred treatment option based solely on the treatment without regard to the potential cost. Comments
from focus group participants indicate that at this point in the survey, respondents assumed that the cost of
the treatment selected would be covered by insurance.
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bidding portion of the survey; however, as mentioned above, 19 of those respondents
indicated a WTP=0. Those respondents who selected drug therapy or refused treatment
were directed to an open-ended question asking them why they chose not to have the
procedure.

Several of the respondents indicated that they were already taking a

cholesterol medication or that they had other medical conditions that made the procedure
unsuitable for them. Some respondents stated that they were concerned about the risk
associated with the procedure, had a fear of surgery, felt they were too old, or would
simply like more time to consult with their own doctor (who they trusted) or other outside
resources (Internet) before making a decision. (See Table 7-12 for all open-ended
responses to Survey 2: Treatment).
One approach for handling the relatively large number of zeros observed in these
data sets is to model WTP using a tobit116 equation. The tobit model is also referred to as
the censored regression model because it is based on the premise that some of the
observations are censored, or unobserved. When the dependent variable is censored,
values in a certain range are all transformed or reported as a single value. A classic
example of this from labor economics is the number of hours worked by women. A large
percentage of married women choose not to work, therefore, their hours are simply
recorded as a zero. Another example discussed by Greene (1993) is the demand for
tickets to an event held at an arena. The capacity of the arena is limited, therefore, when
a sellout occurs, demand for tickets above the seating capacity is unobserved, which
results in a truncated distribution.
A similar argument could be made for the data in these samples. It is possible
that some people would experience disutility from having the screening/treatment. As
the open-ended responses suggest, this may stem from any number of reasons, including
the risk associated with the procedure, a distrust of physicians/medicine, or the anxiety
caused by the knowledge that you are at risk for a potentially fatal condition for which
treatment does not exist. In cases such as these, it is not unreasonable to assume that
some individuals may require payment in order to compensate them for their loss of
utility in order to induce them to accept the screening/treatment. However, since the
potentially negative WTP for these individuals is unknown, their actual WTP is censored
116

Named in reference to Tobin (1958) who first proposed the model (Greene 1993).
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and simply recorded as a zero. Interestingly, those who choose to have the test/procedure
when it is offered for free actually have a WTP=0, so these observations are not truly
censored. Therefore, these observations are distinguished from each other such that only
those not having the test are treated as censored data in much of the econometric
analysis.117
Another method for handling the large number of zeros is to treat WTP for the
screening/treatment as a two part decision using a hurdle model. In this two-part model,
the individual’s decision to participate is modeled using a probit or logit specification;
then, the outcome variable is modeled using a separate regression but only includes those
observations for which participation is observed. The use of a two-part model has
become a common practice in analyzing health data, in particular health expenditures. In
a study by Deb et al. (2006), which uses a two-part model to investigate the effect of
health insurance on medical expenditures, they state “individuals…are more likely to
choose [health] insurance based on personal characteristics such as overall health status,
the existence and severity of chronic health conditions and physical limitations,
preferences for risk, preferences over intensity of treatment, and so on” (Deb et al. 2006
p. 1082). Therefore, it could similarly be argued that an individual’s choice of treatment
(in the absence of insurance) would also be based on similar factors. Deb et al. (2006)
further state that if all of these factors can be included as explanatory variables in the
expenditure equation, then this “will adequately control for the influence of these factors”
(Deb et al. 2006 p. 1082); however, since many of these factors are unobservable,
inclusion of some factors will only control for a portion of this effect; and, as a result,
lead to biased coefficients in the expenditure equation.

Thus, Deb et al. (2006)

recommend modeling the selection of treatment separately from that of expenditures.
7.7 Modeling WTP for Screening
The two approaches discussed above are used to model the WTP for screening.
First, a censored regression model is used and then a two-part model (comprised of a
probit which models the decision to have the screening test, followed by an OLS
117

The cnreg function in STATA is a generalization of tobit that allows the user to designate the censored
group. Therefore, instead of all WTP=0 being censored (which occurs when the “tobit, ll” function is
used), only those who chose not to have the test will be treated as censored data (TEST=0).
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regression on WTP, which only includes those individuals who chose the screening test).
For these models, two general specifications are reported - a basic model that includes
control variables for income, risk aversion, level of education, treatment effectiveness,
and measures of perceived risk as the explanatory variables; and a more detailed model
that includes specific risk factors substituted in for perceived risk.

7.7.1 Basic Model: WTP for Screening
The censored regression on WTP presented in Table 7-13 utilizes the STATA
command cnreg, which is a generalized tobit function. Using the tobit command would
assume that all WTP=0 observations are censored, and would not distinguish between
those who chose to have the test when it was offered for free, versus those individuals
who chose not to have the screening at any price (those observations that are truly
censored). Therefore, using the cnreg function allows only those who chose not to have
the screening to be treated as censored observations.

Explanatory variables in the

censored regression on WTP include household income, whether the respondent lives in a
MSA (to account for nominal differences in income), life insurance118 (as a measure of
the individual’s degree of risk aversion), the amount of the individual’s average monthly
spending on medical care (excluding insurance premiums), level of education, treatment
effectiveness (30% or 85%)119 as indicated on the respondent’s survey, a measure of the
individual’s perceived risk, and controls for the starting bid and the respondent’s level of
certainty regarding their initially stated WTP.

Perceived risk can be measured by the

respondent’s Perceived Risk (after the new information was presented to them), or as a
combination of their Initial Perceived Risk and Change in Perceived Risk120 that resulted
from the new information.
In the first specification (See Table 7-13, Column 1), household income is
positive and significant at the 1% level. The coefficients on MSA, life insurance, and
118

The life insurance variable was also included to capture the individual’s willingness to spend financial
resources to ensure the wellbeing of their family (spouse and children). During the focus groups, several
individuals indicated that they would expend financial resources on the screening for heart attacks to help
ensure that they would be around for their spouse or to care for their children. Because not all individuals
share this trait, it was felt that whether or not the individual had life insurance would be a better proxy for
this unobservable benevolence, as opposed to simply including children and/or married in the regression.
119
“No Treatment” is the omitted category.
120
Change in Perceived Risk = Perceived Risk (after new information) minus Initial Perceived Risk
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medical spending are all positive, as expected, although not significant. The marginal
effect of education on WTP is negative, with significance at the 1% level for those with a
graduate degree. The negative coefficients on education were not the expected result;121
however, this is a consistent finding across all specifications for the entire study, and
appears reflective of a change in how consumers gather information before making
decisions regarding their health care.
In the past, patients would rely almost solely upon their physician as a source of
information related to available treatment options, and when faced with medical decisions
would often defer to the physician’s recommendation. However, focus group comments,
the open-ended responses to these surveys, and conversations with practicing MD’s
indicate that with the emergence of the Internet, individuals now have another reliable
source of information on potential medical care, and this has changed the role of the
physician in consumer medical decision making.

A growing number of patients,

particularly those who are more educated, now view their physician as one source of
information, and are more likely to research information on their own using the Internet.
The opening question for both surveys asked respondents how important it is for their
physician to include them in medical decisions regarding their health.

Ninety-one

percent of those completing Survey 1: Screening and 99% of those completing Survey 2:
Treatment indicated that it was very important that they be included in decisions
regarding their health. Clearly, this indicates that individuals want to understand their
health and be included in making decisions affecting their health.
Although a physician may still have some patients who say “Whatever you think
is best, Doc” and defer to their physicians opinion, there is evidence to suggest that this is
becoming much less common.

Benbasset et al. (1998) discuss how updates in the

medical code of ethics regarding the rights of patients to be informed about their medical
care has changed the doctor-patient relationship over the last few decades. They explain
that the doctor-patient relationship can be viewed as a continuum. At one extreme is the
paternalistic model in which the physician is assumed to have the best interest of the
patient in mind and therefore acts with authority and autonomy in making treatment
121

Grossman’s (1972) theory suggests that those with higher education would be more likely to make
investments in health; therefore, a positive relationship between higher levels of education and WTP would
be expected
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decisions for the patient. Benbasset et al. state that this type of doctor-patient relationship
was not uncommon in the 1950’s. At the other extreme is the informative model in
which the doctor simply provides information, and the patient is primarily responsible for
decisions regarding his/her care. Along this continuum lie varying degrees of shared
decision-making in which the doctor provides advice and the patient participates by
asking questions and expressing preferences regarding treatment options. From a review
of the literature, Benbasset et al. found that individuals who have more severe illnesses,
have lower levels of education, are of a minority ethnic group, are male, and/or are
elderly have a tendency to prefer a passive role in clinical decision-making (Benbasset et
al. 1998). Therefore, it follows that these individuals would be more likely to rely on
their physician in making decisions regarding their medical care.
Based on these findings, it is not surprising that patients with higher levels of
education may now view their physician’s recommendation as simply that “a
recommendation.” Therefore, the negative coefficient on education may suggest that
individuals with higher levels of education are more familiar researching information on
their own, and are therefore less likely to select a medical test on the spot simply because
their physician recommends it. Instead, it appears that highly educated individuals are
more likely to conduct their own research and consider that information in conjunction
with their physician’s recommendation122 prior to making a medical decision.
In the WTP model, the coefficient on the individual’s level of perceived risk (after
the new information) is positive and significant at the 10% level. To test whether the
individual’s WTP is dependent more on their prior perceived risk or perceived risk
stemming from the new information, Initial Perceived Risk and Change in Perceived Risk
are included in the model (See Table 7-13, Column 2). The coefficients on the other
covariates remain essentially unchanged; however, Initial Perceived Risk becomes
significant at the 5% level and Change in Perceived Risk is not statistically different from
zero. This implies that the WTP for screening is not influenced by the new information,
but rather by the individual’s prior (established) perception of risk.
122

Comments from the focus groups and the open-ended responses indicate that the level of trust the
individual has with their doctor will affect how much weight is place on his/her recommendation.
Although the survey indicated that the information presented was from their regular physician, some of
those individuals who refused treatment clearly did not accept this statement.
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To further test whether there is a difference between those who have strong priors
on their Initial Perceived Risk compared to those with weak priors, dummy variables
were created using the respondent’s Initial Perceived Risk and the strength of this prior.
During the survey (immediately following the new information), respondents were asked
the following question: “After reading this new information, I feel my risk of having a
heart attack within the next year is now…” Possible responses included: much higher,
somewhat higher, the same, somewhat lower, or much lower. For those who indicated
that their risk remained “the same” after reading the new information, it is presumed that
these individuals have strong priors regarding their risk of heart attack. For those who
indicated that their risk was either much higher/lower, the new information greatly
affected their perception of risk, suggesting weak priors regarding their risk of heart
attack. When these variables are included in the regression (See Table 7-13, Column 3),
there is a positive and significant (at the 5% level) effect on WTP for Initial Perceived
Risk, but only for those with strong priors regarding their risk of heart attack. This
suggests that those who have a higher perceived risk and have more prior knowledge
about their risk (or at least believe they do) will have a higher WTP for the screening,
compared to those with a higher perceived risk who do not feel as confident about the
accuracy of their prior knowledge,
The starting bid was included as a control variable in all the WTP specifications.
The coefficient on Starting Bid is positive and significant at the 5% level, indicating
some degree of starting bias in the data. As discussed in Chapter 2, the contingent
valuation literature has shown that bidding games are often prone to starting point bias.
Unfortunately, as the empirical results will continue to indicate, the iterative bidding
process used for Survey 1: Screening and Survey 2: Treatment is also subject to some
degree of starting point bias. However, as will be shown later in this chapter (See Section
7.9: Correcting for Starting Point Bias) the correction procedure suggested by Whitehead
et al. (1995) is used to correct for the marginal effect of starting point bias such that
unbiased estimates of WTP are obtained.
The final specification (See Table 7-13, Column 4) includes dummy variables for
treatment effectiveness (30% and 85%)123 as presented on the respondent’s survey. In the
123

“No Treatment” was the omitted category.
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censored regression on WTP, treatment effectiveness is not significantly different from
zero. This finding contradicts the expectation from the theoretical model developed in
Chapter 4, and suggests that a two part model or Heckman model may be a more
appropriate method of analyzing the decision to select and pay for screening.
The basic two-part model includes a probit on whether the individual chooses to
receive the screening test (TEST=1), and an OLS regression on WTP for those
individuals who chose to have the screening. Explanatory variables for the probit model
are essentially the same as the censored model, with the exception of medical
spending.124 In addition, the starting bid and certainty of the respondent’s WTP are not
included as those are not relevant to the decision to have the screening.
Table 7-14 includes a specification similar to the censored model, using various
measures of perceived risk. As before, using Change in Perceived Risk with dummies for
strong and weak priors on perceived risk offers the best fit (See Table 7-14, Column 3).
Household income and MSA are positive as expected, although neither is significant.
Life insurance is positive and significant at the 5% level implying that those who are
more risk averse are more likely to get the screening. Education is positive for those with
a high school education or less, but becomes negative for individuals who have attended
at least some college. Although none of the coefficients on education are significant, the
signs are consistent with the earlier discussion that those with more education are more
likely to conduct their own research when presented with new information before making
a health-related consumer decision.
In terms of perceived risk, Change in Perceived Risk is positive and significant at
the 10% level. This indicates that the new information increases the probability that the
respondent will choose to have the screening test. In particular, the coefficient on this
variable indicates that the brief information presented in the survey increased the base
likelihood of the respondent getting the screening by 3%, ceteris paribus. The negative
coefficient (significant at the 10% level) on perceived risk for those with weak priors
suggests that those individuals with higher levels of perceived risk, who are less certain
124

Medical spending was asked immediately prior to respondents entering their final WTP as a means of
reminding respondents of their budget constraint; therefore those who answered “no” to a zero bid
(indicating that they did not want the screening at any price) did not complete the medical spending
question. See Table 7-15 for a comparison of the probits in Table 7-14 when the mean value of medical
spending is assigned to the individuals who chose not to have the test.
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of those risk assessments, are less likely to get the screening (at least when it is initially
presented to them).125
So far, the results of the probit model have been largely consistent with those of
the censored regression.

However, in terms of treatment effectiveness, there is a

noticeable difference between the two models. The censored regression indicates the
effectiveness of the treatment (for those whose screening indicates they are at high risk)
has no statistical effect on WTP. However, the probit model indicates that treatment
effectiveness is positive and highly significant (at the 1% level) in the respondent’s
decision to have the screening. These inconsistent findings bring up an important point
regarding the potential validity of using a censored regression in analyzing health data.
As discussed earlier in section 7.6.2: General Models for Analyzing Health Data,
different factors may be responsible for the decision to have treatment and other variables
responsible for determining the WTP. If all of these variables only affect one of these
outcomes and all relevant factors are included in the model, then the tobit can produce
reliable results. However, if individual factors influence both the decision to get the
screening and the WTP, or if unobservables driving each of these outcomes is omitted
from the regression, the marginal effects may not be accurate.

The probit clearly

indicates that the effectiveness of available treatment influences the decision to have the
screening. This is further supported by the open-ended responses of those who chose not
to have the screening, many of whom indicated they did not want the screening if
treatment was not available. Therefore, it appears that the two-part model may offer
more accurate results compared to the censored model.
The second part of the model includes an OLS regression on WTP for those
respondents who chose the screening.126 If the tobit is in fact, capturing the combined
effects of the two-part decision, then we would expect household income to be positive
and significant, a graduate level education to be negative and significant, and strong
priors on Initial Perceived Risk to be positive and significant. A comparison of the OLS
regression in Table 7-16, Column 3 to the censored regression in Table 7-13, Column 3
125

It is possible that those individuals would choose to have the screening once they had an opportunity to
research more about it on their own.
126
This includes some respondents for which their WTP=0 (those who would have the screening, but only
if it were offered at no out-of-pocket cost to them).
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suggests that the tobit model is in fact picking up the effects of the OLS regression;
however, the tobit model fails to indicate the significance of treatment effectiveness in
the decision to have the screening. Therefore, based on the basic models that include
general measures of perceived risk, it appears that the two-part model is more appropriate
than the censored regression; and as such, the two-part model is likely to provide more
accurate estimates on marginal effects compared to the censored regression.
Another possible way to analyze the data is using a Heckman selection model.
The Heckman selection model is an appropriate choice if the correlation between the
error terms of the selection equation and regression equation is not equal to zero (ρ ≠ 0);
that is, if there is a relationship between the two equations. A classic application of the
Heckman selection model from labor economics is the estimation of a wage equation for
women. Applying the Heckman model to this example includes specifying a wage
equation that follows the standard model in which the wage is determined by education,
experience, and other relevant factors. In addition, a separate selection equation is also
defined which models the woman’s decision to participate in the labor force. If the
choice to participate in the labor force is made randomly, then the error terms between
these two equations will not be correlated (ρ = 0), making it appropriate to analyze each
decision (and treat the equations) separately. However, if the error terms are correlated
(ρ ≠ 0), then analyzing the equations separately (without taken the selection bias into
account) could result in biased coefficients. This is likely to occur if women who only
have the ability to earn lower wages in the labor market tend to find a higher value for
their productivity elsewhere (i.e. the home); thereby making these women less likely to
participate in the labor force. If this is indeed the case, then it follows that observed
wages will be biased upward as observed wages will tend to be limited to those women
who can earn higher wages. However, using a Heckman selection model will adjust for
the selection bias; thereby providing unbiased coefficients on the covariates for the wage
equation (Maddala 1983) .
To test whether the Heckman selection model is appropriate for this study, two
specifications of a Heckman selection model are applied to the Survey 1: Screening data
and reported in Table 7-17. Model 1 (Table 7-17, Columns 1 and 2) includes Initial
Perceived Risk and Change in Perceived Risk as dependent variables; while Model 2
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(Table 7-17, Columns 3 and 4) includes the strength of the individual’s priors on
perceived risk. Model 1 includes the basic probit equation from Table 7-14, Column 2
as the selection equation, and the basic OLS on WTP from Table 7-16, Column 2 as the
regression equation.

Model 2 includes the basic probit equation from Table 7-14,

Column 3 as the selection equation, and the basic OLS for WTP from Table 7-16,
Column 3. Results of the Heckman models (See Table 7-17) are highly consistent with
those from the two-part models. In terms of the WTP for screening, the marginal effect
of household income is positive and highly significant, as is the individual’s self-reported
level of initial perceived risk.

Including the strength of the individual’s prior on

perceived risk indicates that those who have strong priors have a statistically significant
higher WTP, ceteris paribus. Like the two-part model, education in the Heckman model
has a negative effect on WTP and is statistically significant for those individuals with a
graduate education. In terms of the decision to have the screening test, the selection
equation results indicate that higher levels of education decreases the probability of
having the screening, and like the probit equation, this result is significant for those
individuals with an associates or graduate degree. The Heckman selection equation also
indicates that treatment effectiveness is an important factor in the decision to have the
screening; In fact, the second Heckman model (Table 7-17, Column 4) indicates that
having a treatment available that is 85% effective increases the base probability of having
the screening by 34%.
Overall, the results of the Heckman selection model and two-part model are very
similar, although the marginal effects differ to some degree. Therefore, which is the best
choice? The Heckman selection model provides an estimate of λ = 139.11 and the results
of the likelihood ratio test (χ2 =54.33 and p=0.000) which, according to the Stata
reference manual, is equivalent to testing the null hypothesis that ρ = 0, indicate that the
null hypothesis can be rejected in favor of the alternative hypothesis ρ ≠ 0. Therefore,
these results clearly support (econometrically) the use of the Heckman model in
analyzing the data for Survey 1: Screening. However, in choosing the most appropriate
model, it is also important to understand what the coefficient results imply about WTP.
The Heckman selection model reports coefficients that represent the marginal effects of
the covariates on WTP assuming that all individuals will have the screening. Following
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the example used earlier for women’s wages, it is clear to see why it is important to take
into account the wages that could be earned by women, including those who choose not
to participate in the labor force. However, in estimating the demand for screening, it is
not clear that this is the information that is most relevant to the questions being addressed
by this study.
Clearly, the responses to the open-ended questions for both Survey 1: Screening
and Survey 2: Treatment indicate that some individuals would rationally choose not to
have the screening/treatment. Therefore, if the goal of this study is to better understand
the actual anticipated demand for screening/treatment and its associated marginal effects,
then the Heckman model (although mathematically appropriate) may not provide the
most useful information. In fact, according to the Stata reference manual, the Heckman
model is most appropriate “when the goal is to analyze an underlying regression model or
to predict the value of the dependent variable that would be observed in the absence of
selection” However, “when the goal is to predict an actual response, the two-part model
is usually the better choice” (p. 70). In addition, Manning, Duan, and Rogers (1987) find
that for data sets with a non-significant number of zeros, in which these zeros represent
actual observations (rather than censored data), the two-part model can perform better
than a selection model. It is important to note that for this study the general results of the
Heckman model are consistent with the basic findings of the two-part model. However,
because the goal of this project is to better understand actual anticipated demand for
screening/treatment, the focus will be on the two-part model, and as such, will utilize
those measures of marginal effects in analyzing the influence of various factors on WTP.

7.7.2 Detailed Model: WTP for Screening
To further explore which specific risk factors may be influencing the decision to
have screening and also the determination of WTP for that screening, more detailed
models are reported that include specific risk variables in place of a general measure of
the respondent’s perceived risk. The risk variables include the set of risk factors used
earlier in the perceived risk equations (age, gender, race, family history, cholesterol
problems, diabetes, hypertension, amount of exercise, amount overweight, smoking or
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being exposed to second-hand smoke on a daily basis, and taking cholesterol lowering
medication).
Table 7-18 presents the results of the probit model including the individual risk
factors. In comparing the basic probit model (Table 7-14, Column 3) to the associated
detailed probit model (7-18, Column 3), the pseudo R-squared increases from 0.2205 to
0.3929, indicating that the detailed model containing individual risk factors provides a
better fit for the data, and explains approximately 39% of the variation in the decision to
have the screening. In the detailed model (Table 7-18, Column 3), household income
becomes significant at the 5% level. The coefficient does increase quite a bit from the
basic model; however, the significance of the income variable in the detailed model
(along with the higher R-squared) suggests that the marginal effect of income in Table 718, Column 3 is the more precise estimate. MSA remains positive and insignificant,
although the coefficient increases in the detailed model. Life insurance is positive and
significant at the 1% level. Like income, the coefficient for life insurance increases and
becomes more significant in the detailed model. The signs on the education variables
remain the same as the basic model, with some relative changes in the coefficients. In
addition, the coefficients are significant for those individuals who have attended some
college or received an associate’s degree. The coefficients on the treatment effectiveness
dummies are still positive and highly significant at the 1% level, although the marginal
effects do increase to some extent in the more detailed model. In terms of risk factors,
those that are significant include: male, hypertension, exercise, and heart attack. The
coefficient on male is negative and significant at the 5% level, indicating that men are
less likely to get the screening compared to women. Those individuals who have (or who
have had) high blood pressure are more likely to get the screening and those who exercise
more frequently are less likely to get the screening. Perhaps the most interesting finding
is that those who have had a heart attack are far less likely to get screening. However,
this is consistent with the theory developed in Chapter 4 because these individuals know
they are at high risk of having a heart attack; and therefore, would receive little benefit
from the information provided by the screening.
Table 7-19 presents the results of the OLS regression on WTP for those who
chose the screening. In the detailed model including the risk factors, household income is
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positive and significant at the 1% level. The marginal effect is .000933, resulting in an
income elasticity of willingness to pay for screening equal to 0.48.127 This value should
not be confused with the income elasticity of demand which, as Flores and Carson (1997)
demonstrate, can vary substantially from this value and may even have a different sign.
Therefore, the income elasticity of willingness to pay of 0.48, which is positive and less
than one, does not indicate that screening is a necessity, nor does it provide evidence that
screening is a normal good. In fact, the income elasticity of demand can only be found
using the income elasticity of willingness to pay if additional information on cross-price
elasticities and the budget shares of other available goods is known, such that it can be
included in the calculation (Flores and Carson 1997).
The coefficient on life insurance is positive and significant at the 10% level.
MSA and medical spending also indicate a positive effect on WTP, but it is not
significant.

The coefficients on education are negative with Some College and

Bachelor’s Degree significant at the 10% level and Graduate Degree significant at the
1% level. Having high cholesterol (or low HDL) is positive and significant at the 5%
level and increases WTP for screening by approximately $46. In addition, the negative
and significant coefficient on race, indicates that whites are willing to pay approximately
$43 less for the screening compared to non-whites. To see if the new information has an
effect on WTP in the detailed model, Change in Perceived Risk was added to the model,
however, it was not significantly different from zero.
A comment made by a discussant, when research from this paper was presented at
the ASHE (American Society for Health Economists) conference, suggested that it may
be valuable to estimate WTP for men and women separately, as factors that influence
WTP may vary across gender.

Therefore, to test whether there is a statistically

significant difference between the coefficients of the pooled model versus when the
gender subgroups are treated separately, a likelihood ratio test was conducted comparing
the restricted (pooled) model, to the unrestricted (coefficients are allowed to vary across
gender) models. The null hypothesis for the likelihood ratio test is that the coefficients
are equal (indicating that the data can be pooled); therefore the resulting χ2 = 45.6 and p-

127

(.000933 * 48,223 )/94 = 0.48, where 48,223 is mean household income and 94 is the mean WTP for
screening.
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value of 0.04 indicate that there is a statistically significant difference between the
coefficients and that the subgroups should be treated separately. Columns 3 and 4 of
Table 7-19 include the detailed regression on WTP for the female sub-sample (Table 719, Column 3) and male sub-sample (Table 7-19, Column 4). Although the samples are
significantly smaller, n=119 for females and n=133 for males, the results of the likelihood
ratio test suggest that gender differences exist in regards to factors that influence WTP.
For women, household income, education, frequency of exercise, weight, and diabetes
are significant; whereas for men, the significant factors include the effectiveness of
treatment, high cholesterol, and obesity.
Since one of the issues regarding the analysis of health data is the accuracy of
different models in estimating the marginal effects of the independent variables, Table 720 provides a comparison of WTP models for OLS (for TEST=1), the censored
regression (cens: TEST=1), the standard tobit (with all WTP=0 observations treated as
censored data), and the associated OLS regression (for WTP>0). Based on the above
analysis, it appears that the two-part model is the most appropriate in explaining the
decision to get screening and estimate the individual’s subsequent WTP for screening. In
addition, the detailed models for each of these provide information on specific risk
factors that are likely to affect the individual’s decision to get screening as well as
determine their WTP for the test.
7.8 Modeling WTP for Treatment
As mentioned earlier the mean WTP for a new, more effective treatment
procedure is $7,821.

To better understand the factors influencing the demand for

treatment, a two-part model was used, which includes a probit to model the decision to
have the procedure, and an OLS regression on WTP for those who chose the procedure as
their preferred treatment option.
Tables 7-21 and 7-22 present various specifications for the probit model on the
decision to have the treatment procedure, and Table 7-23 reports the results of the OLS
regression for WTP for those individuals who chose the procedure. Table 7-21 includes
two basic probit models.

The first (Table 7-21, Column 1) closely mirrors the

specification used for the Survey 1: Screening data.
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Explanatory variables include

household income, MSA, life insurance, education, and measures of perceived risk. In
addition, the decision to have the procedure may be influenced by the existence of an
alternative treatment, drug therapy. Those individuals who are already taking cholesterol
lowering medication may feel that the expected benefit from the procedure is not as great
because they are already receiving some form of treatment. Therefore, a dummy variable
is included to control for the possibility that the individual is already receiving treatment
by taking a cholesterol lowering medication.
In the first basic probit model (Table 7-21, Column 1) household income is
positive and significant at the 1% level, indicating that individuals with higher levels of
income are more likely to get the procedure. The sign on MSA is negative; however, it is
not statistically different from zero. Life insurance has a positive coefficient, although it
is also not significant. As before, the education variables are all negative, with those
individuals who have earned a graduate degree having a significantly lower likelihood of
having the procedure. The Change in Perceived Risk variable is positive and significant
at the 5% level. It is interesting to note that in this specification, Change in Perceived
Risk is significant, while Initial Perceived Risk is not statistically significant at all.
Therefore, it appears that the decision to have the procedure is influenced far more by the
change in risk resulting from receiving the new information than on past priors
concerning the risk of heart attack. As expected, the sign on cholesterol medication is
negative, but it is not significant at the 10% level.
As part of Survey 2: Treatment, the new treatment procedure was described to
respondents before they were asked to select a treatment. Those familiar with a heart
catheterization procedure, which involves inserting a small tube into the upper thigh and
“threading” it through the blood vessels up into the coronary arteries of the heart, would
quickly recognize that the new procedure described in the survey is very similar in nature
to a heart catheterization procedure they may have had performed in the past. After the
procedure was recommended by the physician, the respondent was asked to select their
treatment option – the new procedure or drug therapy. The respondent was also given the
option of requesting additional information. Those that requested additional information
were provided with more detailed information provided by the specialist who would be
performing the procedure. The specialist explained the use of a sedative, the expected
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length of time needed for recovery (and away from work), as well as provided a general
description of what the procedure entailed.
During the survey, it was expected that those individuals who have had a heart
catheterization procedure in the past would recognize that they were already somewhat
familiar with the new procedure being presented to them; and as a result, would be more
willing to choose the new treatment.

Likewise, those who requested additional

information may feel less comfortable with the procedure and wish to research it in more
detail on their own prior to making a decision to have the new treatment. Therefore, it is
likely that those who requested additional information would be less likely to choose the
procedure.
The second basic specification of the probit model (See Table 7-21, Column 2)
tests these assumptions by including the dummy variables Heart Catheterization (=1 if
the respondent has had a heart catheterization procedure in the past) and Special
Information (=1 if the respondent requested additional information before selecting a
treatment option). As expected, the marginal effect on Heart Catheterization is positive
and significant at the 5% level, and remains significant across specifications.

The

coefficient on Special Information has a negative sign and is significant at the 10% level;
however, this result is not robust when additional explanatory variables are added to the
model.
In specifying the remainder of the factors that would influence the decision to
have the procedure, comments from focus group participants, as well as the open-ended
responses were incredibly useful. Focus group participants for Survey 2: Treatment
indicated that if they felt the new treatment procedure was valuable enough, they would
utilize many different financial resources available to them in order to pay for it. Some
focus group participants indicated that they would be willing to take out a second
mortgage to access equity in their homes or sell an asset, such as a car or boat.
Therefore, in addition to household income, other measures of wealth are included as
explanatory variables in the probit equation for who chose to have the procedure. These
additional wealth variables include a dummy variable for whether or not the individual
owns their home, as well as a measure of how secure the respondent feels their family
would be in the event that the respondent were to die suddenly. Respondents had the
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option of indicating that their families would be very secure, fairly secure, or not very
secure, which were coded as a 3, 2, and 1 respectively. Therefore a higher value for
Secure indicates a higher level security (presumably wealth) that would be available to
the respondent’s heirs. Although some of this financial security may be the death benefit
from a life insurance policy, the model controls for life insurance, such that the variable
Secure should provide a fairly good proxy for the individual’s current level of wealth.
In choosing to have the procedure, focus group participants indicated that time
away from work and family obligations were important considerations. The procedure
described in Survey 2: Treatment is a surgical procedure. Although the procedure is
considered minimally invasive, it could require a short stay in the hospital if
complications arise.

Therefore, individuals who work would need to plan for the

possibility that he/she could miss several days of work in order to have the procedure. To
account for the fact that some individuals may have more difficulty requesting time off
due to the demands of their job, the variable Stress was included. In addition, individuals
who do not work, but have dependent children to care for may be less likely to choose the
procedure, unless a spouse is available. Therefore, dummy variables for married and
having a dependent child (Child under 18) were also included in the model. In addition,
the variable male was included to account for possible gender differences.
Finally, the open-ended responses indicated that physical limitations may prevent
some individuals from choosing the procedure as their treatment option. Individuals who
are disabled may have difficulty getting to the hospital; or as the open-ended responses
suggest, other medical conditions may increase the risks associated with the procedure.
Individuals who have a very high BMI may feel that the resulting benefit of the
procedure will be less for them due to their weight, or they may be less likely to have the
procedure because they may feel the risk to them of the procedure is actually higher than
the stated risk for the average person. Likewise, individuals who have other chronic
health conditions (as measured by the frequency of MD visits) may feel they will obtain a
lower overall benefit from the procedure. Finally, those who are very old may feel that
the benefit from the procedure is not worth the emotional, physical, and time cost
involved for having the procedure and the associated recovery. To account for these
potential physical limitations, dummy variables for overweight, obese, and very obese is

195

included as well as a dummy variable to account for the possibility that the individual is
disabled.

In addition, frequency of MD visits is included as a proxy for chronic

conditions and a continuous variable for age is included128 to account for limitations that
might arise from increased age.
In the detailed probit model (See 7-22, Column 1) household income, new
information on risk, and having had a heart catheterization procedure are all positively
related to choosing the procedure. Education tends to be negative and is significant for
high school graduates and individuals with a graduate degree. Higher amounts of stress,
being disabled, and increased age all decrease the probability of having the procedure.
These variables suggest that limitations in the individual’s ability to take time off from
work and physical limitations may be factors that hinder individuals from choosing the
procedure.
The sample for Survey 2: Treatment includes two observations for which WTP
was $100,000 and $300,000. These values are considerably higher than the rest of the
distribution, and therefore, may be considered outliers. Both of the respondents who
indicated these amounts also indicated that were in the top savings category, with savings
that exceeded $100,000. Therefore, it is certainly possible that these individuals are
willing and able to pay these large amounts; however, to consider the effect these two
observations have on the marginal effects of the explanatory variables, the same probit
was performed without these potential outliers (See Table 7-22, Column 2).

A

comparison of the two regressions indicates that there is virtually no change in the factors
that are significant or in their coefficients. Additionally, a comparison of the detailed
probit models (Table 7-22) to the basic probit models (Table 7-21) indicate that income,
graduate degree, change in perceived risk, and heart catheter are significant across all
specifications. The predictive ability of the detailed models is higher, indicating that the
marginal effects obtained from this model are likely to be more precise. However, there
is very little change in the coefficient on Change in Perceived Risk across specifications,
indicating that this result is very robust, as is the marginal effect for those who have had a
heart catheterization, which is also very consistent across specifications.

128

Using dummy variables for age (as was done in prior models) indicated that the marginal effect for each
age category was essentially the same, therefore, a continuous variable for age was used.
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The results of a likelihood ratio test (χ2 = 37.45 and p-value of 0.039) suggest that
men and women may be influenced by different factors in terms their decision to have the
procedure. Therefore, regression results for these two subgroups are reported in Table 722. As the probit results in Table 7-22, Column 3 indicate, women with a graduate
degree are less likely to get the procedure; however, as discussed previously, this result
may simply indicate the desire to research the procedure further prior to committing to
have it. In addition, an increase in perceived risk stemming from the new information
tends to increase the probability of having the procedure, as does more frequent trips to
the doctor. However, women who request additional information about the procedure,
are already taking a cholesterol-lowering medication, or report that they are currently
under a great deal of stress, are les likely to select the procedure. Interestingly enough,
for men, the decision to have the procedure appears to be influenced by only a few
factors. Advanced age, being very obese, and working are all highly significant and
reduce the probability of men choosing to have the procedure.129
The final table presents the results of the OLS regression on WTP for the
Procedure (See Table 7-23).

The first model (Table 7-23, Column 1) includes all

observations130, and the second (Table 7-23, Column 2) omits the two potential outliers
discussed above.

A cursory glance reveals that the two models are very different,

indicating that the two omitted observations do have a significant effect on the
coefficients of the independent variables.

Running the model again, indicates that

excluding only the observation for which WTP=300,000, provides results that closely
resembles those in Table 7-23, Column 2. Therefore, the second model (excluding the
outliers) appears to be more accurate.
Looking at the WTP equation in Table 7-23, Column 2, there are several
significant variables of interest. As expected, the higher the individual’s wealth (as
measured by household income and degree of financial security), the more the individual
is willing to pay for the procedure. Using the coefficient on income, the income elasticity
129

Work was interacted with years of education to create a variable to measure the opportunity cost of time.
The models presented in Table 7-22 were also run with this interaction term replacing WORK. The overall
results and individual coefficients were nearly identical in the two specifications. Including the variable
WORK tended to provide a higher R-squared for the WTP models, therefore this was the variable included
in the probit models.
130
All observations for which the individual selected the procedure (Procedure=1).

197

of willingness to pay for the procedure is estimated to be 0.18.131 Again, this value may
diverge from the income elasticity of demand based on the degree of substitutability
between the proposed treatment and other available goods, the cross-price elasticities,
and the share of the budget devoted to each good (Flores and Carson 1997). The
coefficients on Change in Perceived Risk and Special Info are negative and significant
suggesting that when individuals are presented with new information and ask additional
questions about the procedure, they are less confident in the value of the treatment; and
are therefore willing to pay less for it. Finally, frequency of MD visits is negative and
significant, offering evidence to suggest that those with chronic conditions are willing to
pay less for the procedure, presumably because it will have less of an expected benefit to
these individuals.
As before, the results of a likelihood ratio test (χ2 = 95.88 and p-value of 0.000)
strongly suggest that the factors influencing the WTP for the procedure vary across
gender. For women, household income has a positive and significant effect on WTP,
while those who have some college or ask additional questions about the procedure are
WTP significantly less for the procedure. For men, new information that changes their
perceived risk reduces their WTP, which, as discussed earlier, may result from the
individual feeling less confident about the benefits associated with the procedure and
therefore lower WTP. Men who are disabled are WTP more, which may suggest that
men view the procedure and an alternative way to invest in their health. Men who live in
a MSA are willing to pay more for the procedure, which is most likely due to individuals
in urban areas being accustomed to paying more for services; and finally, the positive and
highly significant (at the 1% level) coefficient on the variable Secure suggests that for
men, wealth is a very important determinant in their WTP for treatment.
7.9 Correcting for Starting Point Bias
The empirical results on WTP for both screening and treatment suggest that
starting point bias is present in the data sets. According to Boyle et al. (1985) starting
point bias occurs in iterative bidding when the respondent’s final valuation is influenced

131

(.033 * 43,538 )/7,821 = 0.18, where 43,538 is mean household income and 7,821 is the mean WTP for
the procedure.
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by the first bid the respondent receives. The economics literature has shown that iterative
bidding techniques tend to be prone to starting point bias (Whitehead et al. 1995).
Brookshire et al. (1981) provide two possible explanations for starting point bias. One
possibility is that respondents become bored and terminate the bidding process before
reaching their true WTP, especially if the respondent recognizes that the initial bid is
considerably different from his/her true valuation. A second possible explanation is that
due to lack of consumer markets for the good/service being valued in the survey,
respondent’s have little or no experience valuing the good; therefore, the initial bid may
be viewed as providing market information regarding the value of the good on which the
respondent anchors his/her own valuation (Boyle et al. 1985).
Although several iterative bidding studies have identified starting point bias in
their data, Whitehead et al. (1995) offer two possible methods for adjusting for starting
point bias such that unbiased estimates of WTP can be obtained. Whitehead et al. explain
that the appropriate method to be used depends on the cause of the bias. If the starting
point bias stems from boredom, then Whitehead et al. suggest using the corrective
procedure presented by Farmer and Randall (1994), which includes identifying the
starting point that has no marginal effect on stated WTP. However, if the starting point
bias results from respondents anchoring their valuation on an initial bid that seems
reasonable, then unbiased estimates of WTP can be obtained by subtracting out the
marginal effect of the starting point bias (Whitehead et al. 1995). In fact, Whitehead et
al. show mathematically that if the marginal effect of the starting point bias can be set
equal to zero, that unbiased estimates of WTP can be obtained.
Comments from focus group participants and the completion of the bidding
process for a large percentage of the sample suggests that respondent boredom was not a
key issue for this study, rather it is more likely that respondents were unfamiliar with the
good being valued (since it does not yet exist), and therefore, anchored their valuation on
the initial bid presented to them. Since the set of bids from which the initial bid was
randomly selected was based on the range of valuations provided by focus group
participants in their open-ended surveys, these initial bids would most certainly provide
reasonable values to the survey participants. If this is in fact the source of the starting
point bias for the data collected in this study, then according to Whitehead et al. (1995),
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unbiased estimates of WTP can be obtained simply by subtracting out the marginal effect
of the starting point bias.
The regression results provide a coefficient for the starting point bias, such that
the marginal effect of starting point bias for screening and treatment can be calculated
simply by multiplying the coefficient by the mean initial bid for each good. For example,
the coefficient of starting point bias in the regression on WTP for screening in Table 719, Column 2 is + 0.480. The mean initial bid for Survey 1: Screening was $51.58;
therefore, it follows that the marginal effect from starting point bias on WTP is an
upward bias of $24.76. Therefore, adjusting the mean WTP of $94 down by $25 (in
effect, setting the starting point bias=0), yields a mean WTP for screening equal to $69.
The median WTP for screening was $50; therefore, adjusting for starting point bias
would result in a median WTP of $25. The same procedure can be applied to the Survey
2: Treatment data. The coefficient on the starting bid in Table 7-23, Column 2 is .371.
Multiplying by the mean starting bid for treatment ($5,404.76) indicates an upward bias
of $2,005 due to the initial bid. Adjusting for this potential bias results in a mean WTP
for treatment equal to $5,816 and a median WTP of $495.
7.10 Treatment Effectiveness and Value of Statistical Life
The mean reported WTP for the proposed treatment was $7,821. As part of the
survey, respondents were told that this new treatment was 85% effective. Therefore,
having the treatment would not reduce the individual’s risk of heart attack to zero;
however, it would diminish it considerably.

To find the risk-dollar tradeoff, it is

necessary to consider the total marginal costs and benefits of having the treatment. In
addition to a monetary cost, the treatment also includes a small risk of death equal to
1/10,000.132 Respondents indicated a mean level of perceived risk for a heart attack for
this year to be 30/100,000 or 3/10,000. Since the procedure was stated to be 85%
effective, having the procedure would presumably lower the mean risk by 2.55/10,000.
However, it is expected that the procedure would be effective at reducing this risk for
several years (not just one).

132

This risk stems from the possibility of death from the anesthesia or infection resulting from the
procedure.
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The implied number of years the treatment is assumed to be effective can be
estimated by using the value of a statistical life (VSL). As discussed in Chapter 2,
Viscusi and Aldy’s (2003) review article find the most reliable VSL estimates to be in the
range of 5 million to 9 million dollars. Using this range of VSL estimates and the mean
WTP for treatment of $7,821, it can be inferred that respondents expected the treatment
to be effective for approximately 3.5 to 6 years.133 If the mean WTP adjusted for starting
point bias is used, then the implied expected duration of treatment is slightly lower at 2.5
to 4.5 years.134 Therefore, although a VSL can not be calculated directly using the data
obtained in the survey, the WTP for treatment obtained in the study is consistent with
published VSL estimates assuming that the treatment is effective for an approximate
average of 3.5 - 5 years. Since medically this is a very reasonable estimate given this
type of procedure, the WTP for treatment obtained in this study appears consistent with
estimates from VSL studies.

133

2.55/ 10,000 * number of years effective *VSL = $7,821 + 1/10,000
2.55/ 10,000 * number of years effective * 9 million = $7,821 + 1/10,000 = 3.4 years
2.55 /10,000 * number of years effective * 5 million = $7,821 + 1/10,000 = 6.1 years
134
2.55/ 10,000 * number of years effective *VSL = $5,816 + 1/10,000
2.55/ 10,000 * number of years effective * 9 million = $5,816 + 1/10,000 = 2.5 years
2.55 /10,000 * number of years effective * 5 million = $5,816 + 1/10,000 = 4.5 years
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Table 7-1: Key Summary Statistics for Screening and Treatment Data
Demographics

Screening
(n = 268)

Treatment
(n=295)

Gender

Male
Female

53%
47%

51%
49%

Age

Range
Mean Age

18-83
48

18-91
64

Education

Less than High School
High School Grad
Some College
Associate's Degree
Bachelor's Degree
Graduate Degree

9%
37%
23%
5%
17%
9%

13%
39%
19%
7%
15%
6%

Race

White
Black
Hispanic
Other

77%
8%
9%
6%

88%
7%
3%
2%

Household

Married
Household Size
Head of Household

60%
2.6
85%

66%
2.3
87%

Work Status

Currently Working
Retired
Disabled
Household Income
MSA

65%
20%
6%
$48,223
83%

34%
47%
10%
$43,538
87%

3.4
12%
5%
17%
35%
32%
8%
34%
40%
16-62
28.3
30%
17%
19%

2.8
75%
37%
63%
59%
40%
22%
*
58%
16-77
29.2
38%
23%
16%

Health

Weight

Self-Reported Health Status
Heart Disease
Heart Attack
Taking Cholesterol Medication
High Cholesterol
High Blood Pressure
Diabetes
Live/Work -Smoking Environment
Family History of Heart Attack
BMI Range
BMI Mean
Overweight
Obese
Very Obese

* Data Not Available
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Respondent's Gender
male = 1, female = 0
Respondent's Marital Status
married = 1, not married = 0
Respondent's Age at Time of Joining Panel
(mean age=47.85, SD=16.45, min=18, max=83)
Respondent's Race
(4 categories)

Male

Married

Age

Race

Respondent's Level of Education
(6 categories)
Household Income
(mean = 48,223, SD = 33,398, min = 2500, max= 200,000)
Respondent has Life Insurance
yes = 1, no = 0 (mean = .668)
Respondent resides in a Metropolitan Statistical Area
yes = 1, no = 0 (mean = .825)
Medical Spending
(mean = 47.89, SD = 70.65, min = 10, max= 650, median=35)
Respondent's Weight
(4 categories)
0%=no treatment, 30%=treatment is 30% effective (drug
therapy), 85%=treatment is 85% effective (new procedure)

Education

Household Income

Life Insurance

MSA

Medical Spending

Weight

Treatment
Effectiveness

(mean = .604)

(mean = .534)

Willingness To Pay
(mean = 94.01, SD = 142.59, min = 0, max= 1000,

Description

WTP

Variable
5%
0

25%
15

Median
50

no
89
(33.21%)
no
47
(17.54%)
25%
10
over
80
(29.85%)
30%
94
(35.07%)

yes
179
(66.79%)
yes
221
(82.46%)
5%
10
normal
91
(33.96%)
0%
43
(16.04%)

obese
45
(16.79%)
85%
131
(48.88%)

Median
35

v. obese
52
(19.40%)

75%
48

55-64
46
(17.16%)
other
16
(5.97%)
assoc
14
(5.22%)
75%
67,500

75%
100

Frequency Distribution

male
female
143
125
(53.36%) (46.64%)
married not married
162
106
(60.45%) (39.55%)
18-34
35-44
45-55
68
52
48
(25.37%) (19.40%) (17.91%)
black
hisp
white
206
22
24
(76.87%)
(8.21%)
(8.96%)
college
less HS
HS grad
24
98
61
(8.96%)
(36.57%) (22.76%)
5%
25%
Median
6,250
22,500
45,000

Table 7-2: Summary Statistics for Survey 1: Screening (n=268)

95%
150

bach
46
(17.16%)
95%
112,500

65+
54
(20.15%)

95%
400

grad
25
(9.33%)
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Frequency with which respondent goes to doctor's office for
treatment (mean = 2.20, SD = 1.81, min = 0, max= 10)
Respondent's reported Perceived Risk after new information
(mean = 17.92, SD = 16.0, min = 0, max= 100)

Frequency of MD
Visits
Perceived Risk

Change in Perceived Amount of change in perceived risk from initial value
(mean = 2.84, SD = 8.76, min = -50, max= 80)
Risk

Initial Perceived Risk Respondent's reported Perceived Risk prior to new information
(mean = 15.07, SD = 14.16, min = 0, max= 80)

Amount that Respondent's body mass index is >24.9 (high end
of normal) (mean = 4.38, SD = 6.07, min = 0, max= 28.1)

Amount over Ideal
BMI

Has respondent ever expereince a life threatening condition or
illness yes = 1, no = 0 (mean = .243)

Life Threatening
Condition

Respondent's Reported frequency of Exercise
(5 categories) 0 = none, 4 = most (mean=1.74 SD=1.21)

Does respondent take cholesterol lowering medication
yes = 1, no = 0 (mean = .172)

Cholesterol
Medication

Exercise

Has respondent had a heart attack
yes = 1, no = 0 (mean = .045)

Heart Attack

Respondent's Reported Level of Stress
(6 categories) 0 = none, 5 = most (mean =2.70 SD=1.29)

Self reported heart disease status
yes = 1, no = 0 (mean = .116)

Heart Disease

Stress

Self reported general health status (5 categories)
1=poor, 5=excellent (mean =3.44 SD=1.01 median=3.5)

Description

General Health

Variable

Table 7-2 (continued)
2
39
(14.55%)
No
237
(88.43%)
No
256
(95.52%)
No
222
(82.84%)
No
203
(75.75%)
1
34
(12.69%)
1
257
(95.54%)
25%
0

25%
1
25%
5
25%
4.5
25%
0

1
8
(2.99%)
Yes
31
(11.57%)
Yes
12
(4.48%)
Yes
46
(17.16%)
Yes
65
(24.25%)
0
12
(4.48%)
0
12
(4.46%)
5%
0

5%
0
5%
0
5%
0
5%
-2

Median
0

Median
10

Median
15

Median
2

Median
2.6

2
76
(28.36%)
2

3
87
(32.46%)

95%
47
95%
19

75%
24
75%
5

95%
50

95%
5

75%
3
75%
25

95%
18.1

4
57
(21.27%)
4

5
40
(14.93%)

75%
6.1

3
66
(24.62%)
3

4
94
(35.07%)

Frequency Distribution

5
23
(8.58%)
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No

Yes

b

No
182
(67.91%)

Yes
86
(32.09%)

Hypertension (Broad) Respondent has hypertensiona
yes = 1, no = 0 (mean = .321)

A member of respondent's family has had a heart attack
yes = 1, no = 0 (mean = .399)
First bid in iterative bidding
(mean = 51.68, SD = 28.53, min = 10, max = 100)

Family History
(Broad)

Starting Bid

(continued)

Certainty (Broad)

8
(2.99%)
6

51
(19.03%)
0

107
(39.93%)
10

c

b

certainty of 10 assigned to observations with WTP=0

combines questions from AHA risk quiz with other survey questions

20
(7.46%)
a
combines health data from Knowledge Networks with survey data

Certainty of initial WTP
(mean = 7.28, SD = 2.62, min = 0, max = 10)

Certainty (Broad)

c

Respondent has high cholestrol or low HDL
yes = 1, no = 0 (mean = .302)

High Cholesterol or
Low HDL

a

33
(12.52%)

9
(3.36%)
7

58
(21.64%)
1 or 2

161
(60.07%)
40

187
(69.78%)
No

No
247
(92.16%)

Yes
21
(7.84%)

Respondent has diabetes
yes = 1, no = 0 (mean = .078)

Diabetes (Broad)

81
(30.22%)
Yes

std dev
7.48

Perceived risk if new information had large effect

Weak Prior on
Perceived Risk

mean
1.5

Perceived risk if new information had no effect

Strong Prior on
Perceived Risk

std dev
12.89

Description
mean
9.4

Variable

Table 7-2 (continued)

46
(17.16%)

9
(3.36%)
8

52
(19.40%)
3

50

min
0

min
0

23
(8.58%)

9
(3.36%)
9

57
(21.27%)
4

60

max
60

max
50

Frequency Distribution

78
(29.10%)

33
(12.31%)
10

50
(18.66%)
5

100
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0.22

0.25

0.381

0.496

Respondent has a cholesterol level of 240 or higher OR has
been told by doctor that he/she has high cholesterol
Respondent's HDL ("good") cholesterol is less than 35

Respondent's blood pressure is 140/90 or higher OR has been
told by doctor that he/she has high blood pressure
Respondent reports that he/she gets less than 30 minutes of
physical activity on most days
Respondent reports that he/she is is 20 pounds or more
overweight for their height and build
Respondent has diabetes OR a fasting blood sugar of 126 or
higher OR takes medicine to control his/her blood sugar
Respondent has coronoary heart disease or has a heart attack

High Cholesterol

Low HDL (Good
Cholesterol)
Hypertension

Less than 30 Min.
Physical Activity
20 Pounds or more
overweight
Diabetes

Heart Attack or
Heart Disease

r8

r9

r11

r10

r7

r6

r5

0.045

0.075

0.127

0.34

Smoke or Live/Work Respondent smokes or lives/works with people who smoke
everyday
witrh Smoker

r4

Repondent has a father/brother under age 55 OR mother/sister
under age 65 who expereinced a heart attack

0.172

r2
Family history of
Heart Attack

0.295

r3

Respondent is a male over the age of 45

Mean

0.212

Male over Age 45

Description

Female over Age 55 Respondent is a female over the age of 55

r1

Variable

Table 7-2 (continued - Risk Factors on AHA Risk Assessment Quiz)

0.207

0.263

0.501

0.486

0.434

0.333

0.42

0.474

0.378

0.409

0.457

Std. Dev.

0

0

0

0

0

0

0

0

0

0

0

Min

1

1

1

1

1

1

1

1

1

1

1

Max
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Respondent's Gender
male = 1, female = 0
Respondent's Marital Status
married = 1, not married = 0
Respondent's Age at Time of Joining Panel
(5 categories, mean = 63.71, SD = 13.77, min = 18, max = 91)
Respondent's Race
(4 categories)

Male

Married

Age

Race

Respondent's Level of Education
(6 categories)
Household Income
(mean = 43,538, SD = 30,057, min = 2500, max= 162,500)
Respondent has Life Insurance
yes = 1, no = 0 (mean = .739)
Respondent resides in a Metropolitan Statistical Area
yes = 1, no = 0
Respondent's Weight
(4 categories)
Did Respondent choose the Procedure
yes = 1; no = 0 (mean=.854)
Treatment selected by Respondent Meds=Medication only;
None=neither treatment option was chosen

Education

Household Income

Life Insurance

MSA

Weight

Procedure

Treatment

(mean = .661)

(mean = .505)

Willingness To Pay
(mean = 7,821, SD = 21,084, min = 0, max= 300,000)

Description

WTP

Variable
25%
150

Median
2,500

no
77
(26.10%)
no
38
(12.88%)
over
111
(37.63%)
no
43
(14.58%)
meds
36
(12.20%)

none
7
(2.37%)

obese
67
(22.71%)

v obese
47
(15.93%)

55-64
67
(22.71%)
other
6
(2.03%)
assoc
20
(6.78%)
75%
55000

75%
8,000

Frequency Distribution

male
female
149
146
(50.51%) (49.49%)
married not married
195
100
(66.10%) (33.90%)
18-34
35-44
45-55
7
23
41
(2.37%)
(7.80%)
(13.90%)
white
black
hisp
259
21
9
(87.80%)
(7.12%)
(3.05%)
less HS
HS grad
college
39
116
57
(13.22%) (39.32%) (19.32%)
5%
25%
Median
8750
22500
37500

5%
0

yes
218
(73.90%)
yes
257
(87.12%)
normal
70
(23.37%)
yes
252
(85.42%)
procedure
252
(85.42%)

Table 7-3: Summary Statistics for Survey 2: Treatment (n=295)

bach
44
(14.92%)
95%
112500

65-74
90
(30.51%)

95%
30,000

grad
19
(6.44%)

75+
67
(22.71%)
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Has respondent had a heart attack
yes = 1, no = 0 (mean = .373)
Amount a heart attack affects ability to work, perform daily
activities, and overall quality of life (mean=2.12, SD=1.23)

Heart Attack

Decrease in Quality of
Life from heart attack

Respondent's Reported frequency of Exercise
(5 categories) 0 = none, 4 = most (mean=1.92 SD=1.33)
Amount that Respondent's BMI > 24.9 (high end of normal)
(mean = 4.92, SD = 6.58, min = 0, max= 52.1)

Exercise

Amount over BMI

Respondent's reported Perceived Risk after new information
(mean = 30.22, SD = 21.5, min = 0, max= 100)
Respondent's reported Perceived Risk prior to new information
(mean = 26.56, SD = 18.94, min = 0, max= 85)
Amount of change in perceived risk from initial value
(mean = 3.65, SD = 8.35, min = -20, max= 50)

Perceived Risk

Initial Perceived Risk

Change in Perceived
Risk

Frequency of MD Visits Frequency with which respondent goes to doctor's office for
treatment (mean = 2.20, SD = 1.81, min = 0, max= 10)

Respondent's Reported Level of Stress
(6 categories) 0 = none, 5 = most (mean =2.63 SD=1.33)

Respondent has expereinced a life threatening condition or
illness
yes = 1, no = 0 (mean = .664)

Stress

Life Threatening
Condition

Cholesterol Medication Does respondent take cholesterol lowering medication
yes = 1, no = 0 (mean = .627)

Self reported general health status (5 categories)
1=poor, 5=excellent (mean =2.78 SD=0.96 median=3.5)

Description

General Health

Variable

Table 7-3 (continued)
2
88
(29.83%)
No
185
(62.71%)
1
52
(17.63%)
No
110
(37.29%)
No
99
(33.56%)
1
45
(15.25%)
1
57
(19.32%)
25%
0.1
25%
1
25%
15
25%
10
25%
0

1
27
(9.15%)
Yes
110
(37.29%)
0
39
(13.22%)
Yes
185
(62.71%)
Yes
196
(66.44%)
0
16
(5.42%)
0
60
(20.34%)
5%
0
5%
0
5%
2
5%
2
5%
-5

Median
0

Median
23

Median
25

Median
2

2
80
(27.12%)
2
59
(20.00%)
Median
3.1

2
78
(26.44%)

3
109
(36.95%)

75%
6

75%
40

75%
45

75%
3

3
72
(24.41%)
3
83
(28.14%)
75%
7.1

3
88
(29.83%)

4
65
(22.03%)

Frequency Distribution

95%
20

95%
60

95%
74

95%
5

4
56
(18.98%)
4
36
(12.2%)
95%
16.1

4
38
(12.88%)

5
6
(2.03%)

5
26
(8.81%)
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Respondent requested additional information about procedure
yes = 1, no = 0
Perceived risk if new information had no effect

Perceived risk if new information had large effect

Info Special

Strong Prior on
Perceived Risk

Weak Prior on
Perceived Risk

no
258
(87.46%)
no
151
(51.19%)
std dev
18.74
std dev
9.03

yes
37
(12.54%)
yes
144
(48.81%)
mean
15.26
mean
1.86

Secure

How financially secure family would be if respondent died
(not secure=1, fairly secure=2, very secure=3)

1
2
61
155
(20.68%) (52.54%)
yes
no
233
Own Home
Respondent owns home
62
yes = 1, no = 0
(78.98%) (21.02%)
yes
no
195
100
Work
Respondent works
yes = 1, no = 0
(33.90%) (66.10%)
yes
no
30
Disabled
Respondent is disabled
265
yes = 1, no = 0
(10.17%) (89.83%)
1000
2000
a
Starting Bid
First bid in iterative bidding
47
46
mean = 5404.76, SD = 3415.87, min = 1000, max = 10000)
(18.65%) (18.25%)
0
1 or 2
b
Certainty (Broad)
Certainty of initial WTP
19
12
(mean = 6.83, SD = 3.06, min = 0, max = 10)
(2.99%)
(4.07%)
6
7
19
27
Certainty (Broad)
(continued)
(6.44%)
(9.15%)
a
includes n = 252 (respondents who did not choose the procedure, did not participate in the interative bidding)
b
certainty of 10 assigned to observations with WTP=0

Respondent has child under 18 years old
yes = 1, no = 0

Description

Child Under 18

Variable

Table 7-3 (continued)

5000
51
(20.24%)
3
17
(5.76%)
8
40
(13.56%)

3
79
(26.78%)

min
0

min
0

8000
56
(22.22%)
4
10
(3.39%)
9
15
(5.00%)

max
75

max
85

Frequency Distribution

10,000
52
(20.63%)
5
43
(14.58%)
10
93
(31.53%)
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Respondent has doctor-diagnosed diabetes (from KN health
data) yes = 1; no = 0

Diabetes

Respondent has had heart catheter procedure
yes = 1, no = 0

Respondent has doctor-diagnosed high blood pressure (from
KN - health data) yes = 1; no = 0

Hypertension

Heart Catheter

0.593

Respondent has doctor-diagnosed high cholesterol (from KN
health data) yes = 1; no = 0

High Cholesterol

0.505

0.220

0.397

0.495

0.576

Family history of Heart Respondent has an immediate family member who has
Attack
experienced a heart attack yes = 1; no = 0

0.501

0.415

0.490

0.492

Std. Dev.

Description

Mean

Variable

Table 7-3 (continued)

0

0

0

0

0

Min

1

1

1

1

1

Max

295

295

295

295

295

n

Table 7-4: Survey 1: Screening OLS Regression on General Health
Independent Variable
AGE 35-44
AGE 45-54
AGE 55-64
AGE 65 and above
High School Graduate
Some College
Associates Degree
Bachelors Degree
Graduate Degree
Life Threatening Condition
Amount of Stress
Frequency of Exercise
Amount Over Ideal BMI

Self-Reported General Health as Dependent Variable
- 0.265*
(0.164)
- 0.399**
(0.169)
- 0.461***
(0.173)
- 0.469***
(0.173)
0.080
(0.201)
0.213
(0.216)
0.267
(0.298)
0.448**
(0.223)
0.173
(0.255)
- 0.553***
(0.134)
- 0.142***
(0.044)
0.124***
(0.046)
- 0.039***
(0.009)

- 0.285*
(0.159)
- 0.329**
(0.164)
- 0.448***
(0.168)
- 0.332*
(0.171)
0.064
(0.195)
0.169
(0.209)
0.283
(0.289)
0.410*
(0.216)
0.107
(0.248)
- 0.437***
(0.133)
- 0.117***
(0.043)
0.106**
(0.044)
- 0.029***
(0.009)
- 0.136***
(0.033)

Freqency of MD Visits
Household Income
4.03***
(0.243)

Constant

4.21***
(0.239)

- 0.323**
(0.157)
- 0.384**
(0.162)
- 0.495***
(0.165)
- 0.303*
(0.168)
0.009
(0.191)
0.070
(0.207)
0.187
(0.285)
0.250
(0.218)
- 0.128
(0.253)
- 0.411***
(0.130)
- 0.115***
(0.042)
0.104**
(0.043)
- 0.029***
(0.009)
- 0.121***
(0.032)
5.68e-06***
(1.70e-06)
4.01***
(0.242)

- 0.312*
(0.161)
- 0.454***
(0.165)
- 0.514***
(0.169)
- 0.417**
(0.169)
0.014
(0.196)
0.092
(0.212)
0.157
(0.292)
0.258
(0.223)
- 0.108
(0.259)
- 0.507***
(0.131)
- 0.137***
(0.043)
0.119***
(0.044)
- 0.037***
(0.009)

6.60e-06***
(1.72e-06)
3.82***
(0.243)

F

7.62

8.79

9.28

8.51

Prob > F

0.0000

0.0000

0.0000

0.0000

0.2807

0.3272

0.3558

0.3202

0.2439

0.2899

0.3175

0.2826

0.8779
268

0.8508
268

0.8341
268

0.8552
268

R

2

Adjusted R
Root MSE

2

N
*** significant at the 1% level
** significant at the 5% level
* significant at the 10% level
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Table 7-5: Survey 1: Screening OLS Regression on General Health with Overweight
Variables
Independent Variable
AGE 35-44
AGE 45-54
AGE 55-64
AGE 65 and above
High School Graduate
Some College
Associates Degree
Bachelors Degree
Graduate Degree
Life Threatening Condition
Amount of Stress
Frequency of Exercise
Overweight
Obese
Very Obese

Self-Reported General Health as Dependent Variable
-0.299*
(0.165)
-0.437**
(0.170)
-0.461***
(0.174)
-0.471***
(0.177)
0.111
(0.203)
0.270
(0.219)
0.406
(0.308)
0.490**
(0.225)
0.229
(0.257)
-0.556***
(0.135)
-0.150***
(0.044)
0.121***
(0.046)
-0.155
(0.138)
-0.468***
(0.168)
-0.606***
(0.164)

-0.309*
(0.159)
-0.351**
(0.165)
-0.447***
(0.169)
-0.329*
(0.174)
0.087
(0.196)
0.218
(0.212)
0.401
(0.297)
0.438**
(0.217)
0.153
(0.249)
-0.434***
(0.133)
-0.122***
(0.043)
0.102**
(0.045)
-0.133
(0.134)
-0.368**
(0.164)
-0.492***
(0.161)
-0.140***
(0.032)

Freqency of MD Visits
Household Income
4.098***
(0.253)

Constant
F

6.56

Prob > F
R

2

Adjusted R
Root MSE
N

4.281***
(0.248)

2

7.77

-0.345**
(0.156)
-0.400**
(0.163)
-0.491***
(0.166)
-0.295*
(0.171)
0.029
(0.193)
0.114
(0.210)
0.291
(0.293)
0.273
(0.219)
-0.086
(0.254)
-0.406***
(0.137)
0.120***
(0.042)
0.100**
(0.044)
-0.163
(0.131)
-0.382**
(0.161)
-0.482***
(0.158)
-0.125***
(0.032)

-0.342**
(0.161)
-0.483***
(0.166)
-0.510***
(0.170)
-0.412**
(0.173)
0.039
(0.198)
0.142
(0.216)
0.277
(0.301)
0.290
(0.225)
-0.060
(0.262)
-0.508***
(0.132)
-0.144***
(0.043)
0.116***
(0.045)
-0.187
(0.135)
-0.473***
(0.164)
-0.579***
(0.160)

5.70e-06***

6.67e-06***

1.71e-06
4.091***
(0.249)

(0.1.73e-06)
3.899***
(0.251)

8.27

7.41

0.0000

0.0000

0.0000

0.0000

0.2809

0.3313

0.3599

0.321

0.2381
0.8813
268

0.2886
0.8515
268

0.3163
0.8348
268

0.2777
0.8581
268

*** significant at the 1% level
** significant at the 5% level
* significant at the 10% level
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Table 7-6: Survey 2: Treatment OLS Regression on General Health
Independent Variable
AGE 35-44
AGE 45-54
AGE 55-64
AGE 65-74
AGE 75 and above
High School Grraduate
Some College
Associates Degree
Bachelors Degree
Graduate Degree
Life Threatening Condition
Amount of Stress
Frequency of Exercise
Amount Over Ideal BMI

Self-Reported General Health as Dependent Variable
-0.144
(0.381)
- 0.465
(0.361)
- 0.689**
(0.352)
- 0.780**
(0.348)
- 0.919***
(0.353)
0.095
(0.167)
0.214
(0.189)
0.617**
(0.245)
0.604***
(0.200)
0.475*
(0.253)
- 0.232**
(0.118)
- 0.151***
(0.040)
0.066*
(0.041)
- 0.027***
(0.008)

-0.115
(0.370)
- 0.431
(0.351)
- 0.655*
(0.342)
- 0.716**
(0.339)
- 0.788**
(0.344)
0.023
(0.163)
0.150
(0.184)
0.575**
(0.238)
0.557***
(0.195)
0.388
(0.247)
- 0.195*
(0.109)
- 0.126***
(0.040)
0.061
(0.041)
- 0.022***
(0.008)
- 0.131***
(0.031)

Freqency of MD visits
Household Income
3.77***
(0.410)

Constant

4.08***
(0.405)

-0.111
(0.368)
- 0.405
(0.350)
- 0.629*
(0.341)
- 0.661*
(0.339)
- 0.731**
(0.344)
0.018
(0.163)
0.117
(0.184)
0.545**
(0.238)
0.488**
(0.198)
0.267
(0.255)
- 0.190**
(0.108)
- 0.122***
(0.040)
0.058
(0.040)
- 0.021***
(0.008)
- 0.128***
(0.031)
3.23e-06**
(1.81e-06)
3.91***
(0.416)

-0.138
(0.379)
- 0.433
(0.360)
- 0.658**
(0.350)
- 0.714**
(0.348)
- 0.849**
(0.353)
0.087
(0.166)
0.175
(0.189)
0.580**
(0.244)
0.523**
(0.203)
0.333
(0.262)
- 0.224**
(0.111)
- 0.146***
(0.040)
0.063
(0.041)
- 0.025***
(0.008)

3.73e-06**
(1.86e-06)
3.58***
(0.420)

F

5.33

6.46

6.3

5.29

Prob > F

0.0000

0.0000

0.0000

0.0000

0.2103

0.2577

0.2661

0.2215

0.1708

0.2178

0.2238

0.1796

0.8738
295

0.8486
295

0.8453
295

0.8691
295

R

2

Adjusted R
Root MSE

2

N
*** significant at the 1% level
** significant at the 5% level
* significant at the 10% level
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Table 7-7: Survey 1: Screening OLS Regression on Initial Perceived Risk of a Heart
Attack
Initial
Initial
Initial
Initial
Perceived Risk Perceived Risk Perceived Risk Perceived Risk
1.175
1.529
male
Risk Factors
(1.606)
(1.547)
3.267
2.119
Age 35-44
(2.361)
(2.286)
5.415**
4.163*
Age 45-54
(2.441)
(2.365)
8.064***
7.871***
Age 55-64
(2.631)
(2.532)
6.226**
6.484**
Age 65 or higher
(2.634)
(2.535)
7.586***
7.704***
r1
Male over Age 45
(1.976)
(1.883)
7.672***
7.671***
r2
Female over Age 55
(2.087)
(1.989)
2.676
1.484
3.192
1.778
r3
Family History of Heart
(2.090)
(2.005)
(2.114)
(2.058)
Attack
1.582
0.817
1.546
1.130
r4
Smoke or Live / Work
(1.663)
(1.591)
(1.704)
(1.642)
with Smokers
5.784**
5.422**
6.725***
6.577***
r5
High Cholesterol
(2.491)
(2.375)
(2.466)
(2.373
-1.246
-2.108
-2.368
-3.058
r6
Low HDL
(2.329)
(2.225)
(2.348)
(2.265)
(Good Cholesterol)
0.246
-1.107
0.186
-1.203
r7
Hypertension
(1.939)
(1.866)
(1.949)
(1.900)
1.463
0.164
0.956
-0.086
r8
Less than 30 Minutes
(1.607)
(1.552)
(1.634)
(1.589)
Physical Activity / Day
5.069***
3.360**
5.194***
3.799**
r9
20 Pounds or More
(1.663)
(1.619)
(1.707)
(2.270)
Overweight
4.281
2.475
3.372
2.125
r10
Diabetes
(3.299)
(3.163)
(3.349)
(0.660)
12.833***
9.117**
r11
Heart Disease OR Heart
(4.198)
(4.064)
Attack
7.629***
5.311*
Heart Disease
(2.883)
(2.821)
10.818**
9.467**
Heart Attack
(4.260)
(4.110)
-2.395
-3.170
-3.620
-4.577
Taking Cholestrol
Medication
(2.932)
(2.797)
(3.044)
(2.937)
Medication
-4.301***
-3.914***
General Health
General Health
(0.837)
(.861)
-7.169**
-6.398**
-6.334**
-5.765**
High School Graduate
Education
(2.888)
(2.756)
(2.880)
(2.774)
-6.632**
-5.433*
-6.491**
-5.500*
Some College
(3.056)
(2.921)
(3.054)
(2.947)
-8.499**
-7.616*
-10.227**
-9.045**
Associates Degree
(4.226)
(4.030)
(4.218)
(4.068)
-9.394***
-7.136**
-8.565***
-6.567**
Bachelors Degree
(3.236)
(3.114)
(3.237)
(3.146)
-9.223**
-8.407**
-9.378***
-8.680**
Graduate Degree
(3.625)
(3.457)
(3.623)
(3.490)
12.816***
29.270***
10.682***
26.008***
constant
(2.858)
(4.212)
(3.180)
(4.554)
F
5.88
7.59
5.09
6.19
Category

Independent Variable

Prob > F

0.0000

0.0000

0.0000

0.0000

R2

0.2857

0.3543

0.3030

0.3572

Adjusted R2
Root MSE

0.2372

0.3076

0.2435

0.2994

12.369
268

11.784
268

12.317
268

11.853
268

N
*** significant at the 1% level
** significant at the 5% level
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Table 7-8: Survey 1: Screening OLS Regression on Perceived Risk of a Heart Attack
After New Information
Perceived Risk Perceived Risk Perceived Risk Perceived Risk
after New Info after New Info after New Info after New Info
-.019
0.347
male
Risk Factors
(1.878)
(1.826)
4.555*
3.369
Age 35-44
(2.760)
(2.697)
4.922*
3.628
Age 45-54
(2.853)
(2.790)
9.314***
9.114***
Age 55-64
(3.076)
(2.988)
6.763**
7.029**
Age 65 or higher
(3.079)
(2.991)
7.012***
7.129***
r1
Male over Age 45
(2.275)
(2.197)
8.945***
8.944***
r2
Female over Age 55
(2.403)
(2.320)
3.339
2.156
3.855
2.394
r3
Family History of Heart
(2.406)
(2.339)
(2.472)
(2.428)
Attack
3.980**
3.220*
3.839*
3.410*
r4
Smoke or Live / Work
(1.914)
(1.856)
(1.992)
(1.938)
with Smokers
4.809*
4.450
5.664*
5.511**
r5
High Cholesterol
(2.868)
(2.771)
(2.883)
(2.800)
1.178
0.322
0.061
-0.653
r6
Low HDL
(2.681)
(2.596)
(2.746)
(2.672)
(Good Cholesterol)
-0.616
-.1959
-0.608
-2.045
r7
Hypertension
(2.232)
(2.177)
(2.278)
(2.242)
0.490
-0.800
0.168
-0.909
r8
Less than 30 Minutes
(1.850)
(1.811)
(1.911)
(1.875)
Physical Activity / Day
8.227***
6.531***
8.243***
6.800***
r9
20 Pounds or More
(1.915)
(1.889)
(1.996)
(1.971)
Overweight
1.346
-0.446
1.052
-0.236
r10
Diabetes
(3.789)
(3.691)
(3.916)
(3.816)
13.688***
10.000**
r11
Heart Disease OR Heart
(4.833)
(4.742)
Attack
4.931
2.535
Heart Disease
(3.371)
(3.328)
11.320**
9.924**
Heart Attack
(4.981)
(4.849)
-2.179
-2.948
-2.846
-3.835
Taking Cholestrol
Medication
(3.375)
(3.264)
(3.559)
(3.465)
Medication
-4.269***
-4.045***
General Health
General Health
(0.976)
(1.016)
-6.856**
-6.091*
-6.135*
-5.547*
High School Graduate
Education
(3.325)
(3.215)
(3.367)
(3.274)
-6.609*
-5.419
-6.502*
-5.478
Some College
(3.518)
(3.408)
(3.570)
(3.477)
-7.145
-6.269
-9.065*
-7.844
Associates Degree
(4.865)
(4.702)
(4.932)
(4.799)
-7.104*
-4.862
-6.738*
-4.673
Bachelors Degree
(3.725)
(3.633)
(3.785)
(3.712)
-9.093**
-8.283**
-9.381**
-8.659**
Graduate Degree
(4.173)
(4.034)
(4.236)
(4.118)
13.056***
29.387***
11.556***
27.397***
constant
(3.290)
(4.903)
(3.718)
(5.373)
F
5.15
6.28
4.00
4.77
Category

Independent Variable

Prob > F

0.0000

0.0000

0.0000

0.0000

R2

0.2594

0.3122

0.2545

0.2998

0.2090

0.2625

0.1909

0.2370

14.239
268

13.749
268

14.401
268

13.985
268

Adjusted R
Root MSE

2

N
*** significant at the 1% level
** significant at the 5% level
* significant at the 10% level
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Table 7-9: Survey 1: Screening OLS Regression on Perceived Risk of a Heart Attack
Initial
Perceived Risk
Initial
Perceived Risk
Perceived Risk after New Info Perceived Risk after New Info
-0.494
-1.486
-0.491
-1.434
male
Risk Factors
(1.593)
(1.889)
(1.599)
(1.884)
3.275
5.178*
3.121
4.756*
Age 35-44
(2.350)
(2.787)
(2.363)
(2.785)
5.154**
5.179*
4.995**
4.827*
Age 45-54
(2.487)
(2.951)
(2.504)
(2.951)
7.891***
9.523***
7.860***
9.682***
Age 55-64
(2.675)
(3.173)
(2.709)
(3.193)
6.542**
7.168**
6.264**
6.782**
Age 65 or higher
(2.823)
(3.349)
(2.904)
(3.422)
2.665
3.240
2.639
3.172
Family History
(1.680)
(1.993)
(1.685)
(1.986)
(Broad)
1.107
3.093
1.027
2.985
Smoke or Live / Work
(1.707)
(2.024)
(1.722)
(2.030)
with Smokers
2.680
3.965*
2.621
3.712
High Cholesterol or Low
(2.001)
(2.373)
(2.013)
(2.373)
HDL
1.397
0.907
1.323
0.691
Hypertension
(1.859)
(2.206)
(1.867)
(2.200)
(Broad)
-0.720
-0.829
-0.701
-0.771
Exercise
(0.654)
(0.776)
(0.657)
(0.774)
4.885**
4.602*
4.871**
4.549*
Overweight
(2.003)
(2.376)
(2.009)
(2.368)
5.693**
5.883**
5.700**
5.890**
Obese
(2.409)
(2.857)
(2.415)
(2.846)
8.509***
8.781***
8.493***
8.785***
Very Obese
(2.440)
(2.894)
(2.448)
(2.885)
1.976
0.406
1.615
-0.639
Diabetes
(3.142)
(3.727)
(3.182)
(3.751)
(Broad)
6.633**
4.137
6.111**
2.711
Heart Disease
(2.906)
(3.448)
(2.981)
(3.513)
10.687**
10.987**
10.366**
10.103**
Heart Attack
(4.312)
(5.116)
(4.341)
(5.116)
-1.449
-0.404
-1.374
-0.309
White
(1.914)
(2.271)
(1.928)
(2.273)
1.617
3.952*
Life Threat
(2.011)
(2.370)
0.064
0.573
Stress
(0.634)
(0.747)
-0.726
-1.100
-0.690
-0.740
Taking Cholestrol
Medication
(2.793)
(3.314)
(2.831)
(3.337)
Medication
-6.076**
-6.014*
-6.180**
-6.349*
High School Graduate
Education
(2.914)
(3.457)
(2.926)
(3.449)
-6.642**
-6.130*
-6.913**
-6.976*
Some College
(3.095)
(3.672)
(3.126)
(3.685)
-10.821**
-10.097**
-10.967**
-10.544**
Associates Degree
(4.326)
(5.132)
(4.342)
(5.117)
-8.414***
-7.390*
-8.498***
-7.771**
Bachelors Degree
(3.220)
(3.820)
(3.239)
(3.818)
Graduate Degree
-10.651***
-10.945**
-10.771***
-11.513***
Category

Independent Variable

(3.631)
12.167***
(3.731)

constant

(4.308)
13.142***
(4.426)

(3.665)
11.945***
(4.074)

(4.319)
11.535**
(4.801)

F

4.65

3.25

4.28

3.17

Prob > F

0.0000

0.0000

0.0000

0.0000

0.3047

0.2345

0.3068

0.2465

0.2392
12.352
268

0.1623
14.653
268

0.2351
12.385
268

0.1687
14.597
268

2

R

2

Adjusted R
Root MSE
N

*** significant at the 1% level
** significant at the 5% level
* significant at the 10% level
incorporates additional health data from Knowledge Networks
incorporates both the AHA risk questions and other survey
questions on family history of heart attack
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Table 7-10: Survey 2: Treatment OLS Regression on Perceived Risk of a Heart Attack
Initial
Perceived Risk
Initial
Perceived Risk
Perceived Risk after New Info Perceived Risk after New Info
-1.054
0.076
-1.530
-0.454
Male
Risk Factors
(2.043)
(2.252)
(2.044)
(2.253)
3.714
6.512
5.124
8.082
Age 35-44
(7.083)
(7.810)
(7.075)
(7.800)
6.696
9.548
7.681
10.644
Age 45-54
(6.792)
(7.489)
(6.769)
(7.463)
11.262*
15.954**
11.878*
16.641**
Age 55-64
(6.844)
(7.546)
(6.811)
(7.509)
8.405
12.050*
8.919
12.622*
Age 65-74
(6.730)
(7.421)
(6.696)
(7.382)
4.934
7.830
5.745
8.732
Age 75 and above
(6.777)
(7.473)
(6.749)
(7.441)
3.362*
2.116
2.719
1.400
Family History of Heart
(2.018)
(2.225)
(2.031)
(2.239)
Attack
4.210*
4.722*
4.102*
4.601*
High Cholesterol
(2.464)
(2.717)
(2.450)
(2.702)
0.616
1.479
0.618
1.481
Hypertension
(2.235)
(2.465)
(2.222)
(2.450)
-0.115
0.019
-0.311
-0.199
Exercise
(0.768)
(0.847)
(0.769)
(0.848)
-0.023
0.153
-0.022
0.154
Amount over BMI
(0.166)
(0.183)
(0.165)
(0.182)
2.903
4.766*
2.798
4.648*
Diabetes
(2.499)
(2.756)
(2.485)
(2.740)
5.357**
6.266**
4.559*
5.377**
Heart Attack
(2.366)
(2.609)
(2.384)
(2.629)
3.215***
3.860***
2.961***
3.578***
Decrease in Quality of
(0.968)
(1.068)
(0.971)
(1.070)
Life from Heart Attack
0.489
0.667
0.450
0.623
Taking Cholestrol
Medication
(2.541)
(2.802)
(2.526)
(2.785)
Medication
- 4.871***
- 5.620***
-4.750***
-5.485***
General Health
General Health
(1.167)
(1.287)
(1.162)
(1.281)
4.383**
4.879**
Life Threating Condition
(2.139)
(2.358)
-2.650
-2.745
-2.634
-2.727
High School Graduate
Education
(3.141)
(3.463)
(3.123)
(3.443)
-3.771
-5.458
-4.437
-6.200
Some College
(3.582)
(3.949)
(3.576)
(3.942)
-0.825
-2.690
-1.191
-3.097
Associates Degree
(4.648)
(5.125)
(4.624)
(5.098)
- 7.031*
- 7.603*
-7.027*
-7.598*
Bachelors Degree
(3.878)
(4.276)
(3.855)
(4.250)
- 14.639***
- 14.837***
-15.124***
-15.377***
Graduate Degree
(4.764)
(5.253)
(4.742)
(5.228)
22.893***
21.916**
21.026**
19.838**
constant
(8.760)
(9.659)
(8.757)
(9.654)
F
6.35
7.46
6.32
7.4
Prob > F
0.0000
0.0000
0.0000
0.0000
Category

Independent Variable

R

2

Adjusted R
Root MSE

2

N

0.328

0.3646

0.3382

0.3744

0.2763

0.3157

0.2847

0.3238

16.113
295

17.766
295

16.019
295

17.661
295

*** significant at the 1% level
** significant at the 5% level
* significant at the 10% level
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Table 7-11: Survey 1: Screening Open Ended Responses
Treatment
Effectiveness
85%

Serial

Please tell us why you chose not to have the test even when it was offered for $0 (FREE).

11

because i think it would be scarry to have someone tell you that you could have a heart attack even
though it would be helpful in preventing an attack if there is a too stop it.

85%

176

leave well enough alone

85%

334

85%

456

sometimes i dont beleive in medicine.. i hope i never have to take all kinds of pill to be healthy. also i
am the type of person that i dont what to know i have something cuz i would just worry about it all the
time..
I don't want to have to worry about this type of condition

85%

547

IF IT WAS POSITIVE I WOULDN'T HAVE THE TREAMENTS.

30%

179

I do not go to the doctors, I do not give blood test. I'll die when I die, I put my faith in GOD, not man.

30%

236

I have already had two heart attacks. My heart is in bad shape I have a pace maker to help my heart
funtion better. I probably wasn't the one to ask these queations.

30%

238

because I already know that I have a family history of heart problems and would not change my life
style anyway

30%

283

when its your time its your time why try to prolong the eventual?

none

296

Your information said that there was no treatment available, so why would I want to know that I might
have this problem. I'm ready to die when God is ready for me.

none

339

If there is no treatment or cure, thn I prefer NOT to know.

none

376

none

412

i consider that as the other factors that are analized in a standard blood test, this test must be
included, after being completely determined that is accuratte, so, it must be completely and
oabsolutely generalized for all the people having blood testings
You said earlier that there was nothing they could do for the this blood problem.So why have the test
done?

none

466

yes I would have the teat done if it were free I hit the wrong botton.

none

502

none

512

In this situation, there is not a treatment for vulnaralbe plaque; therefore, if I have it, I do not want to
change my life style or worry about something that cannot be fixed anyway. If there were a treatment
for it, I would be willing to pay $15-$20 for such a test.
If I can't change the outcome, Id rather not know.
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Table 7-12: Survey 2: Treatment Open Ended Responses
Treatment

Serial

Please tell us why you chose not to have the procedure.

Refuse

1015

Refuse

1079

Refuse
Refuse
Refuse

1150
1186
1247

I would like to consult my Dr's first. Ido not know if I am physically able to go thru the test. I had a Carotid artey surgery last year to prevent a stroke
While in the hospital I had a bad heart attack.Since thenI have been very ill at times . My lifestyle has changed But I am content with that.Only I
have a very bitter taste >all food. I think it is the medications..I am S.O.B.at times & have Gas pains & belching.At least I am able to sit here &
answer surveys.
The procedure would be fine but I have a congenital muscle disease that rules out statins or any chloresteral lowering medication. Medication
creates intolerable pain.
i would have to speak to my cardiologist first
I would wish to hear what my present Doctor would recommend since I trust his recommendations
I have normal cholesterol,low blood pressure,normal pulse.My heart problem is cardiac arythmia,one attack for this type of cardiac arrest has a
survival rate of 5%.I now have an implanted defibulator.
This survey is ridiculous. There are many kinds of heart disease. Mine has nothing to do with plaque or cholesterol or heart damage from an
attack, so I can't really answer these questions at all.
I did't answer the last question because I have other problems, which is complicating matters. I have lung disease also.Plus,I was diagnosed as
having lymph atenitis,years ago.
because of the risk
have had all the test - it was only a mild heart attact. and am now on medication
Because, before I have any medical procedure done, I would check other resourdes (other Drs., computer, other heart patients, etc.) to see if
there are other options and procedures for me, and then decide what I wanted to do. And, if I found out there were other options, I would not
appreciate this doctor making it sound like I ONLY had 2 choices in the world. I would feel like he took MY CHOICE away from me when he gave
me only HIS TWO CHOICES. Then I would not go back to him. I would appreciate a doctor who would explain all the options I had(even bypass
surgery, etc.), and give me time to check out every resource. Then, I would discuss MY CHOICE with him & TRUST him more - because, then I
would feel as if he was workimg with me - not for himself, by only giving me his 2 choices.
tell me the good it will do.
I fear any type of operation. Unless I was on the brink of death, I would not choose to have this procedure. So many people come home from a
hospital in worse shape than when they entered it, due to carelessness on the part of doctors and nurses and non-sterile conditions.

Refuse

1380

Refuse

1402

Procedure
Drug
Drug

1262*
1021
1036

Drug
Drug

1056
1058

Drug

1087

Drug
Drug

1090
1097

THERE IS NO GUARANTEE THAT THIS PROCEDURE IS ABSOLUTELY CORRECT. I DO NOT LIKE TO THINK ABOUT ANY INVASIVE
SURGERY WITHOUT KNOWING THAT IT IS CLOSE TO 100% ACCURATE. HAVING HAD A HEART CATHERIZATION I WOULD REALLY
HAVE TO THINK VERY LONG AND HARD ABOUT DOING THIS PROCEDURE.
I'm soon be 65 years old
I am 85 years old right now - if I would be a younger man I would go for the procedure. I already had a heart catherization which told me that I have
vein and artery blockages. I decided to go with just medication and no operating procedures. That was a year and a half ago and I have been
doing good with this medication. The medication I am taking is - Zocor, Plavax, topal asperin and a nitro-dur patch every day.

Drug

1098

Drug
Drug

1103
1105

I have lymphedema and a history of DVT. I will never have an elective surgical procedure on my legs even a simply cather insertion. I take
oumadin regularly and will not risk going off unless absoltely necessary. No MD knowing my history would advise it.
_na_
I HAVE BEEN TOLD I HAVE HAD AHEART ATTACT. BUT I NEVER FELT ANY THING. I DO HAVE AN ENLARGE HERAT, AND HAVE LOST
ABOUT 25 PERCENT OF IT FUNTION, FROM PICTURE OF ECHCOGRAM
Because I have extenuating circumstances. I went through hyperthyroidism, which caused a thyroid storm & some heart damage which makes me
very susceptible to atrial fibrillation & I take medication for it, so it is an additional risk when considering surgery of this kind. I would need much
more consultation with a cardiologist before doing such a procedure. At this time, I am much more apt to go into cardiac arrest than have a heart
attack, I think.
I have had test . I have no plaque.
I fully recovered from my heart attack which was 32 years ago. I have not curtailed my activities, only my choice of foods and have always had my
own cardiologist who I see 4 times a year and all my tests have been excellent.
It is something my Doctor would have to order for me and also the answers I had given on this survey is not the best of my knowledge.I'm not very
good at reading an understandng what I have read.
unsure at this time need more time to think
_na_
_na_
Do not want surgery as I have a great fear of it
I have already a five way bypass and at my age and financial situation I do not think anything expencive is justified
The type of heart problems I have is treated with medication. If it happens more often, then I would consider an invasive procedure to correct the
problem. I believe the more surgery one subjects themselves to the more apt they are for infections, etc., and possible death unless it is a life and
death situation.
I am feeling fine now and I don,t want to go through any more pure Hell than I have already been through in my77 years on earth Thank you

Drug

1113

Drug
Drug

1123
1135

Drug

1167

Drug
Drug
Drug
Drug
Drug
Drug

1171
1177
1199
1206
1223
1228

Drug

1233

Drug
Drug

1258
1275

I would be afraid of this procedure unless I knew for sure that i had a problem I would only try the medication only
Possibly I did not answer correctly.Although I have never had an attack I did have some problem..that could have caused an attack.Mtral valve
prolapse..resulting in a valve replacement and replacing of the aortic valve with 5 by passes.I am on socor and have periotic echo cardiograms
etc.I will discuss this procedure with my physician.it sounds interesting .Knowing the type of practice has surely he may now be aware of this

Drug
Drug

1279
1300

Drug
Drug
Drug

1317
1321
1334

Drug

1350

Drug
Drug
Drug
Drug
Drug
Drug
Drug

1355
1399
1425
1439
1443
1454
1455

_na_
I would choose not to have this procdure done because of the following reasons: ...other medical conditions ... breast cancer, bladder removal with
cancer ... very poor sight, prone to strokes, etc. ...advanced age ...very poor medical health
i have a negative feeling about it
I choose not te procedure because of the high risk it have to the patient maybe death
i resist even taking medication, let alone having a invasive procedure. eating organic, exerciseing and living a stress reduced life makes most
sence to me.
have had five heart attacks. all were when i was still smoking. i quit smoking in 1997. am now overweight, but feel good. my father, 2 brothers, and
only sister died of heart attacks. 2 siblings also had diabetes. after the last coded heart-attack, i sure am not ready for any other surgery. might be
a minimal invasion, but i`m not ready yet. due to see heart Dr. soon. will then ask him what he thinks.
i would not take the meds even. if it my time thats ok
Because I am scared of any Procedure's that require surgery or being put under .....
ionlyhavemiss in heartbeat
I don't know how invasive the 'procedure' is. I am not interested in heart cath--etc.
Don't want to be a ginea pig.
Have no Ins.
I am alreaedy under the care of physicians for my heart disease. I have had an angiogram with the resultant angioplasty. I have had follow-up
angiograms showing no advancement of my disease. If my doctor felt that I should undergo this treatment then I would consider it.
* only one to have answered no to zero bid, all others chose medication or refused treatment
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Table 7-13: Survey 1: Screening Censored Regression on WTP
WTP as Dependent Variable

Independent Variable
Household Income
MSA
Life Insurance
Medical Spending
High School Graduate
Some College
Associates Degree
Bachelors Degree
Graduate Degree
Perceived Risk

8.12e-04***
(2.91e-04)
34.714
(23.132)
17.103
(19.730)
0.193
(0.123)
-13.226
(32.909)
-55.570
(34.972)
-56.032
(49.533)
-48.745
(37.873)
-112.132***
(43.067)
0.996*
(0.551)

8.01e-04***
(2.89e-04)
35.918
(23.042)
18.313
(19.660)
0.179
(0.123)
-11.659
(32.782)
-53.529
(34.845)
-52.314
(49.375)
-43.698
(37.869)
-109.421**
(42.909)

1.438**
(0.629)
-0.182
(0.986)

Initial Perceived Risk
Change in Perceived Risk
Strong Prior on Perceived Risk
Weak Prior on Perceived Risk

7.61e-04***
(2.89e-04)
45.019*
(23.246)
14.365
(19.667)
0.181
(0.123)
-14.261
(32.596)
-60.130*
(34.630)
-53.909
(49.169)
-50.448
(37.390)
-118.914***
(42.576)

0.570
(1.052)
1.790**
(0.714)
-0.991
(1.255)

Treatment Effectiveness 30%
Treatment Effectiveness 85%
Starting Bid
Certainty (Broad)
Constant
LR chi2
Prob > chi2
2
Pseudo R
N

0.724**
(0.307)

0.739**
(0.306)

0.725**
(0.305)

7.62e-04***
(2.88e-04)
44.250*
(23.219)
12.638
(19.723)
0.190
(0.123)
-14.232
(32.606)
-59.803*
(34.634)
-55.035
(49.055)
-50.415
(37.309)
-118.152***
(42.474)

0.516
(1.052)
1.741**
(0.715)
-1.007
(1.254)
-11.869
(26.443)
-22.069
(26.406)
0.819**
(0.329)

4.549

4.636

5.116

5.250

(3.403)
-49.184
(45.291)
30.16
0.0026

(3.387)
-56.786
(45.398)
32.22
0.0022

(3.380)
-53.784
(44.796)
34.17
0.0019

(3.375)
-42.723
(48.291)
34.9
0.0041

0.0092
268

0.0099
268

0.0105
268

0.0107
268

*** significant at the 1% level
** significant at the 5% level
* significant at the 10% level
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Table 7-14: Survey 1: Screening Probit on Choosing the Screening Test
TEST (1=yes, 0=no) as Dependent Variable

Independent Variable
Household Income
MSA
Life Insurance
High School Graduate
Some College
Associates Degree
Bachelors Degree
Graduate Degree
Perceived Risk

4.15e-06
(4.79e-06)
0.0523
(0.357)
0.693**
(0.310)
0.115
(0.602)
-0.754
(0.570)
-1.075
(0696)
-0.352
(0.640)
-0.981
(0.642)
0.008
((0.010)

3.97e-06
(4.81e-06)
0.028
(0.360)
0.712**
(0.315)
0.097
(0.610)
-0.826
(0.585)
-1.180
(0.710)
-0.425
(0.653)
-1.015
(0.652)

0.005
(0.010)
0.030
(0.022)

Initial Perceived Risk
Change in Perceived Risk
Strong Prior on Perceived Risk
Weak Prior on Perceived Risk
Treatment Effectiveness 30%
Treatment Effectiveness 85%

0.946***
(0.372)
1.066***
(0.353)

1.007***
(0.382)
1.088***
(0.357)

3.52e-06
(4.86e-06)
0.137
(0.376)
0.692**
(0.327)
0.105
(0.661)
-1.027
(0.635)
-1.378
(0.747)
-0.592
(0.689)
-1.212
(0.697)

0.037*
(0.023)
0.008
(0.013)
-0.025*
(0.015)
1.172***
(0.417)
1.103***
(0.359)

General Health

3.84e-06
(5.02e-06)
0.129
(0.378)
0.696**
(0.328)
0.102
(0.662)
-1.037
(0.637)
-1.398
(0.751)
-0.596
(0.690)
-1.231
(0.703)

0.037*
(0.023)
0.007
(0.014)
-0.027*
(0.016)
1.200***
(0.433)
1.118***
(0.364)
-0.039

Constant

0.503
(0.650)

0.550
(0.663)

0.626
(0.659)

(0.151)
0.758
(0.835)

LR chi2

22.16

23.4

26.72

26.79

0.0232

0.0245

0.0136

0.0205

0.1828
268

0.1930
268

0.2205
268

0.2210
268

Prob > chi2
Pseudo R
N

2

*** significant at the 1% level
** significant at the 5% level
* significant at the 10% level
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Table 7-15: Survey 1: Screening Probit on Choosing the Screening Test, including
Medical Spending
Independent Variable
Household Income
MSA
Life Insurance
Medical Spending
High School Graduate
Some College
Associates Degree
Bachelors Degree
Graduate Degree
Perceived Risk

Screening TEST (1=yes, 0=no) as Dependent Variable
4.85e-06
(5.11e-06)
0.045
(0.382)
0.643**
(0.326)
0.014*
(0.007)
0.146
(0.628)
-0.825
(0.593)
-1.11
(0.739)
-0.453
(0.664)
-1.081
(0.671)
0.005
(0.010)

4.68e-06
(5.14e-06)
0.019
(0.386)
0.658**
(0.332)
0.015**
(0.007)
0.122
(0.635)
-0.909
(0.607)
-1.221*
(0.749)
-0.543
(0.676)
-1.118*
(0.678)

0.002
(0.010)
0.030
(0.024)

Initial Perceived Risk
Change in Perceived Risk
Strong Prior on Perceived Risk
Weak Prior on Perceived Risk
Treatment Effectiveness 30%
Treatment Effectiveness 85%

0.973**
(0.393)
1.082***
(0.365)

1.035***
(0.403)
1.092***
(0.369)

4.47e-06
(5.23e-06)
0.133
(0.401)
0.658*
(0.348)
0.015**
(0.007)
0.118
(0.697)
-1.200*
(0.679)
-1.496*
(0.796)
-0.776
(0.727)
-1.376*
0.737

0.041*
(0.024)
0.009
(0.013)
-0.028*
(0.016)
1.219***
(0.443)
1.140***
(0.376)

4.72e-06
(5.48e-06)
0.129
(0.403)
0.663*
(0.350)
0.015**
(0.007)
0.115
(0.698)
-1.215*
(0.688)
-1.515*
(0.807)
-0.785
(0.731)
-1.395*
(0.749)

0.041*
(0.025)
0.008
(0.014)
-0.029*
(0.017)
1.244***
(0.473)
1.158***
(0.394)

General Health

-0.027

Constant

(0.171)
0.368
(0.916)

0.188
(0.700)

0.240
(0.717)

0.280
(0.718)

LR chi2

28.72

30.08

33.95

33.97

Prob > chi2

0.0043

0.0046

0.0021

0.0034

0.2369
268

0.2482
268

0.2801
268

0.2803
268

2

Pseudo R
N
*** significant at the 1% level
** significant at the 5% level
* significant at the 10% level

data on medical spending was not available for individuals who did not choose the screening
(TEST=0). The mean value of medical spending was assigned to these observations; therefore, this
table is intended for comparison purposes only.
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Table 7-16: Survey 1: Screening OLS Regression on WTP for TEST=1
WTP as Dependent Variable

Independent Variable
Household Income
MSA
Life Insurance
Medical Spending
High School Graduate
Some College
Associates Degree
Bachelors Degree
Graduate Degree
Perceived Risk

7.19e-04**
3.00e-04
36.078
(23.662)
8.142
(20.348)
0.130
(0.124)
-18.169
(-33.500)
-46.232
(35.839)
-33.48
(52.142)
-49.097
(38.693)
-99.677**
(44.348)
0.939*
(0.565)

6.99e-04**
2.99e-04
37.369
(23.589)
9.623
(20.290)
0.113
(0.124)
-15.733
(33.403)
-43.522
(35.739)
-28.550
(52.026)
-42.680
(38.733)
-95.599**
(44.245)

1.478**
(0.648)
-0.438
(0.993)

Initial Perceived Risk

6.62e-04**
3.00e-04
45.699*
(23.904)
7.246
(20.346)
0.114
(0.124)
-19.473
(33.268)
-49.497
(35.624)
-29.782
(510939)
-49.965
(38.312)
-104.346**
(44.014)

6.75e-04**
(2.99e-04)
42.793*
(23.889)
4.276
(20.349)
0.135
(0.124)
-19.524
(33.235)
-48.124
(35.587)
-32.683
(51.800)
-50.930
(38.204)
-102.985**
(43.884)

0.191
(1.073)
1.805**
(0.727)
-0.441
(1.394)

0.574*
(0.311)

0.590*
(0.310)

0.578*
(0.310)

0.029
(1.073)
1.673**
(0.728)
-0.417
(1.391)
-41.106
(27.953)
-52.289*
(28.036)
0.737**
(0.335)

9.030***

9.176***

9.624***

10.108***

Change in Perceived Risk
Strong Prior on Perceived Risk
Weak Prior on Perceived Risk
Treatment Effectiveness 30%
Treatment Effectiveness 85%
Starting Bid
Certainty (Broad)
Constant
F
Prob > F
2
R
Adj R2
Root MSE
N

(3.500)
-51.889
(46.098)
2.34
0.0076

(3.488)
-61.633
(46.285)
2.39
0.0049

(3.492)
-58.555
(45.721)
2.31
0.0055

(3.491)
-25.182
(48.708)
2.25
0.0047

0.1050
0.0601
140.59
252

0.1155
0.0672
140.05
252

0.1199
0.0679
140
252

0.1328
0.0138
139.56
252

*** significant at the 1% level
** significant at the 5% level
* significant at the 10% level
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Table 7-17: Survey 1: Screening Heckman Selection Models
Model 1

Independent Variable
Household Income
MSA
Life Insurance
Medical Spending
High School Graduate
Some College
Associates Degree
Bachelors Degree
Graduate Degree
Initial Perceived Risk
Change in Perceived Risk

Model 2

Regression
Equation
WTP

Selection
Equation
TEST
(1=yes, 0=no)
7.77e-04***
3.83e-06
(2.93e-04)
(4.46e-06)
36.661
0.122
(23.201)
(0.414)
20.067
0.162
(19.588)
(0.296)
0.106
(0.116)
-10.579
-0.125
(32.705)
(0.400)
-52.209
-0.500
(34.882)
(0.407)
-43.222
-0.714*
(49.422)
(0.381)
-44.248
-0.453
(37.755)
(0.300)
-108.196***
-0.801***
(42.866)
(0.315)
1.453**
0.007
(0.630)
(0.006)
-0.212
0.004
(0.985)
(0.013)

Strong Prior on Perceived Risk
Weak Prior on Perceived Risk

Treatment Effectiveness 85%

Certainty (Broad)
Constant
Wald chi2
Prob > chi2
rho (ρ)
lambda (λ)
LR chi2
Prob > chi2
Censored observations
N
*** significant at the 1% level
** significant at the 5% level
* significant at the 10% level

7.09e-04***
(2.90e-04)
45.206*
(23.226)
16.317
(19.631)
0.104
(0.106)
-14.110
(32.488)
-60.410*
(34.579)
-44.313
(49.191)
-51.515
(37.247)
-117.617***
(42.532)

Selection
Equation
TEST
(1=yes, 0=no)
3.88e-06
(2.70e-06)
0.233
(0.189)
0.276
(0.210)

0.517
(1.054)
1.820***
(0.711)
-0.885
(1.272)

0.096
(0.222)
0.324*
(0.171)

Treatment Effectiveness 30%

Starting Bid

Regression
Equation
WTP

0.477
(0.303)
5.730*
(3.358)
-49.251
(45.189)

0.402
(0.818)

0.467
(0.298)
7.294**
(3.339)
-51.622
(44.669)

0.010
(0.009)
0.002
(0.007)
-0.015
(0.011)
0.226
(0.183)
0.341**
(0.160)

0.283
(0.283)

31.10
0.0033

34.12
0.0020

1
139.66
56.50
0.0000
16
268

1
139.11
54.33
0.0000
16
268
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-0.004
(0.242)
-0.382
(0.270)
-0.775**
(0.386)
-0.492
(0.275)
-0.867***
(0.313)

Table 7-18: Survey 1: Screening Probit on Choosing the Screening TEST (detailed)
Category

Independent Variable

Income

Household Income
MSA

Risk Aversion

Life Insurance

Medical
Expeditures
Education

Medical Spending
High School Graduate
Some College
Associates Degree
Bachelors Degree
Graduate Degree

Treatment
Effectiveness

Effectiveness 30%
Effectiveness 85%

Risk Factors

Male
AGE 35 - 44
AGE 45 - 54
AGE 55 - 64
AGE 65 and above
Family History
(Broad)
Smoking Environment
High Cholesterol or Low
HDL
Hypertension (Broad)
Exercise
Overweight
Obese
Very obese
Diabetes (Broad)
Heart disease
Heart attack
White
Cholesterol Medication
Change in Perceived
Risk
constant
LR chi2
Prob > chi2
2
Pseudo R
N

Test (1= yes, 0 = no) as Dependent Variable
1.27e-05*
(7.35e-06)
0.406
(0.549)
1.508**
(0.600)
0.025*
(0.012)
0.447
(0.833)
-1.721**
(0.807)
-2.407**
(1.109)
-1.203
(0.922)
-1.476
(0.956)
2.047*
(0.746)
1.757*
(0.594)
-0.928**
(0.484)
0.493
(0.706)
-0.636
(0.657)
-1.050
(0.720)
1.442
(1.176)
-0.035
(0.483)
-0.786*
(0.488)
-0.970
(0.615)
2.088**
(0.903)
-0.338*
(0.202)
-0.474
(0.575)
1.550
(1.037)
0.085
(0.664)
-0.546
(0.801)
0.882
(1.041)
-2.977**
(1.401)
0.002
(0.470)
0.266
(0.904)

1.11e-05*
(6.89e-06)
0.426
(0.500)
1.391***
(0.512)

1.13e-05*
(7.02e-06)
0.412
(0.510)
1.533***
(0.550)

0.293
(0.787)
-1.520**
(0.728)
-2.139**
(0.973)
-1.001
(0.836)
-1.385
(0.871)
1.674***
(0.632)
1.529***
(0.520)
-0.960**
(0.445)
0.272
(0.610)
-0.427
(0.571)
-0.929
(0.659)
1.404
(0.984)
-0.056
(0.427)
-0.639
(0.429)
-0.669
(0.493)
1.784**
(0.759)
-0.359**
(0.185)
-0.497
(0.492)
1.221
(0.896)
-0.062
(0.578)
-0.719
(0.710)
0.956
(0.844)
-2.769**
(1.194)
-0.070
(0.420)
0.419
(0.732)

0.678
(1.178)
55.17
0.0024

1.40e-05*
(7.67e-06)
0.353
(0.584)
1.797***
(0.689)
0.030**
(0.014)
0.217
(0.884)
-2.002**
(0.859)
-2.964**
(1.197)
-1.403
(1.004)
-1.411
(0.987)
2.334***
(0.801)
1.923***
(0.617)
-0.837*
(0.515)
0.566
(0.760)
-0.671
(0.696)
-1.423*
(0.812)
1.603
(1.258)
-0.104
(0.502)
-0.911*
(0.511)
-1.118*
(0.658)
2.093**
(0.893)
-0.274
(0.201)
-0.529
(0.604)
1.906*
(1.118)
0.089
(0.694)
-0.479
(0.855)
1.734
(1.167)
-3.267**
(1.421)
0.173
(0.507)
-0.032
(0.955)
0.078*
(0.044)
0.221
(1.249)
58.65
0.0013

1.473
(0.979)
47.96
0.0108

0.089
(0.828)
-1.667**
(0.762)
-2.500**
(1.022)
-1.165
(0.904)
-1.377
(0.909)
1.744***
(0.639)
1.621***
(0.526)
-0.901**
(0.453)
0.261
(0.630)
-0.473
(0.588)
-1.143*
(0.702)
1.332
(1.013)
-0.106
(0.439)
-0.683
(0.436)
-0.686
(0.504)
1.680**
(0.725)
-0.315*
(0.184)
-0.496
(0.503)
1.365
(0.904)
-0.019
(0.583)
-0.630
(0.722)
1.359
(0.933)
-2.745**
(1.179)
0.056
(0.444)
0.288
(0.782)
0.051
(0.035)
1.257
(1.011)
50.3
0.0084

0.4552
268

0.4838
268

0.3957
268

0.4150
268

*** significant at the 1% level
** significant at the 5% level
* significant at the 10% level
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Table 7-19: Survey 1: Screening OLS Regression on WTP for TEST=1 (detailed)
Category

Independent Variable

Income

Household Income
MSA

Risk Aversion

Life Insurance

Medical
Expeditures
Education

Medical Spending
High School Graduate
Some College
Associates Degree
Bachelors Degree
Graduate Degree

Treatment
Effectiveness

Effectiveness 30%
Effectiveness 85%

Risk Factors

Male
AGE 35 - 44
AGE 45 - 54
AGE 55 - 64
AGE 65 and above
Family History
(Broad)
Smoking Environment
High Cholesterol or Low
HDL
Hypertension (Broad)
Exercise
Overweight
Obese
Very obese

WTP
9.46e-04***
(3.07e-04)
31.947
(24.263)
11.228
(20.983)
0.023
(0.131)
-19.623
(33.870)
-61.379*
(36.642)
-63.455
(52.633)
-61.156
(38.588)
-125.781***
(44.411)
-24.930
(29.872)
-27.798
(29.145)
7.583
(18.829)
2.825
(27.539)
10.587
(29.582)
14.687
(31.296)
61.309*
(33.273)
21.350
(19.448)
14.331
(19.604)
56.776**
(23.067)
-11.007
(21.503)
10.189
(7.666)
-18.768
(23.383)
-15.308
(27.602)
28.565
(28.403)

WTP

WTP (Females)

9.33e-04***
(3.08e-04)
32.368
(24.305)
11.353
(21.012)
0.0219
(0.131)
-19.639
(33.915)
-60.755*
(36.705)
-63.302
(52.704)
-60.417
(38.657)
-125.353***
(44.476)
-26.153
(29.974)
-28.664
(29.216)
7.059
(18.873)
3.801
(27.619)
10.516
(29.623)
15.737
(31.382)
61.519*
(33.320)
21.918
(19.495)
15.764
(19.759)
57.743**
(23.147)
-11.465
(21.544)
10.198
(7.676)
-18.727
(23.414)
-15.113
(27.641)
28.632
(28.441)

1.20e-02***
(4.21e-04)
30.606
(32.389)
-6.297
(29.456)
-0.109
(0.180)
-27.392
(51.068)
-70.246
(53.005)
-107.171
(74.687)
-94.664*
(57.712)
-136.029**
(66.764)
27.828
(46.226)
25.634
(43.142)

14.510
(40.958)
-6.070
(43.651)
-23.528
(44.178)
45.620
(49.584)
13.179
(30.171)
-31.987
(30.387)
33.963
(35.996)
-26.686
(33.320)
19.317*
(11.696)
-81.058**
(35.982)
-38.867
(43.516)
-33.878
(38.246)

WTP (Males)
6.72e-04
(4.85e-04)
28.252
(45.900)
24.824
(31.391)
0.147
(0.249)
25.283
(49.912)
-15.789
(55.803)
-17.369
(80.731)
-14.061
(59.722)
-78.925
(66.532)
-84.749*
(44.606)
-88.699*
(45.832)

-22.542
(39.978)
14.035
(42.801)
63.943
(52.742)
66.110
(49.980)
47.852*
(28.414)
43.290
(29.899)
89.128***
(33.758)
-0.343
(34.984)
8.999
(11.404)
44.138
(35.235)
1.580
(39.779)
87.855**
(44.939)

Diabetes (Broad)

55.395

54.217

128.876**

-23.867

Heart disease

(38.611)
48.652
(33.728)

(38.707)
46.798
(33.899)

(52.852)
22.847
(50.030)

(70.339)
50.819
(55.859)

Heart attack
White
Cholesterol Medication
Change in Perceived
Risk
Starting Bid
Certainty (Broad)
constant
F
Prob > F
2
R
Adj R2
Root MSE
N

-14.931

-14.678

-57.302

13.990

(50.826)
-43.511*
(23.061)
-35.523
(32.960)

0.483
(0.339)
8.941**
(3.586)
-33.906
(58.014)
2.01
0.0021

(50.896)
-42.269*
(23.174)
-35.770
(33.006)
-0.634
(0.993)
0.480
(0.339)
9.009**
(3.592)
-33.252
(58.102)
1.95
0.0028

(101.640)
-58.499*
(33.831)
40.178
(49.640)
-1.180
(1.909)
0.344
(0.464)
9.047
(5.902)
8.098
(98.603)
1.66
0.0345

(63.190)
-17.256
(34.628)
-82.775*
(49.729)
-0.210
(1.273)
0.615
(0.546)
7.372
(5.087)
-87.210
(79.205)
1.61
0.0408

0.2205
0.1106
136.75
252

0.2219
0.1082
136.94
252

0.3719
0.1481
131.45
119

0.3303
0.1247
138.3
133

*** significant at the 1% level
** significant at the 5% level
* significant at the 10% level
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Table 7-20: Survey 1: Screening Censored Regression on WTP (detailed)
Category

Independent Variable

Income

Household Income
MSA

Risk Aversion

Life Insurance

Medical
Expenditures
Education

Medical Spending
High School Graduate
Some College
Associates Degree
Bachelors Degree
Graduate Degree
Effectiveness 30%
Effectiveness 85%

Risk Factors

Male
AGE 35 - 44
AGE 45 - 54
AGE 55 - 64
AGE 65 plus
Family History
Smoking Environment
High Cholesterol or Low
HDL
Bhypertension
Exercise
Overweight
Obese
Very obese

cnreg(cens:
TEST = 1)
1.04e-03***
(2.87e-04)
34.297
(22.867)
23.715
(19.769)
0.062
(0.125)
-19.424
(32.339)
-73.475**
(34.590)
-89.027*
(48.867)
-62.096*
(36.777)
-142.559***
(41.868)
5.884
(27.419)
3.317
(26.799)
-1.772
(17.794)
2.319
(26.243)
8.212
(27.680)
4.719
(29.870)
63.122**
(31.350)
21.780
(18.476)
13.274
(18.660)
51.171**
(21.849)
5.044
(20.393)
6.631
(7.200)
-21.601
(22.128)
-12.078
(26.452)
24.005
(26.912)

tobit (cens = 0) OLS (WTP>0)
1.11e-03***
(3.00e-04)
35.220
(24.014)
36.745*
(21.001)
0.065
(0.131)
-24.922
(34.084)
-83.033**
(36.529)
-96.746*
(51.196)
-70.633*
(38.776)
-165.628***
(44.589)
19.809
(29.039)
15.344
(28.469)
-2.178
(18.649)
-3.840
(27.470)
-4.455
(29.255)
-5.718
(31.582)
57.036*
(32.873)
27.09
(19.447)
13.206
(19.684)
58.443**
(22.867)
8.770
(21.349)
7.389
(7.643)
-19.517
(23.373)
-2.066
(27.742)
31.244
(28.338)

8.86e-04***
(3.21e-04)
33.514
(25.490)
5.658
(22.963)
0.035
(0.134)
-27.443
(36.620)
-68.540*
(39.439)
-74.061
(55.140)
-70.931*
(41.745)
-126.571**
(48.879)
-47.613
(32.676)
-51.139
(32.216)
8.410
(19.715)
10.979
(28.811)
13.723
(31.818)
14.402
(33.720)
61.719*
(34.753)
19.582
(20.579)
14.875
(20.952)
58.401**
(24.171)
-16.039
(22.429)
12.145
(8.382)
-24.134
(25.053)
-22.161
(28.958)
20.896
(30.097)

Diabetes (Broad)

54.217

47.721

52.135

49.895

Heart disease

(38.707)
46.798
(33.899)

(35.492)
64.445**
(32.426)

(37.278)
69.528*
(34.114)

(40.180)
44.224
(35.791)

Heart attack
White
Cholesterol Medication

Controls

WTP
(TEST = 1)
9.33e-04***
(3.08e-04)
32.368
(24.305)
11.353
(21.012)
0.0219
(0.131)
-19.639
(33.915)
-60.755*
(36.705)
-63.302
(52.704)
-60.417
(38.657)
-125.353***
(44.476)
-26.153
(29.974)
-28.664
(29.216)
7.059
(18.873)
3.801
(27.619)
10.516
(29.623)
15.737
(31.382)
61.519*
(33.320)
21.918
(19.495)
15.764
(19.759)
57.743**
(23.147)
-11.465
(21.544)
10.198
(7.676)
-18.727
(23.414)
-15.113
(27.641)
28.632
(28.441)

Change in Perceived
Risk
Initial Bid
Certainty
(Broad)
constant
LR chi2
Prob > chi2
2
Pseudo R
F
Prob > F
R2
Adjusted R2
N

-14.678

-48.299

-62.377

-15.105

(50.896)
-42.269*
(23.174)
-35.770
(33.006)
-0.634
(0.993)
0.480
(0.339)
9.009**
(3.592)
-33.252
(58.102)
1.95
0.0028

(47.430)
-41.574*
(21.619)
-38.178
(31.117)
-0.255
(0.953)
0.527
(0.323)
4.088
(3.362)
-39.236
(55.159)
59.4
0.0023

(50.079)
-38.739*
(22.720)
-43.503
(32.575)
-0.199
(0.995)
0.526
(0.338)
5.536
(3.597)
-77.872
(58.881)
64.06
0.0006

(53.722)
-42.559*
(24.598)
-37.920
(34.100)
-0.706
(1.027)
0.554
(0.354)
10.590***
(3.984)
-10.650
(64.265)

0.2219
0.1082
136.94
252
0.1075
252

0.0182

0.0205

268

268

*** significant at the 1% level
** significant at the 5% level
* significant at the 10% level
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1.87
0.0053
0.2264
0.1051
237

Table 7-21: Survey 2: Treatment Probit on Choosing the Procedure
Independent Variable
Household Income
MSA
Life Insurance
High School Graduate
Some College
Associates Degree
Bachelors Degree
Graduate Degree
Change in Perceived Risk
Strong Prior on Perceived Risk
Weak Prior on Perceived Risk
Cholesterol Medication
Heart Catherization
Special Information
Constant
LR chi2
Prob > chi2
2
Pseudo R
N

Procedure (1=yes, 0=no) as
Dependent Variable
1.35e-05***
1.28e-05***
(4.39e-06)
(4.59e-06)
-0.176
-0.291
(0.299)
(0.315)
0.231
0.234
(0.213)
(0.219)
-0.445
-0.427
(0.335)
(0.344)
-0.298
-0.337
(0.374)
(0.386)
-0.367
-0.259
(0.468)
(0.494)
-0.274
-0.180
(0.419)
(0.435)
-1.061**
-0.985*
(0.494)
(0.505)
0.034**
0.035**
(0.015)
(0.015)
0.005
0.005
(0.005)
(0.006)
0.008
0.010
(0.012)
(0.014)
-0.133
-0.240
(0.204)
(0.216)
0.458**
(0.209)
-0.350*
(0.202)
0.816**
0.967*
(0.467)
(0.499)
23.03
31.75
0.0275
0.0043
0.094
295

0.1296
295

*** significant at the 1% level
** significant at the 5% level
* significant at the 10% level
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Table 7-22: Survey 2: Treatment Probit on Choosing the Procedure (detailed)
Category

Independent Variable

Wealth

Household Income
MSA
Secure
Own Home

Risk Aversion

Life Insurance

Education

High School Graduate
Some College
Associates Degree
Bachelors Degree
Graduate Degree

Medication

Change in Perceived
Risk
Strong Prior on
Perceived Risk
Weak Prior on
Perceived Risk
Cholesterol Medication

Familiarity

Heart Catherization

Risk

Special Info
Responsibility

Work
Stress
Married
Child Under 18

Physical
Limiations

Overweight
Obese
Very obese
Disabled
Age
Frequency of MD Visits

Gender

Male
constant
LR chi2
Prob > chi2
Pseudo R2
N

Procedure
(1=yes, 0=no)
1.14e-05**
(5.34e-06)
-0.218
(0.341)
-0.217
(0.179)
0.253
(0.263)
0.230
(0.246)
-0.734*
(0.402)
-0.622
(0.438)
-0.784
(0.557)
-0.381
(0.493)
-1.238**
(0.579)
0.037**
(0.016)
0.005
(0.006)
0.017
(0.016)
-0.416*
(0.258)
0.413*
(0.239)
-0.309
(0.223)
-0.214
(0.296)
-0.224**
(0.089)
0.092
(0.246)
0.169
(0.413)
-0.203
(0.287)
0.391

Procedure
(w/o outliers)
1.12e-05**
(5.35e-06)
-0.216
(0.340)
-0.222
(0.179)
0.256
(0.263)
0.230
(0.245)
-0.733*
(0.402)
-0.617
(0.438)
-0.784
(0.557)
-0.376
(0.493)
-1.282**
(0.582)
0.037*
(0.016)
0.005
(0.006)
0.017
(0.016)
-0.400
(0.259)
0.402*
(0.240)
-0.301
(0.223)
-0.203
(0.297)
-0.228***
(0.090)
0.089
(0.246)
0.163
(0.411)
-0.214
(0.288)
0.374

Procedure
(females)
9.13e-06
(6.96e-06)
-0.394
(0.548)
-0.344
(0.252)
0.214
(0.351)
0.233
(0.334)
-0.718
(0.587)
-0.593
(0.653)
-0.595
(0.906)
-0.343
(0.743)
-2.501***
(1.004)
0.046*
(0.027)
0.005
(0.010)
0.012
(0.019)
-0.865**
(0.396)
0.167
(0.363)
-0.546*
(0.327)
0.349
(0.453)
-0.421***
(0.142)
0.453
(0.352)
0.013
(0.560)
-0.277
(0.408)
0.487

Procedure
(males)
1.80e-05
(1.36e-05)
0.505
(0.748)
-0.332
(0.432)
0.769
(0.698)
0.333
(0.549)
-0.609
(0.878)
0.184
(1.026)
-0.280
(1.097)
0.358
(1.041)
-1.076
(1.249)
0.049
(0.035)
0.005
(0.014)

0.524
(0.581)
0.243
(0.465)
0.240
(0.519)
-1.603***
(0.665)
-3.29e-04
(0.215)
-0.519
(0.681)

-0.232
(0.713)
-0.284

(0.360)
-0.192
(0.350)
-0.723*
(0.375)
-0.022*
(0.012)
0.067
(0.071)
0.367
(0.240)
3.396***
(1.123)
52.79
0.0021

(0.361)
-0.200
(0.351)
-0.720*
(0.374)
-0.022*
(0.012)
0.069
(0.071)
0.360
(0.240)
3.411***
(1.122)
52.63
0.0022

(0.494)
0.450
(0.519)
-0.448
(0.507)
-0.004
(0.017)
0.199*
(0.105)

(0.847)
-1.743**
(0.882)
-1.294
(1.084)
-0.094***
(0.035)
-0.138
(0.145)

2.512
(1.614)
44.98
0.0118

8.015***
(2.984)
33.47
0.0946

0.2154
295

0.2154
293

0.3090
146

0.3838
123

Variable dropped by Stata
due to insufficient variation

*** significant at the 1% level
** significant at the 5% level
* significant at the 10% level
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Table 7-23: Survey 2: Treatment OLS Regression on WTP for Procedure = 1
Category

Independent Variable

Wealth

Household Income
MSA
Secure
Own Home

Risk Aversion

Life Insurance

Education

High School Graduate
Some College
Associates Degree
Bachelors Degree
Graduate Degree

Medication

Change in Perceived
Risk
Strong Prior on
Perceived Risk
Weak Prior on
Perceived Risk
Cholesterol Medication

Familiarity

Heart Catherization

Risk

Special Info
Responsibility

Work
Stress
Married
Child Under 18

Physical
Limiations

Overweight
Obese
Very obese
Disabled
Frequency of MD Visits
Age

Controls

Male
Starting Bid
Certainty (Broad)
constant
F
Prob > F
2
R
2

Adjusted R
Root MSE
N

WTP
(w/o outliers)
0.109**
0.033**
(0.053)
(0.029)
4928.354
2284.069
(4035.789)
(2192.194)
4109.028*
3564.700***
(2184.794)
(1188.434)
-1466.485
-513.044
(3836.191)
(2081.369)
-3198.99
-2794.225
(3534.656)
(1917.513)
-1989.560
-337.581
(4372.609)
(2374.326)
-4689.519
-2497.080
(4969.982)
(2697.980)
-72.099
595.552
(6488.626)
(3520.707)
-4836.537
-2790.105
(5262.481)
(2857.239)
19720.280***
-602.035
(7112.78)
(4009.845)
-456.302***
-174.710*
(175.032)
(95.728)
-51.282
6.819
(78.378)
(42.591)
213.866
-10.362
(155.183)
(84.804)
-441.288
193.514
(3299.370)
(1805.763)
-2211.117
158.622
(3081.394)
(1689.928)
-5974.020**
-3599.107**
(2875.915)
(1563.618)
-1832.511
771.701
(3811.188)
(2075.798)
93.881
936.109
(1184.701)
(651.036)
4128.444
2885.645
(3382.664)
(1836.506)
-7061.518
-3273.953
(4437.608)
(2413.759)
-2608.203
-1838.732
(3652.386)
(1983.329)
5937.888
651.206
(4005.719)
(2185.424)
-412.275
-1676.393
(4686.081)
(2543.341)
1642.73
1345.658
(5209.144)
(2825.726)
-1629.798*
-886.218*
(868.825)
(472.477)
126.413
71.965
(141.643)
(76.87)
-1117.570
-261.545
(3048.717)
(1654.785)
0.739*
0.371*
(0.407)
(0.221)
706.029
60.368
(466.701)
(255.354)
-9967.795
-4970.592
(13,509.030)
(7347.943)
2.53
1.68
0.0001
0.0197
WTP

WTP
(females)
0.077*
(0.043)
-2005.946
(3786.757)
2674.341
(1903.600)
-2811.786
(2958.094)
-1851.460
(2784.271)
-3968.481
(3698.874)
-7984.829*
(4106.417)
-9666.696
(6916.234)
-5888.573
(4520.946)
-3753.547
(13,665.87)
-136.912
(167.009)
22.365
(65.144)
-9.784
(121.414)
-678.573
(2781.216)
2229.917
(2890.720)
-4208.203*
(2452.495)
354.464
(3072.692)
921.855
(1007.738)
2676.920
(2494.228)
-693.851
(3929.575)
-4569.191
(3150.075)
1543.381
(3498.963)
-935.609
(3488.426)
-2494.662
(4144.381)
-1106.354
(697.425)
104.172
(107.310)

WTP
(males)
-0.043
(0.049)
7209.448**
(3223.649)
5333.224***
(1766.389)
2998.222
(3426.934)
-2858.137
(3120.109)
4386.075
(3438.510)
1669.639
(4020.062)
6987.623
(4717.818)
1714.373
(4094.976)
4467.372
(4997.631)
-237.012*
(125.4868)
-12.357
(60.668)
66.064
(149.354)
-135.999
(2609.523)
249.393
(2365.540)
-2957.343
(2212.747)
363.458
(3175.670)
146.502
(993.301)
5089.970
(3281.424)
-5202.266
(3546.365)
-1359.294
(2989.931)
430.263
(3166.646)
-7131.897
(4564.376)
8861.012**
(4459.687)
-326.008
(744.064)
-86.992
(127.409)

0.357
(0.365)
343.120
(420.831)
1021.727
(11,043.29)
1.19
0.2626

0.650**
(0.322)
-69.350
(362.837)
-7926.283
(12,080.18)
1.33
0.1502

0.2480

0.1817

0.2752

0.2642

0.1498
20792
252

0.0739
11278
252

0.0446
11845
117

0.0661
10998
133

*** significant at the 1% level
** significant at the 5% level
* significant at the 10% level
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94

50
Median

Figure 7-1: Distribution of WTP for Screening

Mean
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Mean = 94
Median = 50
SD = 143
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2500 7,821

Figure 7-2: Distribution of WTP for Treatment

Median

Mean = 7,821
Median = 2,500
SD = 21,084

*2 observations (WTP=100,000 and 300,000) are omitted from graph to maintain horizontal scale in order to
view distribution more clearly

Mean
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Chapter VIII: Discussion and Conclusion
8.1 Restatement of Motivation and Purpose
Despite significant advances in coronary care in the last two decades, national
fatality rates from heart attacks have remained predominantly unchanged (Muller 1999).
Recently, it was discovered that treatment was aimed at reducing the amount of plaque in
the coronary vessels, while the cause of heart attacks was dependent on the composition
of the plaque. In particular, cardiologists now believe that 75% of all heart attacks are
caused by a “vulnerable” plaque which creates a blockage in the vessel when it erupts
into the bloodstream causing a clot to form. This new theory explains why traditional
risk factors for heart disease have failed to identify many people who are risk for heart
attack and is evidenced by the fact that over half of the individuals who die suddenly
from coronary heart disease (CHD) had no previous warnings prior to the attack
(American Heart Association 2003). Therefore, many individuals at risk for a heart
attack are not receiving treatment and may not even be aware that they are at risk. As a
result, medical researchers are working to develop a screening method that is inexpensive
and non-invasive enough to administer to the general public to better identify those at risk
for a heart attack. Once an individual is identified as being at high risk, treatment can be
started. Unfortunately, the only treatment currently available is drug therapy, which is
only about 30% effective at reducing heart attacks. Again, the problem being that
cholesterol lowering drugs were developed to reduce the total amount of plaque, which
does not necessarily reduce vulnerable plaque. Therefore now that the cause of heart
attacks is better understood, medical device companies are researching ways to find the
hidden plaque and treat it. Once this is accomplished, it is likely that many individuals
will be eligible for this procedure; however, choosing who receives it will most likely be
based on public policy decisions administered by Medicare.
Because most individuals who are at risk for heart attack are 65 and over, much of
the expenditures for managing heart disease and treating heart attack patients are covered
by Medicare. Therefore, in many heart-related medical cases, public policy determines
who receives care and the level of care that is given. In addition, a large portion of
disability allowances stem from disabilities resulting from CHD and heart attack.
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Therefore, the screening and treatment of vulnerable plaque is certainly an issue that
affects the allocation of public funds. Thus, it is important to understand the underlying
preferences of individuals who are likely to receive these services, such that efficient
decisions can be made regarding who is eligible to receive care and the level of care that
will be provided when these new health options become available.
To obtain a valuation for these services, and better understand the factors
affecting demand, two contingent valuation surveys were conducted to elicit the
underlying preferences of individuals by having them state their WTP for either screening
or treatment. The surveys were developed using decision trees that reflected the medical
options available in both the current and desired states of the world. After receiving
valuable information from focus groups, both surveys were converted into web-based
surveys and administered online. Because Internet surveys are often prone to coverage
bias, Knowledge Networks (KN) was selected to administer the web-based surveys using
their nationally representative panel. Therefore, Survey 1: Screening was administered to
adults representing the general population, and resulted in a sample size of 268
observations. Using health data obtained from KN panel members, Survey 2: Treatment
was administered to adults with doctor-diagnosed heart conditions. This resulted in a
sample of 295 individuals who had a greater level of familiar with heart issues, and as
result, are expected to provide more reliable valuations for the WTP for treatment.
8.2 Comparisons to Earlier Work and Theoretical Expectations
To help establish the validity of the data sets and better understand the factors
affecting the WTP for screening and treatment, models of general health and perceived
risk were developed. The results of these models are consistent with economic theory
and therefore, lend credibility to the data sets used to analyze WTP.

8.2.1 General Health
The general health models for both data sets are consistent with Grossman’s
(1972) model of health production. As expected, age has a negative and often significant
effect on general health, especially for individuals 55 years of age and over. Consistent
with Grossman’s theory, education has a positive effect on general health, and is
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statistically significant for those individuals holding a college degree. Also as expected,
individuals who have experienced a life threatening condition or illness report a lower
level of general health, ceteris paribus, which is consistent with Grossman’s theory of an
accident or injury reducing the health stock. In addition, high levels of stress or being
significantly overweight reduces general health. Investments in health, such as exercise,
improve general health; however, frequent visits to the doctor have a negative effect on
general health, suggesting that this variable is acting as a proxy for chronic conditions
which negatively affect health. Finally, as Grossman predicts, individuals with higher
levels of household income report higher levels of general health, ceteris paribus.
Therefore, the results of the regression on general health support Grossman’s theory of
household health production and lend credibility to the data sets used for this study.

8.2.2 Perceived Risk
Regression models including the American Heart Association (AHA) risk factors,
and controls for cholesterol lowering medication, and education, indicate that several of
the risk factors are significant in determining perceived risk. These include (1) being a
male over the age of 45, (2) being a female over the age of 55, (3) having high
cholesterol, (4) being 20 pounds or more overweight, and (5) having coronary heart
disease or having had a prior heart attack. Education was highly significant and negative
at all levels, suggesting that those with more education have lower levels of perceived
risk. Separating out risk factors that included more than one variable indicated that age,
rather than gender, had more of an effect on perceived risk. In particular, the coefficients
on the “55 to 64” age group is positive and significant across all specifications. This is
not a surprising given that physicians start treating heart disease more aggressively at age
55. Not unexpectedly, individuals who had experienced a heart attack had a higher
perceived risk, and the greater the severity of the attack (as measured by the degree to
which the heart attack affected the individual’s ability to work, engage in their daily
activities, provide for their family, and their overall quality of life), the greater the
individual’s perceived risk. Finally, individuals who reported a lower general health
status or who have experienced a life threatening condition or illness also tended to
indicate higher levels of perceived risk, ceteris paribus.
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Comparing regressions using the individual’s self-reported perceived risk
obtained after the new information was presented versus perceived risk prior to the new
information suggests that individuals understood the new information and responded
accordingly. In fact, even though the information presented in the survey was brief and
to the point, much like the information that would be provided to a patient by a physician,
the regression results support the fact that respondents were able to process this
information correctly. Therefore, as Hoehn and Randall (2002) find in their study, a
small amount of information is enough for respondents to “fill in” the gaps using prior
information. This was evident in this study by the fact that perceived risk (after the new
information) was not well explained by traditional risk factors. In fact, it appears the new
information caused individuals to base their risk perceptions less on traditional risk
factors and “fill in” using prior information, such that they relied more on factors that are
commonly known to affect heart disease, including being overweight and smoking.
Interestingly enough, taking cholesterol lowering medication does not
significantly reduce perceived risk in any of the specifications, for either the Survey 1:
Screening data or the Survey 2: Treatment data. Currently, statin (cholesterol lowering)
medications are only about 30% effective and take a long time to work; therefore, the
findings from the perceived risk models suggest that individuals recognize the
shortcoming of the drug therapy treatment currently available, and lends support to the
need for a new, more effective treatment method.
8.3 Key Results – WTP for Screening and Treatment
The data obtained from Survey 1: Screening indicates that the mean WTP for
screening is $94, with a median of $50 and standard deviation of $143. The regression
results suggest an upward bias of $25 due to the initial bid; therefore, following
Whitehead et al (1995) this value is subtracted in order to obtain unbiased estimates.
Thus, after adjusting for starting point bias, the mean WTP for screening is equal to $69
and the median is $25. These WTP estimates include some individuals who chose not to
have the screening and others who would only receive screening if it were offered at no
out-of-pocket cost. However, most individuals appear to value the screening and would
be willing to spend some of their financial resources to receive it. Even when no
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treatment is available, many individuals have a positive value for the screening. This is
consistent with the finding by Berwick and Weinstein (1985) and suggests that
information obtained from screening does have value for its own sake; namely, that it is
likely to increase the individual’s expected utility by allowing for better planning and
allocation of the individual’s time.
The results of Survey 2: Treatment data indicate that the mean WTP for a
treatment that is 85% effective at reducing the risk of heart attack is $7,821 with a
median of $2,500 and standard deviation of $21,084. The regression results suggest that
setting the starting point bias equal to zero requires a downward adjustment of $2,005.
Therefore, the unbiased mean WTP for treatment is $5,816 and median of $495. This
valuation includes some individuals in the general population who preferred drug therapy
as a treatment option and some individuals who elected to have no treatment at all.
Again, some individuals would only have the treatment if it were offered at no out-ofpocket cost to them; however, as the mean and median indicate, most individuals valued
the procedure and were willing to spend some of their financial resources to receive it.
8.4 Factors that Influence the Demand for Screening and Treatment
In analyzing the factors that influence WTP for the screening and treatment of
vulnerable plaque, the data analysis suggests that some factors appear to influence
whether the individual will choose to have the screening/procedure, while other factors
affect how much the individual is willing to pay for it. A common issue in analyzing
health data is how to handle the large number of zeros that are typically present in the
data. It is often suggested that a two-part model be used, such that a probit/logit equation
is used to model the decision to have the screening/treatment, and then an OLS regression
is used to model WTP, but only using those observations for which participation occurs.
The data analysis for the Survey 1: Screening data and the Survey 2: Treatment data
support the use of a two-part model in estimating marginal effects for factors influencing
WTP.
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8.3.1 The Decision to Have Screening
The decision to have screening was modeled using two specifications of a probit
model. The basic model includes general measures of perceived risk as obtained from
the respondent assessing his/her risk using a computerized visual analog scale. The
detailed model includes specific risk factors as measured by a risk assessment quiz
published by the American Heart Association (AHA) and from health data obtained from
KN which included past diagnoses and other health behaviors of the individuals in the
sample.
The results of the basic probit regression indicate that the new information
received by the respondent (as measured by their change in perceived risk) was an
important factor in the individual choosing to have the screening. In addition, individuals
were more likely to have the test if treatment was available (although the level of
treatment effectiveness was not necessarily important). And finally, those who are more
risk averse (as measured by having life insurance) are more likely to choose the
screening. The results of the detailed probit model support these broad conclusions. In
addition, it appears that males, individuals who exercise, and those who have already
experienced a heart attack are less likely to get the screening.

However, the base

likelihood of getting the screening is significantly increased for individuals with high
blood pressure.
Although the lack of a significant difference between WTP for screening when
treatment is 30% effective versus when treatment is 85% effective may suggest an
insensitivity to scope, it is important to remember that individuals are being asked to
value screening; therefore, the effectiveness of the treatment is one step removed from
the treatment decision. Although respondents may not distinguish very much between a
treatment that is 30% effective and one that is 85% effective when determining their
WTP for screening; it is clear they do differentiate between screening in which treatment
is available versus screening in which no treatment is available in their decision to get the
screening test. Since screening with the possibility of treatment is clearly larger in scope
(offering a higher level of quality), the results of this study do suggest that individuals
completing the CV survey did respond to variations in scope.
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8.3.2 WTP for Screening
The factors influencing the WTP for screening were determined using an OLS
regression for those individuals who chose to have the screening (including those who
would only receive the screening when it involved no out-of-pocket cost). The data
indicates construct validity in that, as theory would predict, higher levels of household
income increases the WTP for screening. This model also suggests that those with higher
perceived risk who have strong priors regarding their risk assessment, will have a higher
WTP for screening. Race appears to matters in that whites (compared to non-whites) will
tend to have a lower WTP for screening, all else constant. And finally, (not surprisingly)
those who are risk averse and have high cholesterol levels are willing to pay more.

8.3.3 Choosing a More Effective Treatment
The results of the probit model indicate that the decision to have treatment is
largely affected by household income as well as the change in perceived risk brought
about by the new information. In addition, familiarity plays an important role in that
having experience with a heart catheter procedure increases the base probability of
choosing the procedure by 0.45, indicating that those individuals who have had a heart
catheterization procedure in the past are significantly more likely to have the procedure.
However, requesting additional information about the procedure decreases the base
probability of choosing the procedure by 0.31, indicating that those who are unfamiliar
with the procedure and ask additional questions are significantly less likely to have the
procedure, even if their perceived risk of a heart attack is high. These results suggest that
providing information about the risks associated with vulnerable plaque is important, but
perhaps even more important is providing information that makes the patient feel more
comfortable with the procedure. Clearly the information provided by the specialist did
not improve the likelihood that the patient would receive the recommended treatment;
however, those who had undergone a heart catheterization procedure in the past were far
more likely to have the procedure. Therefore, if the objective is to encourage patients to
receive the recommended treatment, it may be helpful to conduct a focus group of
patients who have had a heart catheterization in the past to better understand their
apprehensions prior to the procedure and how those views changed following the
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procedure. This information could then be used to create a user-friendly brochure to help
patients unfamiliar with the procedure feel more at ease.
The extended probit model indicates that those individuals with physical
limitations resulting from disability and advanced age may also be less likely to choose
the procedure. Certainly the physician would recognize medical conditions that would
increase the risk associated with the procedure and share those with the patient as part of
the discussion of treatment options. However, being aware that this may be a particular
issue for disabled and elderly patients, care can be taken to ensure the patient is
accurately assessing these risks, such that he/she can make an informed decision based on
actual risks, as opposed to perceived risks that may be unfounded.

8.3.4 WTP for Treatment
As expected, one of the largest determinants of WTP for treatment is consumer
wealth. As theory would predict, individuals with higher levels of household income are
willing to pay more, as are individuals who have greater financial security. Individuals
with chronic conditions (as measured by frequent visits to the doctor) are willing to pay
less for the procedure. This is not unexpected since individuals with chronic medical
problems would be anticipated to have a lower expected utility gain from the procedure.
Finally, information plays a role. Those who request additional information about the
procedure are willing to pay about $3600 less on average compared to those who do not
request additional information. In addition, those who feel their risk increases from the
new information about vulnerable plaque are willing to pay less. These results suggest
that those who are uncertain about the procedure and the risk reduction associated with it
may have significant questions. As a result, these individuals may feel less confident
about the value of the procedure, which translates into a lower WTP.
8.5 Contributions to the Literature
8.5.1 Valuing Heart-Related Health
In determining the reliability of results from a CV study, comparisons can be
made to other studies. Kartman et al. (1996) and Chestnut et al. (1996) estimate WTP to
reduce the occurrence of angina (chest pain). Since angina is only one symptom of heart
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disease, it is expected that the WTP to reduce angina would be significantly less than the
WTP to reduce the probability of a heart attack. However, since angina can have a
significant effect on quality of life, reducing the individual’s ability to work and engage
in daily activities, the WTP for a reduction in angina is expected to be higher than the
WTP for screening. Kartman et al. (1996) find the mean WTP to reduce the number of
chest pain occurrences by 25%-75% is between $290 and $345 (about $380-$450 in
today’s dollars). In order to avoid 8 additional episodes of chest pain, Chestnut et al.
(1996) find a mean WTP of $218 (approximately $290 in today’s dollars). Therefore, the
results from this study seem reasonable in that mean WTP for screening is below reported
estimates of mean WTP for reducing the occurrence of chest pain, yet the WTP for
treatment (which would reduce the risk of heart attack) is significantly greater than the
mean WTP for reducing the occurrence of angina.
A study by Johannesson, et al. (1993) found that individuals in Sweden with
elevated cholesterol levels had a mean WTP of SEK 344 (about $61 in current U.S.
dollars135) per month to achieve a normal cholesterol level. This equates to $732 per
year. Therefore, for the mean WTP for treatment ($7,821), respondents in Sweden could
receive 10 years of normal cholesterol. Given that the effectiveness of the treatment was
estimated to be a maximum of 6.5 years using VSL estimates (See Section 7.9 Treatment
Effectiveness and Value of a Statistical Life), this suggests that individuals in the
Swedish study were not willing to pay as much.136 Of course, the goods being valued are
not exactly the same – the good in the Swedish study reduces one potential cause of heart
attack completely, but leaves other potential risk factors unchanged. Therefore, the new
procedure valued in this study may offer more benefit in that it directly reduces the risk
of heart attack by 85%. In addition, it is possible that differences in WTP could arise
from the different health care systems in the two countries creating cultural differences
regarding consumer WTP for medical treatment.
135

The exchange rate for August 2, 1993 (the month the study was published) was 1 SEK (Swedish Krona)
= .123487 USD. Exchange rate obtained from http://www.x-rates.com/cgi-bin/hlookup.cgi
Therefore, 344 SEK = $42.48 (1993). Using the “inflation calculation” on the Bureau of Labor Statistics
website (http://www.bls.gov/) to adjust by the CPI indicates that $42.48 in 1993 is equivalent to $60.76 in
current (2007) dollars.
136
The results are similar if the mean WTP adjusted for starting point bias is used. A mean WTP of $5,816
would equate to approximately 8 years of normal cholesterol, compared to the maximum implied
effectiveness of 4.5 years using VSL estimates.
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8.5.2 Iterative Bidding with Cheap Talk and Follow-up Certainty Question
The iterative bidding technique used for the web-based surveys worked well in
that a review of individual observations revealed that respondents seemed to take the
bidding seriously, and in many cases, switched responses several times during the
bidding process. Unfortunately, as the empirical results illustrate, starting point bias was
still an issue. However, given the greater efficiency of using a multiple-bounded DC
choice question in eliciting WTP and the power of the Internet to use real-time interface
to generate questions based on past responses, it is likely that this new format will yield
other variations of iterative bidding that may not be prone to starting point bias. In
addition, the computer capabilities of a web-based survey offer greater opportunities for
internal checks that may help reduce the possibility of hypothetical bias.
As mentioned previously, hypothetical bias currently poses one of the greatest
problems for CV. As a result, researchers have attempted to eliminate hypothetical bias
ex ante using a cheap talk script or ex post using calibrations based on a certainty followup question. Blumenschein et al. (forthcoming 2007) find that the cheap talk script is not
effective in removing hypothetical bias, but that recalibrating using only individuals who
are “definitely sure” of their responses can successfully remove hypothetical bias such
that stated intentions correspond with actual purchase decisions. The purpose of this
study was not to test the reliability of these methods; however, because WTP estimates
were obtained following the cheap talk script, as well as the follow-up certainty question,
some limited information as to the reliability of these methods can be offered by this
study.
For the Survey 1: Screening data, the mean initial WTP for screening (following
the cheap talk) was $108; however, it was only $94 following the certainty question.
Likewise, for the Survey 2: Treatment data, the mean initial WTP for treatment
(following the cheap talk script) was $9,928; however, it dropped to $7,821 following the
certainty question. A final certainty question used in the focus groups indicated that most
respondents were “definitely sure” of their WTP following the cheap talk script and the
certainty scale question. Therefore, from these differences, it appears that the cheap talk
script does not sufficiently reduce hypothetical bias, but the combination of the cheap talk
script with a certainty follow-up question may eliminate hypothetical bias (with no ex
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post calibration required). To test whether the cheap talk script with a follow-up certainty
scale question can effectively eliminate hypothetical bias, a study could be conducted
using this method in such a way that stated intentions could be compared to actual
purchase decisions. Because the elimination of hypothetical bias is such an important
issue confronting the ability of CV to provide accurate measures of valuation, this is
certainty a possible topic for future research.

8.5.3 The Role of Information on Consumer Demand for Health-Related Goods
The concepts proposed by Hoehn and Randall (2002) are particularly relevant to
this study. Presumably “new” information on who is at risk for a heart attack is presented
and measures of individual risk perception are obtained both before and after respondents
are made aware of this new information.

As Hoehn and Randall suggest, new

information may have different effects on respondents’ perception of risk, depending on
their priors. The CV surveys used in this study allow for this possible heterogeneity. In
particular, data is collected to determine the direction and magnitude that the new
information has on each respondent’s perception of heart attack risk.
Although the new information presented in the survey was expected to increase
perceived risk; as Hoehn and Randall (2002) suggest, new information does not
necessarily have that effect.

In fact, 65% of the sample who completed Survey

1:Screening indicate that their risk perception did not change after reading the new
information, and 5% indicated that the new information lowered their perception of heart
attack risk. For the Survey 2: Treatment sample the results were similar. Sixty percent
indicated that their perceived risk did not change and almost 5% indicated their risk
decreased after reading the new information. Therefore, in both samples, a majority of
the individuals had strong priors regarding their perceived risk of a heart attack. As the
results of this study indicate, this strength of prior risk perception is an important factor in
the decision to get screening, as well as in determining WTP for the procedure.

8.5.4 Does Information have Value for its own Merit?
Berwick and Weinstein (1985) find that information that has no bearing on
medical decisions comprises about 25% of the WTP for ultrasound for women with
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normal pregnancy. In this study, those who were most certain of their stated WTP
(certainty=10), indicated a mean WTP of $52 for screening when no treatment is
available, a mean WTP of $93 for screening when treatment is 30% effective, and a mean
WTP of $135 for screening when treatment is 85% effective. These results suggest that
the value of information (that does not affect medical decision making) from screening is
approximately 38% of the value of screening when the more effective treatment is
available. It should be noted that the number of respondents who received a version of
Survey 1: Screening in which there was no treatment was fairly small; therefore the
numerical results should be used cautiously; however, the results do suggest that
information from screening (in the absence of treatment) clearly has some value for
individuals. Due to the fact that it is highly likely medical researchers will develop a
screening for vulnerable plaque before they develop a treatment, a more in depth study
focusing on the WTP for screening in the absence of treatment could be a topic for future
research.

In addition, Berwick and Weinstein point out a potential shortcoming of

clinical decision analysis in that it does not include the value of information from a nonclinical standpoint in selecting the best treatment option. This was evidence by Scenario
2 in Chapter 4 in which screening is available, but treatment is not. In this case,
screening would have no bearing on the medical outcomes (as illustrated by the same
branches in Figure 2 for both the screening and no screening options); therefore, clinical
decision analysis would not indicate a preference for screening. Yet the results of this
study, and that of Berwick and Weinstein (1985), both suggest that information clearly
has value for its own merit that should be considered in clinical decision analysis as well
as in decisions affecting public policy.

Copyright © Patricia L. Ryan 2007
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Appendix A: Survey Instruments
{Survey 1: Screening}
{Notes appearing in {brackets} provide information for programming and do not
appear in the online version of the survey. Screen breaks are indicated by either
a page break, dashed line or solid line, the circles represent radio buttons, and
navigational buttons appearing in the bottom right-hand corner of each screen
are indicated by square brackets [ ]}
{I. Welcome Screen}
{1}

How important do you feel it is for your doctor to include you in making
decisions regarding your health?
Select one answer only
○ Very important
○ Somewhat important
○ Not important

[Next Question]
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{II. General Questions}
Medical advances are occurring at a rapid rate; however, this can increase the cost of
providing health care. Because of these rising costs, it becomes important to focus on
how society should allocate its health care resources. The following questions will assist
us in determining what is important to you. Specifically, we would like to ask how you
would spend your own money for a medical test that could better identify who is at risk
for a heart attack.

[Continue]
{2}

Have you ever been told by a doctor that you have heart disease?
Select one answer only
○ Yes
○

No

○

I don’t know

[Next Question]
{3}

Have you ever taken medicine to reduce your cholesterol (Some examples
include: Lipitor, Zocor, Mevacor, Pravachol)?
Select one answer only
○ Yes
○

No

○

I don’t know

[Next Question]
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{4}

Have you ever experienced a heart attack?
Select one answer only
○ Yes
○

No

[Next Question]
{5}

Do you have a relative in your immediate family (spouse, parent, sibling, or child)
who has experienced a heart attack?
Select one answer only
○ Yes
○

No

[Next Question]
----------------------------------------------------------------------------------------------------------{If respondent answers “Yes” to question 5, then ask question 5b}
{5b}

Were you involved in making decisions regarding the treatment of this
family member’s heart condition?
Select one answer only
○ Yes
○

No

[Next Question]
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{6}

Have you ever undergone a heart catheterization procedure?
Select one answer only
○ Yes
○

No

○

I don’t know

[Next Question]
{7}

Are you a cardiologist or other health care professional who has received specific
training in the treatment of heart disease?
Select one answer only
○ Yes
○

No

[Next Question]
{8}

Have you ever had a life-threatening condition or illness?
Select one answer only
○ Yes
○

No

[Next Question]
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{III. Perceived Risk Questions}
According to the American Heart Association, the following are factors that could
increase your risk for a heart attack.
Please click Yes or No to indicate which risk factors apply to you

Are you a man over 45 years old.
Are you a woman over 55 years old, OR
Are you a woman less than 55, who has passed menopause OR
Are you a woman less than 55, who has had her ovaries removed,
but is not taking estrogen.
Did your father or brother had a heart attack before age 55 OR
Did your mother or sister have a heart attack before age 65.
Do you smoke, or live or work with people who smoke every day.

Is your total cholesterol level 240 mg/dL or higher OR Have you
ever been told by your doctor that you have high cholesterol
Is your HDL ("good") cholesterol level less than 35 mg/dL.
Is your blood pressure 140/90 mm Hg or higher, OR have you
been told that your blood pressure is too high.
Do you get less than a total of 30 minutes of physical activity on
most days.

Are you 20 pounds or more overweight for your height and build.
Do you have diabetes OR a fasting blood sugar of 126 mg/dL or
higher), OR do you need medicine to control your blood sugar.
Do you have coronary heart disease, or have you had a heart
attack.

YES

NO

○
○

○
○

DON”T
KNOW
○
○

○

○

○

○

○

○

YES

NO

○

○

DON”T
KNOW
○

○
○

○
○

○
○

○

○

○

YES

NO

○
○

○
○

DON”T
KNOW
○
○

○

○

○

[Next Question]
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Annual Risk of Fatality (Deaths per 100,000 persons)
No
Auto
High
Risk
Accident
Risk
|-----------------|-------------------------------|------------------------//------------>
0
19
50
100,000
By identifying your own risk factors on the previous screen, you probably have a better
awareness of your own risk for having a heart attack. Suppose you were asked to rate
your risk of having a heart attack within the next year using the scale above (0 being NO
risk and 50 being HIGH risk). If your risk of dying in a car accident within the next year
is placed at 19, where would you place your risk of having a heart attack?
Although most people will have a risk in the range of 0 to 50, some people (including
those who have already experienced a heart attack), may have a risk higher than 50
Using the above scale as a guide, enter the number that best describes your risk of having
a heart attack in the next year. ______ {response will be inserted in follow-up certainty
question on page 8}
Enter an answer from 0 to 100000 [_______]
{If response is not between 0 and 100,000, an error message is shown}

[Next Question]

250

New Information on Who is at Risk for Heart Attacks
Most of us learned that a build up of plaque within our arteries puts us at higher risk for
heart attack, yet at some point you have probably heard of a very healthy, young man or
woman who died suddenly of a heart attack. In fact, over 100,000 Americans die each
year without ever having experienced any symptoms of heart disease. A news report that
aired in January 2001 on the television show 20/20 explained how this can occur. The
reporter stated that doctors have discovered that it is not atherosclerosis, or what many of
us know as “hardening of the arteries,” that causes most heart attacks. Instead,
researchers now believe that most heart attacks are caused by something called
“vulnerable plaque.”
[Continue]
What is vulnerable plaque?
Vulnerable plaque is a type of plaque that lies hidden beneath the surface of an artery,
much like lava within a volcano. Because this plaque is only covered by a thin cap,
exercise or stress can “trigger” this plaque to erupt. When this occurs, it causes a blood
clot to form instantaneously within the vessel. This blood clot can block the artery and
prevent blood from traveling to the heart, which results in a heart attack.

[Continue]
Who is at risk for vulnerable plaque and heart attack?
Although those with high cholesterol and other known risk factors (like those mentioned
earlier in this survey) are more at risk, apparently healthy individuals with NO prior
symptoms of heart problems can have vulnerable plaques waiting to erupt. Unfortunately
there is currently no way to determine who has vulnerable plaque and who does not.
Therefore, you may have vulnerable plaque, but be completely unaware that you are at
increased risk of a heart attack.

[Continue]
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After reading this new information, I feel my own risk of having a heart attack within the
next year is now
Select one answer only
○
○
○
○
○

much higher
somewhat higher
the same
somewhat lower
much lower

[Next Question]

Annual Risk of Fatality (Deaths per 100,000 persons)
No
Auto
High
Risk
Accident
Risk
|-----------------|-------------------------------|------------------------//------------>
0
19
50
100,000
Earlier you rated your own risk of having a heart attack as ______ on the scale above.
{insert respondent’s answer from earlier perceived risk question on page 6}
Now that you have learned this new information, where would you place your risk of
having a heart attack within the next year on this scale? ________
Enter an answer from 0 to 100000 [_______]
{If response is not between 0 and 100,000, an error message is shown}

[Next Question]
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{IV. Willingness to Pay Questions}
Suppose you go to your regular physician for a routine exam. During the exam, your
doctor says the following:
As part of your exam I am going to order some routine lab work. The results from these
tests will tell us your cholesterol level; however, I would also like to order a new test to
see if you have vulnerable plaque. Studies have shown that people who have LOW
cholesterol levels and NO other risk factors CAN STILL have a heart attack due to
vulnerable plaque. In fact, people who have heart attacks due to vulnerable plaque often
have no warning and show no symptoms of heart problems prior to the attack.
Nearly 50% of all heart attacks result in death. Therefore, it is very important to identify
those at risk, so that treatment can be given.
[Continue]
{Option 1: Treatment Version}
If this test indicates you have vulnerable plaque, then we can do further testing to
determine if treatment is necessary. If this test indicates you do not have vulnerable
plaque, then you will have the peace of mind from knowing that you are at significantly
lower risk of having a heart attack
{Randomize the following such that of those respondents who receive a “treatment”
version of the survey, half will be told that the treatment is 30% effective, while the other
half will be told that the treatment is 85% effective}
Currently, the standard treatment for vulnerable plaque is drug therapy, which is 30%
effective at reducing the occurrence of a heart attack.
{OR}
There is a new treatment available specifically for vulnerable plaque, which is 85%
effective at reducing the occurrence of a heart attack.
I recommend that you strongly consider having this test. In fact, I recommend that
everyone consider having this test as part of their annual exam or every time they have
their cholesterol checked.
Take a moment to think about what the information from this test would be worth to you.
Is there a benefit from finding out that you are NOT at high risk for a heart attack? On
the other hand, would you benefit from knowing that you ARE at increased risk of a heart
attack and could receive treatment?
[Continue]
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{Option 2: Non-Treatment Version}
Although there is currently NO TREATMENT for vulnerable plaque, the results of this
test would provide you with INFORMATION regarding your risk of having a heart
attack.
I recommend that you strongly consider having this test. In fact, I recommend that
everyone consider having this test as part of their annual exam or every time they have
their cholesterol checked.
Take a moment to think about what the information from this test would be worth to you.
Is there a benefit from finding out that you are NOT at high risk for a heart attack, such as
peace of mind? On the other hand, would you benefit from knowing that you ARE at
increased risk of a heart attack? Although TREATMENT IS NOT AVAILABLE, it
would provide information that may lead you to make different life decisions and allow
you to plan accordingly.
[Continue]

As you consider how much you would value knowing whether or not you are at increased
risk for a heart attack, we would like to make you aware of a problem that occurs in
surveys of this nature called “hypothetical bias.”
Hypothetical bias occurs when people say they will pay more for a particular good or
service than they actually do when paying for it out of their own pocket. For example,
someone may say in a survey that they would buy a pair of sunglasses, but then when
given the opportunity to buy the sunglasses, decide not to. That difference is what leads
to hypothetical bias.
[Continue]
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Studies have shown that “hypothetical bias” exists and that it can be quite large. In one
study, people were asked how much they would pay for therapy to manage a chronic
condition. The results of the study revealed that when the decision was hypothetical,
people said they would pay three times more than they actually chose to pay when the
decision was real. That’s quite a difference, isn’t it?
So, in considering what this blood test is worth to you in terms of the information it will
provide, please also consider that due to hypothetical bias you might be tempted to say
that it is worth more than you would actually pay if the decision to get this test were real.
Do you understand hypothetical bias?
Select on answer only
○ Yes
○ No, I would like further clarification
[Next Question]
{If respondent selects “No, I would like further clarification, then display the following
as the next screen, otherwise continue with the survey}
-----------------------------------------------------------------------------------------------------------Suppose as part of a marketing survey you were shown a pair of sunglasses and asked
whether you would purchase the sunglasses if they were priced at $12. After thinking
about it, you indicated on the survey that yes, you would purchase the sunglasses if they
cost $12.
Later the same day you are in a store and see the exact same sunglasses for sale. They
cost $12; however, you decided NOT to buy them. In this example, what you said you
would purchase was different from you actually chose to purchase. This is a very
common tendency and is called “hypothetical bias.” It occurs what when people say they
will purchase under hypothetical conditions differs from what they actually choose to
purchase under real circumstances.
Do you understand hypothetical bias?
Select one answer only
○ Yes
○ No {Even if they answer no, move on to next question}
[Next Question]
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Suppose you go to your doctor tomorrow and he/she tells you that a test for vulnerable
plaque is now available to you. It is a simple, but accurate blood test that will tell you
whether you are at increased risk for a heart attack. If you have to pay for it out of your
own pocket, how much would you be willing to spend? What is it worth to you?
Before you answer, please consider the following:
Approximately how many dollars per month do you already spend on medical care (not
including insurance premiums)?
Select one answer only
○ Less than $20.00 per month
○ $20.00 to $49.99 per month
○ $50.00 to $99.99 per month
○ $100.00 to $199.99 per month
○ $200.00 to $500.00 per month
○ More than $500.00 per month
○ Don’t know

[Next Question]
So ask yourself these two questions:
Based on what I am already spending for medical care, how much do I have
available to spend on this test?
If I were really faced with making this decision, would I actually pay out of my
own pocket to have this test? Would I really spend my money in this way?

[Continue]
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{***Iterative bidding process – computer will generate up to 5 bids based on the
respondent’s answers. See “Programming Notes on Iterative Bidding” on following
pages for algorithm and examples ***}
{First bid}
Now that you have considered all of these things,
If this blood test cost $______, would you choose to have it done?
Select one answer only
○ Yes
○

No
[Next Question]

{Bids 2-5}
If this blood test cost $______, would you choose to have it done?
Select one answer only
○ Yes
○

No
[Next Question]

{When presenting a $0 bid, add the word “FREE” so that it appears as “$0 (FREE)”}
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{Programming Notes on Iterative Bidding}
{The bidding question will be asked up to 5 times inserting “bids” according to the
following algorithm}
{The initial bid should vary randomly between $10, $40, $50, $60, and $100.}
{If the respondent says “Yes” to the initial bid, the second bid should be DOUBLE the
initial bid (if initial bid is $60, then second bid should be $120). As long as the
respondent says “yes”, continue to double the bid. If the respondent says “No” to the
initial bid, then HALF the initial bid to generate the next bid. Continue to reduce the bids
by HALF as long as the respondent answers “No”. }
{Once the respondent changes their response (from “yes” to “no” OR “no” to “yes”),
subsequent bids should be generated by splitting the difference between the highest “yes”
bid and lowest “no” bid.. For example, if the respondent says “Yes” to $50, but “No” to
$100, then the next bid should be $75 (100+50 divided by 2).}
{If this process does not lead to a number that is an increment of $5, then it should be
rounded DOWN. For example, if the respondent’s highest “yes” bid is $50 and their
lowest “no” bid is $75, then dividing the difference by 2 (50+75 = 125 /2 ) would yield
$62.50. This should be rounded down, so that the next bid is $60. (Because this survey is
asking about the respondent’s willingness to pay for a good, it seemed rounding down the
bids would be a more conservative approach). Since the computer program will most
likely not have a function to round down, this can be accomplished in the following way:
Divide the bid by 5 (62.5 / 5 = 12.5), truncate the result (to yield 12), and then remultiply by 5 (12*5=60). This method should work for all cases in which the bid does
not end in 5 or 0 (zero).
{The bidding process should stop once the response is within a $5 interval or a maximum
of 5 bids have been generated}
{Examples}
Example 1:
$50
Y (double bid from $50 to $100)
$100 Y (double bid from $100 to $200)
$200 N (split difference between $100 and $200)
$150 Y (split difference between $150 and $200)
$175 N
(go to option 3 on page 16 and report range of $150 to $175)
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Example 2:
$50
Y (double bid from $50 to $100)
$100 N (split difference between $50 and $100)
$75
Y (split difference between $75 and $100 and round down)
$85
Y (split difference between $85 and $100 and round down)
$90 N
(record WTP as $85 and go to page 17)
Example 3:
$40 N (divide $40 in half)
$20
Y (split difference between $20 and $40
$30
Y (split difference between $30 and $40)
$35 N
(STOP after 4 bids – record WTP as $30 and go to page 17)
{Extreme cases}
Example 4:
$60 N (divide bid in half)
$30 N (divide bid in half)
$15 N (divide bid in half and round down)
$5
N (divide bid in half and round down)
$0
Y
(record WTP as $0 and go to page 17)
Example 5:
$10
N (divide bid in half)
$5
N (divide bid in half and round down)
$0
N
(record as protest and go to page 16, option 1)
Example 6:
$50
Y (double bid)
$100 Y (double bid)
$200 Y (double bid )
$400 Y (double bid)
$800 Y
(For extremes with no upper bound, go to page 16, option 2)
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{Option 1}
{If a respondent answers “no” to a zero bid, then ask the following open-ended question}
Please tell us why you chose not to have the test even when it was offered for $0 (FREE)
[Continue]
{Direct respondent to Thank You screen and end survey}
{Option 2}
{If a respondent answers “yes” to all 5 bids, then ask the following:}
You indicated that you would pay more than $_____ {insert highest “yes” bid} for this
test. What is the most you would be willing to spend out of pocket for this test to find out
if you are at increased risk for a heart attack?
Enter dollar amount here [_________]

[Next Question]
{this response will be inserted into certainty question on page 17}
{Option 3}
{If the bidding process does not sufficiently converge the respondent’s WTP value to
within a $5 margin of error, then ask the following:}
You indicated that you would pay at least $______ {insert highest “yes” bid}, but less
than $_______{insert lowest “no” bid}.
What is the most you would be willing to spend out of pocket for this test to find out if
you are increased risk for a heart attack?
Enter dollar amount here [________]
[Next Question]
{this response will be inserted into certainty question on page 17}
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If you yourself have never experienced a heart problem, then this is probably the first
time that you have thought about how much you would value this type of test.
Therefore, it is reasonable to assume that you may not be entirely sure how much you
would really be willing to pay out of your own pocket to have it done.
On a scale of 0 to 10, where 0 is “not sure at all” and 10 is “definitely sure”
please indicate how sure you are that you would choose to get this potentially life
saving137 test if it cost $________ {insert respondent’s previously stated WTP}

Not Sure
At All

|------------------------------------------------------------------| Definitely
Sure
0
1
2
3
4
5
6
7
8
9
10

Enter your answer here [________]

[Next Question]
Earlier you said that you would pay $ _____ for this test. {insert previously stated WTP}
Now that you have had a chance to consider how sure you are about this decision, please
enter the amount you would definitely (beyond any doubt) pay for this test. $________

[Next Question]
How many times would you expect to have this test over the course of your lifetime?
Enter number here [______]

[Next Question]

137

“potentially life saving” was changed to “informative” in the non-treatment version of this survey
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{V. Demographic Questions}
To complete the survey, please answer a few questions about your background to help us
better understand which characteristics are important in making these kinds of health care
decisions.
In general would you say your health is:
Select one answer only
○

Excellent

○

Very Good

○

Good

○

Fair

○

Poor
[Next Question]

Is there anyone NOT living with you who is financially or otherwise dependent on you
(for example: child, elderly parent)
Select one answer only
○ Yes
○ No
[Next Question]
Do you have life insurance?
Select only one answer
○ Yes
○ No
○ I don’t know
[Next Question]
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Which of the following best describes how financially secure you feel your family would
be in the untimely event of your death?
Select one answer only
○ very secure
○ fairly secure
○ not very secure
[Next Question]

Thank you for taking this survey on willingness to pay for a testing method to better
determine who is at risk for heart attack. As you may have noticed, the proposed blood
test you were asked about is hypothetical; however, clinical research is currently being
done such that this type of test could become available in the near future. In fact, the
November 25, 2002 issue of U.S. News and World Report describes a blood test that
some researchers now believe can provide additional information on who is at risk for a
heart attack. Therefore, the results from this study could provide valuable information to
decision makers regarding the value that society would place on this blood test.
Thanks again for your participation in this important research.
[Continue]
Thinking about this topic, do you have any comments you would like to
share?
Any comments welcome!

[Continue]
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{Survey 2: Treatment}

{Notes appearing in {brackets} provide information for programming and do not
appear in the online version of the survey. Screen breaks are indicated by either
a page break, dashed line or solid line, the circles represent radio buttons, and
navigational buttons appearing in the bottom right-hand corner of each screen
are indicated by square brackets [ ]}

{I. Welcome Screen}
{1}

How important do you feel it is for your doctor to include you in making
decisions regarding your health?
Select one answer only
○ Very important
○ Somewhat important
○ Not important

[Next Question]
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{II. General Questions}
Medical advances are occurring at a rapid rate; however, this can increase the cost of
providing health care. Because of these rising costs, it becomes important to focus on
how society should allocate its health care resources. The following questions will assist
us in determining what is important to you. Specifically, we would like to ask how you
would spend your own money for a medical procedure that could possibly reduce your
risk of having a heart attack.

[Continue]
{2}

Have you ever been told by a doctor that you have heart disease?
Select one answer only
○ Yes
○

No

○

I don’t know

[Next Question]
{3}

Have you ever taken medicine to reduce your cholesterol (Some examples
include: Lipitor, Zocor, Mevacor, Pravachol)?
Select one answer only
○ Yes
○

No

○

I don’t know

[Next Question]
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{4}

Have you ever experienced a heart attack?
Select one answer only
○ Yes
○

No

[Next Question]
{5}

Do you have a relative in your immediate family (spouse, parent, sibling, or child)
who has experienced a heart attack?
Select one answer only
○ Yes
○

No

[Next Question]
----------------------------------------------------------------------------------------------------------{If respondent answers “Yes” to question 5, then ask question 5b}
{5b}

Were you involved in making decisions regarding the treatment of this
family member’s heart condition?
Select one answer only
○ Yes
○

No

[Next Question]
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{6}

Have you ever undergone a heart catheterization procedure?
Select one answer only
○ Yes
○

No

○

I don’t know

[Next Question]
{7}

Are you a cardiologist or other health care professional who has received specific
training in the treatment of heart disease?
Select one answer only
○ Yes
○

No

[Next Question]
{8}

Have you ever had a life-threatening condition or illness?
Select one answer only
○ Yes
○

No

[Next Question]
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{III. Quality of Life}
About half of the people who experience a heart attack die as a result. For those who
survive, the results can vary substantially – from “no difference” for some, to others who
are left permanently disabled to the point of being completely dependent on others.
Because a heart attack permanently damages the heart muscle, a majority of people who
survive a heart attack experience chronic symptoms such as chest pain, fatigue, and
shortness of breath. If you have experienced a heart attack or have a close friend or
relative who has, then you are probably already aware of how much these symptoms can
affect your everyday life.
[Continue]
The following table describes how a heart attack may affect your quality of life.
Chronic Symptoms:

Ability to Exercise:
Ability to Lift or engage in any
type of Physical Exertion:
Ability to Handle Stress:
Potential Hospitalization:
Work Attendance and
Performance:
Probability of Disability:
Probability of Recurrent Heart
Attack
Probability of Death:

Symptoms such as chest pain, fatigue, and/or shortness
of breath can occur anytime for no apparent reason,
but are especially likely during times of exertion or
stress.
Symptoms may become more severe during exercise
Symptoms may become more severe as a result of any
type of physical exertion (walking up stairs, carrying
groceries, etc.)
Symptoms may become more severe during times of
stress
Severe symptoms may lead to hospitalization and
possibly a heart catheterization procedure
Work attendance may be affected, and symptoms may
affect your ability to perform your job duties
Two-thirds of the people who experience a heart attack
do not make a full recovery
Individuals who experience a heart attack are at a
much greater risk of having another heart attack
About half of all heart attacks are fatal

As you can see, experiencing a heart attack can greatly affect your everyday life.
Please review this table carefully. In a moment we are going to ask you how these
symptoms might affect your life.
[Continue]
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{Option 1}
{If answer to question #4 is “No” then ask following}
Imagine that you experience a heart attack and survive. Take a moment to think
about how this could affect your quality of life. How much physical exertion is required
by your daily life and work? How would your condition affect your ability to handle the
stress you encounter during a typical day?
In the table below, please indicate to what extent each area of your life would be affected
by these symptoms.
-----------------------------------------------------------------------------------------------------------{Option 2}
{If answer to question #4 is “Yes” then ask the following}
Earlier in this survey, you indicated that you had experienced a heart attack. Therefore,
you know first hand the effect it can have. Please use the table below to indicate how
having a heart attack has affected your quality of life
-----------------------------------------------------------------------------------------------------------{Table below should appear for all respondents}
Not at all

Slightly

Moderately

Extremely

○

Quite a
bit
○

Ability to perform
daily functions

○

○

Ability to effectively
complete work duties

○

○

○

○

○

Ability to provide for
family

○

○

○

○

○

Overall quality of life

○

○

○

○

○

○

[Next Question]
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As someone familiar with heart problems, you are probably already aware of several
factors that place could place you at risk for a heart attack, including high blood pressure,
high cholesterol, obesity, diabetes, family history, or having had a prior heart attack
yourself.
[Continue]

Annual Risk of Fatality (Deaths per 100,000 persons)
No
Auto
High
Risk
Accident
Risk
|-----------------|-------------------------------|------------------------//------------>
0
19
50
100,000
Suppose you were asked to rate your risk of having a heart attack within the next year
using the scale above (0 being NO risk and 50 being HIGH risk). If your risk of dying in
a car accident within the next year is placed at 19, where would you place your risk of
having a heart attack?
Everybody’s individual risk is different. Although most people will have a risk in the
range of 0 to 50 some people (including those who have already experienced a heart
attack), may have a risk higher than 50
Using the above scale as a guide, enter the number that you believe best describes your
risk of having a heart attack in the next year. ______ {response will be inserted in
follow-up certainty question on page 28}
Enter an answer from 0 to 100000 [_______]
{If response is not between 0 and 100,000, an error message is shown}

[Next Question]
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New Information on the Primary Cause of Heart Attacks
At some point your doctor probably told you that having high cholesterol and a build up
of plaque within your arteries put you at higher risk for a heart attack; but what you may
not know is that recent medical research has revealed that this is not the whole story.
Researchers have discovered that atherosclerosis or what many of us know as “hardening
of the arteries” is NOT the primary cause of heart attacks. Instead, doctors now believe
that most heart attacks are caused by a certain type of plaque, called “vulnerable plaque.”
What is vulnerable plaque?
Vulnerable plaque is a “soft” plaque that lies hidden beneath the wall of the artery, much
like lava within a volcano. A trigger, such as stress, can cause the plaque to rupture.
When this happens the plaque enters the blood stream and causes a blood clot to form.
This clot can block the artery and prevent blood from flowing to the heart, which causes a
heart attack. Because this process happens so quickly, a person may not experience chest
pain or any other warning signs prior to the attack. Therefore, it is very important to
identify who has vulnerable plaque in order to prevent these heart attacks from occurring.
[Continue]
Identifying and Treating those with Vulnerable Plaque
It is hard to determine who has vulnerable plaque because it lies hidden within the walls
of the arteries. Even laboratory tests, such as those that measure good (HDL) and bad
(LDL) cholesterol cannot identify who has vulnerable plaque. The good news is that
medical research is currently being done to develop a way to detect and treat vulnerable
plaque. In the meantime, patients are typically treated using cholesterol lowering
medication. However, medication alone is only 30% effective at preventing heart
attacks.
Doctors now believe that vulnerable plaque causes 75% of all heart attacks. That is why
developing a new, more effective treatment is so important.
Who is at risk for a heart attack due to vulnerable plaque?
Anyone can have vulnerable plaque, but those who have coronary artery disease or other
risk factors like those mentioned earlier in this survey are thought to be at increased risk.
Because vulnerable plaques tend to be located in several places within the heart vessels,
those who have already experienced a heart attack are thought to be at even greater risk.
In fact, research suggests that over half of the people who have already experienced a
heart attack have at least one other vulnerable plaque that could erupt.
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[Continue]
After reading this new information, I feel my own risk of having a heart attack within the
next year is now
Select one answer only
○
○
○
○
○

much higher
somewhat higher
the same
somewhat lower
much lower

[Next Question]

Annual Risk of Fatality (Deaths per 100,000 persons)
No
Auto
High
Risk
Accident
Risk
|-----------------|-------------------------------|------------------------//------------>
0
19
50
100,000
Earlier you rated your own risk of having a heart attack as ______ on the scale above.
{insert respondent’s answer from earlier perceived risk question on page 26}
Now that you have learned this new information, where would you place your risk of
having a heart attack within the next year on this scale? ________
Enter an answer from 0 to 100000 [_______]
{If response is not between 0 and 100,000, an error message is shown}

[Next Question]

272

{IV. Selecting a Treatment }
Suppose you begin to experience chest pain. You immediately go see your regular
doctor.
Now suppose after some preliminary tests, your doctor tells you the following:
“Your tests indicate that you are at high risk for a heart attack. There
are two possible treatment options. The standard treatment for patients
with your condition has been to prescribe a cholesterol lowering
medication that you would take daily. However, medication alone is only
30% effective at reducing the occurrence of a heart attack.
“Recently, a new treatment has been developed that is more effective.
This treatment involves taking the medication I just described and having
a minimally invasive procedure. Having this procedure in addition to
taking the medication will reduce your risk of having a heart attack by
85%. The procedure does have a very small risk of death associated with
it – about 10 people out of 100,000 who have this procedure die from
medical complications. To put this in perspective, your risk of dying in a
car accident each year is about twice this high or 19 out of 100,000.
[Continue]
“Even though your tests indicate that you are at high risk for having a
heart attack, these tests are not perfect. Performing this procedure would
give us additional information regarding your actual risk. If, during the
procedure, we determine that you are at risk, we can treat you as part of
the same procedure. This procedure could require an overnight stay at the
hospital, but if we determine you are not at risk, you will most likely go
home the same day. Beyond this, no additional recovery time is
necessary. Therefore, once you return home, you should be able to return
to work and your regular routine right away.
“About 50% of heart attacks are fatal. For those who do survive, a heart
attack can greatly reduce an individual’s quality of life. Chest pain,
fatigue, and shortness of breath can greatly diminish your ability to
perform your work duties and can greatly affect your daily routine. Your
tests have indicated that you are at high risk for a heart attack.
Having this procedure would allow us to determine your actual risk with
much more certainty (my typo) and permit us to treat you if necessary.
Therefore, performing this procedure could dramatically increase your
chances of avoiding a fatal or disabling heart attack.”
[Continue]

273

You seek a second opinion and another trusted physician recommends the
same procedure. So, two physicians, including your regular doctor, agree
that you should strongly consider having BOTH the procedure and
medication
Medication
Only
Procedure
and
Medication

30% effective
85% effective
additional risk of death: 10/100,000

Based on the risk and effectiveness of each treatment option, which would
you choose?
Select one answer only
○ Procedure and Medication {Go to page 33}
○

Medication Only {Go to demographic questions}

○

Not sure, I would like more information before deciding {Go to next page}

[Next Question]
------------------------------------------------------------------------------------------------------------

274

{If respondent chooses “Not sure, I would like more information before deciding” then
show the information on the this page and the next as the next two screens}
Because you requested additional information, the doctor who would be performing the
procedure comes in to provide you with more detailed information.
Suppose the doctor tells you the following:
“This is a minimally invasive procedure that involves making a small
incision in your upper thigh so that a very thin flexible tube, called a heart
catheter, can be threaded through the vessel up to the coronary arteries.
This tube will allow me to “see” into the vessel to determine if you have
vulnerable plaque. If vulnerable plaque is found, then I can go ahead and
treat the area as part of the same procedure using a heart catheter designed
specifically for treatment.
“This procedure is very similar to the procedure used to place a stent or to
perform angioplasty. As with those procedures, you will be given a light
sedative to relax you, although you will remain awake throughout the
procedure. However, you will NOT experience any “chest tightness” that
is often experienced with angioplasty or placing a stent. In fact, during
this procedure you should not experience any pain, although you may feel
a little discomfort at times. Following this procedure, you may have to
stay overnight in the hospital for observation. However, if there are no
complications, this will be done on an outpatient basis and you will be
able to return to work and your normal routine the next day.
[Continue]
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{continued from the previous page – screen should only be shown if the
respondent chooses “Not sure, I would like more information before deciding” to
the treatment question on page 30}
“I agree with your regular doctor that given your previous tests which
indicate you are at high risk for a future heart attack, this is the best course
of treatment. Having this procedure in addition to taking medication
reduces your risk of a future heart attack by 85%, compared to a 30%
reduction from taking medication alone. This procedure does have a small
risk of death. About 10 people out of 100,000 who have this procedure
die from medical complications. However, because your test results
indicate that you are at high risk for a heart attack, you are probably at a
greater risk of dying if we do not perform this procedure.
Medication
Only
Procedure
and
Medication

30% effective
85% effective
additional risk of death: 10/100,000

Based on the risk and effectiveness of each treatment option, which would you
choose?
Select one answer only
○

Procedure and Medication {Go to next page}

○

Medication Only {Go to demographic questions}
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Again, take a moment to think about how having a disabling or fatal heart attack might
affect your life and that of your family. This procedure can greatly reduce your chances
of having a heart attack. Think about what that is worth to you and how much you would
value this procedure.
As you consider how much this procedure would benefit you by reducing your chances of
having a heart attack, we would like to make you aware of a problem that occurs in
surveys of this nature called “hypothetical bias.”
Hypothetical bias occurs when people say they will pay more for a particular good or
service than they actually do when paying for it out of their own pocket. For example,
someone may say in a survey that they would buy a pair of sunglasses, but then when
given the opportunity to buy the sunglasses, decide not to. That difference is what leads
to hypothetical bias.
[Continue]
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Studies have shown that “hypothetical bias” exists and that it can be quite large. In one
study, people were asked how much they would pay for therapy to manage a chronic
condition. The results of the study revealed that when the decision was hypothetical,
people said they would pay three times more than they actually chose to pay when the
decision was real. That’s quite a difference, isn’t it?
So, in considering what this procedure is worth to you in terms of the reduction in the risk
of heart attack, please also consider that due to hypothetical bias you might be tempted to
say that it is worth more than you would actually pay if the decision to have this
procedure were real.
Do you feel you understand hypothetical bias?
Select on answer only
○ Yes
○ No, I would like further clarification
{If they respond with “No, I would like further clarification, then display the following as
the next screen, otherwise continue with the survey}
-----------------------------------------------------------------------------------------------------------Suppose as part of a marketing survey you were shown a pair of sunglasses and asked
whether you would purchase the sunglasses if they were priced at $12. After thinking
about it, you indicated on the survey that yes, you would purchase the sunglasses if they
cost $12.
Later the same day you are in a store and see the exact same sunglasses for sale. They
cost $12; however, you decided NOT to buy them. In this example, what you said you
would purchase was different from you actually chose to purchase. This is a very
common tendency and is called “hypothetical bias.” It occurs what when people say they
will purchase under hypothetical conditions differs from what they actually choose to
purchase under real circumstances.
Do you understand hypothetical bias?
Select one answer only
○ Yes
○ No {Even if they answer no, move on to next question}
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Suppose you experience chest pain tomorrow. You go to your doctor and he/she tells you
about your treatment options. You choose to have the new procedure because it could
reduce your risk of having a heart attack. If you have to pay for it out of your own
pocket, how much would you be willing to spend? What is it worth to you?
Before you answer, please consider the following:
Approximately how many dollars per month do you already spend on medical care (not
including insurance premiums)?
Select one answer only
○ Less than $20.00 per month
○ $20.00 to $49.99 per month
○ $50.00 to $99.99 per month
○ $100.00 to $199.99 per month
○ $200.00 to $500.00 per month
○ More than $500.00 per month
○ Don’t know

[Next Question]
Which category best describes how much you currently have in savings?
Select one answer only
○ Less than $2,500
○ $2,500 – $10,000
○ $10,000 - $24,999
○ $25,000 - $50,000
○ $50,000 - $100,000
○ more than $100,000

[Next Question]
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So ask yourself these two questions:
Based on what I am already spending for medical care, how much do I have
available to spend on this procedure?
If I were really faced with making this decision, would I actually pay out of my
own pocket to have this procedure? Would I really spend my money in this way?

[Continue]
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{***Iterative bidding process – computer will generate up to 5 bids based on the
respondent’s answers. Follows same “Programming Notes on Iterative Bidding” as
used in Survey 1: Screening with the following exceptions: }
{The initial bid should vary randomly between $1,000; $2,000; $5,000; $8,000; and
$10,000}
{The bidding process should stop once the response is within a $100 interval or a
maximum of 5 bids have been generated}
{First bid}
Now that you have considered all of these things,
If the procedure costs $______, would you choose to have it done?
Select one answer only
○ Yes
○

No
[Next Question]

{Bids 2-5}
If the procedure costs $______, would you choose to have it done?
Select one answer only
○ Yes
○

No
[Next Question]

{When presenting a $0 bid, add the word “FREE” so that it appears as “$0 (FREE)
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{Examples}
Example 1:
$1,000 – N (divide bid in half)
$500 – Y (split difference between $500 and $1,000 and round down to nearest $100)
$700 – N (split difference between $500 and $600)
$600 – Y
(STOP after 4 bids – record WTP as $600 and go to page 40)
Example 2:
$2,000 – N (divide bid in half)
$1,000 – Y (split difference between $1,000 and $2,000)
$1,500 – Y (split difference between $1,500 and $2,000 and round down)
$1,700 – N (split difference between $1,500 and $1,700)
$1,600 – Y
(record WTP as 1,600 and go to page 40)
Example 3:
$5,000 – Y (double bid)
$10,000 – Y (double bid)
$20,000 – N (split difference between $10,000 and $20,000)
$15,000 – N (split difference between $10,000 and $15,000)
$12,500 – N
(go to option 2 on page 39 and report range of $10,000 to $12,500)
{Option 1}
{If respondent answers “no” to a zero bid, then ask the following open-ended questions}
Please tell us why you chose not to have the procedure even if it were offered for $0
(FREE)
{Direct respondent to Thank you screen and end of survey}
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{Option 2}
{If the bidding process does not sufficiently converge the respondent’s WTP value to
within a $100 margin of error, then ask the following:}
You indicated that you would pay at least $______ {insert highest “yes” bid}, but less
than $_______{insert lowest “no” bid}.
What is the most you would be willing to spend out of pocket for this new procedure that
could significantly reduce your risk of a future heart attack?
Enter dollar amount here [________]
[Next Question]
{Option 3}
{If a respondent answers “yes” to all 5 bids, then ask the following:}
You indicated that you would pay more than $_____ {insert highest “yes” bid} for this
procedure.
What is the most you would be willing to spend out of pocket for this new procedure that
could significantly reduce your risk of a future heart attack?
Enter dollar amount here [_________]
[Next Question]
{Option 4}
{If a respondent answers “no” to all 5 bids, then ask the following:}
You indicated that you would NOT be willing to pay $_____ {insert lowest “no” bid} for
this procedure.
How much would you be willing to spend out of pocket for this new procedure that could
significantly reduce your risk of a future heart attack?
Enter dollar amount here [_________]
[Next Question]
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If you yourself have never experienced a heart problem, then this is probably the first
time that you have thought about how much you would value this type of procedure.
Therefore, it is reasonable to assume that you may not be entirely sure how much you
would really be willing to pay out of your own pocket to have it done.
On a scale of 0 to 10, where 0 is “not sure at all” and 10 is “definitely sure”
please indicate how sure you are that you would choose to get this potentially life saving
procedure if it cost $________ {insert respondent’s previously stated WTP}

Not Sure
At All

|------------------------------------------------------------------| Definitely
Sure
0
1
2
3
4
5
6
7
8
9
10

Enter your answer here [________]

[Next Question]
Earlier you said that you would pay $ _____ for this procedure. {insert respondent’s
previously stated WTP}
Now that you have had a chance to consider how sure you are about this decision, please
enter the amount you would definitely (beyond any doubt) pay for this procedure.
$________

[Next Question]
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{V. Demographic Questions}
To complete the survey, please answer a few questions about your background to help us
better understand which characteristics are important in making these kinds of health care
decisions.
In general would you say your health is:
Select one answer only
○

Excellent

○

Very Good

○

Good

○

Fair

○

Poor
[Next Question]

Is there anyone NOT living with you who is financially or otherwise dependent on you
(for example: child, elderly parent)
Select one answer only
○ Yes
○ No
[Next Question]
Do you have life insurance?
Select only one answer
○ Yes
○ No
○ I don’t know
[Next Question]
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Which of the following best describes how financially secure you feel your family would
be in the untimely event of your death?
Select one answer only
○ very secure
○ fairly secure
○ not very secure
[Next Question]

Thank you for taking this survey on willingness to pay for a more effective treatment
method. As you may have noticed, the proposed treatment method you were asked about
is hypothetical; however, clinical research is currently being done such that this type of
procedure could become available in the near future. Therefore, the results from this
study could provide valuable information to decision makers regarding the value that
society would place on a procedure that would reduce the occurrence of heart attacks.
Thanks again for your participation in this important research.
[Continue]
Thinking about this topic, do you have any comments you would like to
share?
Any comments welcome!

[Continue]
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Appendix B: Key Statistics from Focus Groups
Focus Group #1 Screening / Paper version
This focus group included 6 individuals between the ages of 31-47.

1
2
3
4
5
6

# Risk Perceived
Factors Risk
(initial)
2
40
5
10
3
12
2
5
2
5
2
2

Mean Initial WTP = $146.67
Mean Final WTP = $109.17

Perceived
Risk (w/
new info)
60
10
15
15
7
18

Initial
WTP

Certainty
(scale 0-10)

Final
WTP

Certainty

500
0
100
200
50
30

8
10
6
10
3
9

350
0
25
200
50
30

Yes, definitely
Yes, probably
Yes, definitely
Yes, definitely
Yes, probably
Yes, probably

Median = $75
Median = $40

Max = $500
Max = $350

Min = $0
Min = $0

Change in mean WTP (after certainty question) = - $37.50 (25.6% decrease)
The mean for the Initial WTP for the screening was $146.67. However, after
participants had an opportunity to assess the certainty of their initial WTP amount and
then revise their stated WTP, the mean (Final WTP) for screening fell to $109.17.
Therefore, the certainty question led to a $37.50 (25.6%) decrease in the mean WTP for
the screening test.
The responses given by the focus group to the open-format WTP question in this
survey helped establish the starting bids that were used in the online version of Survey 1:
Screening. Since the mean was more likely to be influenced by a single response, the
median was used as a guide in establishing the starting bids of $10, $40, $50, $60, $100.
The computer algorithm used to generate the bids would either double the
previous bid or half it (depending on the answer given by the respondent); therefore,
these starting points also allowed the 5 possible bids to cover a range of values from $0$1600, which more than covers the range of values ($0-$500) given by the focus group
participants.
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Focus Group #2 Treatment / Paper Version
This focus group included 4 individuals between the ages of 36-49.

1
2
3
4

Perceive
d Risk
(initial)
40
10
12
5

Perceived
Risk (w/
new info)
60
10
15
15

Mean WTP1 = $9,500
Mean WTP2 = $13,250

Initial
WTP

Certainty
(scale 0-10)

Final
WTP

Certainty

2,000
10,000
1,000
25,000

10
10
10
5

2,000
25,000
1,000
25,000+

Yes, definitely
Yes, definitely
Yes, definitely
Yes, definitely

Median = $6,000
Median = $13,500

Min = $1,000 Max = $25,000
Min = $1,000 Max = $25,000

Change in mean WTP (after certainty question) = $3,750 (28.3% increase)
The mean for the Initial WTP for the procedure was $9,500. However, after
participants had an opportunity to assess the certainty of their initial WTP amount and
then revise their stated WTP, the mean (Final WTP) for the procedure increased to
$13,250. Although the certainty question was originally designed to help prevent the
possibility of hypothetical bias (and therefore was expected to lead to a reduction in the
mean WTP); the certainty question in this case had the opposite effect. Although this
may at first glance seem problematic; when the participant’s reasoning (which was given
during the focus group) is considered, it actually lends credibility not only to the validity
of their final stated WTP, but also to the inclusion of the certainty question.
The participant who increased their maximum WTP from $10,000 to $25,000
indicated that answering the certainty question gave her an opportunity to reflect and
compare this purchase decision to other large purchases she has made, such as buying a
car. She said “while I was thinking about how certain I was of the value I put down, I
began to consider how much would I pay for a car, or a mortgage payment? My life is
worth more than those things, so I realized I would sell my car or take out a second
mortgage to pay for this.” The other participant who stated they would pay $25,000 said
“I’ve had a life threatening disease and when it comes down to it, your life is worth
everything. When it comes down to your life, raising your children, and seeing your
children grow up, wouldn’t you take out a mortgage? You’d do almost anything to live.”
Therefore, these comments suggest that the inclusion of the certainty question gave the
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individuals an opportunity to compare this decision to other large purchase decisions they
have made in the past, such as the purchase of a car. By asking them about their certainty
level, it also gave them an opportunity to consider additional sources of income that
could be used to finance the cost of the procedure, such as refinancing their home or
asking family members for help.
In addition, the focus group discussion indicated that participants thought about
quality of life. Many participants said the warm-up questions made them think about
how a heart attack would affect their life. Their comments also clearly indicated that they
were considering their budget constraint. One participants made the comparison of
“What is my life worth? Versus what can I afford?” and all the participants seemed to
know exactly where they were going to get the money they said they would spend for the
procedure. As one participant said “your part on hypothetical bias really made me think
about that more seriously. Because you put that information in there it made you say
‘o.k. I’m not just going to throw down a number.’”
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Appendix C: Informed Consent
{Informed Consent Screen for Survey 1: Screening}
You are invited to participate in an important study concerning a potential new screening
test to better identify who is at risk for a heart attack. Researchers at the University of
Kentucky are conducting it. It will take about 10-15 minutes to complete.
If you agree to participate in the University of Kentucky study, we think that you will
find the study interesting.
Part one contains questions about your perceived risk of having a heart attack and
what you might be willing to pay for a screening test that would provide more
information about your risk
Part two contains background questions about you and your feelings.
You have the right to skip any questions you don’t want to answer. You also have the
right to withdraw from the study at any time without penalty. The potential risk to
respondents from completing the survey is minimal. The benefit from completing this
survey is that you will be contributing to research on how people value a potential new
screening test that could help identify individuals at risk for a heart attack.
Participation is completely voluntary. As always, your identity will be unknown to
anyone looking at the data from the study. All of the conditions and terms described in
the “Knowledge Networks, Inc. Privacy & Terms of Use Policy” document that you
received when you got your WebTV equipment apply to the University of Kentucky
study. If you have questions about the study you may contact the investigator, Patricia
Ryan at 508-740-9941. She is being guided in this research by Dr. Glenn Blomquist. If
you have questions about your rights as a participant in the University of Kentucky study,
or are dissatisfied with any aspect of it, you may contact the Office of Research Integrity
at the University of Kentucky at 859-257-9428 or toll free at 1-866-400-9428.
Would you like to participate in the University of Kentucky’s survey? (If you say “No”
you will be directed to a different survey.)
Select one answer only
○ Yes
○ No
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{Informed Consent Screen for Survey 2: Treatment}
You are invited to participate in an important study concerning a potential new medical
treatment for patients with heart disease. You have been chosen for this study because
you indicated in a previous survey that you have a doctor-diagnosed heart problem.
Researchers at the University of Kentucky are conducting it. It will take about 10-15
minutes to complete.
If you agree to participate in the University of Kentucky study, we think that you will
find the study interesting.
Part one contains questions about how you feel having a heart attack would affect
your quality of life and then asks what you would be willing to pay for a potential
new medical procedure that could reduce your risk of having a heart attack.
Part two contains background questions about you and your feelings.
You have the right to skip any questions you don’t want to answer. You also have the
right to withdraw from the study at any time without penalty. The potential risk to
respondents from completing the survey is minimal. The benefit from completing this
survey is that you will be contributing to research on the value people place on a potential
new medical procedure that could reduce the occurrence of heart attacks.
Participation is completely voluntary. As always, your identity will be unknown to
anyone looking at the data from the study. All of the conditions and terms described in
the “Knowledge Networks, Inc. Privacy & Terms of Use Policy” document that you
received when you got your WebTV equipment apply to the University of Kentucky
study. If you have questions about the study you may contact the investigator, Patricia
Ryan at 508-740-9941. She is being guided in this research by Dr. Glenn Blomquist. If
you have questions about your rights as a participant in the University of Kentucky study,
or are dissatisfied with any aspect of it, you may contact the Office of Research Integrity
at the University of Kentucky at 859-257-9428 or toll free at 1-866-400-9428.
Would you like to participate in the University of Kentucky’s survey? (If you say “No”
you will be directed to a different survey.)
Select one answer only
○ Yes
○ No
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Appendix D: Survey Variables and Data Assignment

Survey 1: Screening Data
General health assigned for item non-response (data obtained from KN health data):
serial #88 = 1 (poor) serial #227=2 (fair); designated by genHEALTHassign==1
Stress missing for serial #116, 541, 545, 384, 552, 464, 243, 548, 496, 424, 368. All
assigned mean =2.700389; Identified by Stressassign=1 (0 otherwise)
Serial #431 originally had 10 for number of risk factors. Since 2 risk factors are mutually
exclusive, this would have meant that this individual said “yes” to every possible item
that applied to them. A check of the data file revealed that this respondent selected yes
for everything except r6 (low HDL). The respondent is a 25 year old female; therefore r1
(male over 55) and r2 (female over55) were changed to =0. Other information about the
respondent’s medical history was checked and changes were made accordingly. Family
history of heart problem was confirmed, smoking environment could not be confirmed or
denied, so it was left as r4=1, health data indicated that individual did not have diabetes
or high cholesterol, so r5, r6, and r7 changed to =0. Health data on frequency of exercise
indicates that individual exercises on a regular basis, so r8 (less than 20 minutes physical
activity per day) changed to =0; individual has not had a heart attack (q4) and does not
have coronary heart disease (q2), so r10 changed =0. Amount over BMI = 7.1, so r9 left
as=1. In the end, r1, r2, r5, r6, r7, r8, r10, r11=0 and r3, r4, r9 =1 for this observation.
Changes to serial #431 prompted an internal check that revealed others had marked both
r1 (male over 45) and r2 (female over 55). All were women, many of whom were
elderly, so it is likely that they just saw “over 45” and checked the first box even though
they are not “males over 45” After confirming their gender with panel data from KN, r1
was changed to =0 for serial #230 (66 year old female), 342 (50 year old female)*, 237
(63 year old female), 530 (65 year old female), and 458 (58 year old female). Number of
risk factors was also adjusted accordingly.
Two additional observations selected “are you a man over 45” when they are actually
women and answered “no” to “are you a woman over 55.” Both are females in their 70’s,
who again, may not have read very carefully. Since information on their actual gender
and age was available from KN, these risk factors were adjusted to match, such that for
serial #249 (71 year old female) and #277 (72 year old female), r1 was changed to =0 and
r2 was changed to =1. Number of risk factors was also adjusted accordingly.
Serial #234 did not answer either perceived risk question; however, the respondent did
indicate that the new information did not change their risk of having a heart attack.
Therefore, initial perceive risk was assigned the sample mean = 15.07491. Since the
individual indicated their risk did not change, perceived risk was also set equal to
15.07490, such that no change occurred between these two measures, as the respondent
indicated.
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Survey 2: Treatment Data
General health assigned for item non-response (data obtained from KN health data):
serial #1245 = 2 (fair); designated by genHEALTHassign==1 (=0 otherwise)
Exercise missing for serial #1038 and 1360. Both assigned mean =1.924915; designated
by ExerciseassignMEAN=1 (0 otherwise)
BMI and amount over BMI (AMToverBMI) missing for serial #1244, 1430, 1410, 1036,
1206. All assigned mean BMI = 29.21379 and mean AMToverBMI=4.917241;
Identified by BMIassignMEAN=1 and AMToverBMIassignMEAN=1 (0 otherwise)
Frequency of MD visits (freqMDvisits) missing for serial #1023 and 1022. Both
assigned mean = 3.204778; Identified by freqMDvisitsassignMEAN=1 (0 otherwise)
Perceived risk (perRISK) missing for serial #1233 and 1317. Both assigned mean =
30.21502; Identified by perRISKassignMEAN=1 (0 otherwise)
Quality of life after MI (QUALpostMI) missing for serial #1219, 1214, 1129, and 1334.
All assigned mean = 2.116838. Designated by QUALpostMIassignMEAN=1 (0
otherwise)
SECURE missing for serial #1364, 1308, 1466, 1299, 1245, and 1439. All assigned
mean= 2.062284; Identified by SECUREassignMEAN=1 (0 otherwise)
WTP for serial # 1220 changed from $65,000 to $6,500. While looking at some
observations that were potential outliers (top 95%), it was discovered that this individual
answered “yes” to a bid of $6,000 and “no” to both a bid of both $7,000 and $8,000.
Therefore, based on the responses to the bidding, it is highly likely that when this
individual was asked to enter the amount they were WTP, they accidentally hit an extra
zero and entered $65,000 instead of the intended amount of $6,500. Given that this
individual has a household income of $25,000 with savings of $6,250 and is over the age
of 75 (and may have poor eyesight or not be as familiar using the computer), it seems
much more reasonable that this respondent was attempting to enter 6500 and not 65000
as their WTP. Therefore, the WTP for this observation was changed to correct for this
likely data entry error.
Assigned mean (78.12351) for medical spending to 28 observations (27 “I don’t know”
and 1 skipped/refused)
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Indicates if panel member replied to the survey invitation
Indicates if this was a resumed interview (100 minutes or more) 0=no, 1=yes
Indicates if panel member agreed to the consent screen 0=no, 1=yes
Date interview started
Time interview started
Date interview ended
Time interview ended
Duration of interview in minutes
Final post-stratification weight

Q1
Q2
Q3
Q4
Q5
Q5B
Q6
Q7
Q8

How important do you feel it is for your doctor to include you in making decisions regarding your health?
Have you ever been told by a doctor that you have heart disease?
Have you ever taken medicine to reduce your cholesterol?
Have you ever experienced a heart attack?
Do you have a relative in your immediate family who has experienced a heart attack?
Were you involved in making decisions regarding the treatment of this family member's heart condition?
Have you ever undergone a heart catheterization procedure?
Are you a cardiologist or other health care professional who has received specific training in the treatment of heart disease?
Have you ever had a life-threatening condition or illness?

GENERAL QUESTIONS FOR BOTH SURVEYS

RESPOND
RESUME
CONSENT2
DT_START
TM_START
DT_END
TM_END
DURATION
WEIGHT
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Indicates which version (regular or alternate text) that was randomly selected for respondent to receive
Indicates which version of the regular text (30% or 85% effectiveness rate for treatment) that was randomly selected

Q13
Q14
Q15

Q10
Q11
Q12

Using the above scale as a guide, enter the number that best describes your risk of having a heart attack in the next year.
After reading this new information, I feel my own risk of having a heart attack within the next year is now…
Now that you have learned this new information, where would you place your risk of having a heart attack within the next year on this
scale?
Do you understand hypothetical bias?
Do you understand hypothetical bias? (after additional information with example)
Approximately how many dollars per month do you already spend on medical care (not including insurance premiums)?

RISK FACTORS
Q9_1
Are you a man over 45 years old?
Q9_2
Are you a woman over 55 years old, OR Are you a woman less than 55, who has passed menopause OR Are you a woman less than 55,
who has had her ovaries removed, but is not taking estrogen?
Q9_3
Did your father or brother have a heart attack before age 55 OR Did your mother or sister have a heart attack before age 65?
Q9_4
Do you smoke, or live or work with people who smoke every day?
Q9_5
Is your total cholesterol level 240mg/dL or higher, OR Have you ever been told by your doctor that you have high cholesterol?
Q9_6
Is your HDL ("good") cholesterol level less than 35mg/dL?
Q9_7
Is your blood pressure 140/90 mm Hg or higher, OR have your been told that your blood pressure is too high?
Q9_8
Do you get less than a total of 30 minutes of physical activity on most days?
Q9_9
Are you 20 pounds or more overweight for your height and build?
Q9_10
Do you have diabetes OR a fasting blood sugar of 126mg/dL or higher, OR do you need medicine to control your blood sugar?
Q9_11
Do you have coronary heart disease, or have you had a heart attack?

VER
REGVER

SURVEY 1

296
highest bid - includes all bids and questions 17 and 18

On a scale of 0 to 10, where 0 is "not sure at all" and 10 is "definitely sure" please indicate how sure you are that you would choose to get
this potentially life saving test if it cost $______ {insert highest bid}
Now that you have had a chance to consider how sure you are about this decision, please enter the amount you would definitely (beyond
any doubt) pay for this test.
How many times would you expect to have this test over the course of your lifetime?
In general would you say your health is
Is there anyone NOT living with you who is financially or otherwise dependent on you?
Do you have life insurance?
Which of the following best describes how financially secure you feel your family would be in the untimely event of your death?

HIGHEST

Q19

Q21
Q22
Q23
Q24
Q25

Q20

Q18

You indicated that you would pay more than $_____ {insert highest yes bid} for this test. What is the most you would be willing to spend
out of pocket for this test to find out if you are at increased risk for a heart attack? What is the most you would be willing to spend out of
pocket for this test to find out if you are at increased risk for a heart attack?
You indicated you would pay at least $_____, but less than $_____. What is the most you would be willing to spend out of pocket for this
test to find out if you are at increased risk for a heart attack?

lowest no bid
highest yes bid

LOWNO
HIGHYES

Q17

If this blood test cost $_____, would you choose to have it done?
Randomly generated first bid (10, 40, 50, 60, 100)
Response to Bid 1
Bid 2 based on response to first bid (doubles or halves)
Response to Bid 2
Bid 3 based on previous responses to bids 1 and 2
Response to Bid 3
Bid 4 based on previous responses to bids 1-3
Response to Bid 4
Bid 5 based on previous responses to bids 1-4
Response to Bid 5

BID1
BID1RESP
BID2
BID2RESP
BID3
BID3RESP
BID4
BID4RESP
BID5
BID5RESP

ITERATIVE BIDDING
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Using the above scale as a guide, enter the number that you believe best describes your risk of having a heart attack in the next year

After reading this new information, I feel my own risk of having a heart attack within the next year is now
Now that you have learned this new information, where would you place your risk of having a heart attack within the next year on this
scale?
Based on the risk and effectiveness of each treatment option, which would you choose?
Based on the risk and effectiveness of each treatment option, which would you choose? (after additional information)
Do you feel you understand hypothetical bias?
Do you understand hypothetical bias? (after additional information)
Approximately how many dollars per month do you already spend on medical care (not including insurance premiums)
What category best describes how much you currently have in savings?

Q10

Q11
Q12

Q13
Q14
Q15
Q16
Q17
Q18

Please use the table below to indicate how having a heart attack has affected your quality of life
Ability to perform daily functions
Ability to effectively complete work duties
Ability to provide for family
Overall quality of life

Q9b_1
Q9b_2
Q9b_3
Q9b_4

QUALITY OF LIFE
Imagine that you experience a heart attack and survive. Take a moment to think about how this could affect your quality of life…
Q9a_1
Ability to perform daily functions
Q9a_2
Ability to effectively complete work duties
Q9a_3
Ability to provide for family
Q9a_4
Overall quality of life

SURVEY 2
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On a scale of 0 to 10, where 0 is "not sure at all" and 10 is "definitely sure" please indicate how sure you are that you would
choose to get this potentially life saving procedure if it cost $
Now that you have had a chance to consider how sure you are about this decision, please enter that amount that you would
definitely (beyond any doubt) pay for this procedure
In general would you say your health is
Is there anyone NOT living with you who is financially or otherwise dependent on you
Do you have insurance
Which of the following best describes how financially secure you feel your family would be in the untimely event of your death?

Q24

Q27
Q28
Q29
Q30

Q25

Highest bid - includes questions 21-23

HIGHEST

Q23

Q22

You indicate that you would pay at least $_____, but less than $_____. What is the most you would be willing to spend out of pocket for
this new procedure that could significantly reduce your risk of a future heart attack?
You indicated that you would be willing to pay more than $____ for this procedure {highest bid}. What is the most you would be willing to
spend out of pocket for this new procedure that could significantly reduce your risk of a future heart attack
You indicated you would NOT be willing to pay $ ____ {lowest bid} for this procedure. How much would you be willing to spend out of
pocket for this new procedure that could significantly reduce your risk of a future heart attack?

lowest no bid
high yes bid

LOWNO
HIGHYES

Q21

If the procedure cost $_____, would you choose to have it done?
Randomly generated first bid (1000, 2000, 5000, 8000, 10000)
Response to Bid 1
Bid 2 based on response to first bid (doubles or halves)
Response to Bid 2
Bid 3 based on previous responses to bids 1 and 2
Response to Bid 3
Bid 4 based on previous responses to bids 1-3
Response to Bid 4
Bid 5 based on previous responses to bids 1-4
Response to Bid 5

BID1
BID1RESP
BID2
BID2RESP
BID3
BID3RESP
BID4
BID4RESP
BID5
BID5RESP

ITERATIVE BIDDING
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PPAGE
PPAGECT4
PPAGECAT
PPDUALIN
PPEDUC
PPEDUCAT
PPETH
PPGENDER
PPHHHEAD
PPHHSIZE
PPHOUSE
PPINCIMP
PPMARIT
PPMSACAT
PPREG4
PPREG9
PPRENT
PPSTATEN
PPT01
PPT1317
PPT18OV
PPT25
PPT612
PPWORK
PPHE0003
PPHE0004
PPHE0005
PPHE0006
PPHE0007
PPHE0014
PPHE0015
PPHE0088
PPHE0149
PPHE0151
PPHE0153
PPHECHOL
PPHEDIAB
PPHEHPRB
PPHEHYPE
PPHE_BMI

Age
Age - 4 categories
Age - 7 categories
Dual income hh
Education (highest degree received)
Education (categorical)
Race / ethnicity
Gender
Household head
Household size
Housing type
Household income
Marital status
MSA status
Region 4 - based on state of residence
Region 9 - based on state of residence
Ownership status of living quarters
State
Presence of household members - children under 2
Presence of household members - children 13-17
Presence of household members - adults 18+
Presence of household members - children 2-5
Presence of household members - children 6-12
Current employment status
In general, would you say your health is …
Height 1 (feet)
Height 2 (inches)
How much do you weight without shoes?
During an average week, how often do you exercise?
How much stress, strain, or pressure have you been under during the past few months?
Compared to the last few years, would you say that your stress level is better?
How often do you go to a doctor's office or medical clinical for treatment of any ...
What kind of medicine are you taking? - heart problem or disease
What kind of medicine are you taking? - high cholesterol
What kind of medicine are you taking? - hypertension
Derived: has r ever had high cholesterol? (doctor-diagnosed only)
Derived: has r ever had diabetes? (doctor-diagnosed only)
Derived: has r ever had heart problems or disease? (doctor-diagnosed only)
Derived: has r ever had hypertension? (doctor-diagnosed only?
Body mass index (bmi; weight x 704.5 in numerator)
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